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Lambs castrated and tail-docked (c+td) by tight rubber ring experience severe acute
pain lasting up to 3 hours. The use of behaviour to assess the severity of this pain has
been validated. Within 5-7 days of application of rubber rings to the neck of the
scrotum and the tail, chronic inflammatory lesions form at the sites of the rings.
These lesions take 6-7 weeks to heal and can become severely infected. The presence
of these chronic inflammatory lesions has been associated with the infrequent
expression of the behaviours used to assess acute pain from c+td. It has been
proposed that the occurrence of these behaviours is indicative of chronic
inflammatory pain, but the use of behaviour has not been validated for the
assessment of this pain. The aim of this thesis was to test the following hypotheses:
1. Lambs undergoing castration and tail-docking by tight rubber ring
experience chronic inflammatory pain for up to six weeks, in association
with chronically inflamed lesions.
2. The chronic inflammatory pain experienced by lambs is sufficient to induce
changes in their behaviour.
3. Quantification of these behavioural changes constitutes a valid measure of
the chronic inflammatory pain experienced by rubber ring castrated and tail-
docked lambs.
Two methods were used to determine the presence of chronic inflammatory pain.
The analgesic self-administration paradigm has been used as a means of investigating
the experience of chronic inflammatory pain in rats suffering from adjuvant induced
arthritis (AA). Similarly, in the studies reported in this thesis, the ability of RR c+td
lambs to self-administer a NSAID was used to determine the presence of chronic
inflammatory pain. Up-regulation of the synthesis of AVP and reduction in the
synthesis of CRH in the parvocellular portion of the hypothalamic paraventricular
nucleus (pPVN) has also been detected in rats with AA. Using in situ hybridisation
histochemistry, evidence of such changes in the control of the HPA axis were sought
in the present studies, to confirm the presence of chronic inflammatory pain in RR
c+td lambs. Throughout the self-administration and neurohistochemical studies, the
severity of chronic inflammatory lesions and the expression of potential 'pain'
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behaviours were recorded to determine the significance of these measures with
respect to chronic inflammatory pain. Evidence of a relationship between lesion
severity and the magnitude of the change in behaviour was also sought.
The studies reported in this thesis further support the relationship between
assessments of lesion severity and quantified changes in behaviour that have been
associated with acute pain. The validity of the use of subtle changes in posture and
changes in feeding motivation to quantify chronic inflammatory pain was supported
as the consumption of analgesic creep feed resulted in elimination of the abnormal
expression of these behaviours. Some evidence that c+td lambs select more analgesic
feed was also present in these studies, although the responses were not reliable
within and between individuals. No evidence was found of changes in the expression
of hormones in the HPA axis that are characteristic of chronic inflammatory pain in
rats.
Definitive evidence of the experience of chronic inflammatory pain was not provided
by either the self-administration paradigm or the neurohistochemical studies. The use
of changes in behaviour to assess chronic inflammatory pain must still be validated,
but it is proposed that the incidence of abnormal lying and changes in feeding
motivation are reliably associated with the severity of chronic inflammatory pain.
It is possible that the unchanged expression of AVP and CRH mRNA in the pPVN is
a reflection of differences in the mechanisms of control of the chronically activated
HPA axis in the rat and the sheep. It is also considered likely that lambs were unable
to learn about the pain relieving properties of the analgesic creep feed, because the
study did not provide the appropriate opportunity to learn the association. It is
suggested that lambs may be able to control their experience of pain by adopting
changes in posture and through activation of local endogenous analgesic
mechanisms, thus avoiding the need for activation of the pPVN or other central
mechanisms and precluding the need for the lamb to select an analgesic treatment.
The evidence supports the assertion that chronic inflammatory lesions from RR c+td
are painful, a conclusion that can be used to further oppose of the use of RRs
commercially. The potential use of RR c+td lesions as a model of chronic
inflammatory pain was demonstrated.
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Chapter l. Rubber Ring Castration and Tail-docking: painful routine procedures.
I. I. Introduction
Castration and tail-docking (c+td) are procedures carried out routinely on the
majority of male lambs in the U.K. and in other lamb producing countries. Numerous
reasons for carrying out these procedures have traditionally been given, including
improvement of carcass quality, prevention of indiscriminate breeding and
prevention of fly strike of the tail and breech. However, over the last 50 years, the
practice has been questioned, from the perspective of both production and the
welfare of farmed animals. Research has provided considerable evidence of severe
acute pain following c+td by conventional methods. This acute pain has been
successfully quantified using behaviour (Mellor and Murray, 1989a; Molony et al,
1993; Molony et al, 2002). Evidence suggests that lambs may also experience
chronic pain lasting up to six weeks after treatment (Kent et al, 1999; Kent et al,
2000). However, the use of behaviour to quantify this pain has not been validated.
The main aim of this thesis is to address the problem of recognition and assessment
of chronic pain in lambs.
1.2. The law controlling the practice ofcastration and tail-docking.
In the U.K. several pieces of legislation regulate the routine practice of c+td. Firstly
the Protection of Animals Act 1911-1988, as amended, and the Protection of
Animals Act (Scotland) 1912-1993 as amended, are intended to prevent cruelty to
animals. Under this legislation an act of cruelty is one that causes unnecessary and
substantial suffering and it is an offence to carry out any operation 'without due care
and humanity'. The performance of c+td is not considered to be cruel under the
Protection of Animals Act, provided it is carried out in accordance with the
requirements of The Protection of Animals (Anaesthetics) Act 1954-1982, as
amended. According to this Act castration can be carried out, by constriction of the
blood supply to the scrotum (for example by the application of a tight rubber ring
(RR)), without the use of anaesthetic, provided that the device is applied within the
first week of life. Castration by other methods (again without anaesthetic) may be
1
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carried out in lambs up to 3 months of age. In lambs older than 3 months of age,
castration must be carried out using anaesthetic. Under the Veterinary Surgeons Act
1966-1991, castration of lambs within the provisions of the Protection of Animals
(Anaesthetics) Act 1954-1982 may be carried out by suitably trained and experienced
lay person over the age of 18, but the castration of lambs over 3 months of age can
only be carried out by a veterinary surgeon. Similarly, tail-docking by constriction of
the flow of blood to the tail may be carried out by a trained and experienced lay
person over the age of 18 in accordance with the Veterinary Surgeons Act 1966-
1991, without anaesthetic, provided that the procedure is carried out within the first
week of life in accordance with the Protection of Animals (Anaesthetics) Act 1954.
Tail-docking can be carried out using any other conventional method at any age
without an anaesthetic. The Agriculture (Miscellaneous Provisions) Act also
influences the practice of c+td. Under section 2 of this Act, government ministers are
given the power to introduce statutory instruments regulating specific procedures that
may be carried out on agricultural land. One such piece of legislation is the Welfare
of Livestock (Prohibited Operations) Regulations (1982) under which it is required
that sufficient tail must be left after docking so that the vulva is covered in female
sheep and the anus is covered in males. Under section 3 of the Agriculture
(Miscellaneous Provisions) Act (1968) government ministers retain the right to
introduce Codes of recommendations for the welfare of livestock (better known as
the welfare codes) that are intended to promote good welfare by encouraging best
practice. Under the Welfare of Livestock Regulations (1994) it is a legal requirement
that anyone keeping livestock must be familiar with the welfare codes and, although
these codes are not law, they may be used in court as evidence of poor practice if
caretakers are charged with an offence related to their care of their livestock under
the Agriculture (Miscellaneous Provisions) Act (1968). The codes of
recommendations for the welfare of livestock (sheep) were revised in 2000 and
include the recommendation that farmers should take time to consider whether c+td
are necessary, for each flock in turn. It is also recommended that the pain and distress
caused by the procedures and the potential stress caused by gathering and handling
the animals should be taken into account in weighing up the necessity of the
procedures. The welfare codes also recommend that castration should only be carried
2
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out when a strong bond has developed between the ewe and her lambs and that
surgical castration should only be carried out by shepherds in exceptional
circumstances. They also state that tail-docking should only be considered necessary
when there is substantial evidence to suggest that welfare problems will result if tail-
docking is not carried out and that both c+td should be carried out together in order
to avoid stress from double handling.
1.3. Why Castrate and tail-dock?
Legal acceptance of mutilations like c+td has come about mainly because of what
Robertson (1965) describes as 'reputable historical background'. The procedures
have traditionally been considered necessary within the farming community (Wohlt
et al, 1982; Robertson, 1965) and are still considered necessary by many farmers in
the U.K. (Hosie et al, 1996). However, the necessity and justification for carrying out
both procedures have increasingly been the subject of debate. Substantial evidence of
pain as a result of c+td now exists and with this knowledge comes the ethical
requirement to ensure that the need for these procedures is both reasonable and
substantial, rather than simply being the product of tradition. The rationale behind
the practice of castration and that of tail-docking are somewhat different. A summary
of the arguments for and against c+td are considered separately below.
1.3.1. Arguments for and against castration.
Castration of lambs is considered necessary for several interconnected reasons. All
these reasons are related to husbandry and productivity and few benefits for the
lambs can be recognised. Firstly it is argued that castration of lambs facilitates their
management (FAWC, 1994; Hosie et al, 1996; Robertson, 1965). After castration of
male lambs, all lambs may be housed or grazed together, irrespective of their sex,
without the risk of indiscriminate breeding. Castration is thought to reduce the
development of secondary sexual behaviours, including aggression and mounting
(FAWC, 1994). This assumption has been quantitatively assessed in two- and three-
week-old pigs in which aggression, mounting and attempts at mounting were reduced
by both surgical and immuno-castration (Cronin et al, 2003). A reduction in
aggression in both surgically and immuno-castrated bulls was also observed by Price
3
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et cil (2003). No quantitative study on the effect of castration on aggression and
mounting behaviours in sheep were found, but it is likely that castration has a similar
effect on behaviour in this species. A reduction in secondary sexual behaviour is
desirable as the risk to stockpersons may be reduced (although the risk must be
considered less from rams than from bulls or boars). The more frequent occurrence
of mounting seen in entire males is considered likely to result in bruising. The
presence of bruising has been considered to be an indicator of welfare problems
before slaughter (Jarvis and Cockram, 1994) and is one of the most frequent causes
of downgrading or rejection of the carcass after slaughter (Green et al, 1995)
resulting in significant losses for the meat industry (Jarvis and Cockram, 1994;
McNally and Warriss, 1996). However, evidence suggests that bruising does not
necessarily occur as a result of high libido and mounting in ram lambs, but as a result
of riding behaviour during transportation and handling at livestock markets and in
the slaughter house (Jarvis and Cockram, 1994). This is supported by evidence that
bruising in lamb carcasses is much more prevalent in lambs sold through livestock
markets for slaughter than in those sold direct from the farm to the slaughterhouse
(Jarvis and Cockram, 1995). As the majority of lambs are currently sent for slaughter
through the market place, the higher incidence of bruising in these animals is itself a
cause for concern both for production and welfare reasons (Jarvis and Cockram,
1995). Evidence in cattle suggests that, of the cattle sold for slaughter through
livestock markets, young bulls showed the least bruising and their carcasses were
rejected less frequently than steers and heifers (McNally and Warriss, 1996). This
may be a result of more careful or permissive handling and smaller grouping of
entire males, because they are considered to be more volatile and sensitive in
character and are more likely to become aroused in stressful conditions (Field, 1971).
If it could be shown that the greater expression of arousal in entire males is
associated with a greater perception of stress by the individual, this argument might
be considered the only benefit realised by the castrated individuals themselves. From
a production point of view, it is known that stress before slaughter results in a
reduction in meat quality, with an increase in dark cutting meat of lesser value
(Voisinet et al, 1997), and thus it is argued that the potentially greater experience of
stress in entire males will result in reduced meat quality after slaughter (Field, 1971).
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Further arguments for castration are also related to productivity. It is commonly
supposed that meat from entire males, including rams, produces an unpleasant odor
and taste when it is cooked and is considered by many to render the meat unfit for
human consumption (Field, 1971). Entire male cattle, pigs and sheep develop heavier
musculature around the neck and shoulders than castrated animals. The value of cuts
of meat from these areas is lower and it has been argued that castrates produce better
cuts of meat and have a higher dressing percentage (the percentage of empty live
weight that can be converted to saleable carcass) overall (Robertson, 1965). Wethers
are known to fatten more quickly and to deposit more fat, which was in the past
considered more favourable (Robertson, 1965). For these reasons, ram lambs,
especially those with 'excessively male characteristics', were less likely to qualify
for the 'Variable Premium', a government subsidy that was paid for each lamb that
attained certain standards of conformation and fat quantity and distribution (FAWC,
1994; Hosie et al, 1996). The system of subsidies has now changed and premiums
are no longer paid on the basis of lamb quality (the variable premium was phased out
from 1989), but are instead paid on a headage basis for every ewe which has given
birth or is at least one year old by the 15th of May of that year. The payment is
supplemented if the stock are kept on poor grazing under the 'Less Favoured Areas'
scheme (DEFRA, 2003; FAWC, 1994). Thus, qualification for variable premiums
themselves can no longer be used to justify the use of castration on financial grounds.
Furthermore, consumer demand now strongly favours lean meat. European policy
has therefore also changed to favour the production of leaner meat (FAWC, 1994)
and meat wholesalers are now willing to accept the leaner carcasses of ram lambs,
even with excessive male characteristics (Anderson, 2001).
It has long been recognised that the effects of castration are less evident and that
masculine characteristics are less objectionable in male lambs than in cattle and pigs
(Robertson, 1965). Furthermore, evidence shows that, if fed on a medium to high
plane of nutrition, ram lambs gain weight more quickly and show higher rates of feed
conversion than wethers (Field, 1971; Mahgoub and Lodge, 1994; Notter et al, 1991;
Robertson, 1965). It has also been shown that the dressing percentage obtained from
rams fed on good quality feed is close to or equal to that for wethers, and may exceed
it, if the weight of the testes (sold as 'lamb fries') is taken into account. It is likely
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that this is a reflection of the fact that finished ram lambs can be sold before they
reach puberty at 5 months of age, the age at which the characteristically male build
begins to become apparent (Field, 1971). Robertson (1965) reviewed evidence from
8 studies using taste panel tests and found that meat from ram lambs was considered
to be as flavoursome or more flavoursome than that from wethers in 6 out of 8
studies. It was also found that, although meat from ram lambs was considered
slightly less juicy and tender, the differences were small and were not significant to
result in downgrading of the meat (Robertson, 1965). In a more recent but similar
taste panel study, Anderson (1996) found that meat from grass fed lambs was the
most tasty and juicy and that there was no difference in taste between meat from
rams lambs and wethers. In support of these conclusions the New Zealand Animal
Welfare Advisory Committee in their 'Code of recommendations and minimum
standards ofwelfare of sheep' state that no unpleasant smell and flavouring is present
in meat from pre-pubescent ram lambs.
The more sensitive nature of ram lambs by comparison to wethers might certainly
raise welfare and production concerns, as has been noted. However, as little
difference has been found between the quality of meat from rams compared to
wethers, the production concerns appear unfounded. Despite this, the tendency to
handle entire male stock more carefully, minimising any effect of stress on meat
quality, could improve the well-being of stock overall.
Undoubtedly the ability to run all lambs together ensures that the husbandry of
wethers within flocks is easier than that of rams, but as has been noted, most farmers
should be able to finish lambs and sell them before they reach puberty at 5 months of
age (Anderson, 1996; Hosie et al, 1996). In a survey of castration methods, farmers
considered it possible to separate and fatten male lambs that had not been
successfully castrated before they reached puberty, irrespective of the farming
system (Hosie et al, 1996), and it has been proposed that extending this practice for
all male lambs may be possible on the majority of farms (Anderson, 1996). Anderson
(1996) indicated that ram lambs could be run together with ewe lambs until reaching
5-6 months of age, but that after this time separation was advisable. According to
Anderson (1996), leaving male lambs entire is now normal practice on hill farms in
Scotland and Wales, where the lambs are often destined for sale in Europe. Although
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some substantial changes in stock management are necessary if ram lambs are to be
kept on as stock lambs, such changes are beginning to be accepted in the farming
community. It has been shown that, if successfully managed, a non-castration policy
can have considerable production advantages. In New Zealand in 1970, a non-
castration policy (more than two thirds of male lambs) resulted in an increase in the
production ofmeat by an estimated 1000 tonnes annually in 1970 (Field, 1971).
1.3.2. Arguments for and against tail-docking.
Tail-docking is carried out mainly to reduce the occurrence of 'fly-strike' (myiasis
and pseudomyiasis by maggots of the blow fly family (Calliphoridae)) of the tail and
breech area (FAWC, 1994; French et al, 1994a). Faecal and urinary soiling of the tail
and breech area provides warm damp environment suitable for the development of
larvae (Graham, 1997). It is argued that tail-docking reduces such soiling and
therefore theoretically reduces susceptibility to strike (French et al, 1994a; Riches,
1941; 1942; Wohlt et al, 1982). Thus tail-docking is seen as a means of preventing a
condition that can cause damage to the wool and dermis and in serious cases can
result in loss of appetite and condition and potentially death (Henderson, 1990;
Schmidt and Roberts, 1996). The reduction in soiling of the tail and breech area is
also considered to be advantageous for other reasons (French et al, 1994a). It has
been argued that tail-docking facilitates care during breeding and lambing (FAWC,
1994) and has been said to increase breeding efficiency in ewes (Wohlt et al, 1982).
In many cases tail-docking may be carried out simply to improve the appearance of
lambs, giving them a consistent and square shape favoured by buyers and meat
producers (Wohlt et al, 1982; FAWC, 1994).
The relationship between fly-strike and tail-docking was first examined by Riches et
al (1941; 1942) and later by French et al (1994b). French et al (1994b) studied the
incidence of strike in seven farms in South West England. Lambs that had been tail-
docked by RR in the first week of life were found to be less likely to be the victim of
strike than those that had not been tail-docked. They also found that undocked lambs
were more soiled with faeces and urine than docked lambs and a relationship
between the extent of soiling and the occurrence of strike was found. It was pointed
out that, as the docked and undocked lambs in this study were kept together in the
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same flocks, no conclusion could be drawn about the likelihood of strike occurring in
the flock as a whole, but only that, within the flock, strike was most likely occur in
the undocked and therefore most soiled lambs. No differences in the survival of
lambs were found in this study. Riches et al (1941; 1942) also found that
susceptibility to fly strike was associated with tail-docking, but the methodology and
conclusions of these studies were more complex. Riches et al (1941; 1942) examined
the differences in strike susceptibility after the tail had been docked to a range of
lengths. The results showed that tail-docking resulted in a reduced occurrence of fly
strike only when the remaining tail was approximately 10 centimetres long, as is
common practice in the U.K. today. Very short docking increased susceptibility to
both tail and breech strike in comparison to docking tails to 10cm. Whilst long-tailed
and undocked lambs were more susceptible to tail strike, they were no more
susceptible to breech strike than lambs with tails docked to 10cm. Thus, it must be
concluded that both the length of the remaining tail and the degree of soiling are
critical factors in fly strike susceptibility. French et al (1992) found that there are
regional variations in the incidence of fly-strike. As might be expected, this survey
showed that the incidence of strike is more likely in warmer areas in the South West
and South East of England and less in the North. Thus the need for tail-docking to
reduce fly strike might be considered more necessary where climatic conditions are
favourable for the flies and their larvae. However, as French et al (1994c) point out,
the necessity of tail-docking merely demonstrates that the methods used to control
scouring and the blowflies themselves are inadequate. Alternative methods of control
of fly-strike include dipping, dagging and spraying and their use as alternatives to
tail-docking have been promoted.
It has been argued that tail-docking increases breeding efficiency in ewes (Wohlt et
al 1982). Evidence in support of this tenet was sought by Riches (1942), but no
evidence of such an effect was found in a sample of 197 ewes, comprising undocked
and medium- and short-docked ewes. Dagging can be carried out to reduced soiling
of the tail and breech areas. Critical differences in the ease ofmanagement of docked
lambs and ewes over undocked animals must be found before ease of management
can to be used to justify the practice of tail docking. The docking of lambs' tails
simply to improve the appearance of the lamb, although traditional, is considered
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ethically unacceptable. The possibility of breeding sheep for short tails and for
reduced wool on the legs, abdomen and breech has recently been raised in Australia
(Scobie et al, 1999). Whilst the welfare implications of selection for such traits must
be carefully evaluated, this proposition has the potential to reduce the extent of
soiling, incidence of fly-strike and facilitate management without the need for tail-
docking.
It must be recognised that, for farmers, production benefits are likely to be the main
incentive for the voluntary practice of a non-c+td policy. Where the production
benefits are not sufficient to induce a change in farming practice, despite evidence of
adverse welfare effects, the law should take into account scientific evidence and
ensure that the degree to which production considerations compromise welfare is
minimised.
1.4. Methods ofcastration and tail-docking.
There are three principal methods by which lambs are castrated in the U.K.;
application of a rubber ring (RR) to the neck of the scrotum, crushing the spermatic
cords with a bloodless castrator and open or surgical castration involving the
excision of the testes. Tail-docking is carried out using one of four methods; RR,
surgical docking, a combination of surgery and bloodless castrator and the use of a
hot docking-iron. Descriptions of these procedures and a summary of the risks
known to be associated with their use is given in Table 1.1. C+td in the U.K. is most
commonly achieved by the application of RRs because they are cheap, effective,
quick and easy to use (Barrowman et al, 1954; Hosie et al, 1996; Kent et al, 2001).
1.5. Can lambs experience pain in response to these routine mutilations?
RR c+td was introduced to the U.K. from New Zealand in the early 1950s
(Barrowman et al, 1953). The effects of this new procedure on lambs were
investigated by Barrowman et al (1953; 1954). It was concluded in these early
studies, that older lambs may experience significant pain as a result of RR c+td
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to quantify pain resulting from RR c+td in lambs of different ages and to identify
practical means by which the resulting pain can be reduced. The identification of the
least painful means of castrating and tail-docking lambs might at first seem simple,
but in practice the determination and quantification of pain in animals is difficult
because the experience of pain is essentially a subjective perception (Kitchell and
Johnson, 1985) and pain is a word used primarily to describe a human experience.
Whilst the animals' responses to the experience of animal pain can be measured, the
magnitude of the actual experience itself cannot be measured. Because, unlike most
humans, animals are incapable of reporting their experience of pain, their ability to
experience pain at all has been questioned. However, whilst there are some
neuroanatomical differences in the peripheral and central mechanisms involved in
the sensation and perception of pain, the mechanisms underlying pain in mammals as
well as other vertebrates are considered to be very similar and it is this that permits
the use of animals as models for the investigation of pain in humans. Animal and
human studies have shown that the application of high intensity thermal, mechanical
or chemical stimuli to somatic or visceral structures results in activity in the
peripheral nociceptors (with A5- and C- afferent fibres). This activity is relayed via
parts of the dorsal horn grey matter to the brain through the spinothalamic tract and
other ascending pathways carrying nociceptive information. On reaching the
thalamus, this information is relayed to the somatosensory cortex (perception of
pain), parietal insular cortex and the anterior cingulate and limbic cortices
(motivational-affective dimensions of pain in humans) (Kitchell and Johnson, 1985,
Zimmerman, 1986; Guilbaud et al, 1994; Meyer et al, 1994; Woolf, 1994; Short,
1998). The neurophysiological, physiological and behavioural responses of animals
to such stimuli, reported to be painful in humans, are generally similar to the
recorded in humans. These responses appear to serve the same functions as those in
humans, which are; withdrawal from the stimulus, minimisation pain, facilitation of
healing, elicitation of help and modification of behaviour (learning) to prevent future
exposure to the stimulus (Bateson, 1991; Molony et al, 1997). In order to move
beyond the debate over the ability of animals to experience pain, Molony (1986;
1992) advocated that the study of animal pain continue under the assumption that
animal pain serves the same function as human pain and that the experience is
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similar, but that human and animal pain are not necessarily the same. Thus, Molony
and Kent (1997) proposed the following definition of animal pain:
Animal pain is an aversive sensory and emotional experience representing an
awareness by the animal of damage or threat to the integrity of its tissues; it changes
the animal's physiology and behaviour to reduce or avoid damage, to reduce the
likelihood of recurrence and to promote recovery; unnecessary pain occurs when the
intensity or duration of the experience is inappropriate for the damage sustained or
when the physiological and behavioural responses to it are unsuccessful at alleviating
it.
Molony and Kent (1997).
The strategies that have been employed to determine the presence and severity of
animal pain, in response to experimentally induced and naturally occurring stimuli
and as a result of husbandry practices, are many. The validity, sensitivity and
reliability of these measures is continually questioned in the literature, for example
methods of assessment of post-operative pain resulting from beak-trimming in
poultry, c+td in lambs and ovaro-hysterectomy in dogs were recently the subject of a
critical review by Rutherford (2002). Methods used to recognise and assess the acute
pain from RR c+td include electrophysiological studies, quantification of behavioural
changes and quantification of HPA activation by measurement of changes in the
plasma Cortisol concentration.
1.6. Recognition and assessment of acute pain from rubber ring castration and tail-
docking.
1.6.1. Electrophysiological studies
Cottrell and Molony (1995) made electrophysiological recordings of visceral afferent
activity in the superior spermatic nerve in lambs in response to the application of
RRs to the neck of the scrotum. The presence of a ring resulted in 'vigorous
discharge' in nociceptors of the testes and pampiniform plexus (a network of veins
associated with the testis and epididymus). Application of an extremely tight ligature
(pressure unquantified) to the neck of the scrotum resulted in cessation of all nervous
activity within two minutes and recovery of activity within 5 minutes of ligature
removal. The RR resulted in the application of less pressure than the ligature and
resulted in successive blockade of nerves of different conduction velocities (larger,
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faster, myelinated fibres first). The pressure applied by a single standard RR was
insufficient to block all afferent activity within an hour after application and afferent
activity was recorded for up to 90 minutes after ring application. Whilst Cottrell and
Molony (1995) measured visceral afferent activity in the superior spermatic nerve, it
is likely that the RR castration has similar effects in the middle and inferior
spermatic nerves (Molony and Wood, 1992). Cottrell and Molony (1995) found that
nociceptors with afferent fibres in the superior spermatic nerve are not activated by
short scrotum castration (where RR is applied at the neck of the scrotum with the
testes proximal to the ring), but they did not measure activity in any of the somatic
afferent nerves from the scrotum including the ilioinguinal nerve, caudal scrotal
nerve or the scrotal branch of the superficial perineal nerve. As short scrotum
castration by RR produces a behavioural response in lambs (Molony et al, 2002), it is
likely that stimulation of somatic nociceptors is also important to the overall
experience of pain in RR castrated lambs.
Graham (1997) carried out similar studies in lambs to measure activity in nociceptors
in deep and superficial nerve trunks innervating the tail in response to the application
of a RR at the level of the fourth caudal inter-vertebral space during tail-docking. In
Graham's studies, afferent activity was again gradually reduced after application of
the RR and complete conduction block was achieved in the preparations within 11-
44 minutes. From these results no conclusion can be drawn as to the time taken for
all afferent activity from the tail to cease after application of the ring. It was
suggested that the rate at which conduction block was achieved would vary
depending on whether the ring was placed at an intervertebral space or over bone.
As well as stimulating nociceptors in the neck of the scrotum and in the tail
mechanically, the application of the RR results in total occlusion of the blood and
lymphatic vessels to the scrotum within 1 minute, resulting in ischaemia (Cottrell and
Molony, 1995) and is likely to have a similar effect on the tail. As mechanoreceptors
in the portion of the scrotum and tail distal to the ring continue to respond to
stimulation for some time after application of the RR, it has been proposed that
ischaemia contributes to the eventual blockade of conduction (Cottrell and Molony,
1995). This view was supported by Graham (1997) who found that removal of the
RR resulted in the recovery of afferent activity within a few minutes. Thus, it was
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concluded that conduction block by the application of RRs is likely to be achieved as
a result of a combination of factors including disruption of conduction by ischaemia
and/or compression and failure of receptors as a result of the effects of ischaemia
(Graham, 1997). Occlusion of the blood supply itself can result in an increase in
visceral afferent activity (Grubb et al, 1990) and is likely to contribute to the overall
sensation of pain because the pressure applied by the RR is insufficient to result in
immediate cessation of afferent activity (Cottrell and Molony, 1995; Graham, 1997).
However, neither one of these studies attempted to identify afferents that responded
to chemical changes that occur as a result of ischaemia, for example those
responding to hypoxia, hypoglycaemia, hypercapnia and acidosis. Chemoreceptors
will also respond to inflammatory mediators released from damaged tissue under the
ring, again contributing to the overall perception of pain. As veins are more
superficial than arteries, it is likely that, after application of the RR, the pressure in
the testes and tail increases before occlusion of the blood supply is complete. This is
particularly true in larger lambs where the pressure of the ring is distributed over a
larger area. This may result in increased sensitivity of the afferent nerves of the
scrotum, testis and associated structures (Cottrell and Molony, 1995). The
combination of ischaemia and the destruction of innervation ultimately results in
necrosis of the scrotum and its contents, which eventually falls off.
1.6.2. Performance as a measure ofacute pain.
Whilst studies of electrophysiology provide definitive evidence of nociceptive
stimulation by the application of RRs, this work does not provide a means by which
the severity of pain can be easily quantified in the field. Traditionally, the degree of
pain suffered by animals as a result of procedures such as c+td has been estimated by
identification and quantification of a decrease in daily live weight gain (DLWG)
(Robertson, 1965). Assessment of DLWG is used in studies of pain in lambs and
other ruminants after c+td. Wohlt et al (1982) found that lambs tail-docked surgically
at 14, 28 and 42 days old showed a reduced DLWG during the two weeks after tail-
docking compared to the two weeks before tail-docking. However, the authors found
no significant difference in weight gain between lambs tail-docked surgically or by
RR. Similarly, Ware et al (2000) found that tail-docked male lambs were lighter than
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undocked lambs 8-12 weeks after tail-docking, although this effect was not observed
in ewe lambs and was only seen on one of three study farms. Rhodes et al (1994)
found no difference in DLWG following tail-docking of 16 day old lambs using a
bloodless castrator in the first 14 days after treatment and Kent et al (2000) found no
differences in DLWG in the 28 days after c+td of newborn lambs by RR. Castration
itself has been shown to reduce weight gain in lambs in the long-term (Field, 1971),
but as the effects of castration on growth (inhibiting development of secondary
sexual characteristics) do not become apparent until puberty at approximately 5
months of age, growth checks at around the time of castration in young lambs are
unlikely to be associated with emasculation. However, DLWG is subject to
considerable variation between studies and cannot be considered sufficiently reliable
to confirm the presence or absence of acute pain from c+td without further evidence.
1.6.3. Behavioural assessment of acute pain from rubber ring castration and tail-
docking and evidence supporting its use.
Barrowman et al (1953) and (1954) used behaviour as a means of determining the
presence and degree of acute pain experienced by lambs after RR c+td. The
behaviour was not recorded in a quantified way, but was simply recorded
descriptively. However, these were the first behavioural studies in which it was
suggested that lambs experienced significant pain and distress as a result of c+td
using RRs or the Burdizzo. Barrowman et al (1953) described the response of 16-39
day old lambs to RR castration and reported abnormal walking (sideways and
backwards), rolling, falling, turning to the scrotum and 'great uneasiness' which
occurred almost immediately after application of the rings until 20 minutes after
treatment. Later Barrowman et al (1954) compared the responses of very young
lambs (less than 1 week old) to either RR castration or tail-docking, with that of 21-
30 day-old lambs. In this study, Barrowman et al reported that there were few or no
signs of distress in lambs castrated at less than a week of age, instead the lambs
appeared 'indifferent' to the procedure. Older lambs, castrated at 21-30 days of age,
showed almost immediate behavioural signs of distress as described by Barrowman
et al (1953). The expression of these behaviours reached a maximum 15 minutes
after treatment but all lambs showed resting between 30 minutes to one hours after
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treatment. It was noted that the response was extremely variable with some
individuals seeming 'quite oblivious of interference'. After tail-docking by RR,
young lambs showed some signs ofmild distress, including restlessness, which lasted
up to 15 minutes. In contrast, they recorded severe signs of distress in 21-30 day-old
lambs in response to tail-docking, again including falling, rolling and kicking. These
behaviours were apparent immediately after treatment and lasted for up to 30
minutes. The lambs subsequently showed quiet lying and resumed grazing, suckling
and sleeping within 2 hours. Again Barrowman et al (1954) noted considerable
variation between individuals. Barrowman et al (1954) concluded that the evidence
of distress in lambs c+td under a week of age was limited, whilst older lambs showed
significant behavioural signs of distress in response to both c+td. It was thus inferred
that younger lambs are less able to perceive pain from c+td than older lambs and are
considered likely to have been influential in the introduction of U.K. legislation
restricting the use of what was at the time a new method of c+td, without an
anaesthetic, to the first week of life.
In the first quantified behavioural study of 7 day-old lambs subjected to RR c+td or
to tail-docking alone, Mellor and Murray (1989a) concluded that behaviour was a
sensitive means of determining the severity and duration of distress from the
nrnppHnres Tn thi<; ctnHv in crrminQ nf nvpr SO Ismhc q nnap behaviours waspuvvuuivj. —- J 5 O* ~ J ~ ~ ~ ^ O viiM X
recorded at specific, but irregular, intervals over the first 4 hours after treatment.
Some of these behaviours had been previously described by Barrowman et al (1953;
1954). In direct conflict with the conclusions drawn by Barrowman et al (1954),
Mellor and Murray (1989a) found that lambs undergoing c+td by RR at 7 days of age
showed behaviours which they considered to be consistent with the experience of
significant distress. The results of this study were later confirmed using the same
behavioural observation methods (Mellor et al, 1991; Wood et al, 1991; Lester et al,
1996) and these behavioural methods were found to be sufficiently sensitive to detect
differences between much smaller groups (between 6 and 18 lambs) of c+td lambs
and controls.
Similar changes in behaviour were observed in response to RR c+td in studies using
more detailed examination of active and postural behaviours (Molony et al, 1993;
Kent et al, 1995; Molony and Kent, 1997; Kent et al, 1998). In lambs castrated by
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RR at three ages (5, 21 and 42 days old), Molony et al (1993) recorded posture in a
scan sample every 2 minutes for the first 96 minutes and every 6 minutes until 180
minutes after treatment. The postures recorded included; normal standing (SI),
normal ventral lying with legs tucked in with the head either down (VI) or up (V2),
abnormal standing postures including, just detectable abnormal gait with swaying
and abnormal stance with trembling (S2) or kicking and stamping, walking
backwards, resting or walking on the knees and falling over (S3), standing still with
no movement or statue standing which can include trembling (SS) and abnormal
lying postures including lateral lying with legs extended (as described by Mellor and
Murray (1989a)) with the head up (LI) or down (L2) or with kicking and rolling (L3)
and abnormal ventral lying with the hind legs either partially (V3) or fully (V4)
extended. Restlessness was recorded on an all occurrences basis for the first 96
minutes after treatment. In later studies active behaviours, including restlessness,
foot-stamping, rolling, lip-curling, tail-wagging, easing-quarters, head-turning and
vocalisation, were recorded on a continuous, all occurrences basis (Kent et al, 1995;
Molony and Kent, 1997; Kent et al, 1998). Differences in behaviour were found
between c+td lambs and handled controls and in all of these studies, temporal
differences in the expression of behaviours were found, as was described by Mellor
and Murray (1989a). For example, during the first hour after RR c+td, Molony et al
(1993) found that lambs of all ages showed restlessness, which gradually declined
over the first hour after treatment. In contrast the duration of time spent in abnormal
postures persisted for up to 3 hours after treatment. These results were confirmed in
further studies (Kent et al, 1995; Molony and Kent, 1997; Kent et al, 1998) and it
was noted that during the first hour after treatment the intensity of expression of
abnormal behaviours may be such that almost no normal lamb behaviour is observed
(Molony and Kent, 1997).
The welfare implications of these studies are clear. As RR c+td can only legally be
carried out in the first week of life, the process of gathering and the application of the
rings must be carried out at a time when the bond between the ewe and her lambs
may not be strongly established. Lambs may be unable to show normal following
and suckling after treatment and the chances of mis-mothering are high. Also,
without suckling for a period potentially lasting several hours, young lambs may
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grow weak and if these procedures are carried out within the first few hours after
birth lambs may not suckle sufficient colostrum to gain the benefit of passive
immunity. These problems can and do result in increased loss of life (FAWC, 1994).
In response to severe pain, animals may show vigorous escape or avoidance
behaviours. In contrast, severe pain may also be avoided or controlled if the animal
adopts certain postures that reduce stimulation of the affected region, for example by
staying very still or stretching to avoid contact with the region (Sanford et al, 1989;
Kent and Molony, 2003). On this basis, Molony et al (1993) hypothesised that the
expression of a high frequency of active behaviour during the first hour after RR
c+td was a response to initial severe inescapable pain resulting from stimulation of
somatic and visceral nociceptors by the RR. This view is upheld by the
electrophysiological analysis carried out by Cottrell and Molony (1995) who found
that conduction block in visceral afferents was not complete within 90 minutes after
application of the rings. Molony et al (1993) also proposed that some of the postures
adopted were indicative of escapable pain, the severity of which could be reduced
when lambs adopted the abnormal lying and standing postures observed over the 3-4
hours after treatment. The implication of this proposal is that pain that results in
postural changes, but not in a significantly higher expression of active behaviour, is
less severe than that which results in the frequent expression of active behaviour.
Molony et al (1993) found few differences in the behaviour of lambs c+td at 5, 21
and 42 days old and concluded that there was no evidence to suggest that younger
lambs experienced less acute pain than older animals, supporting the view of Mellor
and Murray (1989a). Instead the evidence suggests that lambs in all three age groups
experiences severe acute pain lasting up to 3 hours after application of the RRs. This
was not consistent with the assertion by Barrowman et al (1953; 1954), that younger
lambs show no signs or limited signs of distress as a result of c+td. Molony et al
(1993) did find that restlessness was more evident in older lambs c+td at 42-days-
old. The authors suggested that this difference was a function of the greater quantity
of tissue contained within the ring, which reduced the pressure applied to underlying
nerves by the ring and therefore increased the time taken to block the conduction of
afferent activity, an assertion that was supported by the finding of Cottrell and
Molony (1995) and Graham (1997).
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1.6.4. Measurement ofHPA acitivity.
Pain, as a stressor, results in activation of the hypothalamo-pituitary-adrenal (HPA)
axis. Activation of the HPA axis results in an increase in the release of
adrenocorticotrophic hormone (ACTH) from the anterior pituitary gland, which in
turn stimulates the release of Cortisol from the adrenal cortex. Measurement of
Cortisol can be used to quantify the degree of HPA activation and thus, indirectly, as
a measure of stress resulting from routine husbandry procedures. Quantification of
the concentration of Cortisol in plasma or saliva has been used to assess the stress
produced by routine procedures in sheep, including restraint, separation (Moberg et
al, 1980) and mulesing, a routine mutilation that results in severe pain in lambs (Fell
and Shutt, 1989). Whilst pain is undoubtedly a stressor resulting in activation of the
HPA axis, many other components of the RR c+td procedure are likely to induce
stress. For this reason, it is often difficult to determine the extent to which pain itself
is responsible for the overall magnitude of the HPA response. The contribution of
many extraneous variables can be taken into account by the inclusion of suitable
controls in the experimental design. For example the systemic concentration of
Cortisol in sheep is affected by breed (Mellor and Murray, 1989b) age (Moberg et al,
1980; Mellor and Murray, 1989b) and, in lambs over 15 days of age, circadian and
diurnal rhythms are also a factor (Parraguez et al, 1989). Additional stress from
catch-up, restraint and even the effects of expectation as a result of previous
experience can be controlled for. Some factors cannot be controlled for however, for
example, RR c+td produces a vigorous active behavioural response. As exercise
itself is a stressor, this behaviour may augment the overall Cortisol response
observed. The measurement of Cortisol has been used in the study of acute pain
associated with RR c+td, and has generally been found to support the use of
behaviour as a means of assessing distress resulting from the procedures. However,
interpretation of diverging behavioural and plasma Cortisol data has proven difficult
and in many cases the conflicts have not been resolved.
Mellor and Murray (1989a) compared the plasma concentrations of Cortisol in c+td
lambs and lambs that were tail-docked alone with that of handled control lambs. A
further group of lambs were injected with a high dose of ACTH to provide a positive
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control for activation of the HPA axis. A peak in the plasma concentration of Cortisol
was recorded 30 minutes after RR treatment in both c+td and tail-docked only lambs,
but the magnitude of the response was significantly higher in lambs undergoing both
c+td. The concentration of Cortisol also returned to pre-treatment levels sooner in
tail-docking only lambs than in c+td individuals (60 minutes and 90minutes
respectively). The initial rate of increase in the concentration of Cortisol was the
same in c+td lambs as in the lambs treated with ACTH and it was concluded that the
Cortisol response to RR c+td was maximal. The maximum concentration of Cortisol
after ACTH administration was however much higher than that reached in castrated
and tail docked lambs and occurred later. Mellor and Murray concluded that the
overall Cortisol response to RR c+td was not limited by the capacity of the adrenal
gland to respond to stress. The magnitude of the maximum plasma concentration of
Cortisol in response to RR castration is variable with values of 40-239 nmol/l
recorded (Mellor and Murray, 1989a; Lester et al, 1991; Wood et al, 1991; Kent et
al, 1993; Kent et al, 1995; Dinniss et al, 1997; Graham et al, 1997; Kent et al, 1998;
Sutherland et al, 1999; Sutherland et al, 2000). These differences are likely to reflect
the different ages and breeds of lambs (Moberg et al, 1980; Mellor and Murray,
1989b; Kent et al, 1993) and conditions of treatment used in different studies. In
contrast the peak plasma concentration of Cortisol consistently occur at between 30-
60 minutes after treatment and return to pre-treatment levels is consistently reached
by 90-120 minutes after (Mellor and Murray, 1989a; Lester et al, 1991; Wood et al,
1991; Kent et al, 1993; Kent et al, 1995; Dinniss et al, 1997; Graham et al, 1997;
Kent et al, 1998; Sutherland et al, 1999; Sutherland et al, 2000).
Mellor and Murray (1989a) compared changes in the expression of behaviour, over
the four hours after treatment, with the changes in the plasma concentration of
Cortisol. A consistent association between the changing plasma concentration of
Cortisol and the occurrence of restlessness and immobility was found. The authors
therefore concluded that restlessness and immobility provided useful indicators of
marked distress. In contrast, lateral lying with neck extension, which was recognised
as an abnormal posture in lambs, was not considered to be a useful indicator of
distress because lambs continued to show these postures when the plasma
concentration of Cortisol declined. Thus, it might be concluded that these behaviours
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were representative of exhaustion and/or hyperthermia occurring as a result of the
vigorous expression of active behaviours soon after application of the rings.
Dantzer and Mormede (1983) emphasised the importance of considering
psychological aspects of stressful experiences when interpreting the behavioural and
physiological responses induced. In their discussion they maintained that if the
behavioural and physiological responses to stress represent attempts to minimise the
adverse effects of a stressor, their ability to cope must be judged on the basis of
whether or not these attempts were successful. Molony et al (1993) suggested that
the expression of a high frequency of active behaviour, in response to c+td, is
representative of the experience of acute unavoidable pain and is associated with the
barrage of afferent activity resulting from mechanical and ischaemic stimulation of
nociceptors in the scrotum and testes (Cottrell and Molony, 1995). The association of
these behaviours with maximal release of Cortisol might be therefore considered
representative of the inability or failure of the lambs to cope both physically and
psychologically with exposure to the stressor and that the pain dominates the lambs'
experience. In contrast, abnormal postures, as described by Mellor and Murray
(1989a), may be used by the lamb to reduce the experience of pain (Chapman et al,
1985) and therefore represent the experience of avoidable pain (Molony et al, 1993),
since these postures continue to be expressed during the time when the majority of
activity in visceral and somatic afferents has ceased (Cottrell and Molony, 1995;
Graham, 1997). The expression of such postural changes could therefore be taken as
evidence of successful coping, resulting in a decline in the plasma concentration of
Cortisol, despite continued expression of abnormal lying postures. Thus, whilst the
abnormal lying may not always decline at the same time as Cortisol, such changes in
posture may still be reliably associated with the experience of a degree of acute pain
and may represent a useful indicator of controllable pain.
In contrast to the studies of Mellor and Murray (1989a), the behaviour of lambs c+td
by RR at 4, 21 and 42 days of age, recorded by Molony et al (1993), and parallel
analysis of the plasma concentration of Cortisol, reported separately by Kent et al
(1993), supports the use of changes in posture to assess acute pain. Initially lambs of
all ages spent almost all their time in abnormal lying and standing postures, but their
expression declined over the 180 minutes of observation, showing a strong
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relationship with the decline in plasma Cortisol. The peak and subsequent decline in
time spent in abnormal lying postures recorded by Lester et al (1996), after c+td by
RR, occurred at approximately the same time as the peak and decline in the plasma
concentration of Cortisol. However, Kent et al (1993) noted that observations of
lateral lying were correlated with the expression of high frequencies of active
behaviours and may be a consequence of such behaviour rather than necessarily
associated with the experience of pain per se.
1.6.5. Reduction in pain by local anaesthesia and analgesia.
The behavioural and physiological responses of lambs during the first 4 hours after
RR c+td can be eliminated or reduced by the prior administration of multiple
injections of the local anaesthetics (LA) lignocaine or bupivacaine, into the tail and
scrotum and its contents, to block nervous transmission (Wood et al, 1991; Dinniss et
al, 1997; Graham et al, 1997; Kent et al, 1997). These results provide evidence that
the behavioural and physiological responses to RR c+td in lambs are directly
associated with the effects of afferent nervous activity caused by application of the
RRs. Cottrell and Molony (1995) provided electrophysiological evidence to support
this assertion, finding that vigorous activity in visceral nociceptors caused by the
application of the RR was eliminated by intratesticular administration of 0.1ml of 2%
lignocaine. Wood et al (1991) noted that the effects of lignocaine lasted much longer
than expected in RR c+td lambs and it was suggested that its effects were prolonged
by the restriction of blood flow from the scrotum, which prevented the distribution of
the anaesthetic away from the site of injection. In comparison with other methods of
pain relief, LA has been found to be a more effective means of reducing pain from
c+td; including epidural administration of local anaesthetic (bupivacaine), analgesic
spray (salicylate and cooling from alcohol evaporation) during tail-docking, and
intramuscularly administered non-steroidal anti-inflammatory (diclofenac) used
during tail-docking (Graham et al, 1997) and the opioid analgesics morphine and
etorphine, the ot2 adrenoceptor agonists, xylazine and the non-steroidal anti¬
inflammatory, carprofen administered prior to c+td (Wood, 1991; Price and Nolan,
2001). The administration of LA is a legal requirement prior to c+td in lambs over
three months of age. In order to investigate the use of LA more routinely in younger
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lambs, the use of a high-pressure needleless injector to administer LA safely and
efficiently has recently been tested on farms (Kent et al, 2004) and was favoured by
farmers.
Evidence of the involvement of endogenous analgesia in reducing acute pain from
RR c+td was found by Wood et al (1991). The opioid antagonist, naloxone was
administered intravenously to RR c+td lambs to block the effects of endogenous
opioids. Naloxone pre-treatment resulted in a significant increase in the amount of
time spent lying laterally in comparison with c+td lambs that did not receive
naloxone. A non-significant increase in the plasma concentration of Cortisol was also
recorded in these lambs. This hyperalgesia suggests that castration and tail-docking
is sufficiently painful to induce some opioid dependent endogenous analgesia
appeared to be small. Sheep are thought to gain relatively little benefit from the
administration of exogenous opioids to relieve pain from c+td (Wood, 1991) and
thus the stimulation of endogenous analgesia sufficient to result in a change in
behaviour is, in itself, highly significant. This does not rule out the possible
contributions of other endogenous analgesic mechanisms but the extreme
behavioural responses described suggest that lambs cannot cope, with the pain
produced by rubber ring castration and tail docking, by using endogenous analgesia.
1.6.6. Tissue damage as a measure ofacute pain.
As mentioned in section 1.5, the assessment of pain is complicated by the fact that
only the effects of pain can be measured rather than the pain itself. As an alternative,
the degree of damage caused by a procedure, and the predicted severity of pain, can
be used as a 'yardstick' against which the effects of pain can be compared and
validated as indices for its assessment. This strategy relies on the assumption that the
degree of pain experience is directly related to the quantity of tissue damage. In order
to confirm the validity and reliability of the use of changes in behaviour to assess
acute pain resulting from RR c+td, Molony et al (2002) carried out just such a
process of validation. Molony et al (2002) subjected lambs to 6 RR treatments of
varying severity. These treatments were, in descending order of severity; bilateral
c+td, bilateral castration, unilateral castration, short scrotum castration, short scrotum
castration with local anaesthetic, handled controls. Acute pain was assessed using the
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behavioural parameters, described by Kent et al (1995). The plasma concentration of
Cortisol was also measured. These variables were used in a principle components
analysis to identify which of them accounted for the majority of the variation in the
data. These variables were then used in a discriminant analysis to identify those
variables that could be used to assign the lambs to the correct treatments most
accurately. Using data recorded during the first 60 minutes after treatment, 79% of
lambs were accurately allocated to their correct treatment group. After simplification
of the data, by using the sum of active behaviour including vocalisation, the sum of
abnormal standing postures and the sum of abnormal lying postures, lambs were
allocated to their correct treatments groups as accurately using 60 minutes of data
and more accurately using data from longer observations. The addition of the plasma
concentration of Cortisol did not improve the efficiency with which lambs could be
categorised into their correct treatment group and was therefore considered to
provide a supplementary measure of RR castration pain under these conditions. This
view is supported by Kent et al (1993), who found that the area under the plasma
Cortisol concentration against time curve did not appear to reflect the dramatically
higher expression of abnormal behaviour in RR treated lambs. Indeed, in the
majority of studies the concentration of Cortisol returned to normal levels within 90-
120 minutes (Mellor and Murray, 1989a; Lester et al, 1991; Wood et al, 1991; Kent
et al, 1993; Kent et al, 1995; Dinniss et al, 1997; Graham et al, 1997; Kent et al,
1998; Sutherland et al, 1999; Sutherland et al, 2000), whilst abnormal behaviour was
recorded for up to three hours after application of the rings (Wood, 1991, Molony et
al, 1993; Kent el al, 1995; Molony and Kent, 1997; Kent et al, 1998). Kent et al
(1993) suggested that, as the capacity of the adrenal gland to store and release
Cortisol is not limitless and responses to severe pain may be subject to a 'ceiling'
Cortisol response. By administration of a high dose of ACTH into otherwise
untreated lambs Mellor and Murray (1989a), showed that the Cortisol response to RR
c+td does not represent the maximum possible release of Cortisol from the adrenal
gland. However, the mechanisms of Cortisol release in response to c+td have not
been elucidated and the factors controlling Cortisol release in response to painful
stimulation are different to those that result from systemic administration of
exogenous ACTH. The endogenous HPA response is stressor specific and the
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magnitude of the Cortisol response is dependent upon subtle changes in the synthesis
and release of corticotrophin releasing hormone (CRH) and arginine vasopressin
(AVP) from the hypothalamus, the sensitivity of target tissues to the release of these
hormones and the magnitude of the ensuing pituitary ACTH response (see Chapter
8). Thus, it remains possible that the Cortisol response to RR c+td may have reached
a maximum (Kent et al, 1993). If the plasma concentration of Cortisol is used as the
method of assessment, less pain may be recognised than is actually experienced by
the lambs after RR c+td.
Further analysis in the study by Molony et al (2002) showed that simplification of
the data by grouping the 7 original treatments into 3 categories of pain; severe,
moderate and mild or no pain and using an index of behaviour that included only
abnormal lying and the sum of active behaviour during the first 60 minutes after
treatment, the lambs were allocated to the correct pain category in 91% of cases. In
practical, field conditions, when accurate and rapid assessment of pain in individual
animals must be considered the ideal, categorisation of pain into three such brackets
is likely to be sufficient to allow appropriate treatment to be initiated. More sensitive
grading of pain could then be used under experimental conditions to determine the
efficacy of treatment and to allow adjustments to the treatment. This study provides
clear evidence that the degree of change in behaviour associated with RR c+td is
directly related to the quantity of tissue damaged by the ring and that a simplified
index of quantified behaviour can be used to assess acute pain associated with RR
c+td.
Quantified behavioural measures of acute pain from RR c+td have been used to
validate the use of visual analogue scales (VAS) for the qualitative assessment of
acute pain of RR c+td. Such VAS's may be used by experienced or trained personnel
for rapid, on-farm assessments (Kent et al, 2001). These 'on-farm' methods have
also been used to find practical means by which pain from rubber ring castration and
tail docking can be reduced.
1.6.7. Assessment ofacute pain caused by surgical and bloodless castration and tail-
docking.
C+td by methods other than RR results in different types of tissue damage and
therefore different types of pain. The use of the same behavioural measures to
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quantify and compare acute pain resulting from different methods of c+td has been
attempted, with the aim of determining the relative severity of acute pain caused by
these procedures. Whilst this work has generated useful information about the
comparative effects of different methods of c+td, the limitations of the use of
behavioural assessment, developed for the quantification of acute pain from RR c+td,
to determine the relative severity of acute pain caused by other methods of c+td have
become apparent. There is ample discussion in the literature to demonstrate the
difficulties associated with using Cortisol to compare the effects of different methods
of c+td. A particular case in point is that of the study of surgical and RR c+td by
Shutt et al (1988) who attempted to use behavioural and physiological changes to
determine which method resulted in the experience of least pain. Shutt et al (1988)
described the active behaviours that occur after RR c+td, which were broadly in
accordance with those reported in other studies (Mellor and Murray, 1989a; Molony
et al, 1993). They also described the responses of surgically treated lambs. Surgically
treated lambs flinched and vocalised in response to the cutting of the scrotum and tail
and the removal of the testes. When released they adopted a hunched posture with
splayed legs and remained subdued in the corner of the pen. Shutt et al (1988) also
found that the Cortisol and [3-endorphin response in surgically treated lambs was
much greater than that in RR treated lambs. On the basis of this evidence, the authors
concluded that surgical c+td was less painful than RR treatment. It was supposed that
the significant release of P-endorphin was sufficient to reduce the perception of any
pain that was present and it was considered that there was little behavioural evidence
of pain. Several studies have since reported that the behavioural response to surgical
c+td is very different from that observed in RR treated lambs (Molony et al, 1993;
Lester et al, 1996). Molony et al (1993) found that the behaviour of surgically c+td
lambs was characterised by abnormal standing postures, particularly in older lambs
(21 and 42 days old). In comparison with RR treated lambs, surgically castrated and
tailed docked lambs showed little restlessness. Similarly Lester et al (1996) reported
behaviour predominated by abnormal standing with limited restlessness in surgically
c+td lambs. The nature of abnormal standing in surgically treated lambs in these
studies was qualitatively different from that seen in RR treated lambs. Rather than
showing rolling kicking and restless behaviour like that observed in RR treated
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lambs, surgically treated lambs showed abnormal standing, standing very still
immediately after treatment, moving no part of their bodies, for several minutes at a
time. This behaviour continued for at least 150 minutes after treatment (Molony et al,
1993; Lester et al, 1996). The only movement recorded during this 'statue standing'
was trembling. Minimisation of movement is likely to restrict aggravation of
damaged and sensitised tissue, thus reducing pain (Sanford et al, 1989; Kent and
Molony, 2003), but no conclusion can be drawn about the comparative degree of
pain experienced by surgically treated lambs, with respect to other methods of c+td,
until the significance of statue standing can be elucidated. This can only be achieved
by comparing responses to incremental stages of the surgical c+td procedure.
Validation of the use of suppressed food and water consumption and body weight as
a means of determining the severity of post-operative pain in rats has been
investigated in this way (Liles and Flecknell, 1993). Activation of the HPA axis as a
result of surgical c+td peaked at a similar amplitude to that recorded in RR treated
lambs, but the peak occurred earlier and the concentration remained higher for longer
in 5, 21 and 42 day old lambs (Kent et al, 1993). Lester et al (1996), also found that
the Cortisol response peaked earlier and remained elevated for longer in surgically
treated lambs, but also recorded a higher peak plasma concentration of Cortisol than
was found in RR treated lambs. Thus, in both these studies the area under the
concentration/time curve for plasma Cortisol was significantly higher after surgical
treatment. The earlier peak in the concentration of Cortisol is likely to be the result of
immediate tissue damage caused by the knife (Kent et al, 1993). Lester et al (1991)
found that the plasma concentration of Cortisol did not return to pre-treatment values
until eight hours after treatment. As discussed in section 1.6.4, the conclusions that
can be drawn from measures of activation of the HPA axis are also limited when
comparing results between methods of c+td because the HPA axis can be activated
by a huge number of uncontrollable variables, particularly when comparisons are
made between treatments that result in different types and degrees of tissue damage.
Surgical castration requires an incision to be made in the scrotum and the testes to be
removed by cutting and traction (FAWC, 1994). Such tissue damage results in the
immediate release of inflammatory mediators and they in turn stimulate the release
of CRH further activating the HPA axis (Kent et al, 1995). The release of
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inflammatory mediators results in the stimulation of peripheral nociceptors and in
central and peripheral sensitisation. Inflammatory stimulation of the HPA axis may
be accompanied by an increase in the severity of the pain perceived. Haemorrhage is
also known to result in up-regulation of the HPA axis (Darlington et al 1992) and is
often a consequence of surgical c+td (FAWC, 1994). Sheep show aversion to
personnel encountered during previous aversive experiences (Fell and Shutt, 1989).
Psychological aversion to the handler taking blood samples following surgical c+td
is a likely consequence of the procedure. As the effects of RR c+td do not generally
become apparent until 2-3 minutes after application of the rings (Shutt et al, 1988),
and lambs show no apparent response to the action of ringing (Barrowman et al,
1954; Shutt et al, 1988), RR treated lambs are less likely to associate the experience
of pain with the handler and thus will habituate to restraint for blood sampling more
quickly than surgically treated lambs.
The behaviours exhibited by Burdizzo c+td lambs are also rather different from those
expressed by RR treated lambs. After Burdizzo c+td, lambs characteristically show
abnormal standing (particularly statue standing) and ventral lying postures with leg
extension (Kent et al, 1995). Dog sitting, a ventral lying posture with all four legs
tucked under the body as is seen in dogs, and trembling have also been described in
these lambs (Kent et al, 1995). In Burdizzo treated lambs, the plasma concentration
of Cortisol reached a peak earlier and took longer to decline than that observed in
lambs castrated with standard RRs, but was of smaller amplitude (Kent et al, 1995).
The application of the Burdizzo for c+td crushes tissues in the spermatic cords, bone
and muscles of the tail and connective tissues, as well as crushing the nerves and
blood vessels. This injury is different again from that resulting from surgery and RR
application. Like surgical c+td, tissue injury occurs at the time of treatment resulting
in elevation of Cortisol to reach a peak at a similar time to that reported in response to
surgical treatment (Kent et al, 1993; Kent et al, 1995). HPA activation is also
sustained for longer than that recorded in response to RR treatment (Kent et al,
1995), but again this could be mediated by inflammation, haemorrhage and
psychological factors rather than being reliably indicative of the sustained experience
of pain. In contrast to surgical treatment, the peak in plasma Cortisol is less than that
obtained after either surgery or RR treatment suggesting that the initial injury is not
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as painful as that experienced during RR or surgery. This view is not consistent with
that of Thornton and Waterman-Pearson (1997) who found more sustained
hypoalgesia after use of the combined methods of c+td than was recorded in response
to RR treatment, whilst hypoalgesia was most pronounced after surgical treatment.
Thus when the degree of stimulation of endogenous antinociceptive systems was
considered to be directly related to the severity of pain experienced, these authors
proposed that rubber-ring castration and tail-docking could be considered the least
painful method of castration and tail-docking.
1.7. Chronic effects ofrubber ring castration and tail-docking.
Much of the quantitative research into the severity of pain resulting from RR c+td
has been directed towards the determination of the severity of acute pain experienced
by lambs during the first few hours after application of the RRs. However, concern
regarding the chronic effects of the use of RRs has also been expressed. Within one
week after application of the RRs, the ischaemic skin immediately proximal to and
under the RR begins to break down and an open lesion forms (Barrowman et al,
1953; 1954; Fenton et al, 1958; Molony et al, 1995; Kent et al, 1997; Kent et al,
1999; Kent et al, 2000; Sutherland et al, 2000). These lesions show varying degrees
of swelling, inflammation and sepsis and take 6-7 weeks to resolve (Barrowman et
al, 1953; 1954; Fenton et al, 1958; Molony et al, 1995; Kent et al, 1997; Kent et al,
1999; Kent et al, 2000; Sutherland et al, 2000). In combination with measurement of
the width of the castration lesions, an eleven point scale of lesion severity was
developed by Molony et al (1995), taking into account swelling, erythema and
infection. This scale has been used to follow the changes in lesion severity for six to
seven weeks after application of the rings, until complete healing occurs. A gradual
increase in lesion severity rises to a peak at around 3-4 weeks after treatment and
subsequently gradual healing is observed (Molony et al, 1995; Kent et al, 1997; Kent
et al, 1999; Kent et al, 2000). This scale of severity has also been used to compare
lesions in calves and lambs following the use of different methods of c+td, including
those intended to reduce acute pain, (Molony et al, 1995; Kent et al, 2000) and in
lambs of different ages (Kent et al, 1999). In lambs, the severity of lesions increases
with increasing age (Barrowman et al, 1954; Kent et al, 1999). As the age and
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weight of the lambs increases the quantity of tissue contained within the ring
increases, so that the force applied by the ring is spread over a greater area. As the
integrity of the skin breaks down, the ring effectively cuts through the dying tissue.
Thus, the more tissue displaced by the ring the greater the potential size of the lesion
where the skin and underlying tissues were previously attached. Molony et al (1995)
proposed that, because of the wider distribution of forces from the ring in older,
larger lambs, an incomplete seal between the healthy tissue proximal to the ring and
the necrotic tissue distal to the ring could slow the rate at which the scrotum and its
contents dries out providing conditions suitable for the multiplication of bacteria and
allow micro-organisms or their products to gain access of to living tissue. The use of
the Burdizzo, in combination with the RRs, results in more rapid breakdown of
tissues at the ring and healing of the lesion, but does not reduce the overall severity
of the procedure (Kent et al, 2000). The use of local anaesthetic had no effect on the
rate of lesion healing (Kent et al, 2000).
The presence of the lesion at the site of the RRs is in itself a good indicator that
chronic inflammatory pain is present in these animals. Chemical nociceptors in the
vicinity of the lesion are activated by inflammatory mediators released from
damaged cells, including bradykinin, serotonin and hydrogen ions (see Millan, 1999
for a review). The sensitivity of these nociceptors is also increased by inflammatory
mediators, including bradykinin, the prostaglandins, leukotrienes, histamine,
serotonin, interleukins and substance-P which is released from stimulated sensory
afferent. Thus, the threshold of nociceptor activation is reduced, the occurrence of
spontaneous nociceptor activity is increased and activation in response to non-
noxious stimulation occurs (Levine and Taiwo, 1994). These electrophysiological
changes mean that in the presence of inflammation, more pain is perceived in
response to noxious stimulation (hyperalgesia), pain is perceived following non-
noxious stimulation (allodynia) and pain may occur in the region in the absence of
stimulation. By analogy pressure sores in humans occur as a result of ischaemia,
typically in patients who are bedridden and unable to move themselves frequently to
restore circulation. As the necrotic tissue comes away, patients are left with
inflammatory lesions of varying severity in the dermal layers. These lesions are
reported to be extremely painful (Young, 1990; Hanks, 1991; Jepson, 1992).
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The amputation of the scrotum and its contents and of the tail results in the
destruction of the distal portion of the nerves of the scrotal and tail regions. In limb
amputations, the remaining portion of the transected nerve cells produces axonal
processes in order to re-innervate the amputated tissue. When the growth of these
processes towards the target peripheral structure is obstructed, the axonal processes
intertwine forming balls termed neuromata. These neuromata can spontaneously
produce nervous impulses, particularly at the site of injury, and can result in
peripheral and central sensitisation and therefore chronic, intractable, neuropathic
pain (Devor, 1994). Neuromata have been observed in chickens following beak
amputation (Bernard and Gentle, 1985) and in dogs after tail-docking (Gross and
Carr, 1990) and have been associated with self mutilation in this species. Neuromata
have also been found in lambs, in the end of the remaining tail (French and Morgan,
1992) and may also be present in scar tissue at the site of scrotum amputation. The
presence of neuromata suggests that chronic neuropathic pain may occur after RR
c+td.
Measurement of DLWG has been used to determine the presence of any long-term
effects of rubber ring castration and tail-docking on productivity. Reduced appetite
and consequentially, weight loss or reduced weight gain are associated with chronic
pain in both humans and animals (Chapman, 1985; Kitchell and Johnson, 1985;
Zimmerman, 1986; Short 1998), thus long-term changes in LWG in lambs following
RR c+td could be associated with chronic pain from the lesion. Whilst slight
differences in DLWG are apparent in cattle after RR castration, evidence of an effect
on this production parameter are not convincing, providing little evidence of
significant chronic pain. In cattle, Fenton et al (1958) found that the LWG in RR
castrated calves was lower than that seen in control calves by at least 1kg per week
throughout the first five weeks after application of the rings. The differences were
greatest during the third and fourth weeks after treatment (2.05 and 2.07kg/week for
weeks 3 and 4 respectively), when inflamed lesions were apparent in most or all of
the calves. However, the difference was only significant at P<0.05 on week four.
Similarly, Molony et al (1995) found a difference in DLWG of approximately 0.1kg
between control calves and those castrated with RRs, but in this case the difference
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was not significant. Kent et al (2000) found no differences in DLWG between RR
c+td lambs and controls.
Studies in both calves and lambs have shown that some of the abnormal behaviours
used to measure the severity of acute pain from RR c+td are observed throughout the
6 weeks after treatment, although with much lower frequency. A gradual increase in
the frequency of expression of these behaviours has been observed, peaking at 3-4
weeks after treatment and coinciding with the peak in lesion severity (Kent et al,
1999; Kent et al, 2000). The expression of abnormal behaviours has proven to be a
valid means of quantifying acute pain associated with RR c+td, but as the responses
of the animal are different depending on the degree of chronicity of the pain, there is
no recognised method by which chronic pain can yet be quantified in animals
(Sanford et al, 1986). A relationship between the severity of chronic inflammatory
lesions from c+td and the expression of some abnormal 'acute pain' behaviours has
been recognised and it is possible that their quantification may provide a means of
assessing putative chronic inflammatory pain from these procedures in lambs.
However, the presence of chronic pain (as apposed to discomfort) in these lambs is
yet to be determined and the incidence of abnormal behaviours is low and highly
variable (Kent et al, 1997; 1999; 2000).
1.8. The need for recognition and assessment ofchronic inflammatory pain in lambs
after rubber ring castration and tail-docking.
In 1994 the Farm Animal Welfare Council submitted a report on the welfare of sheep
making recommendations to agriculture ministers that proposed changes to the
practice of RR c+td (FAWC, 1994). FAWC accepted that there was substantial
evidence of acute pain following RR c+td and of little difference in the degree of
acute pain suffered in lambs treated between 1 day and 6 weeks of age. It was also
noted mis-mothering and loss of lambs were common problems of castrating lambs
in the first week of life. FAWC therefore recommended that the use of RRs should
be permitted, without an anaesthetic, in lambs up to six weeks of age, although this
position was to be reviewed when alternative methods of c+td were identified.
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1.9. Aims ofthis thesis.
Thus, FAWC's recommendations emphasised the importance of determining the
presence and significance of chronic inflammatory pain in association with c+td
lesions and the need for validation of possible methods of quantification of this pain.
The recognition of chronic inflammatory pain from RR c+td and the validation of
methods of assessing this pain were the main aims of the studies reported in this
thesis. For the purposes of this thesis the phrase 'chronic inflammatory pain' refers to
pain lasting 6-7 weeks, in association with chronic inflammatory lesions produced by
rubber ring castration and tail-docking. This includes ongoing pain resulting from
continuous activation of sensitised nociceptors at the site of the lesion and episodes
of acute pain from incidental stimulation of sensitised nociceptors. The contribution
of central sensitisation to this pain is unclear. Amputation of the scrotum, its contents
and the tail could result in the formation of neuromas and chronic neuropathic pain
could be experienced both during and beyond resolution of the chronic inflammatory
lesion. Thus neuropathic pain is not considered in these studies.
The studies were carried out to test the following hypotheses;
1. Lambs undergoing castration and tail-docking by tight rubber ring
experience chronic inflammatory pain for 6-7 weeks, in association with
chronically inflamed lesions.
2. The chronic inflammatory pain experienced by lambs is sufficient to induce
changes in their behaviour.
3. Quantification of these behavioural changes constitutes a valid measure of
the chronic inflammatory pain experienced by rubber ring castrated and tail-
docked lambs.
Two strategies were used to test these hypotheses. First, in studies using a self-
administration of analgesic paradigm, the ability of lambs to make a motivational,
discriminative choice was tested, based on their experience of pain and prior
knowledge of the consequences of their actions. It was hypothesised that lambs
experiencing chronic inflammatory pain would learn about the benefits of consuming
a feed containing an analgesic and subsequently select this feed in preference to a
similar alternative that did not contain analgesic. Second, neurophysiological
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evidence of changes in the regulation of the HPA axis that have been associated with
the presence of chronic inflammatory pain from adjuvant induced arthritis, were
sought in the parvocellular region of the paraventricular nucleus of the
hypothalamus. In both sets of studies, the results were examined with respect to the
expression of the abnormal behaviours validated for the quantification of acute pain





Chapter 2. General Methodology
2.1. Animals
All animals were made available from the stock of Moredun Research Institute
(Clinical Division) and were returned to the flock after experiments, following
veterinary inspection, unless otherwise stated.
2.2. Breeds
Three breeds of lambs were used for this research: Dorset x Finnish Landrace,
Greyface x Suffolk and Scottish Blackface. The Dorset ewes were lambed in
December and January allowing experiments to be carried out during January and
February. The Greyface and Blackface ewes were lambed from March to May and
provided lambs for experiments from April to August. It was necessary to change
breeds from Greyface x Suffolk lambs in the year 2000 to Scottish Blackface lambs
in 2001 as Moredun Institute changed stock during the course of this project. This
change was part of the Moredun Institute's program to eliminate problems with
disease on their farms. It is considered that this change affected results.
2.3. Management
The lambs were housed, with their dams, in pens bedded with straw. All animals
were provided with fresh water and hay ad libitum. Ewes were fed 500g of ESCA
Ewe Nuts (SAC, Seafield Mill, protein 18%, fibre 8%) daily, which was divided
between a morning and evening feed. The lambs were given constant access to lamb
creep feed (Nustart Lamb Creep Pellets, Pye-Frankland Balanced Feeds, protein
18%, fibre 8%) and had access to their dam to suck milk. The supply of creep feed
was topped up twice daily unless otherwise stated. The animals were brought into the
experimental environment one week prior to any treatment. At least 3 days before the
experiment began, and at 25-days of age, the lambs were treated with a coccidiostat
(Vexocan, Janssen Laboratories Ltd., lmg diclazuril/kg body weight, 0.25% w/v
solution). A second dose was given before the lambs were returned to the flock.
Before being returned to the flock all lambs were vaccinated (Heptivac) and wormed
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(3% Levacide Drench, Norbrook Laboratories Ltd., Newry, 7.5mg levamisole
hydrochloride per kilogram of body weight.)
2.4. Weighing
All lambs were weighed at the beginning of each experiment, at least 3 days after
being brought into the experimental environment. Whilst the lambs were small
enough they were weighed using a spring balance. The balance was first calibrated
using a 10kg standard weight. A specially designed sling, which supported the
animal by the chest and abdomen, was then used to suspend each lamb under the
balance. Where it was necessary to obtain lamb weights throughout an experiment,
lambs of 7 weeks of age and above were weighed using a flat bed scale with a crate
designed for lambs and a digital display unit. These scales allowed lambs to walk on
and off with little handling. The flat bed scales were also calibrated using a 10kg
standard weight.
2.5. Blood sampling
At least 3 days after being brought into the experimental environment, wool was
shaved from a wide area of the ventral neck of each lamb to expose both jugular
veins. Blood samples (volume depending on experiment) were taken from alternate
jugular veins to minimise vascular damage. 21 gauge 1-inch needles were used and
samples were taken into heparinised tubes (Sarstedt monovettes) that mixed the
blood and heparin as blood is drawn. The samples were immediately cooled to <4°C
in ice and, within 15 minutes, were centrifuged at 3000 rpm for 10 minutes. The
plasma was divided between two plastic tubes and stored at -20°C unless otherwise
stated. The two tubes of plasma could then be used for two separate analyses (HPLC
flunixin and colorimetric analyses for plasma protein or ELISA for prostaglandins).
All blood analyses were completed within 9 months of the sample being taken. All
tubes were labelled with the experiment number, lamb identification number and
sample number. Jugular blood samples could usually be taken within approximately
30 seconds and any effects on the lamb appeared to be minimal.
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2.6. High performance liquid chromatography for extraction and quantification of
flunixin meglumine in plasma
The concentration of flunixin meglumine in the plasma of animals that had been
administered the drug orally or intravenously, was measured using isocratic, reverse-
phase high performance liquid chromatography (HPLC). The specifications of this
technique were recommended and developed in the Department of Veterinary
Pharmacology, University ofGlasgow.
2.6.1. Chemicals and solutions
The following solutions were prepared for use in the extraction procedure:
Citrate/Phosphate Buffer
0.5818g of di-Sodium hydrogen orthophosphate (N2HPO4) and 1,67g of citric acid
powder were weighed out and transferred to 100ml volumetric flask. Distilled water
(glass) was added to make 100ml of solution. The pH was adjusted to 3.0 using 5M
hydrochloric acid. This buffer was stored at 4°C and was used within 60 days (two
months).
Mobile Phase
1 litre ofmobile phase (eluant) was made up using a ratio of 70:30 acetonitrile/ glass
distilled water. 5ml of acetic acid was added to each litre of mobile phase. Mobile
phase was filtered before use using a 0.2pm nylon filter.
Standard Compound Solutions
A range of concentrations of standard solutions of flunixin meglumine was provided
by Ian Gibson at the Department of Veterinary Pharmacology, University of
Glasgow. The method used to prepare these solutions was as follows. lOOmg of
flunixin meglumine was weighed out using an analytical balance (Mettler AE106).
This was transferred to a 100ml volumetric flask. Mobile phase was added to bring
the total volume of solution to 100ml, producing a solution of concentration
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lOOOpg/ml. Further standard solutions of flunixin meglumine were made by serial
dilutions of the 1000pg/ml solution. Solutions were provided at the following
concentrations; O.lOpg/ml, 0.25pg/ml, 0.50pg/ml, l.OOpg/ml, 2.50pg/ml, 5.00pg/ml,
lO.OOpg/ml.
2.6.2. External standards
Four standard solutions at a range of concentrations were used as external standards,
in the HPLC extraction procedure, in order to determine how efficient the extraction
process was. The peak area (mV) for each concentration was compared with that of
internal standard of the same concentration to determine the percentage of recovery
of flunixin meglumine from plasma samples after extraction. The peak areas (mV)
for the range of external standards were also used to provide a measure of linearity of
the standards, ensuring that standard preparation had been accurate. The
concentrations of standards solutions used as external standards were O.lOpg/ml,
0.25pg/ml, 0.50pg/ml and l.OOpg/ml.
2.6.2. Preparation ofinternal standards
500pl of blank plasma (ovine plasma containing no flunixin meglumine) was
aliquoted into six labelled (S1-S6) ground-necked glass tubes. 50pl of mobile phase
was aliquoted into tube SI. 50pl of 0.5pg/ml, 1.0pg/ml, 2.5pg/ml, 5.0pg/ml and
10.0pg/ml standard flunixin meglumine solutions were aliquoted into tubes S2, S3,
S4, S5 and S6 respectively. The tubes were then vortexed for 10 seconds. This
provided plasma samples containing flunixin meglumine (spiked samples) at
concentrations of Opg/ml, 0.05pg/ml, O.lpg/ml, 0.25pg/ml, 0.50pg/ml and
l.OOpg/ml (one in ten dilution of standards).
2.6.3. Extraction offlunixin meglumine from samples
500pl of each plasma sample was aliquoted into a 15ml ground-necked glass tube.
The rest of the procedure was carried out in a fume cupboard; 200pl of
phosphate/citrate buffer was added to each tube and the contents of the tube was
vortexed for 10 seconds. 6ml of chloroform was added to each tube to extract
38
Chapter 2.
flunixin meglumine. The tubes were stoppered and mixed for 20 minutes on a slow
rotary mixer. The samples were then centrifuged at 3500rpm for 20 minutes (Model
J-6B, Beckman Coulter Bioresearch). Centrifugation separated the contents of the
tube into two phases; an aqueous phase that was separated from a solvent phase by a
layer of protein. The aqueous phase was discarded using a glass Pasteur pipette. The
protein layer was pushed aside. 5ml of solvent phase was transferred to a clean glass
tube. These extracts were evaporated to dryness under a stream of oxygen-free
nitrogen using a heated dry block (Techne dri-block) at 50°C. The dried extracts
were stored at 4°C overnight.
2.6.4. Reconstitution offlunixin meglumine extracts
The dried down extracts were removed from the fridge and left to warm to room
temperature for 30 minutes. The extracts were then reconstituted using a minimum of
200pl of mobile phase. The volume of mobile phase used to reconstitute the extract
was increased depending on the expected concentration of flunixin meglumine in the
sample.
The extracts from internal standards were reconstituted using the following volumes
of mobile phase, 200pl, 200pl, 500pl, 200pl, 500pl to extracted standards of
concentrations Opg/ml, 0.05pg/ml, 0.lpg/ml, 0.25pg/ml, 0.50pg/ml and l.OOpg/ml
respectively. After adding the required volume of mobile phase, the tubes were
vortexed for 30 seconds and then sonicated for 2 minutes.
2.6.5. HPLC detection offlunixin meglumine
An HPLC system, provided by the department of Pre-clinical Veterinary Medicine
was used to detect and measure flunixin meglumine in the extracts. This system
consisted of a solvent degasser (Phenomenex, DEGASSEX, DG 4400) to remove
bubbles of gas from mobile phase (eluant) and gradient pump (Pharmacia, 2248) set
to pump the eluant through the column at a flow rate of l.Oml/minute and a
maximum pressure of 3000psi, a sampling valve with a lOOpl sample loop to load
each sample, a guard column (C8, Octyl, MOS, 4.0mm x3.0mm) and a C8 (Prodigy
5, 250mm long, 4.6mm diameter, 5p packing density, Intersil, Hichrom Ltd) column,
a U.V. detector (Pharmacia, LKB VWM 2141), to detect peaks of the components of
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the sample as they come off the column, set for a wavelength of 287nm and a
detection range of-0.1 - 1.0V and EZCROM (Scientific Software Inc., CA, USA)
HPLC data integration software for PC.
Initial equilibrium of the system was obtained with mobile phase by purging all the
lines and then allowing mobile phase to flow through the whole system for 10-15
minutes. Before analysis of samples, the four external standards (concentrations
O.lOpg/ml, 0.25pg/ml, 0.50pg/ml and l.OOpg/ml) and the extracted internal
standards Opg/ml, 0.05pg/ml, O.lpg/ml, 0.25pg/ml, 0.50pg/ml and l.OOpg/ml) were
quantified on the HPLC.
lOOpl of each external or reconstituted internal standard was injected through the
sampling valve, thus loading the sample loop. The valve was then rotated pushing the
sample into the eluant stream. The peak representing flunixin meglumine came
through the column after approximately 7 minutes. EZCHROM was used to calculate
the area under the peak (mV). After every four samples an external standard was
used to ensure no drift would interfere with the quantification process.
The extracted plasma samples were then analysed using the same technique.
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Figure 2.2 Chromatogram output from HPLC analysis of samples containing flunixin
meglumine, (a) the chromatogram following HPLC of an external standard at a concentration
of l.Opg/ml of FM (b) an internal (extracted) standard at the same concentration.
A:\AR04S10 — Channel A
2.5 5.0
Minutes
A:\AR164 — Channel A
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2.6.7. Quantification ofplasma concentration of'flunixin meglumine
For calculation of the plasma concentrations of flunixin the linearity (R ) of external
and internal standards must be > 0.97.
The percentage recovery (%) of flunixin meglumine for each internal standard was
calculated in order to test the efficiency of the extraction technique. The following
equation was used.
% recovery =(intp/extp) x extc x (volrec/volpias) x (100/83.33) x (l/intc) x 100
where:
intp = area of peak of internal standard
extp = area of peak of external standard
intc = concentration of internal standard
extc = concentration of external standard
volrec= volume ofmobile phase in which extracted internal standard was
reconstituted
volpias= volume of original plasma sample
83.33= % of solvent taken to measure recovery (5ml/6ml)xl00
A mean percentage of recovery of >90% was required for all internal standards for
each batch of samples.
The plasma concentration of flunixin meglumine in each sample was then calculated
according to the following equation:
Concentration = samp/extp x extc x volrec/volpias x 100/83.33 x 1/eff x 100
where:
samp= area of peak of sample
eff = mean percentage recovery for run
83.33= % of solvent taken to measure recovery (ie (5ml/6ml)xl00)




Lambs were allocated to treatment group on the basis of live-weight so that each
group contained lambs of a range of weights and so that the mean live-weight for
groups were approximately equal.
Three treatments were used:
Lambs were castrated using tight rubber rings. The rings used had an outside
diameter of 15mm and an inside diameter of 5mm (Paragon Rubber Co Ltd.). In
order to carry out castration the lambs were inverted. Both testes were then squeezed
down into the scrotum. The ring was stretched using an elastrator and the scrotum
and testes were pushed through the ring until it could be released around the neck of
the scrotum.
Tight rubber rings were also used to dock the tail. The length of the tail was felt so
that individual vertebrae could be distinguished. The ring was released so that the
ring was placed between two vertebrae as far as possible. Tails were docked so that
the remaining tail would just cover the anus. The whole castration and docking
procedure normally took no longer than 1 minute. Castration and tail-docking (c+td)
were usually carried out together as one treatment unless otherwise stated.
Control, handled lambs were up-turned in the same way as c+td lambs. The testes
were squeezed down into the scrotum and the tail was held. No rubber rings were
applied before the lamb was released. This procedure took less than 30 seconds.
In the self administration study described in chapter 6 and the first
neurohistochemistry study described in chapter 9, lambs were castrated at 4 weeks of
age. In the second self administration study (described in chapter 7) and in the
second neurohistochemistry study the lambs were castrated at 6 weeks of age.
2.8. Assessment ofchronic inflammatory lesions
The chronic inflammatory lesions resulting from c+td were examined and assessed
twice weekly. Each lamb was caught and turned over for inspection. The presence or
absence of the tail and scrotum was noted. The width of the lesion was measured to
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the nearest millimetre, using vernier callipers. Subjective assessment of the severity
of the lesion was made using the scale described by Kent et al (2000) (see Table 2.1).
Table 2.1. Eleven-point scale used for subjective assessment of the severity of
lesions as described by Kent et al (2000).
Score Definition
0.0 + 0.5 Intact skin with no swelling or reddening. Complete healing with no
residual scab.
1.0 + 1.5 Swelling but skin intact or healing lesion with a scab.
2.0 + 2.5 Severe swelling but skin intact. Also narrow, reddened, ulcerated wound
around the perimeter of the ring, little or no exudate, and slight swelling.
Healing lesion showing scab with underlying scar tissue and exudate
3.0 Wide reddened ulcer surrounding ring, no exudate present. Large lesion,
with exudate and swelling if tail or scrotum gone.
3.5 Reddened lesion with pus and localised swelling.
4.0 + 4.5 Reddened lesion with exudate, pus and extensive swelling.
5.0 Large reddened lesion with much exudate and pus, necrotic tissue and
extensive swelling. Advice from N.V.S. required.
2.9. Behavioural analysis
Observations of behaviour were made by direct observation of the lambs using 3
experienced observers. Observers were first trained to recognise behaviours, either
by direct observation of c+td lambs or by observation of c+td lambs on video tapes.
Observers were spaced in strategic positions around the penned area and on raised
platforms so that every animal could be observed from at least two angles at all
times. The experimental animals were divided into manageable batches for
observation. Each batch included an equal number of animals from each treatment
group as far as possible. No more than 12 animals were observed at any time unless
otherwise stated. Observations were continuous for 2 hours or 3 hours as stated for
each experiment. Observations were recorded directly onto laptop computers using
'The Observer' behavioural analysis software (Noldus Information Technology). All
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observations were made according to the ethogram described in Table 2.2 below.
This ethogram is adapted slightly from that described by Molony et al (1995) for
assessment of chronic pain in calves. The behaviours 'chew' and 'horn' were added
to the original ethogram (Molony et al, 1995) as these behaviours occurred
frequently in penned lambs in at least one experiment. Slight adaptations to the
ethogram for each experiment are described where necessary, for example Greyface
x Suffolk and Dorset Finn lambs do not have horns suitable for use in 'horn'
behaviour.
Active behaviours (see table 2.2) were recorded continuously throughout the
observation time. Every occurrence of behaviour was recorded providing frequency
data. Using 'The Observer' software, this method of observation is described as
'focal animal sampling with multiple actors' and each occurrence of a behaviour is
described as an 'event'.
Postures of lambs were recorded during scan samples every 6 minutes throughout the
observation time. At each scan the lambs' postures and behaviours were recorded.
This data provided an accurate estimate of the proportion of time that lambs spent in
each posture and the proportion of time that lambs spent eating, idling, sleeping and
ruminating. Using The Observer software, postures are described as 'behavioural
states'. The posture for each animal is recorded first and each posture is then
qualified with a 'modifier' behaviour in which the lamb is occupied. For example a
lamb may be described as standing normally (SI, the behavioural state), eating (the
modifier).
Two of the observers were the normal handlers of the animals. During the week prior
to the start of the experiment these handlers spent as much time as possible in the
barn with the animals in an effort to minimise the effect of the observers on the
sheep. Observers were seated on the platforms for at least 5 minutes before
observations started to allow the animals time to settle.
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Table 2.2. Ethogram used during behavioural observations of lambs adapted from
that described by Molony et cil (1995)
Behaviour Abbreviation Definition
Active Behaviour
Restlessness rst Combined frequency of getting up and lying down. Each recording
accounts for one incidence of getting up and one incidence of
lying down. Incidences of lambs rising half way and then lying
down again were included.
Easequarters eq Movement of front or hind leg that is not sufficiently violent to be
considered a kick. Movement of the whole body or hind quarters
and tensing of the hind leg, during resting, in standing or lying
positions after which the location of the animal does not move.
Head turn ht Turning of the head beyond the shoulder to reach the back, flank,
navel, scrotum and inside and outside of hind leg. Grooming
actions included.
Footstamp/ kick fsk Violent raising and lowering of a leg whilst standing, or use of the
leg to kick out in standing or lying posture.
REQ score REQ Combined score of activity calculated by summing rst, fsk and eq.
Itch quarters iq Scratching or rubbing of hind quarters and side on an inanimate
object.
Horn hn Scratching by tilting of head upwards and backwards and/or to one
side so that one or both horn comes into contact with body.
Chew cw Mouthing or chewing bars of pen.
Teat seek ts Attempts to suckle whether successful or not.
Tail wag tw Rapid sideways movements of the tail. Wagging immediately
before teat-seeking not included. Each separate bout of wagging
recorded as one occurrence.
Play Pi Butting others and objects, gambolling, pawing, jumping onto and
down from obstacles. Each bout of play behaviour recorded as
one incidence.
Posture
Normal lying V1, V2 Ventral lying with legs tucked under the body with head down (V1)
or or up (V2).
Abnormal lying V3, Ventral lying with legs partially or fully extended and sitting on
hind-quarters (dog sitting).
Lateral lying LL Lying on side with one shoulder flat on the ground. Legs extended
with head up or down.
Normal standing S1 Standing still, walking or playing with no apparent abnormalities.
Abnormal SS, S2 Standing abnormally still for more than 10 seconds, especially with
standing hind legs slightly apart and with tail tucked in and back arched
(SS). Standing or walking unsteadily with notable abnormalities.
Eat e Eating hay, concentrate, straw-bedding and drinking. Can be
performed lying or standing
Idle i Describes behaviour when the lamb is not performing other
behaviours in ethogram. Can be lying or standing.
Ruminate r Regurgitation of food for further mastication, characteristic chew
motion of jaw, preceded by regurgitation of bolus and followed by
swallowing of bolus. A bout of rumination contains pauses in
between boluses of 5 to 10 seconds when the lamb prepares to
regurgitate the next bolus.






Chapter 3. Pharmacokinetics of Flunixin Meglumine in Lambs: oral and intravenous
administration.
3.1.1. Introduction
There are no analgesics that are licensed for use in sheep. This complicates the
selection of a suitable analgesic for use in this species, both by veterinarians in
practice and for research purposes and could therefore compromise the welfare of the
animals. In studies of self-administration of analgesics, the use of narcotic analgesics
may be problematic because of the potential for the development of physical
dependence and tolerance associated with the administration of these drugs over a
long period of time. For this reason a non-narcotic alternative was sought.
3.1.2. Non-steroidal anti-inflammatory drugs
Non-steroidal anti-inflammatory drugs (NSAIDs) are a group of non-narcotic, anti¬
inflammatory drugs that have proven to have potent, anti-pyretic and analgesic
properties. The principle mechanism by which these drugs act, first proposed by
Vane (1971), is by inhibition of the biochemical pathway leading to the production
of prostaglandins. This mechanism is now classed as one of the defining
characteristics of the NSAIDs (Higgins and Lees, 1984).
Following tissue damage, phospholipids are released from cell membranes. These
phospholipids are broken down by phospholipase A2, releasing arachidonic acid.
Arachidonic acid is converted by the enzyme cyclo-oxygenase (COX) into unstable
intermediate compounds and then converted to prostaglandins and thromboxanes. It
is also broken down by lipoxygenase producing leukotrienes (Cunningham and Lees,
1994). The prostaglandins are constituents of the inflammatory soup of mediators
that can sensitise peripheral nociceptors, thus lowering their threshold of activation
(Lascelles, 1996). They are also involved in vasodilation and increase of blood vessel
permeability (Cunningham and Lees, 1994).
Two isoforms of COX exist (Smith et al, 1994). COX-1 is a constitutive enzyme
expressed in most tissues. The eicosanoids produced by this isoform are critical for
the maintenance of normal homeostatic functions, including maintenance of the
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gastrointestinal (GI) tract mucosa, platelets and blood flow. The second isoform,
COX-2, is synthesised by macrophages and inflammatory cells, only after
stimulation by cytokines and is central to the production of inflammatory
prostaglandins (Papich, 1997).
3.1.3. Cyclo-oxygenase inhibition
Most NSAIDs inhibit both COX-1 and COX-2 and have been found to cause
vomiting, ulceration, bleeding and perforation of the GI tract in dogs (Vonderhaar
and Salisbury, 1993). These toxic effects are mainly caused by the inhibition of
COX-1 (Papich, 1997), but may also be caused by direct irritation of the gut mucosa
by the tablet itself (Haslock, 1998). These effects are more severe in young animals
as their hepatic and renal clearance mechanisms are not mature and the drug takes
longer to be cleared from the system (Papich, 1997).
Some NSAIDs are more specific to the inhibition of one isoform of COX than to the
other, illustrated by the COX-2: COX-1 ratio, (i.e. the ratio of concentrations
required to inhibit COX-2 and COX-1). For example aspirin has a very high COX-2:
COX-1 ratio (i.e. it requires a higher concentration of drug to inhibit COX-2 than
COX-1), whilst those of ibuprofen and carprofen are amongst the lowest (Papich,
1997). Thus, in order to reduce the adverse effects of NSAIDs, the search for new
NSAIDs has centred on the development of COX-2 specific drugs.
3.1.4. Central action ofNSAIDs?
According to the theory that NSAIDs act by inhibition of COX and therefore
prostaglandin production, the action ofNSAIDs should be dependant on the presence
of inflammation. Without inflammation, the drugs should, theoretically, have no
effect on the threshold of response to noxious stimulation. However, there is
evidence that NSAIDs (a particular example is carprofen) can induce analgesia in the
absence of inflammation. NSAIDs have been reported to act on the central nervous
system, preventing central sensitisation after peripheral injury by inhibiting spinal
glutamate and substance P receptors (Malnrberg and Yaksh, 1992). A thalamic site of
action has also been proposed (Jurna and Burne, 1990).
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3.1.5. Flunixin meglumine; a NSAID
The NSAID flunixin is the tri-fluoromethyl derivative of clonixin, and is
administered as the N-methyl-d-glucamine salt, flunixin meglumine (FM) (Ciofalo et
al, 1977). FM is classified as a carboxylic acid (Cheng et al, 1998b) and is a weak
acid with a pH of 5.82 (Johansson and Anler, 1988). It is licensed for use in dogs,
horses and cattle (Welsh et al, 1993) and has been shown to have potent analgesic
effects in humans (Zederfeldt et al, 1977) mice, rats and monkey (Ciofalo et al,
1977), in the donkey (Cheng et al, 1996) and goat (Anderson et al, 1991). The
pharmacokinetics and efficacy of the drug in sheep have recently been investigated,
but these investigations are incomplete.
3.1.6. Flunixin meglumine in the sheep
In a study of the pharmacokinetics of FM in sheep, Welsh et al (1993) found that
there was no significant difference between the kinetic characteristics of the drug
after intravenous administration at 1.0 and 2.0mg/kg body weight, indicating that the
concentration of FM in plasma is directly proportional to the dose in this species. The
drug was rapidly distributed in plasma (2.3 and 2.7 minutes respectively), a rate
similar to that found in cattle (9.6 minutes; Anderson et al, 1990). The elimination
half-lives of FM at 1.0 and 2.0mg/kg i.v. (229.8 and 205.9 minutes) were also similar
to those found in cattle (188.4 minutes; Anderson et al, 1990) and in dogs (220.2
minutes; Hardie et al, 1985). However, the mean body clearance rate was slower
than that found in cattle (Hardee et al, 1985; Anderson et al, 1990), horses, donkeys
(Coakley et al, 1999) and dogs (Hardie et al, 1985).
3.1.7. Intra-muscular administration offlunixin meglumine in sheep
After intra-muscular (i.m.) administration to sheep at 1.1 and 2.2mg/kg body weight,
Welsh et al (1993) found that the bioavailability of FM was at least 70%, which is
again, similar to the bioavailability found in cattle after i.m. administration
(Anderson et al, 1990). FM was found to be absorbed rapidly from the site of i.m.
injection, reaching a maximum concentration of 5.9±0.47pg/ml within 45 minutes
after a l.lmg/kg i.m. dose was administered. Welsh et al (1993) concluded that the
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i.m. route of administration may therefore be suitable in the treatment of acute pain
in the sheep.
3.1.8. Efficacy offlunixin meglumine in sheep
Further studies have shown that FM is a potent analgesic in sheep. When FM was
administered intravenously it significantly attenuated the development ofmechanical
hyperalgesia after the application of a tourniquet to the forelimb of sheep (Welsh and
Nolan, 1994). It was also found to attenuate hyperalgesia resulting from abdominal
surgery (Welsh and Nolan, 1995) and hyperalgesia resulting from repeated
subcutaneous injections of carrageenan (Welsh and Nolan, 1994).
Studies of COX inhibition have shown that, in sheep, FM inhibits COX-2 more
strongly than COX-1 (Cheng et al, 1998b). Thus FM has some COX-2 selectivity in
this species.
The anti-inflammatory effects of NSAIDs are often found to last longer than would
be expected from the plasma concentration of the drug (Cheng et al, 1998a). Studies
in other species have shown that FM preferentially penetrates inflamed tissue, from
which it is eliminated more slowly than from normal tissue (Cheng et al, 1998a).
However, in a tissue cage study in sheep, FM was found in high concentration in
both inflamed and non-inflamed tissue and was eliminated more slowly from these
tissues than from plasma (Cheng et al, 1998a). As it was expected that the
concentration of FM would be higher in inflamed tissue, Cheng et al (1998a)
proposed that in sheep, less of the drug may be bound to protein than in other
species. This would enable penetration of non-inflamed tissue, in which the blood
supply and permeability of blood vessels was normal.
3.1.9. Flunixin meglumine has central actions in sheep
Chambers et al (1995) examined the mechanisms by which FM induces analgesia.
They tested the effects of i.v. administration on the threshold of noxious mechanical
stimulation in both healthy and lame sheep (foot rot). Serum thromboxane levels
were measured to assess COX inhibition. FM treatment produced a small rise in
noxious threshold of both healthy and lame sheep, indicating analgesia. Two
neurotransmitter systems, considered to be of major importance in the processing of
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nociceptive information in the sheep were examined: the opioidergic system and the
a.2-adrenergic system. When these systems were blocked by pre-treatment with
antagonists (naloxone and atipamezole respectively), the rise in pain threshold to
noxious mechanical stimulation caused by FM was prevented. This evidence
suggests that FM produces analgesia in the absence of inflammation and that central
mechanisms, mediated via opioidergic and (^-adrenergic pathways, are involved
(Chambers et al, 1995).
3.1.10. Oral administration offlunixin meglumine
In studies in cattle, by Odensvik (1995) and Odensvik and Magnusson (1996), oral
administration of FM, by consumption of feed coated with drug granules, was found
to be as effective in inhibition of prostaglandins as i.v. administration. Cmax was
reached by 3.5 hours. Inhibition of prostaglandins was found within one hour and
continued until 30 hours when the last sample was taken. It was proposed in these
studies that oral administration could provide an alternative to i.v. administration of
FM in cattle. FM is also administered orally in horses and dogs. In a pilot trial by this
research group, FM was incorporated into feed and administered to lambs at a dose
of l.lmg/kg, the drug reached a Cmax of 1.38 pg/ml within 30 minutes of
administration. However, no information on the pharmacokinetics of FM after oral
administration in sheep has been found in the literature.
3.1.11. Aims ofthe present study
While the pharmacokinetic and pharmacological knowledge on the use of FM in
sheep is growing, certain information was required for the successful use of FM in
studies of self-administration. I.v. doses of both 1.0 and 2.0mg/kg have been
recommended for sheep in the literature (Welsh et al, 1993; White and Taylor, 2000)
and no study has been found that recommends a dose rate for oral administration in
this species.
Pharmacokinetic data from oral administration was required to allow direct
comparisons with data from i.v. and i.m. administration studies and with oral data
from cattle and other species. This information was also required for better design of
the protocol for self-administration studies. For example, the rate at which the
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plasma concentration of the drug rises in lambs dictates the extent of the delay
between consumption of drugged feed and the onset of analgesic effects.
Papich (1997) recommended that in general, animals over six weeks of age can be
treated as adults with respect to drug administration. However, as the animals used in
studies of self-administration span this age group (i.e. 4-12 weeks of age), it was
considered important to determine the pharmacokinetics of the drug in lambs of this
age, for comparison with data from older animals.
The efficacy of FM after oral administration in sheep is also unknown. As discussed
in section 3.1.8, the inhibition of prostaglandins can provide an estimate of efficacy.
The measurement of 15-keto-13,14-dihydro-prostaglandin F2a has been
recommended in sheep as this 1st stage metabolite of PGF2C1 has a longer half-life in
plasma than PGF2C1. It is therefore more accurately measurable and less susceptible
to breakdown during sample collection and analyses than the parent compound
(Odensvik, 1995; Zarco et al, 1988a; 1988b).
No account of the effects of FM on the general behaviour of sheep or any other
species, have been found. Any subtle changes in behaviour resulting directly from
the administration of FM could be misinterpreted during self-administration studies,
when behaviour was to be examined for changes in response to chronic inflammatory
lesions. Thus, examination of the behaviour of healthy lambs, which were
administered with FM, was considered necessary so that this information could be
taken into account in future studies of lamb behaviour involving FM administration.
The aims of this study were therefore to determine the pharmacokinetics of FM in 6-
week-old lambs after oral and i.v. administration at 1.0 and 2.0mg/kg body weight, to
estimate the efficacy of FM by measurement of 15-keto 13,14-dihydro-prostaglandin





3.2.1 Animals and treatments
Twenty eight, six-week-old, healthy, twin, male lambs (Finnish Landrace x Dorset)
were housed in groups with two sets of twin lambs (4 lambs) and two ewes in each
4x4m, straw-bedded pen. The animals were subject to the normal management
procedures outlined in chapter 2 part 2.3. Briefly, animals had continuous access to
fresh water and hay. The ewes were fed 500g of ESCA ewe nuts daily. The lambs
were given constant access to lamb creep feed (Pye-Frankland Balanced Feeds,
Lamb Creep Pellets), in a creep area enclosed within the pen, and had constant
access to their dams to suck milk. Four days prior to treatment the animals were
brought into the experimental environment and the lambs were weighed. The lambs
were divided between the following groups with weight balanced as far as possible
across the groups.
IV1 = Intravenous administration of flunixin meglumine (FM) at a dose of lmg/kg
body weight.
IV2 = Intravenous administration of FM at a dose of 2mg/kg body weight.
01 = Oral administration of FM at a dose of 1 mg/kg body weight.
02 = Oral administration of FM at a dose of 2 mg/kg body weight.
Each pair of twins was assigned to receive either oral or intravenous administration
and one lamb from each pair received flunixin at either 1 or 2 mg/kg body weight.
3.2.2. Administration routes
Finadyne ® Solution (Shering-Plough Animal Health, flunixin meglumine) was
administered intravenously at doses of either 1 or 2mg/kg body weight into one
jugular vein.
For oral administration the dose of Finadyne ® Granules (Shering-Plough Animal
Health, flunixin meglumine) was mixed with 10ml distilled water. The lamb was
caught and a stomach tube was introduced into the reticulo-rumen by either an
experienced shepherd or the named veterinary surgeon. The suspension of Finadyne
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® was introduced using a syringe and was flushed through with 50ml of distilled
water.
3.2.3. Blood sampling
Blood samples were taken at different time intervals depending on the route of
administration of FM. Lambs that received an intravenous dose of FM were sampled
at 2, 5, 10, 20 and 30 minutes and 1, 2, 4, 8, 12, and 24 hours after administration.
Lambs that received an oral dose of FM were sampled at 30 and 45 minutes and 1, 2,
4, 6, 8, 12, and 24 hours after administration. Blood samples were taken as described
in Section 2.5. Briefly, 7ml samples were taken alternately from the left and right
jugular veins starting at the side contralateral to the site of injection of the drug to
avoid contamination. The samples were taken into heparinised tubes, immediately
cooled in ice and, within 15 minutes, were centrifuged at 3000 rpm for 10 minutes.
Plasma was stored at -20°C.
3.2.4. Behavioural observation
Behavioural observations were recorded directly onto 'The Observer' behavioural
analysis software while watching the lambs. Two pens (8 lambs) were observed,
simultaneously, by two experienced observers. Two observation periods of 30
minutes were made 3 and 5 hours after administration of the drug, using the
ethogram described in Section 2.8. The behaviour 'chew' was not recorded on this
occasion.
3.2.5. High performance liquid chromatography for extraction and quantification of
flunixin meglumine in plasma.
The concentration of FM in plasma, of animals which were administered the drug
orally or intravenously, was measured using isocratic, reverse-phase high
performance liquid chromatography (HPLC) as described in section 2.6.
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3.2.6. Enzyme-linked immunosorbent assayfor 15-keto-l3,14-dihydro-prostaglandin
E2a-
In order to provide some estimate of the efficacy of Finadyne ® at the doses
provided during this trial, enzyme-immuno assay for 15-keto-l3,14-dihydro-
prostaglandin F2a was attempted. As there is no commercially available kit for
quantification of this prostaglandin, the method had to be developed from its basic
components. Within the time available the method was not sufficiently successful to
produce reliable results, however a reliable standard curve was produced and slight
modifications to the method could prove sufficient to produce reliable results. The
protocol as developed so far can be found in appendix A.
3.2.7. Pharmacokinetic analyses
The plasma concentration of FM for each lamb was plotted against time and was
subjected to non-compartmental (regression) analysis using the computer program
WINNONLIN (version 4.0 Lexington, KY, USA). Two models were used for the
analysis. For orally administered doses of FM, the extra-vascular administration
model from the WINNONLIN library of non-compartmental analyses was used. The
data for intravenously administered doses were analysed using the bolus IV
administration model. The area under the plasma concentration versus time curve
(AUC or zero moment curve) and area under the product of the concentration x time
versus time (AUMC or first moment curve) for both i.v. and oral data were
calculated using the linear trapezoidal rule, until Tmax was reached. The log
trapezoidal rule was used to calculate AUC and AUMC after extrapolation of the
data from the last sample to infinity. The last four points on the concentration time
curve were used to fit the regression and therefore estimate the slope, lambda z (A.z),
of the terminal elimination phase. The maximum concentration (Cmax), the time at
which the maximum concentration (Tmax) occurred and the elimination half-life
(t'A) were also calculated in WINNONLIN. From these values, further
pharmacokinetic parameters were calculated according to the following equations:
55
Chapter 3.
Mean Residence Time (MRT) - the arithmetic average time that each drug molecule
remains in the system.
MRT = AUMC/AUC
Apparent Volume of Distribution (Vd) - Volume of fluid required to contain the total
amount of drug in the body at the concentration observed after i.v.
administration.
Vd = (Doseiv x MRT) / AUCiv
Mean Absorbance Time for Oral Administration (MAT) - the arithmetic average
time that each drug molecule takes to be absorbed into the plasma compartment.
MAT = MRT0 - MRTiv
Bioavailability (F) - The proportion of the dose that reaches the blood (therefore
biologically active) after oral administration, taking into account absorption
and metabolic degradation.
F = (AUC0 / AUCiv) x 100%
Total Body Clearance (CI) - Rate of elimination of drug by metabolism or excretion.
CI = Dose / AUC
3.2.8. Statistical analyses
Statistical analyses were carried out using Minitab 9 and Genstat 5.2 statistical
analysis packages. All data were tested for normality using the Anderson Darling test
for normality in Minitab. Parametric and non-parametric tests were subsequently
used where appropriate. None of the data were successfully normalised by
transformation.
General linear models (GLM), a version of analysis of variance (ANOVA), were
used to evaluate differences in the concentration of FM and pharmacokinetic
parameters after administration at doses of 1 or 2 mg/kg by oral and i.v. routes.
Variation between groups as a result of the route of administration, the dose and
interactions between the route and dose was sought. Where necessary, post hoc
Student's T-tests were performed to determine where the differences lay. Students T-
tests or Mann-Whitney U tests were used to examine differences between parameters
that applied only to two of the groups.
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Generalised linear models (regression analysis) were used to compare behaviour
between groups. Where differences occurred, post hoc T-tests were used to
determine where the differences lay. Paired T-tests or Wilcoxon Sign rank tests,
depending on the distribution of the data, were used to determine differences
between behaviour of lambs before and after the administration of FM, irrespective




3.3.1. Plasma concentration offlunixin meglumine
The changes in the plasma concentration of FM, after i.v. and oral administration at
lmg/kg and 2mg/kg, for all animals are presented in figure 3.1a-d. The mean plasma
concentration for each treatment group at each time point is shown is also shown in
table 3.1. with the statistical significance of the differences between groups shown in
table 3.2.
During the first two hours after administration, the plasma concentrations of FM
were different depending on both the route of administration and on the dose. These
differences were statistically significant at P<0.01. The difference in plasma
concentration of FM was most noticeable after 30 minutes when the concentration
was shown by GLM to be highly statistically different between groups both in
respect of the dose and the group (P>0.0001 see table 3.2). As expected, the
maximum concentration of the drug in plasma (see table 3.1) was highest in IV2
animals (20.39pg/ml ±7.71) and lowest in 01 lambs (0.91pg/ml ±0.34).
After oral administration the plasma concentration of FM had reached a maximum
by the time the first sample was taken for 1 individual receiving l.Omg/kg and 3
individuals receiving 2.0mg/kg. It is likely that the true maximum plasma
concentration of FM in these animals occurred earlier than the first time point. The
maximum plasma concentration of FM occurred later for one individual receiving
2.0mg/kg FM (at 2 hours after administration).
After 4 hours no difference in the plasma concentration of FM was found between
lambs receiving an oral or i.v. dose (GLM, F3,25=0.79, P=0.384). However, there was
still a significant difference after 4 hours, between the plasma concentrations of FM
in lambs receiving FM orally at the 1.0 and 2.0 mg/kg (Students T-test, T],i3=-6.89,
P=0.0002). This difference in plasma concentration of FM between lambs dosed
orally at the two doses remained significant 12 hours after administration
(0.15±0.06pg/ml and 0.32±0.12pg/ml for 01 and 02 lambs respectively), but there
was no difference between them 24 hours after drug administration.
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Figure 3.1. Change in concentration of FM in plasma of 6-week old lambs during the first 24
hours after administration of the drug, (a) i.v. administration at l.Omg/kg. (b) i.v.
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Table 3.1 The mean (±SEM) concentration of FM in plasma during the first 24 hours after
administration at 1 and 2 mg/kg either orally or intravenously to 6-week old lambs, with the
statistical significance of the differences between groups shown in table 3.2.
Mean Plasma Concentration of Flunixin meglumine (ug/ml)
Time (h) i.V. (1 mg/kg) (+/-SEM) I.V. (2mg/kg) (+/-SEM) Oral (1 mg/kg) (+/-SEM) Oral (2mg/kg) | (+/-SEM) Significance
0 0 0 0 0 0 0 0 0
0.03 11.1 4.19 20.39 7.71 - - - -
0.08 8.593 3.25 16.22 6.13 - - - -
0.17 7.374 2.79 13.98 5.28 - - - -
0.33 6.03 2.28 10.9 4.13 - - - -
0.5 5.13 1.94 8.77 3.31 0.91 0.34 2.26 0.89
0.75 - - 1.10 0.42 2.20 0.83
1 3.82 1.44 6.38 2.41 1.18 0.45 2.43 0.92
2 0.83 0.31 3.39 1.28 0.83 0.31 1.88 0.71
4 1.09 0.41 1.37 0.52 0.61 0.23 1.64 0.62
6 - - 0.48 0.18 1.09 0.41
8 0.28 0.10 0.41 0.15 0.34 0.13 0.60 0.23
12 0.11 0.04 0.23 0.09 0.15 0.06 0.32 0.12
24 0.01 0.00 0.04 0.02 0.03 0.01 0.05 0.02
Table 3.2. Results ofGLM and post-hoc analyses of the differences in concentration of FM
in plasma of 6-week old lambs after administration orally or intravenously at 1 or 2 mg/kg.
Time (h) GLM I.V. (1mg/kg) vs Oral (1 mg/kg) vs I.V. (1 mg/kg) vs I.V. (2mg/kg) vs






0.08 - - T=-3.96, P =0.0023 - - -
0.17 - - T=-5.46, P =0.0003 - - -
0.33 - - T=-4.69, P =0.0009 - - -
0.5 F=97.13, P=0.000 F=22.61, P =0.000 T=4.09, P =0.022 T=-3.49, P =0.013 T=8.05, P =0.0005 T=7.65, P >0.0001
0.75 - - - T=-2.65, P =0.038 - -
1 F=34.17, P=0.000 F=11.37, P=0.003 T=-2.59, P =0.029 T=-2.72, P =0.023 T=-2.05, P =0.0023 T=9.27, P>0.0001
2 F=15.14, P=0.001 F=86.02, P=0.000 T=-8.68, P<0.0001 T=-4.54, P =0.0039 T=0.00, P=1.000 T=4.29, P =0.0013
4 F=0.79, P =0.384 F=4.89, P =0.037 T=-0.72, P=0.49 T=-6.89, P =0.0002 T=1.49, P=0.19 T=-1.03, P=0.33
6 - - - T=-4.25, P =0.0022 - -
8 F=1.51, P=0.232 F=0.41, P =0.530 T—1.21, P=0.25 T=-2.58, P =0.032 T=-0.81, P=0.44 T=-1.57, P=0.15
12 F=2.21, P=0.150 F=16.28, P=0.000 T=-2.12, P =0.057 T=-3.46, P =0.0071 T=-0.94, P=0.37 T=-1.38, P=0.19




A summary of the pharmacokinetic parameters calculated in this study is presented
in table 3.3 as the mean (+SEM). The results of statistical tests of the significance of
the differences in these parameters between groups are summarised in table 3.4.
The Cmax for all four groups were significantly different, confirming results
reported above. The Cmax for the 2.0mg/kg dose was approximately twice that for
the l.Omg/kg dose after both oral and i.v. administration. The time at which Cmax
(Tmax) occurred did not differ between groups 01 and 02 (W=52, P=1.00),
however. One individual, in group 01, showed a Cmax that was twice that of the
other individuals in the group (2.25pg/ml). A second individual, in group IV2, also
showed a much higher Cmax than the other individuals in the group (34.6pg/ml).
The data for plasma FM concentration from a third individual showed very
abnormal, fluctuating results and was eliminated from further analysis.
The MAT for groups 01 and 02 were the same (3.14+ 0.55 and 3.14+ 0.56
respectively, Ti, 13=0.01, P=0.99). This shows that the drug was absorbed from the
gut after oral administration at the same rate irrespective of the dose used.
There was a significant effect of route of administration on the elimination half-life
(t'A). t/2 of FM appeared to be slightly higher after oral administration (GLM, route
F3,25=4.31, P=0.049). Further analysis showed that the difference in t'A was only
significant between 01 and IV1 (Ti, 13=2.26, P=0.045), the groups receiving the
lower dose and was the result of a particularly low t'A in the IV1 group.
The MRT was significantly higher in lambs that were administered the drug orally
than in those receiving an intravenous dose (GLM, route F3>25=33.12, P>0.0001),
reflecting the time taken for the drug to reach the blood after administration. The
dose administered did not however, significantly affect MRT.
The initial examination of the differences in AUC, using GLM, indicated that the
effect of the dose of drug administered had a more significant effect on the AUC than
the route of administration (F3>25=20.61, P>0.0001 and F3j25=14.17, P=0.001




Table 3.3. Means (±SEM) of the pharmacokinetic parameters for FM administered to 6-week
old lambs either orally or intravenously at 1 or 2 mg/kg.
Mean I.V. Mean I.V. Mean Oral Mean Oral
(+/-SEM) (+/-SEM) (+/-SEM) (+/-SEM)
Parameter Units 1 mg/kg 2mg/kg 1 mg/kg 2mg/kg
n=7 n=7 n=7 n=6
CMAX ug/ml 13.21 23.87 1.16 2.64
(+/-1.56) (+/-3.43) (+/-0.19) (+/-0.36)
tMAX h - - 0.75 1.00
(0.75-1) (0-1)
MAT h - - 3.14 3.14
(+/-0.55) (+/-0.56)
t1/2 h 3.04 4.25 4.65 4.67
(+/-0.46) (+/-0.49) (+/-0.54) (+/-0.46)
MRT h 3.16 3.54 6.30 6.67
(+/-0.46) (+/-0.38) (+/-0.58) (+/-0.69)
AUC ug.h/ml 13.22 23.34 6.88 14.76
(+/-2.13) (+/-2.78) (+/-0.93) (+/-1.61)
AUMC ug.h2/ml 42.60 81.90 42.56 96.54
(+/-10.87) (+/-14.09) (+/-5.69) (+/-11.92)
F % - - 61.63 69.45
(+/-16.45) (+/-12.50)
CI ml/h/kg 20.79 19.58 - -
(+/-3.25) (+/-1.94)
Vd(ss) ml/kg 67.05 63.53 - -
(+/-17.36) (+/-8.34)
Table 3.4. The results of GLM and post-hoc analyses to determine differences in
pharmacokinetic parameters between groups after the administration of FM either orally or
intravenously at doses of either 1 or 2 mg/kg. Post-hoc tests were either Student's T-tests or





I.V. (1 mg/kg) vs Oral (1 mg/kg) vs
I.V. (2mg/kg) Oral (2mg/kg)




CMAX F=11.10, P=0.000 F=10.25, P =0.004 T=-2.83, P =0.022 T=-3.58, P =0.006 T=-7.65, P =0.0003 T=-6.16, P =0.0008
TMAX - - - W=52.0, P = 1.00 - -
MAT - - - T=0.01, P=0.99 - -
T1/2 F=4.31, P =0.049 F=1.57, P =0.222 T=-1.78, P=0.10 T—0.03, P=0.98 T=2.26, P =0.045 T=-0.63, P=0.54
MRT F=33.12, P=0.000 F=0.47, P =0.500 T=-0.62, P=0.55 T=-0.41, P=0.69 T=4.18, P =0.0015 T=-3.97, P =0.0033
AUC F=14.17, P=0.001 F=20.61, P =0.000 T—2.87, P=0.015 T=-4.24, P =0.0022 T—2.73, P =0.026 T=-2.67, P =0.026
AUMC F=0.43, P =0.516 F=17.72, P=0.00 T=-2.21, P=0.049 T=-4.09, P =0.0035 T=0.00, P = 1.00 T=0.79, P =0.440
F - - - T=-1.29, P=0.22 - -
CI - - T=0.32, P=0.76 - - -
Vd - - T=-0.18, P=0.86 ■ - "
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This result is shown more clearly by the comparison of AUMC between groups. The
GLM of AUMC showed that the effect of the route of administration of the drug did
not significantly affect (at P>0.05) the magnitude of the AUMC (F3,25=0.43,
P=0.516), but that the dose at which the drug was administered was still extremely
important (F3,25=17.72, .P>0.0001). In fact the AUMC after administration of FM at
2.0mg/kg was approximately twice that from administration of FM at l.Omg/kg
irrespective of the route of administration.
The bioavailability of FM after oral administration was 61.63% (±16.45) and 69.45%
(±12.50) for 01 and 02 lambs respectively. These values were not statistically
significantly different at/?>0.05.
Similarly, the elimination rate (CI) and the volume of distribution (Vd(ss)) did not
change between groups IV1 and IV2 (Ti,i3=0.32, P=0.76 and T1,13=0.18, P=0.86
respectively) showing that these parameters were also independent of dosage.
3.3.3. Behavioural analyses
The results of behavioural observations are shown in tables 3.5 and 3.6. The route of
administration and the dose administered has little effect on the behaviours expressed
by lambs in any group. When the behaviour of all the lambs after the drug had been
administered was compared with the behaviour of the same lambs on the previous
day, again there was little difference in the behaviour expressed. However, during
control observations the day before drug administration, lambs spent more time
eating than they did after the drug was administered (Tij=2.54, P=0.038). There
were no differences in any other behaviour expressed.
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Table 3.5. Summary of behavioural observations in 6-week old lambs after administration of
FM orally or intravenously at doses of 1 or 2 mg/kg. Data are expressed as median (Q1-Q3)
or mean (±sd) depending on the distribution of the data. The data recorded during the two 30
minute observation periods was first summed to provide a measure of behaviour over the full
hour of observation time, (a) summary of posture and behavioural states data, (b) summary
of the frequency of active behaviour.
Behaviour I.V. 1 mg/kg I.V. 2mg/kg Oral 1 mg/kg Oral 2mg/kg
S1 8 20 12 16
(6-22) (16-32) (8-26) (8-26)
V1 0 0 4 0
(0-2) (0-2) (0-4) (0-4)
V2 28 16 24 20
(14-28) (8-24) (12-26) (10-24)
V3 0 0 0 0
(0-0) (0-0) (0-0) (0-0)
eat 4 8 12 8
(2-16) (2-8) (4-26) (6-24)
idle 18.29 25.71 8.57 9.14
(+/-11.04) (+/-11.04) (+/-9.07) (+/-9.72)
ruminate 12 4 12 0
(4-18) (2-8) (2-20) (0-14)
sleep 0 4 4 0
(0-0) (0-4) (0-6) (0-4)
Behaviour I.V. 1 mg/kg I.V. 2mg/kg Oral 1 mg/kg Oral 2mg/kg
restlessness 2.86 2.57 2.29 3.86
(+/-1.70) (+/-1.57) (+/-2.19) (+/-1.51)
easequarters 1.14 0.86 2.00 1.57
(+/-3.42) (+/-2.57) (+/-1.46) (+/-1.07)
teatseek 1 2 1 1
(1-2) (1-2) (0.5-2) (0.5-1)
tailwag 0 0 0 0
(0-0) (0-0.5) (0-0) (0-0)
play 0 0 0 0
(0-0) (0-0) (0-0) (0-0)
headturn 0 1 1 2
(0-0) (0-2) (0-3.5) (0-2)
rub quarters 0 0 0 0





Maximum plasma concentration offlunixin meglumine
The maximum plasma concentrations of FM after i.v. administration were 11.1
+4.19pg/ml and 20.39 ±7.71 jag/ml for 1.0 and 2.0 mg/kg doses respectively. These
Cmax values were much lower than those previously observed in adult sheep
(approximately 22 and 34pg/ml for 1.0 and 2.0 mg/kg doses respectively) (Welsh et
al, 1993). In cattle, Odensvik (1995) found a Cmax of 16.16 ±5.28pg/ml after i.v.
administration at 2.2mg/kg. This is likely to be a reflection of the larger volume of
distribution in this species (Odensvik, 1995).
After oral administration of FM at 1.0 and 2.0mg/kg the Cmax values achieved were
1.18 ±0.45|Lig/ml and 2.43 ±2.43pg/ml respectively. These concentrations are lower
than those achieved after i.m. administration of FM at 1.1 and 2.2 mg/kg in sheep
(5.9 ±0.47pg/ml and 11.0 ±1.97pg/ml respectively). This reflects differences in the
ease with which FM can reach the blood after administration by different routes.
After oral administration, incomplete systemic availability of the drug generally
results, as the drug may be metabolised in the intestinal mucosa or liver (Baggot,
1992). The pH of the rumen is 5.5-6.5 (Odensvik, 1995). The trapping of ions in the
rumen can inhibit absorption significantly, if the drug administered is alkaline. As
FM is a weak acid with a pH of 5.82, ion trapping should not represent a significant
threat to absorption from the rumen. However, the lambs in this study were not
weaned and the suckling of alkaline milk may have neutralised the rumen
environment sufficiently, such that ion trapping was a significant factor reducing
absorption. If absorption was inhibited in this way, lower Cmax values might be
expected after oral administration.
The Cmax achieved after administration at a dose of 2.0mg/kg in the present study
was twice that achieved after oral administration of the drug, at a dose of 2.2mg/kg,
in adult cattle (0.9 ±0.05pg/ml) (Odensvik, 1995). This may be partially because the
drug was administered with a feed, but may also be due to the time taken for
absorption into the plasma compartment and the large volume of distribution in this
species (Odensvik, 1995). As discussed above, it was the Cmax values after i.v.
administration that were lower than those expected in sheep. This evidence refutes
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the proposal that the suckling of milk inhibited the absorption of FM from the rumen
in this study.
The Cmax achieved after i.v. administration at l.Omg/kg was approximately half that
achieved after administration at 2.0mg/kg i.v. A similar result was found for the
Cmax achieved after oral administration at the two doses in this study and is
consistent with data from intramuscular (i.m.) administration in a previous
pharmacokinetic study in sheep (1.1 and 2.2mg/kg doses) (Welsh et al, 1993). This
indicates that in sheep, between doses of 1.0-2.2 mg/kg, the concentration of FM in
plasma is directly proportional to the dose, irrespective of the route of administration.
Time taken to reach maximum plasma concentration offlunixin meglumine
The times taken to reach Cmax (Tmax) were 0.75 (0.75-1) hours and 1.0 (O-l)hours
for 1.0 and 2.0mg/kg respectively, after oral administration. These times were not
significantly different at /><0.05. After i.m. administration of FM in adult sheep, at
1.1 and 2.2mg/kg, Tmax occurred at or before 0.75 and at or before 1 hour after
administration respectively. This shows that, in sheep, FM is as quickly absorbed
into plasma after oral administration as it is after i.m. administration.
A study by Pyorala et al (1999) showed that FM caused the worst tissue damage (of
the drugs tested, including phenylbutazone) in cattle after i.m. administration at
2.2mg/kg, destroying around 80g of tissue around the site of injection. Severe tissue
lesions of this sort may persist for months (George et al, 1995) and have serious
welfare and economic implications, particularly if several injections were required
over a period of time. Oral administration of FM could therefore prove to be a
valuable alternative to i.m. administration.
After oral administration, at 2.2 mg/kg, in cattle, FM took much longer to reach
Cmax (3.5 ±1.0 hours). This time included the time taken for cattle to completely
consume feed containing the granules of drug. However, the concentration of FM in
plasma was sufficient to inhibit prostaglandins within the first hour (Odensvik,
1995). It was concluded that FM reaches effective plasma concentrations within a
few minutes after administration either orally or by i.m. administration in cattle. It is




The mean absorption times (MAT), which is the arithmetic average time that each
drug molecule takes to be absorbed into the plasma compartment, were 3.14 ±0.55
hours and 3.14 +0.56 hours for 1.0 and 2.0 mg/kg doses respectively. The MAT and
Tmax data show that over this range, the dose administered makes no difference to
the rate of absorption ofFM after oral administration in 6-week-old lambs. MAT was
much longer in cattle (6.3 ±1.8 hours) (Odensvik et al, 1995). It would appear
therefore that the rumen in 6-week-old lambs represents less of a barrier to FM
absorption than in adult cattle. Differences in absorption time between these studies
are also likely to be related to the larger volume of distribution in cattle.
Volume ofdistribution
The volumes of distribution (Vd(ss)) previously found in sheep, after 1.0 and 2.0
mg/kg i.v. doses (166.2 ±37.2 ml/kg and 151.8 ±26.3 ml/kg) (Welsh et al 1993) were
more than twice those found in the lambs in this study (67.5 ±17.36 ml/kg and 63.53
±8.34 ml/kg). The Vd(SS) found in this study are also low in comparison with that
found in dogs after a 1.1mg/kg i.v. dose (181 ±79.0 ml/kg) (Hardie et al, 1985). As
mentioned above, the Vd(ss) for FM in cattle (782 ±237 ml/kg) (Odensvik, 1995) after
an i.v. dose at 2.2mg/kg, is extremely high by comparison with that in sheep and
dogs. There was no effect of dose on the Vd(SS) in the present study, which is
consistent with previous studies in sheep (Welsh et al, 1993).
3.4.2. Elimination parameters
Clearance
The dose rate did not affect the rate of clearance (CI) of FM from plasma. CI was
20.79 ±3.25 ml/kg/hr and 19.58 ±1.94 ml/kg/hr for 1.0 and 2.0 mg/kg i.v. doses
respectively. CI in these lambs was very low in comparison with adult sheep; 36 ±1.8
ml/kg/hr and 42 ±1.8 ml/kg/hr (Welsh et al 1993). CI in sheep has been found to be
much lower than in dogs; 63.6 ±13.9 ml/kg/hr (Hardie et al, 1985) and cattle; 115
±11 ml/kg/hr (Odensvik, 1995). Although differences in the modelling of the data in
different studies was considered to be a possible cause of these interspecies
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differences, it was concluded by Welsh et al (1993), that sheep simply clear the drug
more slowly than other species. In the present study, non-compartmental analyses
were carried out using the same programme and models as those used by Odensvik
(1995). Modelling discrepancies therefore cannot account for differences in the CI
observed between these trials. It is likely that the difference between CI in lambs and
adult sheep is caused by the relative immaturity of hepatic and renal clearance in
these younger animals (Papich, 1997).
Elimination half-life
In the present study the elimination half-lives (t'A) after i.v. administration at 1.0 and
2.0 mg/kg were 3.04 ±0.46 hours and 4.25 ±0.49 hours respectively. Again, the dose
having no effect on t'A at p< 0.05. This is comparable with data found in adult sheep
at the same dose rates; 3.83 and 3.43 hours respectively (Welsh et al, 1993), and with
that found in dogs after i.v. administration at l.lmg/kg; 3.67hours (Hardie et al,
1985). Although the CI of FM from plasma was very low in lambs in this study, the
Vd(ss) was also very low. Therefore, there was no overall difference in t'A between
this study and the study by Welsh et al (1993) in sheep. However, the t'A found in
cattle after i.v. administration at 2.2mg/kg was much longer; 5.2 hours (Odensvik,
1995), despite the relatively rapid CI, reflecting the much larger Vd(SS) found in cattle.
After oral administration the t'As were 4.65 ±0.54 hours and 4.67 ±0.46 hours, with
dose having no effect at p<0.05. There was no difference between t'A between oral
and i.v. administration routes at the higher dose rate in this study. After i.v. and oral
administration at l.Omg/kg however there was a small but significant difference in
the t'A. This may reflect the fact that the Vd(SS) was slightly higher (although not
significantly) at the lower dose, whilst the CI at l.Omg/kg was almost exactly the
same as that for the 2.0mg/kg dose. However, in cattle, the t'A was found to be
slightly higher after oral administration than i.v. administration at 2.2mg/kg although
this difference was also not significant. This evidence suggests that a trend for
elimination to take slightly, but not significantly, longer, after oral administration,
such that small differences in the Vd(SS) between oral and i.v. routes, as seen in the
present study at the lower dose, can push this trend into significance. It should be
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noted that the means for the t'A presented in this study are arithmetic means and not
harmonic means as quoted in some other studies.
3.4.3. Parameters incorporating absorption and elimination
Mean residence time
The mean residence time (MRT) is the arithmetic average time that each drug
molecule remains in the system. In the present study, the MRT after oral
administration was twice that observed after i.v. administration, but was not affected
by the dose at /?<0.05. This is also comparable with data from cattle in which the
MRT after oral administration was also twice that observed after i.v. administration;
12.7 ±1.0hours and 6.4 ±1.6 hours for oral and i.v. administration respectively
(Odensvik, 1995). This reflects the time taken for absorption after oral administration
Area under the zero moment curve
The area under the concentration-time curve (AUC) (or area under the zero moment
curve) is directly proportional to the total amount of drug introduced to the plasma
compartment, irrespective of the rate at which it enters. In the present study the AUC
after the 2.0mg/kg dose was approximately twice that observed after administration
at l.Omg/kg, irrespective of the route of administration. This is further evidence that
the plasma concentration of FM is directly proportional to the dose rate over this
range. This relationship was also observed after oral and i.v. administration in cattle
(Odensvik, 1995) and after i.m. administration in sheep (Welsh et al, 1993).
Area under the first moment curve
The area under the concentration x time- time curve (AUMC) (or area under the first
moment curve) further illustrates the direct relationship between the plasma
concentration of FM and the dose administered, by increasing the importance of the
elimination and absorption phases of the curve. As absorption and elimination after
oral administration take slightly longer, these phases are larger on the first moment
curve after oral administration. Thus, the difference between the AUMC for groups
01 and IV1 and between 02 and IV2 is reduced to insignificance, but the AUMC for
administration at l.Omg/kg remains half that observed at 2.0mg/kg.
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Bioavailability after oral administration
Incomplete systemic availability results after oral administration of FM. The drug
may be destroyed by 'first pass' metabolism in the liver or intestinal mucosa. The
absorption of the drug also depends on its ion content and that of the gut content. If
significant ion-trapping occurs in the gut, less of the drug will be absorbed. These
factors are particularly important in ruminant species. The large capacity of the
rumen, accommodating continuous fermentation, significantly dilutes the drug, the
histological structure of the epithelium slows absorption and higher efficiency of
metabolism by the liver all act to reduce the bioavailability of the drug, in
comparison with carnivorous and monogastric species (Baggot, 1992). Comparison
of AUC for i.v. and oral administration at the same dose provides an estimate of how
much of the oral dose reaches the plasma and is therefore biologically active. This is
termed bioavailability (F). After i.m. administration in sheep the bioavailability of
FM was estimated to be 70%. However, this is likely to be an over estimation as the
doses used were not the same for the two routes of administration (1.1 and 2.2mg/kg
i.m. and 1.0 and 2.0mg.kg i.v.). The bioavailability in the present study, after dosing
at 1.0 and 2.0mg/kg both orally and i.v., was 61.6 ±16.5% and 68.5 +12.5%
respectively. The difference was not significant at /?<0.05. This is comparable with
the bioavailability of FM after i.m. administration in sheep (Welsh et al, 1993) and
with that from oral administration in cattle at 2.2mg/kg; 60.1 ±5.0% (Odensvik,
1995).
3.4.4. Prostaglandin inhibition
Attempts to measure the inhibitory effects of FM on prostaglandin were unsuccessful
in this study. However, in comparison with data from studies of prostaglandin
inhibition evidence suggests that the plasma concentrations of FM achieved in this
study after oral administration at both 1.0 and 2.0mg/kg should be sufficient to
significantly inhibit prostaglandins. After oral administration of FM at 1.0 and
2.0mg/kg the Cmax values achieved were 1.18 ±0.45pg/ml and 2.43 ±2.43pg/ml
respectively, reached 0.75 and 1 hours after administration.
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The Cmax achieved after oral administration of FM at a dose of 2.2mg/kg, in adult
cattle was 0.9 ±0.05pg/ml (Odensvik, 1995). This maximum was achieved 3.5 ±1.0
hours after administration (but included the time taken to consume the granules).
However, the plasma concentration of FM after oral administration was sufficient to
inhibit prostaglandins by as much as i.v. administration at the same dose within an
hour of administration. The concentrations of FM achieved after oral administration,
at l.Omg/kg, in the present study exceed those in cattle after oral administration at
2.2mg/kg (Odensvik, 1995) by 0.5 hours after administration. This indicates that, in
the present study, the plasma concentration of FM may well have been sufficient to
induce inhibition of prostaglandins within the first 30 minutes after administration.
Also, Cheng et al (1998a) studied of the selectivity of FM for inflamed tissue and the
resulting inhibition of inflammatory prostaglandins. They found that the Cmax of
FM in exudate was 1.82 ±0.21 pg/ml, which was sufficient to inhibit inflammatory
prostaglandins by 100%. They also found that a plasma concentration of 0.00012
±0.00006pg/ml of FM was sufficient to inhibit inflammatory prostaglandins by 50%,
144 hours after administration.
3.4.5. Behaviour
Observation of the behaviour of lambs in this study revealed no gross behavioural
abnormalities that might be associated with NSAID toxicity. There was a reduction
in the amount of time spent eating after administration of FM irrespective on the
treatment group in comparison with pre-treatment observations. Chambers et al
(1995) identified the opioidergic system and the ot2-adrenergic system as possible
means by which FM could act centrally to induce analgesia, in the absence of
inflammation. One of the unwanted effects of opioids is appetite suppression. The
decrease in eating after FM administration could thus be a reflection of actions of
FM through opioidergic pathways. This might be tested by the co-administration of
an opioid antagonist such as naloxone. Given this hypothesis, it is paradoxical that no
differences in the time spent eating were found between groups during the post-
treatment phase. This refutes the former proposal as the concentration of the drug
and consequently the route of administration and dosage should be important factors
in the development of appetite suppression. The similarity in the occurrence of eating
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however does indicate that the oral gavage methodology itself had no confounding
effect in comparison with i.v. dosing.
3.4.6. Conclusion
The results of this study indicate that oral administration of FM is a suitable, or
possibly better, alternative to i.v. and i.m. administration in sheep, even for the
treatment of severe acute pain. FM reached plasma quickly after oral administration
at both doses and at concentrations sufficient to significantly inhibit inflammatory
prostaglandins. This indicates that the delay between consumption of drugged feed,
during self-administration studies, and the onset of analgesic effects is short, and is
probably less than 30 minutes. Published evidence supports the conclusion that oral
administration is as effective in terms of absorption time and level of prostaglandin
inhibition as i.m. and i.v. administration respectively. As FM is known to penetrate
and remain in inflamed tissue for longer than in plasma (Cheng et al, 1998a), it is
likely that the inhibition of prostaglandins persists for longer than the time taken for
elimination from the plasma compartment. The bioavailability of FM after oral
administration in lambs was also as high as that achieved after i.m. administration in
sheep (Welsh et al, 1993). The results indicate that an oral dose of l.Omg/kg should
be sufficient for use in self-administration trials
FM administration induced a decrease in the amount of time spent eating,
irrespective of the route of administration and the dose. This result must be







Chapter 4. Preference studies and the use of self-administration to determine the
presence and significance of chronic inflammatory pain.
4.1. Introduction
The behavioural and physiological signs of chronic pain are highly variable within
and between subjects (Short, 1998). They are also dependent on the specific
condition and the degree of chronicity encountered (Kitchell and Johnson, 1985).
Self-administration of analgesic was first used to determine the presence of chronic
inflammatory pain by Colpaert et al (1980; 1982), in studies of adjuvant-induced
arthritis (AA). The self-administration protocol was used in these studies to compare
the consumption of an analgesic fluid in arthritic rats with that of controls, in a
preference test paradigm.
In the studies reported in this thesis, self-administration of analgesic was used to
determine the presence of chronic inflammatory pain from castration and tail-
docking in lambs. These studies were based on those by Colpaert et al (1980; 1982)
in rats. In this chapter, the relevance of preference testing to assess the subjective
experience of pain in animals will be evaluated. The use of such tests to investigate
mechanisms by which conditioned feed associations develop in sheep will then be
reviewed. Finally, the use of preference testing theory to determine the presence of
chronic inflammatory pain from analgesic self-administration studies in rats will be
discussed.
4.2. Assessment ofwelfare: the importance ofsubjective feelings/experience
It is generally agreed that how an animal feels and the strength of those feelings
determines, to a greater or lesser extent, that animal's welfare (Dawkins, 1990). In
order to properly assess animal welfare, we must have a means of determining the
type and strength of animals' subjective feelings. The inability of animals to
communicate their feelings verbally remains a challenging barrier (Duncan, 1992),
limiting the refinement of our assessments. Whilst the experience of pain in animals
remains a controversial subject, it is commonly accepted in the field of animal
welfare research, that whilst animal pain may not be exactly the same experience as
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that in humans, it serves the same function and is similarly aversive (Molony, 1986;
Molony, 1992; Molony and Kent, 1997; Dawkins, 1990). The presence of pain can
therefore seriously affect welfare.
4.3. Use ofpreference testing to assess welfare
Using a strategy adopted from early psychological research (Kilgour et al, 1991),
scientists have attempted to overcome the barrier of communication between humans
and animals by providing the animal with an opportunity to express their feelings in
preference tests. In such preference tests, animals are effectively asked how they feel
by allowing them to 'vote with their feet' (Duncan, 1992). In order to make a choice
in a preference test, the animal must have some understanding of the available
choices. To facilitate this, most preference paradigms incorporate a simple pre-test
conditioning period in which animals are given an opportunity to learn the
association between their own actions, the characteristics of the stimulus provided
and the positive or negative consequences of the experience of that stimulus
(Lawrence and Illius, 1997). The positive or negative consequences of the animal's
behaviour in response to the stimulus are reinforcers for that behaviour (Hogan and
Roper, 1978), because they increase or reduce respectively the likelihood of that
action occurring again. The animal thus learns to make an operant response in order
to gain or avoid the stimulus. A simple association may be learned between the act of
locomotion and proximity to the stimulus, but more complex abstract associations
may also be learned (Lawrence and Illius, 1997). The animal is then given the
opportunity to express an informed choice between the options experienced during
the conditioning period. Adaptations of this methodology have been used widely in
animal welfare research in order to draw conclusions about the animal's well being.
In studies in sheep, Rushen (1986b) used latencies of approach as a simple measure
of the relative aversive nature of electro-immobilisation and mechanical restraint
after sheep had experienced both handling procedures during conditioning.
Alternatively, Y- and T-mazes provide a simple and controlled environment in which
animals must choose between two stimuli. The animals are again given a
conditioning period in which they learn the position and nature of the two stimuli in
the maze separately. They are subsequently given access to a maze containing both
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stimuli and allowed to make a choice between them. This approach was also used to
measure the relative aversion to different restraint methods in sheep (Rushen, 1986a).
In other preference studies, animals' use of space may be used to determine preferred
aspects of their environment (Gonyou, 1991). The use of space by animals given
access to more than one controlled environment may be used to infer preferences for
certain aspects of that environment (Nicol, 1997). This technique was used by
Dawkins (1981) to assess cage size preferences in laying hens. Similarly, but in a
less controlled paradigm, use of space was used to demonstrate preferences of sheep
and goats for sheltered areas of their environment just prior to parturition (Gonyou
and Stookey, 1983; O'Brien, 1983). This methodology has also been used in
pharmacology to determine the positive and negative consequences of drug
administration (Carr et at, 1989). In such studies animals are conditioned using drug
administration associated with a distinctive location, and a second location that is not
associated with the drugged state. The preference for both locations is subsequently
tested giving a measure of conditioned place preference. The technique has been
used to assess positive reinforcement from intrinsically rewarding drugs (Mucha and
Iverson, 1984) and as a model to evaluate the pain-relieving properties of analgesics
(Sufka, 1994).
Measurement of the strength of preferences or aversions gives an indication of the
extent to which welfare may be compromised by the inability to access or avoid a
stimulus (Dawkins, 1983; Duncan, 1992). In an expansion of operant conditioning
and associative learning studies, Dawkins (1983) hypothesised that the economic
theory of consumer demand (already used in the field of behavioural ecology) could
be used to demonstrate the strength of preferences in animals. According to this
theory, consumers alter their purchasing patterns to maximise utility (satisfaction),
depending on the availability of economic resources or the cost of the desired items.
If income remains the same but the cost of desired items increases, the purchase of
essential items should be maintained whilst the purchase of non-essential or luxury
items should decline. Similarly if the cost of goods remains stable but income is
reduced, the purchase of such luxury items should again decline.
In more complex operant conditioning tests, animals must learn to perform multiple
actions in order to gain a reward or avoid an undesirable stimulus. For example, in
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studies of feeding motivation, sheep were required to learn to push through a
weighted door in order to reach a ration of feed. When sheep had learned the initial
task, they were then required to do more work in order to reach the feed by adding
weight to the door. Thus, the motivation to reach the feed was tested (Jackson et al,
1999). Alternatively the availability of 'currency' may be reduced by limiting the
time available for performance of a selection of behaviours. The relative necessity of
litter over food was thus tested in laying hens and it was found, unsurprisingly, that
the need for litter was less than that for feed after feed deprivation for 18 hours
(Dawkins, 1983). It is hypothesised that if an animal is highly motivated to carry out
a behaviour (as demonstrated in such operant tests) then non-performance of that
behaviour may constitute significant suffering (Dawkins, 1990).
4.4. Criticisms ofpreference testing
Whilst preference testing is elegant in theory, it is also simplistic and has received
justified criticism on several levels. In any choice paradigm, the preference shown
can only ever be relative to the options given, whether in a simple or complex
environment (Gonyou, 1991; Duncan, 1992). Thus the selected stimulus may either
be the most preferred or the least aversive of the available options, a difference with
major implications for the welfare of the animals concerned (Duncan, 1992). In free
choice tests, the decision to spend a specified duration of the available time in one
environment over another may represent an active choice rather than an expression
of aversion for one particular environment or a preference for another (Duncan,
1992). Also, as Lawrence and Illius (1997) point out, use of consumer demand
theory may result in over restriction of time 'currency' or increases in cost, to the
extent that the animal only has the time or the motivation to express the most critical
behaviours, thus only fundamental physiological needs are detected (Lawrence,
1986).
Variations in preferences within and between animals may also occur as a result of
prior experience of the stimulus. If an animal has little relative experience of one
stimulus, for example wood-shaving litter for a battery reared hen, it is likely to
approach it with caution initially. Later however, with more experience of the
substrate, these birds show a strong preference for litter over wire flooring (Dawkins,
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1981). The degree of arousal and the environmental conditions (e.g. temperature)
may also influence choices made. For these reasons, animals may express different
preferences in their natural environments and the validity of highly controlled testing
paradigms has been questioned (Lawrence and Illius, 1997)
According to traditional operant conditioning theory (theory of equipotentiality), all
animals should be able to learn to perform any behaviour in order to reach any
desirable target (Roper, 1983). However a great deal of evidence against this
hypothesis has since been found. It is now considered that the ability of animals to
learn associations between their actions and the target stimulus are subject to species
specific and task specific constraints. Associations between certain pairings of action
and reinforcer may simply be incompatible (Sevenster, 1973). In these circumstances
an animal may appear not to be very highly motivated to perform a behaviour
(Dawkins and Beardsley, 1986). This was demonstrated in a study by Young et al
(1994), in which pigs were required to interact with different types of manipulanda to
obtain a food reward. The pigs in this study were better able to learn to manipulate a
wooden 'arm' with their mouths than to push a paddle with their snouts to receive a
food reward. It has been suggested that reduced ability to learn an association in such
cases demonstrates that the animal is being asked to make associations between
behaviours that belong to different motivational systems (Hogan and Roper, 1978;
Dawkins and Beardsley, 1986). Thus an animal is better able to learn behaviours, for
example in association with food, that are species typical feeding behaviours (Young
et al, 1994). For these reasons choices offered to animals must be sensible, natural
choices to which animals are likely to be able to express a sensible preference.
In the use of preference testing theory to study the subjective feelings of animals, it is
assumed that animals will make decisions that are good for their welfare (Duncan,
1992). However, an animal will show a preference on the basis of how it feels at that
moment in time and such preferences may not be of benefit to long-term welfare.
Temporal variations in motivation to perform behaviours occur and it has been
supposed that most animals do not have the ability to plan for the whole of a day
(Dawkins, 1990). Dawkins (1983) used the terms proximate and ultimate needs to
describe differences in motivation to perform behaviour at different times.
Behaviours that are required in order for the animal or its offspring to survive, like
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eating, drinking and predator vigilance, might be considered ultimate needs, having
significant evolutionary function. Whereas proximate needs are those motivated
behaviours that are not essential for the animals' ultimate survival. Dawkins notes
that in a captive environment proximate and ultimate needs become disassociated
such that, whilst dust bathing in chickens is a proximate need that relates directly to
an ultimate need in the wild, there is less need to maintain feathers for warmth and
predator evasion in captivity (Dawkins, 1983). For this reason preference studies
have moved away from short-term instantaneous samples of preference, to studies
determining preference over longer periods of time (Lawrence and Illius, 1997).
4.5. Conditioning in response to feeding in sheep.
Domestic sheep are selective close grazers (Angus, 2000) that consume a wide
variety of plant species (Zahorik et al, 1990). The reasons for the extent of the
variation in their diet are not fully understood (Early and Provenza, 1998). However,
sheep select food on the basis of conditioned associations between the characteristics
of the food and unique, systemic and hedonic consequences of consuming that food
(Arsenos and Kyriazakis, 1999). In other words, they show preference and aversion
for feed types on the basis of previous experience.
Garcia and Koelling (1966) demonstrated the classical (or Pavlovian) conditioning of
an association between a food's characteristics and the unique consequences of its
ingestion, in rats. They showed that rats given a novel tasting liquid to drink later
showed aversion to that liquid when sickness was induced experimentally, using
toxins or x-radiation, soon after ingestion. Thus the rats learned to associate the
outcome (sickness) with the taste of the novel liquid. It is thought that all animals use
such conditioned food associations, in conjunction with internal feedback of
physiological needs to consider the choices available in the immediate environment
and to optimally select their diet (Provenza, 1996).
4.5.1. Central and peripheral mechanisms controlling conditionedfood associations
Many mechanisms for the control of feed intake have been proposed (see Novin,
1983 for a review) and no attempt to provide a complete review of the topic will be
made here. Instead pathways that are generally accepted as important to the control
79
Chapter 4.
of feed intake and the formation of conditioned food associations will be
summarised. Sensory characteristics, unique to each food are dictated by its chemical
and physical properties. These characteristics are sensed by chemo-, osmo- and
mechanoreceptors at all levels of the gastrointestinal tract (Glenn and Erickson,
1976; Anil et al, 1993; Mbanya et al, 1993; Smith, 1996). It has been shown that
feed intake cannot be controlled by the selective stimulation of one modality specific
group of gastrointestinal receptors, but that the relative importance of stimulation of
each group of receptors is dependent on the degree to which other groups are being
stimulated. Thus, the degree of gut distension (mechanoreceptor stimulation)
required to significantly reduce food intake is dependent upon the chemical and
osmotic characteristics of the feed (Anil et al, 1993; Mbanya et al, 1993).
Anatomical and electrophysiological studies have shown that sensory information
from these receptors is transmitted along visceral and gustatory nerves to synapse in
the nucleus of the solitary tract (NST) in the medulla. Axons project from the NST to
the parabrachial nucleus (PBN). Visceral and gustatory neurones are also known to
project to the hypothalamus and bed nucleus of the stria terminalis (BNST) and to
the prefrontal and orbitofrontal cortex (the limbic forebrain) (Glenn and Erickson,
1976; Norgren, 1983; Novin, 1983). The importance of these pathways in the
integration of visceral and gustatory information has been shown in studies in which
lesions of these pathways reduced the ability of rats to develop conditioned food
associations (Anil and Forbes, 1980; Crawley et al, 1984; Spector et al, 1992).
Gustatory projections to the thalamus and cortex are accepted, but the degree to
which these areas are influenced by visceral afferent information is unknown
(Norgren, 1983). In studies in which the activity of the cortex was experimentally
reduced using anaesthesia or functional decortication by the application of potassium
chloride onto the surface of the brain, it has been shown that conditioned associations
between foods and the systemic and hedonic consequences of consuming it can occur
without the need for cognitive function (Buresova and Bures, 1973; Burmudez-
Rattoni et al, 1988; Provenza et al, 1994). Thus, it is thought that conditioned
associations develop through (sub-cortical) automatic processing of food
characteristics and sensory feedback (Provenza et al, 1994). Evidence indicates that
the limbic system and the emetic system (Grant, 1987; Mitchelson, 1992), serotonin
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(Leibowitz and Alexander, 1998), noradrenalin (Miner, 1992; Wang et al, 1999),
dopamine (Berridge, 1996), cytokines (Weingarten, 1996), arginine vasopressin
(Brownson et al, 2002) are involved in the formation of conditioned food preferences
and aversions. It is likely that the full complexity of the nervous and hormonal
interactions involved in the formation and expression of feed preferences is yet to be
realised.
4.5.2. Conditioning ofnutritional value offoods in sheep.
Classically conditioned associations between the characteristics of a given food and
its nutritive value have been demonstrated in sheep. For example, Villalba and
Provenza (2000a) conditioned lambs by delivering an intra-ruminal infusion of starch
during grazing on straw, a forage of low nutritive value. In control animals, water
was delivered into the rumen instead. After a period of food restriction, lambs that
were given straw paired with starch infusion during conditioning, ate more straw
than lambs that were given straw paired with an infusion of water. Further studies
have shown sheep do not simply select the most nutritious food, but that their diet
selection is dependant on the animal's nutritional status in relation to the nutrients
provided by available foods. In a study by Kyriazakis et al (1996), lambs were
experimentally infected with a sub-clinical burden of the intestinal parasitic helminth
Trichostrongylus columbriformis. Typically, helminth parasitism reduces growth rate
and disrupts absorption of protein from the small intestine (Coop and Jackson, 2000).
In this study, infected lambs were found to select foods containing a higher
concentration of protein than uninfected control animals (Kyriazakis et al, 1996).
Cosgrove and Neilzen (2000) demonstrated that helminth infected lambs are also
able to select a diet with a higher protein concentration (clover-rich) in the more
complex and natural field environment. These studies both found that the diet
selection made by the lambs reduced the nutritional deficit induced by sub-clinical
parasitic infection, resulting in recovery of growth rate. Furness (1988a) reported
remarkable evidence that wild and feral populations of ruminants are also able to
dramatically alter their diet in order to minimise the effects of nutrient deficiencies.
During observations of ground nesting tern and Arctic skua populations on the
islands of Foula and Rhum, Furness and his colleagues observed characteristic
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mutilations to fledglings that included head, leg and wing amputations, but no
damage to the body. In many cases mutilated birds had survived the attack and the
amputation had healed. Whilst it was not understood why the body of the birds had
not been consumed, these attacks were at first put down to predation by small
carnivores. However, during nocturnal observations of semi-feral Shetland sheep on
Foula, one individual was observed to use its nose to flip over a tern chick and bite
off its legs (Furness, 1988b). Two more sightings of this behaviour were observed in
the flock of sheep of Foula and mutilated birds accounted for 5% of the 4000 chicks
hatched that year. Similar behaviour was observed in red deer on Rhum (Furness,
1988a). Close examination of the mutilated birds showed that in many cases the skin
of the leg or wing remained intact, but that the bones had been selectively removed.
It was proposed that the sheep and deer selected the bones in order to attenuate
calcium and phosphorus deficiencies resulting from poor quality grazing in their
island habitat (Furness, 1988a), although this hypothesis was not tested.
Mechanisms also exist by which sheep prevent excessive intake of any nutrient.
Excessive consumption of nutrients may have as serious adverse effects as deficiency
of nutrients (Forbes and Kyriazakis, 1995). Preference for food of a given nutritive
value will vary depending on the nutritive status of the animal (Provenza et al, 1996)
and is inversely proportional to the number of recent feedback events (Hogan and
Roper, 1978). This theory was demonstrated by Wang and Provenza (1996) who
showed that lambs fed flavoured feeds that were paired with intra-ruminal infusions
of energy or protein, subsequently preferred flavours that had previously been
associated with protein or energy respectively.
Sheep are also able make dietary selections that attenuate the adverse effects of over-
ingestion of nutrients. For example, Cooper et al (1996) fed sheep with a barley-
based ration of high grain content, a feed that can cause ruminal acidosis. These
sheep preferred a ration of feed mixed with sodium bicarbonate over a second ration
that did not contain sodium bicarbonate. In a similar study, Phy and Provenza
(1998a) found that grain-fed lambs preferred fluids containing sodium bicarbonate or
lasacosis. Both sodium bicarbonate and lasacosis reduce grain induced ruminal
acidosis (Ha et al, 1983; Chow et al, 1994).
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Nutrient specific preferences or aversions represent points along a continuum. For
example ruminants tend to prefer foods that are highly digestible resulting in greater
nutritive feedback (Provenza, 1996). However, if the rate of nutrient release is too
high, the animal may become ill (Cooper et al, 1996) and aversion to the food will
follow (Provenza et al, 1996). This was demonstrated by Arsenos and Kyriazakis
(1999) who used intra-ruminal infusions of high and low concentrations of casein (a
source of nitrogen) as nutritive stimuli. After conditioning in which a novel food was
paired with a low dose of casein, lambs showed a preference for that food. However
lambs receiving a high dose of casein later showed aversion to the novel feed.
Evidence shows that sheep are able to select foods to rectify nutrient deficits, avoid
over-ingestion of specific nutrients and attenuate the consequences of over-ingestion
of nutrients. Thus, there is strong evidence that as a result of conditioning, sheep are
able to balance nutritive utility against an internal feedback system that provides
information on the animals' long-term nutritional status. This enables them to show
preference or avoidance towards available feeds along a continuum, selecting those
that will optimally satisfy their nutritive requirements at that time (Forbes and
Kyriazakis, 1995).
4.5.3. Conditioning oftoxicological status offoods in sheep.
Under natural and captive grazing conditions sheep encounter plant species that
contain varying quantities of phytotoxins that have toxic effects on consumption
(Angus, 2000). In good conditions, when sufficient alternative grasses and herbs are
available, sheep are able to minimise their consumption of toxic plants (Angus,
2000). However, in less favourable conditions it may become necessary for
herbivores to consume more phytotoxin-containing plants in order to satisfy
nutritional requirements. It is generally accepted that sheep select a diet that avoids
or minimises consumption of phytotoxins whilst maintaining optimal nutritional
status (Westoby, 1974; Belovsky and Schmidt, 1994). In the majority of studies of
conditioned aversions to toxins in sheep (Provenza, 1996; Kyriazakis et al, 1998),
lithium chloride (LiCl) was the toxin used to study the development of conditioned
associations. For example, in ewes and lambs, 2% of LiCl incorporated into a
palatable feed of rolled barley or rabbit pellets was sufficient to induce conditioned
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aversion to that feed (Thornhallsdottir et al, 1987). In their study conditioned
aversion was maintained, without repeated exposure, for up to 60 days. In a study by
Launchbaugh and Provenza (1994), lambs were exposed to a range of novel feeds
into which LiCl was incorporated at a range of concentrations. The strength of
aversion was found to be proportional to the concentration of LiCl. In a further study
Hills et al (1999) used sulphur to induce feed aversion, and again higher doses of the
toxin were associated with stronger aversion to the feed in which it was incorporated.
Kyriazakis et al (1998) used oxalic acid, a component of many plant species
commonly eaten by ruminants, to study conditioned food aversion. Over
consumption of oxalic acid results in the formation of calcium oxalate crystals in
cells causing cell damage and reduced calcium availability. The effects of oxalic acid
ingestion are more general than those of LiCl, which specifically stimulates the
emetic system, and therefore better resemble naturally occurring toxicity. The results
of the investigation support the conclusions of the studies using sulphur and LiCl
outlined above, with lambs showing greater aversion to higher concentration of the
toxin under these more natural conditions. It should be noted that conditioned
aversions are typically observed in animals that have not shown overt symptoms of
toxicity (Provenza, 1996) suggesting that sheep have evolved strategies to reduce the
risk of toxicosis from ingestion of poisonous plants.
On encountering a novel food, sheep show a tendency to sample only small amounts
initially (Launchbaugh and Provenza, 1994). This food neophobia is considered to be
a behavioural adaptation that helps to prevent toxicosis when sampling potentially
toxic novel foods (Chappie and Lynch, 1986). If illness does not occur, consumption
of novel feeds is gradually increased (Chappie and Lynch, 1986; Chappie et al,
1987a; 1987b). It is frequently observed that, although conditioned food aversions
may be developed following a single experience of the food (Burritt and Provenza,
1991), aversions are not absolute. Sheep show a tendency to continue sampling small
amounts of aversive feeds after an initial aversion has been established
(Thornhallsdottir et al, 1987; Launchbaugh and Provenza, 1994; Hills et al, 1999)
and will increase their intake when the feed is no longer associated with toxin-
induced illness (Thornhallsdottir et al, 1987; Provenza, 1996). This behaviour is
consistent with the theory that sheep use conditioned associations to optimise
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nutrient intake but minimise toxin intake. A further protective adaptation observed
by Launchbaugh and Provenza (1994) is that the aversion learned in response to
illness is generalised to foods with similar characteristics. In their study,
generalisation of aversion became more persistent as the dose of toxin, and thus
degree of malaise, was increased. The risk of toxicosis from related plant species
may thus be reduced in natural conditions.
4.5.4. Constraints on conditioning ofassociations in sheep.
As discussed in section 4.4 learning of conditioned associations is subject to species
specific and test specific constraints (Garcia and Koelling, 1966; Sevenster, 1973;
Roper, 1983; Hogan and Roper, 1983; Dawkins and Beardsley, 1986). Conditioned
responses to foods are no exception to this rule.
4.5.4.1. Discrimination between feeds.
Firstly, in order to develop and maintain a conditioned association, the animal
requires cues by which foods may be distinguished. No association can be learnt if
two foods of differing nutritional and toxicological status do not differ in any other
respect (Forbes and Kyriazakis, 1995). Studies have shown that the relative value of
perceptible cues for discrimination between foods varies between species (Wilcoxon
et al, 1971), but that those characteristics that can be most reliably related to the
specific food are generally the most useful (Forbes and Kyriazakis, 1995).
Flavour and smell are determined by the biochemistry of the food and are therefore
intrinsically linked to the unique consequences of consuming the food (Provenza,
1996). For this reason, flavour and smell represent reliable cues by which foods of a
particular nutritive and toxicological status may be identified and accordingly, are be
the cues that are most relied upon during feed selection. In experimental
manipulations of diet selection in ruminants, cattle, goats and sheep, have been found
to be able use flavour as a cue to discriminate between the nutritive and toxicological
value of feeds (Zahorik, 1990; Kronberg et al, 1993; Arsenos and Kyriazakis, 1999).
In nature, flavour and taste cues are very reliably linked to specific consequences and
as a result associations between certain types of flavour and consequence are easier
for the animal to learn. For example sweet flavours are naturally preferred to sour or
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salt (Sclafani, 1995) and associations between sweet flavour and carbohydrate
infusion are easier to learn than carbohydrate infusions paired with salt of sour
flavours (Ramirez, 1996). Further, sheep show a natural aversion to strong flavours
and smells (Launchbaugh and Provenza, 1994; Baumont et al, 2000), probably
because more intense flavours and smells are naturally associated with phytotoxin-
containing plants (Launchbaugh and Provenza, 1994). However, these constraints are
not absolute and sheep also appear able to learn associations between unusual
pairings of flavour and smell, if exposure is maintained. For example, in a study to
examine the effect of flavour strength on the maintenance of conditioned flavour
aversions, lambs initially consumed less of the food containing the strongest
concentration of oregano flavouring and showed aversion to this flavour when it was
paired with a dose of LiCl. Subsequently however, lambs were given the flavoured
feed that was not paired with LiCl for one day and on the next day they increased
their intake of strongly flavoured feed. Thus when the strongly flavoured, but
nutritious food was no longer associated with malaise, the lambs overcame their
natural aversion to the strong flavour and the previously conditioned flavour aversion
(Launchbaugh and Provenza, 1994).
Texture is also highly specific to particular feeds and it is considered likely that
touch is used by sheep to distinguish feeds (Baumont et al, 2000). Evidence suggests
that sheep tend to select feeds with physical characteristics that make them easier to
manipulate and therefore increase rate of intake (Kenney and Black, 1984; Inoue et
al, 1994). Again, this constraint is not absolute and sheep have been found to be able
to learn associations between foods that are difficult to manipulate and therefore
have a slow rate of ingestion, such as straw, and the highly nutritious stimulus of
protein infusion (Villalba and Provenza, 2000b).
According to the argument that intrinsic characteristics of a feed are the most reliable
cues to consequence, the location of the feed should not be as valuable an indicator
as flavour, smell and texture as there is often no direct association between location
and the nutritional value or toxicological status of the food (Forbes and Kyriazakis,
1995). However, evidence in chickens suggests that the location of the food can be
used as a cue if sensory information about the food is limited (Steinruck et al, 1990
as cited by Forbes and Kyriazakis, 1995). In Steinruck's study, changing the position
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of the test feeds resulted in a decline in selection of the preferred option. The
preference was reinstated after a short time in which the location of the feeds was
relearned. During foraging, in natural conditions with diverse feeding options, sheep
must find a balance between many factors that have an impact on optimal diet
selection, including the spatial distribution of plants within a feeding site (Baumont
et al, 2000). Thus location of feeds may be relevant to diet selection in sheep, as the
position of a desired feed may be learned over time. However, it is generally
considered that food location is less valuable as a cue for the sub-conscious
development of conditioned food associations and that the location-food association
becomes the principle cue only when no other cue is available to distinguish feeds
(Forbes and Kyriazakis,1995).
4.5.4.2. Hedonic characteristics offeeds.
The sensory characteristics of feeds may stimulate hedonically motivated feeding
behaviours and change the strictly physiological basis of the control of diet selection
(Baumont et al, 2000). Flavour, smell and texture are sensory stimuli for which
animals may develop hedonic preferences independent of nutritive or toxicological
considerations. This may explain why sheep often consume clover to beyond the
point of satiety, which can cause illness as a result of over-ingestion of cyanogenic
compounds (Parsons et al, 1994). However it appears that, in common with
nutritionally influenced diet selection, sheep base hedonic selection on the degree of
variety. For example, Wang and Provenza (1996) found that lambs ate more of their
high-energy diet if it contained a variety of feeds, rather than one feed.
4.5.4.3. Effect ofexperience on diet selection.
As mentioned in section 4.5.3, food neophobia is often expressed when novel foods
are offered. Sheep show a tendency to sample small amounts of a novel food until it
is determined whether that food is associated with negative post-ingestion
consequences (Launchbaugh and Provenza, 1994). It has been found that if familiar
flavours and odours are mixed with novel foods, neophobia is reduced (Van Tien et
al, 1999). Conditioning of an association between a novel feed and negative
consequences occurs more easily than an association between a familiar and
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previously harmless feed and negative consequences. For example, in a study by
Burritt and Provenza (1991), lambs were given a selection of novel and familiar
feeds paired with a dose of LiCl. When the learning of conditioned taste aversions
were later tested, conditioned aversions were found with novel but not familiar feeds.
If all the foods with which they were tested were familiar, the lambs avoided the
food that they had eaten the most of during the conditioning meal (Phy and Provenza,
1996). There is some evidence that even flavours experienced in their mothers milk
or in utero result in conditioned associations in lambs (Nolte and Provenza, 1992).
Social experiences also influence preferences as lambs benefit from their mothers
experience by learning what to eat from them. Thornhallsdottir et al (1987) showed
that lambs housed individually ate more of a novel feed than singly housed ewes and
than lambs housed singly with their ewe, even after the feed had been paired with
LiCl infusion to make them ill. It has also been suggested that social influences can
greatly reduce individual variability in food intake (Chappie et al, 1987a; 1987b;
Forbes and Kyriazakis, 1995)
4.5.4.4. Effect ofdelay on the development ofconditioned associations.
It is often considered that the consequences of consuming foods are only realised
after some temporal delay because of the need for digestion and absorption of
nutrients and toxins (Arsenos et al, 2000). This is in conflict with the traditional view
of the rules of association and conditioning, that in order to learn an association, the
consequence must be realised within a few seconds or minutes after the action
(Roper, 1983). In order to investigate the ability of animals to learn despite delays in
consequence, time delays have been incorporated into experimental paradigms.
Zahorik and Houpt (1981) concluded that lambs do not possess the
neurophysiological mechanisms for long-delay learning. However, more recent
evidence suggests that sheep do indeed possess the capacity to learn negative and
positive conditioned associations despite significant delays (30mins - 8 hours) in
consequence (Burritt and Provenza, 1991; Arsenos et al, 2000).
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4.5.5. Selection offeeds to attenuate illness.
As has been discussed in section 4.5.2, studies have shown that sheep are able to
select food to minimise the effects of nutrient deficiencies (Kyriazakis et al, 1996)
and to reduce the effects of excessive intake of nutrients (Phy and Provenza, 1998b).
By extension, it is considered possible that animals can select foods for medicinal
purposes. Observational evidence of food selection for medicinal purposes is widely
reported in the primate literature. For example in three chimpanzee populations along
the Western shores of Lake Tanganika, thirteen plant species have been identified as
being selected for medicinal purposes. Individual chimpanzees showing symptoms of
discomfort and disease have been observed to consume these plants and evidence, for
example reduced faecal parasite egg counts, suggests that they do indeed have some
medicinal properties. Many of these plants were also used by native human
populations to reduce parasite burdens, relieve menstrual pain and headaches and
attenuate malaise. At least half have been shown to have pharmacological properties
consistent with claimed ethnomedicinal effects (Huffman and Wrangham, 1994).
4.6. Chronic inflammatory pain and self-selection ofanalgesic.
In the 1950s and 60s adjuvant-induced arthritis (AA) was developed in the rat in
order to study the pathophysiology of arthritis and to determine the therapeutic
effects of anti-inflammatory compounds on the condition (Colpaert et al, 1980). AA
develops 11 to 16 days after the sub-cutaneous injection of heat-killed
Mycobacterium butyricum, resulting in oedema and inflammation around paws
(especially hind) and joints and radial swellings in the tail associated with each
intervertebral disc (Colpaert, 1987). The development of the condition varies
between individuals, but may persist for several months with the appearance of
deforming joint lesions in some individuals (Pearson, 1963). Rheumatic disease
causes chronic pain in human patients (Burckhardt, 1984) and AA in the rat is
considered to be a satisfactory model of the condition. It was suggested that AA
might also be useful as an experimental model of chronic inflammatory pain
(Colpaert et al, 1980). However, Colpaert et al (1980) considered the evidence
insufficient to move forward with studies in which the relevance ofAA as a model of
chronic pain was only assumed. In order to show unequivocally that AA was
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associated with chronic pain, Colpaert et al (1980) exploited the ability of rats to
learn conditioned associations between consumptive behaviour and post-ingestion
consequences. It was argued that, in arthritic rats, consumption of a solution
containing analgesic would result in pain relief, inducing a conditioned association
between the characteristics of the fluid and analgesia. In a pre-test training period,
during the first 7 days after adjuvant innoculation, control rats (n=24) and AA rats
(n=24) were first familiarised with a palatable saccharin and glucose solution
containing no analgesic provided for one hour each day. At the start of the next week
the rats were deprived of water for two days. On the third day they were offered a
second solution that contained suprofen (0.5mg/ml) and small amounts of sodium
hydroxide during a one-hour conditioning period. On days 4 to 7 of the protocol the
rats were given the opportunity to choose between these two fluids during an hour-
long test period. No other fluid was available to the rats. Measures of body
temperature, weight and paw diameter were made to assess the progress of the
inflammatory process in rats with AA. The volume of each fluid consumed during
the test was measured. The deprivation, conditioning and then choice protocol was
continued until 77 days (11 weeks) after inoculation of AA rats. Following
inoculation, the body temperature of adjuvant inoculated rats initially increased but
then returned to near normal, before increasing again over the last 3 weeks of the
study. The sum of the diameter of the hind paws and tibiotarsal joints was used as a
measure of inflammation. Inflammation increased after the first week, rising to a
peak between 3 and 4 weeks after inoculation when the mean diameter was nearly
25% greater than that in control animals. Inflammation then declined, before
levelling out to a plateau at 6 weeks after inoculation until the end of the study.
Inflammation in AA rats did not decline to reach the diameter measured in control
rats. The body weight ofAA rats declined dramatically during the first 4 weeks after
innoculation, losing more than 20% of their body weight in this time. The weight of
control rats showed no decline and increased gradually throughout the study. The
lowest body weight in AA rats coincided with the peak in inflammation at 21-28
days after inoculation. AA rats were found to consume more suprofen solution than
control animals, but this difference was only found to be significant during weeks 4-
7 (28-49) after inoculation, slightly after the peak in inflammation. The difference in
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suprofen consumption was greatest 5 weeks after inoculation when AA rats
consumed 10% more than controls. Suprofen consumption then declined to near
control levels by 8 weeks after inoculation. At the peak of consumption the volume
of suprofen solution consumed provided a dose of 5.9mg/kg, a dose nearly 5 times
that required to significantly reduce inflammation (Awouters et al, 1975 as cited in
Colpaert et al, 1980). It was concluded that rats suffering from AA self-administered
more suprofen solution than control rats and that the data were consistent with the
hypothesis that AA is associated with significant chronic pain.
In discussion of these results, Colpaert et al (1980) raised several significant
criticisms of their methodology which were later discussed again in analyses of a
later study by the same author (Colpaert, 1987). Firstly, the relevance of the study as
a means of demonstrating chronic pain was questioned as it is possible that the rats
with AA may have selected suprofen in order to reduce inflammation rather than to
reduce the experience of pain. This criticism was put forward because the dose of
suprofen self-administered by rats with AA was considered to be sufficient to
significantly attenuate inflammation (Awouters et al, 1975 as cited in Colpaert et al,
1980). The presence of a time-delay between the peak in paw diameter and the peak
of suprofen intake is inconsistent with this idea. However it is has been argued that
although paw diameter can give an indication of the progress of inflammation in AA,
there are components of the inflammatory process that are not well represented by
this measure of inflammation (Rainsford, 1982). It is therefore possible that suprofen
intake was reinforced by alleviation of inflammatory processes and pain not
indicated by paw diameter (Colpaert, 1987).
In 1980, Colpaert et al suggested that the time-delay between the peak in
inflammation and the peak in suprofen intake in AA rats could be explained by the
slow onset of effects of the NSAID, resulting in a delay in acquisition and extinction
of the conditioned association. This is in accordance with previous studies in rats
which indicated that the development of conditioned associations can occur despite
delays in consequence, but that acquisition of the association can take longer under
these conditions (Garcia and Koelling, 1966). It is also conceivable that a delay in
consequences would result in a delay in extinction of the conditioned association as
rats continued to seek reward. Unconditioned aversion to the taste of the suprofen
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solution is likely to further delay the acquisition of a conditioned association between
the aversive taste and positive post-ingestion consequences.
Colpaert (1987) suggested that because rats were given only sweet solution to drink
in the week following inoculation, those with AA may have developed a conditioned
aversion to its taste because of its association with the onset of disease. Thus whilst
this conditioned aversion may not have been strong enough to overcome the
unconditioned aversion to the suprofen solution, it may have resulted in slightly
elevated suprofen intake in arthritic rats in comparison to controls.
Whilst it is conceivable that rats with AA consumed more suprofen than control rats
in order to reduce pain or inflammation or because of conditioned aversion to sweet
solution, an alternative explanation could be proposed, an idea supported by Shaman
et al (1993). The development in the arthritic condition may result in changes in the
relative hedonic or nutritive status of the suprofen and sweet solutions. In lambs,
physiological imbalances caused by nutrient deficiency (Furness, 1988a; 1988b) and
excess (Wang and Provenza, 1996) and by parasitism (Kyriazakis et al, 1996)
induced changes in diet selection that attenuated adverse effects. Thus it seems
reasonable to suppose that AA in the rats resulted in changes in the relative
preference for the flavour of the two test solutions. Thus either preference for sweet
solution might be reduced, indirectly increasing the intake of suprofen, or the
preference for suprofen solution might increase. The pattern of change in relative
preference would still be associated with that of the development and resolution of
inflammation and could show a time lag with respect progression of inflammation,
because of a delay between changes in the inflammatory process and realisation of
adverse effects.
It should be noted that the differences in intake of suprofen solution between groups
was less than 10% for the majority of the study and that the variability of intake
within groups was high. Colpaert et al (1980) artificially reduced this variation
within groups, by combining the data for the four tests days of each week and it was
on this data that statistical analyses were based. Thus, the difference between groups
was exaggerated. Because the variability in suprofen intake within groups was high,
it is likely that the variation in the active concentration of the suprofen in the blood
was also high. However, as the plasma concentration of suprofen was not measured,
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the significance of differences in plasma suprofen between groups could not be
determined. In a study of self-administration of carprofen in lame broiler chickens,
the effect of variation in feed intake on the resulting plasma concentration of
analgesic was demonstrated (Danbury et al, 2000). Danbury et al (2000) used a
similar protocol to that described by Colpaert et al, 1980; 1982), using lame and
sound broiler chickens with access to drugged and undrugged, differently coloured
feeds. After a conditioning period, the birds were given a choice of the two feeds. A
formula to accommodate the continuing overall increase in lameness was
incorporated into the analysis and the results indicated that lame birds with access to
analgesic ate significantly more analgesic feed than sound (control) birds (P0.001)
and showed a slight preference for analgesic feed over the undrugged alternative.
However there was no significant difference in the plasma concentration of
carprofen, suggesting that the differences in intake observed were insufficient to
result in measurable differences in the active concentration of the drug in blood.
Thus the evidence of self-administration was weakened.
In order to address some of their own criticisms of the original study, Colpaert et al
(1982) demonstrated self-administration using the opiate analgesic fentanyl. Fentanyl
has little anti-inflammatory action and a rapid onset of analgesic effects after oral
administration (Niemegeers et al, 1976 as cited by Colpaert et al, 1982; Colpaert et
al, 1982). Thus, the use of fentanyl eliminated the possibility that AA rats selected
analgesic for anti-inflammatory properties and reduced the likelihood of a delay in
acquisition of the association. The protocol was adapted from that in the previous
study. Suprofen solution was replaced with fentanyl dissolved in tap water at a rate
of 0.008mg/ml and two further control groups (one untreated (n=29) and one
inoculated with adjuvant (n=28)) were included in a second experiment. In this
second experiment, rats were not exposed to the analgesic solution but had a choice
of only sweet solution or tap water, to control for differences in the hedonic and
nutritive value of the solutions. The frequency of vocalisation was recorded as a
measure of 'irritability', a behavioural sign characteristic of chronic pain in humans
(Procacci et al, 1979). The intake of fentanyl solution in AA rats was initially higher
than that in control animals and declined more slowly. Fentanyl intake in AA rats
significantly exceeded that in control animals during weeks 3, 4 and 5 of the study. It
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was also noted that the peak of fentanyl intake in AA rats occurred during the third
week after inoculation and coincided with the peak of inflammation and thus there
was no time-delay between decline in intake of analgesic and decline in
inflammation. In the analgesic control groups, water consumption was very stable
throughout the study and accounted for a mean of 7% of the total fluid intake in both
control and AA rats. This was higher than the consumption of fentanyl dissolved in
water by the control rats indicating that the taste of fentanyl itself was aversive. The
intake of fentanyl solution in AA rats exceeded 7% of total fluid intake during the
first four weeks after inoculation, indicating that AA rats selected more fentanyl than
control rats despite the aversive flavour of the analgesic. The volume of analgesic
fluid consumed by AA rats corresponds to a dose of 0.44-0.24mg/kg, a dose known
to increase tail-flick latencies in acute pain studies (Niemegeers et al, 1976 as cited
by Colpaert et al, 1982). However it was noted that this dose did not appear
sufficient for control rats to overcome the aversive nature of the fentanyl solution and
find the narcotic properties of the opioid solution reinforcing for hedonic reasons. A
peak in the rate of vocalisation was observed that coincided with the onset and peak
of inflammation and fentanyl intake and was also considered to be consistent with
the presence of chronic pain. Similarly an initial sharp decline in body weight and
subsequently lower growth rate, was observed in AA that did not receive analgesic.
A reduced growth rate was also found in the previous study (Colpaert et al, 1980)
and is significant as it is characteristic of a depression-like condition associated with
chronic pain in humans (Zimmerman, 1986). A comparison of the weight of AA rats
with and without access to analgesic would have provided a potential means of
determining the significance of the effect of analgesic administration. However, the
body weights of AA rats with access to analgesic were not measured and this
comparison could not be made. Rats with AA vocalised more often than control
animals in this study (Colpaert et al, 1982). Because fentanyl has no anti¬
inflammatory action, the increased intake of the analgesic solution in this study could
not have been induced by conditioned association of an anti-inflammatory effect.
Further, arthritic rats with a choice of sweet solution and water (but no analgesic) did
not select more water than non-arthritic rats. This evidence refutes the suggestion
that rats developed a conditioned aversion to the sweet solution during the post-
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inoculation familiarisation period, inducing a measurable increase in consumption of
analgesic solution. The evidence given in this study does not answer the criticism
that the relative hedonic status of sweet versus analgesic solution might be altered by
the arthritic condition. This effect could also be closely associated with the temporal
progression of the disease.
Also, as in the previous study, the variation within groups was such that a significant
effect of AA on fentanyl intake could only be found when the data for the four days
of choice in each week were combined, thus artificially reducing variation. Again the
plasma concentration of analgesic was not measured. The dose of fentanyl reached a
maximum of 0.44mg/kg, a dose sufficient to increase thresholds in tail-flick latency
tests. However fentanyl intake only differed between groups by a maximum of 11%
throughout the study. Again concentrations of fentanyl in blood were not measured
and it is therefore not known whether the small difference in intake of fentanyl,
accompanied with wide variation, resulted in a significant difference in the plasma
concentration of fentanyl between groups.
In a further study reported in 2001, Colpaert et al incorporated many more controls
into the self-administration protocol in order to show with more certainty that self-
administration of fentanyl occurred as a result of analgesic reinforcement in a
chronic pain condition and not as a result of hedonic sensations associated with the
opioid analgesic. Using the self-administration protocol reported in two previous
studies Colpaert et al 1980, 1982), rats were given the opportunity to experience the
effects of the consumption of fentanyl solution in a conditioning period. They were
then given the choice between the analgesic solution and a familiar and highly
palatable sweet solution containing glucose and saccharin in a preference test. Within
this experimental paradigm, further treatment groups (n=9-17) were included in order
to control for opioid dependence in control and arthritic rats. In one group, rats were
fitted with a sub-cutaneous osmotic mini-pump that delivered the steroid
dexamethazone at a constant rate. Similarly pumps delivering naloxone
hydrochloride and fentanyl citrate were implanted sub-cutaneously in other groups.
The pumps were implanted on day 14 and removed again on day 28 after inoculation
and the effects of these treatments on the occurrence of self-administration of
fentanyl were recorded. It was concluded that self-administration had occurred,
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reducing the sensation of pain from AA. Firstly AA rats consumed more fentanyl
solution than control animals, in keeping with previous studies. Continuous infusion
of dexamethazone, dramatically reduced inflammation and resulted in a dose
dependant decline in intake of fentanyl solution in AA rats. At the highest dose of
dexamethazone, fentanyl intake was reduced to the same level observed in control
rats and is consistent with a reduction in pain caused by the steroid treatment.
Infusion of naloxone also reduced fentanyl self-administration, although by less than
dexamethazone (55% and 65% reductions respectively). However, it is known that
intermittent reinforcement of a behaviour once linked with positive reinforcement,
results in a more stable maintenance of that behaviour than a reliable reinforcement
schedule (Roper, 1983). This may explain why naloxone treatment did not result in
total loss of the self-administration phenomenon. However, according to this theory
an initial increase in fentanyl consumption would have been expected.
Infusion with fentanyl also resulted in a decline in fentanyl self-administration. This
result indicates that self-administration occurred as a result of analgesic
reinforcement of fentanyl consumption and not because of hedonic reinforcing
properties of the opioid solution. Both dexamethazone and fentanyl treatment
resulted in an increase in the overall consumption of fluid during the hour-long test
period whilst naloxone treatment did not. This result refutes the suggestion (Shaham
et al, 1993) that the perception of the taste of the analgesic solution is altered
somehow in the arthritic condition resulting in hedonic reinforcement of the solution
in arthritic rats.
A criticism, identified by Colpaert (1987), that applies to all these studies and
remains unanswered by changes in protocol is that, whilst self-administration of
analgesic may indeed represent the presence of chronic intractable pain from AA, it
could also be a reflection of the presence of acute secondary pain as a result of
hyperalgesia and allodynia. The presence of chronic pain cannot therefore be
determined absolutely from these studies.
4.7. Conclusion
In conclusion, whilst preference testing and the ability of animals to leam
conditioned associations may be used to aid determination of subjective experiences,
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these studies are subject to many species and individual specific constraints that limit
conclusions. Despite this, these techniques have been used with success to study
factors involved in the selection of foods in sheep and many of the behavioural and
physiological mechanisms that result in specific selections have been deduced. It has
been shown that sheep are able to learn to select feeds on the basis of learned
positive and negative associations between characteristics of the feed and the
nutritive and toxic effects of their consumption. In contrast with traditional views of
associative learning, it has also been shown that sheep are capable of learning these
associations when there is a considerable delay between cue and consequence.
Previous experience, social influences and natural constraints on learning modify
preferences and the aversions shown by individuals and these effects must be
controlled for in preference studies. The ability of rats to learn conditioned
associations between the characteristics of fluids and the effects of their consumption
has been used in preference studies to determine the presence of chronic
inflammatory pain from AA. These studies indicate that rats are able to learn the
association between a novel-tasting liquid containing an analgesic and its pain-
relieving properties, thus indicating the experience of pain in rats with AA.
97
Chapter 5
General Methodology for Self-
administration studies
Chapter 5.
Chapter 5. Self-administration studies: General Methodology
5.1. Animals and management
Single, male lambs were housed in straw bedded pens (1.6 x 3.2m) with their dams.
Pens were adjacent to one another and encompassed a creep area in which lambs
could obtain feed without competition from the ewe. In keeping with general
management procedures (see Section 2.2), the animals had ad libitum access to hay
and fresh water at all times. The ewes were fed 500g of ESCA Ewe Nuts (SAC,
Seafield Mill, protein 18%, fibre 8%) daily. Lambs had access to their dam to suck
milk. Lambs also had access to creep feed (Nustart Lamb Creep Pellets, Pye-
Frankland Balanced Feeds, protein 18%, fibre 8%) which was provided in
accordance with the protocol required for the self-administration experiments.
5.2. Experimentalfeeds
Two experimental feeds were used in the self-administration protocol:
The un-drugged feed was commercially available creep feed (Nustart) with nothing
added. To produce analgesic feed, powdered creep feed pellets (Nustart) were mixed
with Finadyne® granules (flunixin meglumine, Shering-Plough Animal Health) and
then repelleted (Roslin Institute Feed Mill). In these studies Flunixin meglumine
(FM) was to be administered orally at a dose of l.lmg/kg of body weight. The drug
was incorporated so that 1.1mg of FM was contained within 2.8g of re-pelleted creep
feed. A full dose for a 40 kg lamb was therefore contained in 112g of feed. The re-
pelleted creep pellets were the same diameter as the original creep feed but were
paler in colour. It was considered likely that the analgesic feed had a different taste to
the un-drugged feed although no attempt was made to confirm or define this taste
difference.
5.3. Treatments
The 28 lambs were weighed and assigned to four groups so that live-weight was
balanced across groups, with seven lambs in each group (n=7). The location of the
lambs within the barn was balanced as far as possible so that an equal number of
lambs from each group were positioned towards the outside, inside and close to
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aisles. This was to attempt to ensure that any variables resulting from the
experimental environment had an equal effect across groups.
The animals were brought into the barn one week prior to any treatment to ensure
that they were acclimatised to the environment and that they were eating creep feed.
The daily consumption of creep feed was recorded, for each lamb, during the week
prior to the beginning of the experiment, so that the amount of creep feed available
could be adjusted to account for appetite.
Two groups of lambs were castrated and tail-docked (C) using tight rubber rings.
Two groups of lambs were handled (H), as necessary for castration and tail-docking,
but no rings were applied. (A full description of the methods for castration and tail-
docking and handling of controls can be found in Section 2.7.)
One castrated and tail-docked (C) group and one handled (H) group of lambs were
then assigned to 'drugged' (D) treatment. These animals had access to one hopper
containing analgesic feed and a second hopper containing un-drugged feed during the
self-administration experiment. The second castrated and tail-docked (C) group and
the second handled (H) group of lambs were assigned to 'non-drugged' (N)
treatment. These animals had access to two hoppers, both containing un-drugged
feed during the self administration experiment. Both hoppers were placed at the back
of the creep area for all lambs. These treatments are outlined in Table 5.1.
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5.4. Pen layoutfor experimentalprocedure
Figure 5.1 (a) A diagrammatic representation of the pen layout during the self-administration
experiments. The lamb and ewe had access to water (blue) and hay (yellow). The ewe was fed
her daily ration in a feed bucket (brown) to which the lamb had limited access. A creep gate
divided the pen into two areas so that the lamb had access to the whole pen but the ewe could
not enter a test area where the test feeds were available. The hoppers containing the analgesic
(red) and un-drugged (green) test feeds were placed at the back of the pen, but the side at
which the different feeds were placed was balanced across groups. CN and HN lambs were
given two hoppers containing un-drugged feed, (b) Photograph showing pen layout during
self-administration experiments.
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5.5. Colorimetric determination of total plasma protein and albumin
The total concentration of protein and the concentration of albumin in the plasma of
the lambs was determined by quantitative colorimetric analysis. The long-term
administration of flunixin meglumine, a non-steroidal anti-inflammatory drug, may
cause adverse effects. Increased plasma protein may indicate dehydration potentially
caused by reduced absorption of liquid, because of reduced integrity of the gut wall.
Total plasma protein and albumin were therefore measured to provide some
indication of any adverse effects of the NSAID.
5.5.1. Assayfor totalprotein
The total protein analysis kit (Sigma Diagnostics) is based on the biuret reaction,
where the copper ions in the blue alkaline reagent, react with the peptide bonds of the
proteins producing a purple solution with a maximum absorbance at 540nm. The
intensity of the colour is proportional to the concentration of protein in solution.
5.5.2. Total protein assay protocol
Plasma samples were removed from storage at -20°C and thawed at room
temperature. They were inverted several times once thawed.
10 tubes were labelled blank (B) (distilled water), two controls (CI and C2) (one of
normal and one of abnormal protein concentration (Accutrol™ Sigma Diagnostics),
and protein standards (S1-S5) (concentrations of 2, 4, 6, 8, and 10 g/L) (Sigma
Diagnostics). Sufficient tubes were also labelled for each animal sample (1,2...).
1.0ml of total protein reagent (Sigma Diagnostics) was aliquoted into each tube. 20pl
of distilled water, was aliquoted into tube B. 20pl of normal protein concentration
control was aliquoted into tube CI and 20pl of abnormal protein concentration
control was aliquoted into tube C2. 20pl of each standard was aliquoted into tubes
S1-S5. Finally 20pl of each sample was aliquoted into the sample tubes. The tubes
were then inverted gently several times to ensure thorough mixing. The tubes were
incubated for 10 minutes at room temperature.
200pl from each tube was aliquoted, in duplicate, into a 96 well plate for
measurement of absorbance (Dynex MRX TCII Microplate Reader and Revelation
software, © Dynex Technologies U.K. Ltd). The absorbance was measured at
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540nm. The total protein concentration was then calculated according to the
following equation.
Total Protein (g/L) — (Asam/Astandard) X Cstandard
where Asam = absorbance of sample
Astandard= absorbance of standard
Cstandard= concentration of standard
5.5.3. Assayfor albumin
The albumin reagent (Sigma Diagnostics) used contains bromcresol green (BCG).
Albumin binds to BCG producing a blue-green colour with a maximum absorbance
at 628nm.
5.5.4. Albumin assay protocol
Plasma samples were removed from storage at -20°C and thawed at room
temperature. They were inverted several times once thawed.
10 tubes were labelled blank (B) (distilled water), two controls (CI and C2) (one of
normal and one of abnormal albumin concentration (Accutrol™ Sigma Diagnostics),
and albumin standards (S1-S5) (concentrations of 2, 4, 6, 8, and 10 g/L Sigma
Diagnostics). Sufficient tubes were also labelled for each animal sample (1,2...).
1.0ml of BCG (Sigma Diagnostics) was aliquoted into each tube. lOpl of distilled
water, was aliquoted into tube B. 1 Ojul of normal albumin concentration control was
aliquoted into tube CI and lOpl of abnormal albumin concentration control was
aliquoted into tube C2. lOpl of each standard was aliquoted into tubes S1-S5. Finally
lOpl of each sample was aliquoted into the sample tubes. The tubes were then
inverted gently several times to ensure thorough mixing. 200pl from each tube was
aliquoted, in duplicate, into a 96 well plate for measurement of absorbance (Dynex
MRX TCII Microplate Reader and Revelation software, © Dynex Technologies U.K.
Ltd). The absorbance was measured at 628nm within 1 minute. Albumin
concentration was then calculated according to the following equation.
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Albumin (g/L) — [(Asam — Abiank)/(Astandard — Ablank)] X Cstandard
where Asam = absorbance of sample
Astandard= absorbance of standard
Abiank = absorbance of blank
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Chapter 6. Self-administration of analgesic to determine the presence of chronic
inflammatory pain from castration and tail-docking of lambs.
6.1. Introduction
Feed aversion, the avoidance of foods that have been associated with a negative
consequence after consumption, is a well-known phenomenon that has been induced
experimentally in many species including sheep (Garcia and Koelling, 1966;
Kronberg et al, 1993; Thomhallsdottir et al, 1987; Olsen et al, 1989; Zahorik et al,
1990; Nolte et al, 1998). More controversially, animals (including sheep) have been
reported to selectively consume food in order to obtain specific nutrients or
medicinal properties in circumstances of naturally occurring or experimentally
induced ill-health (Furness, 1988a; 1988b; Huffman and Wrangham, 1994;
Kyriazakis et al, 1996; Ramirez, 1996; Arsenos and Kyriazakis, 1999). Thus, these
animals are considered to be capable of learning an association between the act of
consuming a feed and either a negative or positive consequence of that action. It has
been shown that sheep are capable of making this association even when the
consequence of consuming the food is temporally dissociated from the act of food
consumption by between 30 minutes and 8 hours (Burritt and Provenza, 1991;
Arsenos et al, 2000).
In the early 1980s Colpaert et al (1980; 1982) used the ability of rats to make such
associations to validate the use of experimentally-induced arthritis as a model of
inflammatory pain. Colpaert et al (1980) postulated that, if rats with adjuvant-
induced arthritis experienced chronic inflammatory pain, they would learn the
association between the positive pain-relieving consequences of consuming a liquid
containing analgesic. Although variation between individuals in these studies was
high and no measure of the concentration of the analgesic in the blood was taken,
rats that had been inoculated with Mycobacterium butyricum consumed slightly more
of the analgesic fluid than did vehicle-inoculated control animals. Colpaert et al
(1980; 1982) concluded that these rats had indeed learned the association between
analgesia and consumption of a novel-tasting liquid. The results of these early
investigations were recently confirmed in a more conclusive study (Colpaert et al,
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2001). Using the same experimental paradigm as before, Colpaert et al (2001) again
found that rats with experimentally induced arthritis consumed more of the analgesic
liquid than control animals. However, when inflammatory pain was reduced by the
infusion of fentanyl citrate, naloxone and dexamethasone from subcutaneously
implanted pumps, the selection of analgesic fluid over a highly palatable sucrose
solution diminished, indicating that the initial selection of the analgesic fluid was
likely to have been associated with the consequent induction of analgesia.
During the first 6 weeks after c+td by RR, lambs express behaviours that have been
validated for the assessment of acute pain (Kent et al, 2000). These behaviours are
expressed infrequently (by comparison with the acute behavioural response),
however the presence of ths behaviour is associated with chronic inflammatory
lesions resulting from c+td and suggests that lambs may experience chronic
inflammatory pain. The expression of such behaviours in sheep may be considered
particularly significant, as the behavioural indication of disease in this prey species
should be considered maladaptive (Bateson, 1991). However, it is also possible that
the intermittent expression of 'pain' behaviours is indicative of only mild discomfort
or transient irritation. Consequently the use of these behaviours to assess chronic
pain must be validated.
The purpose of this study is to determine whether the chronic inflammatory lesions
resulting from RR c+td are associated with chronic pain, which the presence of
'pain' behaviours would suggest, and to validate the use of these behaviours to assess
this pain. As lambs have been shown to be capable of learning the association
between the consumption of a feed and subsequent beneficial effects, it is
hypothesised that lambs showing pain behaviours in association with chronic
inflammatory lesions experience pain and that they will demonstrate their experience
of pain by learning the positive post-ingestion consequences of consuming a novel
feed containing an analgesic. A pilot study was carried out by Rutherford (1999),
investigating the ability of c+td lambs to self-administer the non-steroidal anti¬
inflammatory drug (NSAID), flunixin meglumine (Finadyne © Shering Plough
Animal Health). In Rutherford's study c+td and handled control lambs were given a
training period starting 7 days after c+td. On the first day of training lambs were
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offered a feed containing flunixin meglumine in a hopper at one side of the back of
the pen. The following day an undrugged feed was offered in a different hopper
placed at the other side of the back of the pen. Training continued alternating feeds
each day for eight days. The lambs were then offered a choice of both feeds over a
three-week period until lesions resulting from RR c+td had healed. Both the feed
containing flunixin meglumine and the undrugged feed were also mixed with grass
meal in an effort to avoid neophobia of the drugged feed (Van Tien et al, 1999). A
quantity of each of these feeds sufficient to give lambs a l.lmg/kg dose of NSAID
was sprinkled over ordinary creep feed in each of the two hoppers. The behaviour of
the lambs was observed weekly throughout the study using methods described by
(Molony et al, 1995). The severity of lesions from c+td was also recorded using
methods described by (Kent et al, 2000).
The presence of a self-administration phenomenon was not proven in Rutherford's
study. Several factors in the methodology are considered to have reduced the power
of the study. Initially, when lambs were 15-18 days old, the volume of feed they
consumed was small and potentially insufficient for lambs to have consumed an
efficacious dose of analgesic creep feed during training. Also the variation in the
weight of feed consumed was very high throughout the study (e.g. 113.2 +132.2g in
one of the pens). This may have been related to high variation in the severity of the
lesions. However, full results of lesion severity were not presented and thus this
interpretation of the data could not be tested. As the lambs grew older they ate more
feed and the relative proportion of feed taken from the analgesic hopper decreased.
The feed hoppers were weighed 24 hours after the daily allowance of feed was given.
It is considered likely that the critical selection of feed occurred during the first 3-4
hours within the 24-hour period and that any preference may have been disguised by
prolonged access to the feeds. Furthermore, lambs appeared to consume feed
containing grass meal selectively (Rutherford, personal communication) and
therefore any motivation to consume feed containing NSAID may have been
disguised by a confounding motivation to eat feed containing grass meal that was
available in both hoppers.
Despite these conflicting issues, small differences in the weight of analgesic feed
consumed were detected. During the first week of choice testing (15-20 days after
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c+td) c+td lambs ate a significantly greater proportion of their feed from the hopper
containing NSAID creep feed. Handled control lambs showed no significant
preference for food from either hopper. However, after the first week of choice
testing and until the lesions had healed (22-37 days after c+td) neither c+td lambs nor
handled controls showed a preference for either feed. There were some differences in
the behaviour of c+td lambs in comparison with handled controls, particularly in the
incidence of easing quarters. It was suggested that these differences were associated
with chronic inflammatory pain.
The methodology of the present study is based on that described by Rutherford
(1999). However, several important changes were incorporated in order to reduce the
degree of variation and thus increase the power of the experiment. Firstly, lambs
were c+td at 4 weeks of age, and were trained at 5-6 weeks of age, in an effort to
ensure that they would be consuming sufficient creep feed during training and to
provide the best possible opportunity for the lambs to learn the post-ingestion
consequences of consuming analgesic creep feed. The increase in age and therefore
size was also expected to result in more severe c+td lesions (Kent et al, 1999), thus
ensuring that all lambs developed lesions of sufficient severity to be more
consistently associated with 'pain' behaviours (Kent et al, 1999) and the experience
of putative chronic pain. No flavouring was used to disguise the taste or smell of the
NSAID, thus removing the potential for a confounding preference of this flavour and
at the same time providing a cue, in addition to that of location, by which lambs
could identify the feeds. Evidence suggests that, whilst lambs may be able to use
location as a cue to distinguish between foods (Forbes and Kyriazakis, 1995;
Baumont et al, 2000), the cues of taste and smell are more reliably associated with
the consequences of feed consumption and therefore the association between smell
and taste and post-ingestion consequences should be easier for the lambs to learn




6.2.1. Animals and management
28 four-week-old, single, male lambs (Greyface x Suffolk) were housed, with their
dams, in adjacent, straw-bedded pens (1.6 x 3.2m) with a separate creep area (in
accordance with management procedures outlined in Section 5.1). In keeping with
general management procedures (see Section 2.2), the animals had ad libitum access
to hay and fresh water. Ewes were fed 500g of concentrated feed daily and lambs had
access to their dam to suck milk.
6.2.2. Experimentalfeeds
Two experimental feeds were used for the self-administration protocol.
The un-drugged feed was simply commercially available creep feed (Nustart Lamb
Creep Pellets, Pye-Frankland Balanced Feeds, protein 18%, fibre 8%)
The analgesic feed was made by combining this creep feed with Finadyne® granules
and repelleting the mixture as described in Section 5.2. The re-pelleted creep feed
was slightly paler than the original creep feed and was more brittle. It is also
considered likely that this feed had a distinctive taste and smell.
6.2.3. Treatments
The 28 lambs were weighed and assigned to four groups, each with 7 lambs, so that
live-weight was balanced across the groups. The location of the lambs within the
barn was balanced to ensure that any variables resulting from the experimental
environment had an equal effect across groups.
The daily consumption of creep feed was recorded for each lamb during the week
prior to the beginning of the experiment so that the volume of creep feed available
could be adjusted to account for appetite.
The treatment groups were as described in Section 5.3. and Table 5.1
6.2.4. Self-administration protocol
The self-administration protocol was started 6 days after castration. During the first 8
days of the protocol, the lambs were subject to a training regime where they were
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given the opportunity to learn the associations between the benefits of consuming
either analgesic or un-drugged feeds and the location and taste of these feeds.
Subsequently lambs were offered a choice of both analgesic and un-drugged feeds
for five days in each week. The comparative volumes of analgesic and un-drugged
feed consumed were measured on choice days, providing an estimate of preference.
On the last two days of each week, all lambs were given access to only un-drugged
feed, to minimise any unwanted effects of the long-term administration of NSAID
and in accordance with the manufacturer's recommendations for its use in horses.
The lambs were weighed once each week to ensure the correct dose of analgesic
could be administered to each lamb.
The self-administration protocol was continued for 6 weeks while the chronic
inflammatory lesions developed and then healed.
6.2.4.1. Pen layoutfor experimentalprocedure
The layout of the pen was as described in section 5.4
6.2.4.2. Training Regime
Two hoppers were introduced to each pen at the left and right sides of the back gate
of the creep area, approximately 0.50m apart, as illustrated in Figure 5.4.
On the first two days of training, lambs with access to analgesic feed (CD and HD)
were given a quantity of analgesic feed (sufficient to provide a dose of l.lmg/kg
body weight) placed in one hopper on top of un-drugged feed. The total amount in
the hopper was equal to the daily allowance of feed for each lamb. The second
hopper was left empty.
On the third and fourth training days, the hopper that had contained analgesic feed
was left empty. The second hopper was filled with a volume of un-drugged feed
equal to the daily allowance for each lamb. The hopper in which analgesic feed was
placed did not change nor did the position of the hoppers within the pen.
The lambs in groups with no access to analgesic feed (CN and HN) were also given
two hoppers at the back of the creep area. On the first two days, one hopper was
filled with a volume of un-drugged feed, equal to the daily allowance for each lamb,
and again the second hopper remained empty. On the third and fourth days of
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training the first hopper was left empty and the second hopper was filled with a
volume of un-drugged feed equal to the daily allowance for each lamb. Again, the
position of the hoppers within the pen was not changed. The hopper containing feed
was thus alternated every two days for the eight training days.
In order to show preference, the lambs had to learn to make the association between
the benefits of consuming analgesic or un-drugged experimental feeds and the
sensory characteristics of the feeds (taste, smell, texture and location (left or right)).
To facilitate learning, it was essential that the lambs consumed the entire dose of
analgesic feed during training. The quantity of feed available during training was
thus restricted to half the appetite of each lamb. The hoppers were removed from the
pen and weighed after 3 and 23 hours.
6.2.4.3. Preference testing
Following training, lambs were offered a choice of both experimental feeds in the
designated hoppers on the first five days of each week. Each hopper contained a
volume of feed equivalent to the full daily allowance so that lambs could obtain all
their food from one hopper. The hoppers were removed from the pen and weighed
after 3 and 23 hours.
During preference testing no restrictions were made on the volume of feed
consumed, up to a maximum daily allowance of 500g. The lambs therefore, with
access to both hoppers, could consume up to lOOOg of creep feed each day.
The side (left or right) of the pen at which analgesic feed could be found for each
lamb was selected at random using random number generation (Microsoft Excel).
For the purposes of analysis an 'analgesic' hopper was nominated at random for
lambs in the un-drugged groups (CN and HN). The proportion of the total feed
consumed that was taken from the analgesic hopper (CD+HD) or nominated
analgesic hopper (CN+EIN) was calculated and used in statistical comparisons.
6.2.5. Behaviour at hoppers
In order to determine, not only the choice of feed that lambs selected, but also the
way in which the selection was made, the behaviour of lambs at the hoppers was
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filmed, using CCTV cameras, for subsequent analysis. The latency, frequency and
duration of visits to each hopper was recorded.
6.2.6. Lesion assessment
The chronic inflammatory lesions resulting from c+td were examined and assessed
twice each week. Each lamb was caught and inverted. The presence or absence of the
tail and scrotum were noted. The width of the lesion was measured, using callipers,
to the nearest millimetre. Subjective assessment of the severity of the lesion was
made using the scale described by Kent et al (2000) as described in Table 2.1. Using
this system, the severity of the lesion was scored on a scale of 0 - 5 in increments of
0.5.
6.2.7. Behavioural analysis
Observations of behaviour were made, once each week, on the second day of
preference testing. Two observation periods, for 2 hours each, were made between
14.00 and 19.00. The methods used are explained fully in Section 2.8. Three
experienced observers were spaced around the penned area on raised platforms to
ensure that every animal could be observed from at least two angles at all times. The
animals were divided into 3 manageable batches for observation (one group of 12
lambs and two groups of 8). Each batch included an equal number of animals from
each treatment group. Observations were recorded directly onto computers (Dell
Latitude Laptops) using The Observer behavioural analysis software (Noldus
Information Technology). All observations were made according to the ethogram
shown in Table 2.2. The behaviours 'chew' and 'horn' were omitted from the
ethogram on this occasion because these behaviours were not observed in this breed
of lamb. The frequencies of active behaviours were recorded, continuously,
throughout the observation time. Postures of lambs were recorded during scan
samples every 6 minutes. At each scan, the lamb's posture and behaviour was
recorded.
Two of the observers were the normal handlers of the animals. During the week
before the start of the experiment these handlers spent as much time as possible in
the barn with the animals in an effort to minimise the effect of the observers on the
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sheep during behavioural observations. Observers were seated on the platforms,
above the sheep, for at least 5 minutes before observations started, allowing the
animals time to settle.
In between the two observation periods, the hoppers were weighed (3 hour sample),
the lambs were blood sampled and assessments of chronic inflammatory lesions were
made.
6.2.8. Blood samples
4ml blood samples were taken on the second preference test day (according to the
methods described in Section 2.5), between 3 and 4 hours after the test feeds were
first placed in the pen, between the two behavioural observation periods and after the
hoppers had been weighed. The samples were immediately cooled to <4°C on ice
and were centrifuged at 3000rpm for ten minutes, within ten minutes of drawing.
Plasma was transferred to labelled plastic tubes and stored at -20°C until required
for analysis.
6.2.9. Colorimetric determination of total protein in plasma
The concentration of total plasma protein was determined using quantitative
colorimetric assay as described in Section 5.5.
6.2.10. High performance liquid chromatographyfor extraction and quantification of
flunixin meglumine in plasma.
The plasma concentration of flunixin meglumine for all lambs receiving drugged
feed, was measured using isocratic, reverse-phase high performance liquid
chromatography (HPLC) as described in section 2.6.
6.2.11. Statistical analysis
General linear models (GLM) were used to determine differences between groups in
the weight of lambs, the consumption of feed during training, the weight of creep
feed eaten during choice, the proportion of feed eaten from the analgesic hopper
(first transformed using log-tan transformation), the frequency of visits and
proportion of total duration spent at the analgesic hopper (transformed using log-tan
112
Chapter 6.
transformation) during choice and the concentrations of flunixin meglumine (after
square root transformation) and total protein in plasma. Further GLMs were used to
examine the effects of analgesic feed consumption during training (as a covariate in
the analysis) on the proportion of feed taken from the analgesic hopper (transformed
using log tan transformation). In this analysis, a regression is used initially to
determine the effects of the covariate before ANOVA is used to examine the
differences between groups resulting from treatments. GLMs test the significance of
the effects of c+td and analgesic treatments and the interaction between the two
treatments on the variable in question. GLMs were carried out for each sample point
during the study. Fisher's approach was used post-hoc to determine where the
differences lay.
Student's t-tests were used to compare the width of castration lesions and Mann-
Whitney U tests to compare the severity scores for c+td lesions. Regression analysis
was used to identify any relationship between the size of the lesion and the
proportion of feed consumed from the analgesic hopper (no transformation).
Genstat (version 5) was used to carry out generalised linear models on behavioural
data. Differences identified using the generalised linear model were examined more
closely post-hoc using Fisher's approach to determine where differences lay. Data on
active behaviours were analysed using Poisson distribution and the logarithmic link
function, whilst data on posture were analysed using the Binomial proportions model




6.3.1. Weight of lambs
At the start of the study the lambs were divided into groups with their weights
balanced across treatments. Thus, there were no initial statistically significant
differences in the weight of lambs between treatments at P<0.05. The average weight
of lambs in each group more than doubled from approximately 15kg to 31kg over the
six weeks of the trial. There was some evidence that lambs in group CN put on
weight more slowly, thus their weight was increasingly lower than that of the other
lambs (see figure 6.1). However, this effect did not reach statistical significance at
any time in the trial.
Figure 6.1. Change in live-weight (kg) of lambs over the duration of the trial, expressed as mean
(±sd), n=7.
-5 5 15 25 35 45
Time after castration and tail-docking (days)
6.3.2. Training
The consumption of feed on the four days when lambs had access to the analgesic
hopper was summed to give a total for feed consumption for each lamb on analgesic
training days. The same was done for feed consumption on un-drugged days. These
results are shown in figure 6.2. On analgesic training days, when the lambs in groups
CD and HD had access to analgesic creep feed, the total feed consumption was
114
Chapter 6.
significantly affected by drug treatment (F3,25= 6.17, P=0.020), although c+td did not
have a significant effect at P>0.05. Further analysis using Fisher's approach revealed
that CD lambs ate significantly more in total than those groups without access to
analgesic (73,25=6.13, P>0.0001 and £3,25=6.25, PO.OOOl for HN and CN lambs
respectively). FID lambs also ate significantly more in total than both groups of
lambs without access to analgesic (73,25=3.04, P=0.0054 and ^25=-3.16, P=0.0041 for
HN and CN lambs respectively). Although no difference in the total weight of feed
consumed on 'analgesic' training days was found between CN and HN lambs (73,25=-
0.11, P=0.9107), it was noted that CD lambs ate significantly more than HD lambs
(C,25=3.09, P=0.0049).
Thus, on training days where drugged food was available to CD and HD lambs, these
lambs ate more than those that had access to only un-drugged feed (groups CN and
HN). In contrast, on days when only un-drugged feed was available, there was no
significant effect of c+td, drug or the interaction between them on the quantity of
feed consumed. The trends in food consumption remained the same however.
Although all lambs consumed feed on days when access to only the 'analgesic'
hopper was offered, the variation within groups in the weight of feed consumed
during training was high. Some lambs ate very little of either feed during training.





















Total weight of feed consumed
The total weight of feed consumed throughout choice testing is shown in figure 6.3.
There was little difference in the total weight of feed consumed by lambs in each
group. However, on day 21 c+td lambs consumed significantly more feed than
handled controls (F3-25=5.07, T>=0.034), a result confirmed using Fisher's tests. On
day 36, analysis using GLM indicated that there was a significant effect of c+td,
analgesic treatment and of the interaction between c+td and analgesic treatment on
the total feed consumed. Further investigation using Fisher's approach revealed that
CD lambs ate significantly more than the other groups of lambs (£3,25=9.84,
'3,25=13.08, and /3i25=11.29 at PO.OOOl for HN, CN and HD lambs respectively).
The analysis also revealed that HN lambs ate significantly more than HD lambs
('3;25=-3.23, ,P=0.0035). On day 42 a significant effect of c+td treatment was found
again (with no associated effect of analgesic), however the pattern in the data was
different on this occasion with CN and HN lambs consuming significantly more than
CD and HD lambs. Thus, despite the occurrence of occasional differences in feed
consumption, no consistent differences were observed. The only temporally
consistent pattern within the data was that lambs ate more on the first day of choice
in each series of five days. On the second day of choice in each cycle, lambs ate
much less, but subsequently increased their intake again over the remaining three
days of testing in each cycle. This pattern was consistent across groups.
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The proportion of feed that was taken from the analgesic hopper by lambs in all
groups over the course of the study is shown in figure 6.4. Analyses to determine
differences in the proportion of test feed taken from the 'analgesic' hopper showed
that on days 30, 34, 37, 38, and 43, there were significant differences between groups
as a result of analgesic treatment but that c+td had no effect on feed selection (see
table 6.1a). Post-hoc analysis using Fisher's approach confirmed that lambs with
access to analgesic feed (CD and HD) ate significantly less from the 'analgesic'
hopper than those in groups CN and HN (i.e. lambs without access to analgesic feed).
In order to determine whether training had been effective, the weight of feed
consumed on 'analgesic' days during training was used as a covariate in a GLM used
to assess differences in the proportion of total feed that was taken from the
'analgesic' hopper. The inclusion of the consumption of 'analgesic' feed during
training as a covariate accounted for variance in the analysis on days
13,20,22,23,28,36,37,41 and 42 of preference testing. However, as can be seen from
table 6.3b, the significance of the effect was not consistent across the study. Also, the
regression coefficients for the covariate were negative throughout the study,
indicating an inverse relationship between the weight of'analgesic' feed eaten during
training and the proportion of feed taken from the analgesic hopper during the choice
test, i.e. the more analgesic feed eaten during training, the lower the proportion taken
from the analgesic hopper during subsequent choice.
Figure 6.4. Mean (±sd) proportion of test feed consumed from the analgesic hopper during choice
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6.3.4. Behaviour at the hoppers
There were few real differences in the latency of approach to the hoppers and the
frequency and duration of visits to the 'analgesic' hopper. The variation in the
latency to approach hoppers was high (see figure 6.5a), but was less in the groups
with access to the analgesic feed. The latency of approach seemed to be consistently
lower in CD and HD lambs throughout, although this difference was only significant
on day 15 after c+td (F3>23=7.16, P=0.018). Towards the end of the trial, lambs in
groups CD and HD visited the hopper less frequently than the lambs in groups CN
and HN. This effect of analgesic treatment was significant on day 36 (F3,23=8.23, P=
0.009) (confirmed by post-hoc testing) and neared significance on day 43 (F3,23=4.14,
P=0.055). These results are shown in figure 6.5b. As can be seen in figure 6.5c,
lambs in group CD appeared to spend longer at the analgesic hopper during day 15,
this difference however was found to be non-significant at P<0.05.
Figure 6.5. Behaviour of lambs at the test hoppers during the first three hours after the hoppers were
placed in the pen, n=7. (a) Mean (±sd) latency of approach to hoppers, (b) Mean (±sd) frequency of
visits to the 'analgesic' hopper, (c) Mean (±sd) proportion of the total duration of time spent feeding































































































6.3.5. Plasma concentration of flunixin meglumine
The mean (±SEM) plasma concentrations of flunixin meglumine 3-4 hours after test
feeds were first given, in lambs in groups CD and HD are presented in figure 6.6.
The plasma concentration of flunixin meglumine in HD lambs was highest during
training (0.28 ±0.09pg/ml) but dropped to 0.13 (+0.06)pg/ml during the first week of
choice. The plasma concentration remained at around this lower level for the
remainder of the trial. In CD lambs, the mean plasma concentration of flunixin
meglumine was also high during training (0.39± 0.10pg/ml) but remained high
during the first week of choice (0.35± 0.1 lpg/ml). The difference between the
plasma concentration of FM in CD and HD lambs was significant at this point (day
16) (Fi 13=4.86, P= 0.048). After the first week however, the plasma concentration of
FM in CD lambs also declined and there were no further significant differences in
concentration between the two groups for the remainder of the trial. A synopsis of
this statistical analysis is shown in table 6.2. A GLM was carried out in which the
proportion of the total feed consumed that was taken from the analgesic hopper was
included as a covariate in order to determine whether proportion of feed taken from
the analgesic hopper provided a good measure of drug intake. However the analysis
showed that the proportion of feed taken from the analgesic hopper had no influence
over the plasma concentration of FM.
Figure 6.6. Mean (SEM) concentration (pg/ml) of FM in plasma 3-4hours after test feeds were given,
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The mean (±SEM) concentrations of protein found in plasma are shown in figure 6.7.
There was an initial decline in plasma protein from pre-trial values on day 3 after
castration, which continued through training and into the first week of preference
testing. However, the concentration of plasma protein rose again slightly throughout
the remainder of the trial. These changes occurred in all groups and statistical
analyses revealed no significant differences as a result of treatment. When the
concentration of flunixin meglumine in plasma was added to the analysis as a
covariate for groups CD and HD, it was not found to have influenced the plasma
concentration of total protein within groups of lambs.
Figure 6.7. Mean (SEM) total concentration (g/L) of protein in plasma in CD and HD lambs over the




The width and score of scrotal lesions and the score of tail lesions for lambs in
groups CD and CN are presented in figure 6.8. The severity of scrotal and tail lesions
reached a peak 20 days after castration in CD lambs. This was slightly later than that
observed in CN lambs (peak at day 13 and day 16 for scrotal and tail lesions
respectively). There were some significant differences between the severity of
lesions observed in lambs with and without access to analgesic. Scrotal lesions in CD
lambs were consistently wider than those in CN lambs between days 16 and 27 after
treatment. This difference neared but did not reach significance at P<0.05 throughout
this period. On day 20 however, the severity score of scrotal lesions in CD lambs was
significantly higher than in CN lambs (W=69.0, P=0.032).
The scrotums and tails of CD lambs appeared to drop off earlier than those of CN
lambs (scrotum - median (Ql-Q3)= 34 (34-41) and 41(37-41) days and tail - mean
(±sd) = 27.6 (+ 10.4) and 27.5 (±7.2) days for CD and CN lambs respectively).
However statistical analysis showed that that the differences were not significant
(Mann-Whitney W=24.5, P=0.443; Student's t-test T 1,13—0.01, P=0.999 for scrotums
and tails respectively). In a regression analysis, the weight of the lamb had no effect
on the proportion of feed that was consumed from the 'analgesic' hopper. However,
when regression analyses were carried out on the width of the lesion and the plasma
concentration on FM in CD lambs, a positive relationship was found that reached
significance on day 20 (Fi,6=6.23, P=0.032), just before the width of lesions reached
a maximum in CD lambs.
The weight of lambs was used as a covariate in a GLM to test for differences in
lesion width between CD and CN lambs. On days 13 and 20 after treatment the
weight of lambs had a significant effect on the width of the lesion (F 1,11=11.92,
P=0.006 and Fi,n=6.23, P=0.032 for days 13 and 20 respectively), whilst analgesic
treatment had no significant effect. Pictures of the changing severity of a chronic
inflammatory lesion over the 6-weeks after ring application in a representative lamb
are shown in Appendix D.
Figure 6.8. Severity of lesions from c+td of CD and CN lambs (n=7) (a) Mean (±sd) width of lesions
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6.3.8. Behavioural analysis: postures
SI
There was no consistent significant pattern of expression of SI during the trial in any
group (see figure 6.9a and b). The total number of observations in which SI posture
was recorded was lower in CN lambs and the highest in CD lambs but this difference
was not significant. A significant effect of both c+td and analgesic treatments
(although not the interaction between them) on SI posture was found during training
(day 9). Post-hoc analyses using Fisher's tests showed that FIN lambs were observed
significantly less frequently in this posture than the other lambs (*3,24=2.13, P=0.0428
(CN), C,24=2.92, P=0.0073 (HD), f3,24=2.83, P=0.0090 (CD)). On day 15, a
significant effect of c+td (C,24=-2.39, F>=0.017) and of the interaction between the
effects of c+td and analgesic treatment (*3,24=2.51, P=0.012) on the time spent in SI
posture was found. Post-hoc Fisher's testing revealed that CN lambs were observed
in SI posture significantly less frequently than FIN lambs (*3,24=-2.39, P=0.024), but
that no other differences existed between the groups.
VI
Lambs in group HN appeared to show consistently more VI posture during the trial
(see figure 6.9c and d). However statistical analysis showed that only c+td had a
significant effect on day 9 (*3,24=-2.22, f=0.036) and post-hoc analysis showed that
HN lambs only showed significantly more VI posture than CN lambs (C.24=-2.22,
P=0.036). The effect of c+td neared significance again on day 22 (*3,24=-1.80,
F>=0.071) and in the sum of observations for the whole trial period (*3,24=-1.89,
/>=0.072). There were no other consistent differences in the expression of VI
posture.
V2
Slightly more consistent differences were found in the expression of V2 posture (see
figure 6.9e). Significant effects of c+td were found on days 29 (*3,24=2.28, P=0.023)
and 36 (*3,24=2.11, P=0.034) and an effect of the interaction between c+td and
analgesic treatment was also found on day 36 (*3,24=-1.98, P=0.048). Post-hoc
analysis showed that this result indicated only that CN only showed significantly
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more V2 posture than HN lambs and that no other statistically significant differences
were present. Overall these differences were reflected in the total number of
observations in which lambs were recorded in V2 posture (see figure 6.9f). Again
c+td had a significant effect (^24=2.12, P=0.044) and post-hoc analysis showed that
CN lambs spent more time in V2 posture than HN lambs (^3,24=2.13, P=0.043) .
Normal postures
Overall there was no significant difference in the expression of normal postures (a
sum of postures expressed frequently by control animals) during the trial. The
variation in the expression of these postures was wide. There were no consistent
trends in the sum of normal postures (see figure 6.9g and h).
Abnormal postures: V3, SS and LL
Statue standing (SS) did not occur at any time during the trial. There was dramatic
variation in the expression of V3 posture, with few individuals accounting for most
of the behaviour. No significant differences in its expression were found between
groups (see figure 6.9i). Overall, CN lambs appeared to show slightly more in total
of this posture, whilst its occurrence in CD lambs was similar to that seen in the
handled lambs (see figure 6.9j). HN lambs showed very high within group variability
in the expression of this behaviour. There were also no significant differences in the
expression of LL posture (see figure 6.9k). In total there were no significant
differences in the expression of abnormal postures between groups (see figure 6.91).
However c+td lambs had a greater tendency to show abnormal lying than handled
lambs, when the total expression of abnormal postures was summed (see figure






The number of observations that CN lambs spent eating (see figure 6.9n) declined
during the first 4 weeks after castration, reaching a low of 6.4(±2.1) observations on
day 29. This low coincided with the peak in the width of lesions and occurs in a time
period during which maximum scores of severity were recorded for scrotal and tail
lesions. The number of observations in which CN were observed eating then
increased. None of the other groups showed a temporal pattern to the number of
observations spent eating and there were no statistically significant differences
between the groups at any point during the trial or when the behaviour was combined
for the whole trial (see figure 6.9p).
Idling
C+td animals had a tendency to show more idling than handled lambs (see figure
6.9q). Analysis using generalised linear models indicated that c+td had a significant
effect on the occurrence of idling behaviour on day 36 (*3,24=3.01, P=0.003). Post-
hoc Fisher's approach testing showed that again only CN lambs showed significantly
more of this behaviour than HN lambs (^3,24=3.01, P=0.006) although the difference
between CN and HD lambs neared significance (*3,24=2.00, P=0.057). The effect of
c+td on the occurrence of idling was also close to significance (^3,24=1 -92, P=0.066)
when observations of this behaviour were summed for the whole trial (see figure
6.9r)
Rumination
There was no obvious consistent pattern in the occurrence of rumination over the
whole trial (see figure 6.9s and t). However, on day 22, an effect of analgesic
treatment on the number of observations spent ruminating was observed (*3,24=2.63,
P=0.015). This effect on rumination was also seen when the occurrence of the
behaviour was summed for the whole trial (*3,24=2.74, P=0.012). Post-hoc testing
showed that on day 22 HD lambs ruminated significantly more than HN lambs
(*3,24=2.63, P=0.014). This difference was also significant when the behaviour was
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summed for the whole trial period (*3,24=2.74, P=0.011). No statistically significant
differences were found in the occurrence of the behaviour between any other groups.
Sleeping
Finally, c+td had a significant effect on the number of observations in which sleeping
was recorded on day 9 after treatment (*3,24=2.41, P=0.024). Post-hoc testing
revealed that HN lambs slept significantly more than CN lambs (*3,24=2.26,
P=0.033). C+td lambs showed a tendency to sleep less than handled animals for the
remainder of the trial, although no significant differences were found during each
weekly set of observations or when the behaviour was summed for the trial (see
















Figure 6.9. Proportions of observations that lambs were observed in postures and behavioural states
during two 2 hours observation periods with scan samples every 6 minutes, (a) Mean (±sd) proportion
of observations in SI posture for each weekly observation throughout the trial, (b) Total mean (±sd)
proportion of observations observed in SI as a summary for the whole study period, (c) Median (Ql-
Q3) VI (d) Total mean (±sd) VI (e) Mean (±sd) V2 (1) Total mean (±sd) V2 (g) Mean (±sd) normal
(h) Total median (Q1-Q3) normal (i) Median (Q1-Q3) V3 (j) Total median (Q1-Q3) V3 (k) Total
median (Q1-Q3) LL (1) Median (Q1-Q3) abnormal (m) Total median (Q1-Q3) abnormal (n) Mean
(±sd) eating (p) Total mean (±sd) eating (q) Mean (±sd) idling (r) Total mean (±sd) idling (s) Mean
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6.3.9. Behavioural analysis: frequency ofactive behaviour
Chapter 6.
Restlessness
There was some indication that c+td lambs showed more restlessness than handled
control animals as shown in figures 6.10a and b. On day 22 a significant effect of
c+td on the expression of restless behaviour was found (£3,24=2.27, P=0.023). Post-
hoc analysis showed that both CN and CD lambs showed more restlessness than HN
lambs (73,24=2.26, P=0.032, C,24=3.78, P=0.0009 respectively) and that the difference
in the expression of the behaviour neared significance between CD and HD lambs
fe,24-1.83, P=0.079). On day 43 a significant effect of c+td, analgesic treatment and
their interaction was found and post-hoc Fisher's approach analysis indicated that
FIN lambs were significantly less restless than CN lambs (73,24=2.56, P=0.017). Han
lambs also less restlessness than HD lambs although this difference did not reach
significance (C,24=1.96, P=0.061). In total c+td lambs appeared to show more
restlessness over the whole trial although this difference was not significant at
P<0.05.
Easing quarters
CN lambs also appeared to show more easing quarters behaviour than the other
lambs (see figures 6.10c and d). On day 43 a significant effect of c+td, analgesic
treatment and their interaction was detected. Further analysis showed that CN lambs
did indeed express more of this behaviour than HN lambs (*3,24=3.44, P=0.002).
Easing quarters also occurred more frequently in HD than HN lambs (C,24=2.08,
P=0.048). In total, c+td was found to have an effect on the frequency of easing
quarters behaviour, an effect that neared significance at P<0.05 (C,24= 1.92,
P-0.067). It appeared that c+td lambs showed more of this behaviour than handled
controls.
Foot-stamping and kicking
There was no difference in the frequency of foot stamping and kicking between
groups, although in total it appeared that c+td animals showed this behaviour more
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frequently (see figure 6.10e). However, foot stamping occurred very infrequently in
all groups, with one or two individuals accounting for most of the behaviour.
REQ
When the occurrence of the active behaviours described above (restlessness, easing
quarters and foot-stamping) was summed for each observation time (see figure 6.1 Of)
and totalled for the trial (see figure 6.10g) to give an REQ score. It was found that in
general c+td animals showed these behaviours more frequently than handled
controls, although this did not reach statistical significance at p<0.05. On day 43 a
highly significant effect of c+td and the interaction factor was found as well as a
significant effect of analgesic treatment. Fisher's approach showed that HN lambs
showed significantly less active behaviour than both CN and HD lambs (C,24=3.99,
P=0.0005 and /3,24=2.60 .P=0.015 respectively). CN lambs also showed more active
behaviour. The effect of c+td on the frequency of active behaviour was also seen
when the expression of behaviours was summed for the trial ((3,24=2.22, P=0.036).
Post-hoc Fisher's approach testing demonstrated that active behaviour was observed
more frequently in CN than HN lambs (C,24=2.05, P=0.048) although the difference
was not highly significant.
Tail-wagging
CN, CD and HD lambs showed tail wagging with increasing frequency until day 29
before their expression of the behaviour declined (see figure 6.1Oh), although in CD
lambs this pattern was not as clearly defined as in CN and HD lambs. This pattern of
behaviour was not observed in HN lambs however. On day 29 an effect of c+td on
the frequency of tail-wagging was found ((3,24=2.46, P=0.021). Post-hoc testing
showed that HN lambs showed less tail-wagging than both HD and CD lambs
(Z3,24=2.49, P=0.020 and ^,24=2.18, P=0.039). When the behaviour was summed for
the trial (see figure 6.1 Oi), CD lambs showed the most tail wagging and the greatest
variation in the expression of the behaviour, but the overall differences between




There was an overall decline in the frequency of teat seeking in all groups over the
duration of the trial, from approximately 9 down to 2 teat-seeking attempts in 4 hours
(see figure 6.1 Oj). There were no significant differences in the expression of this
behaviour between groups at any time during the trial or when the total frequency of
the behaviour was compared for the whole trial (see figure 6.10k).
Head-turning
There was wide variation in the expression of head turning with groups, a fact that
may account for the lack of significant differences between groups in head turning to
any target. Overall CD animals seemed to show more of the behaviour than the other
lambs but again because of high variation this difference was not significant at any
time or for the total frequency of this behaviour in the trial (see figures 6.101 and m).
Play
Play occurred but at very low frequency in all groups and again the variation within
groups was high with some lambs expressing much more behaviour than others.
There were no significant differences in the expression of play throughout the trial or
when the behaviour was summed for the trial (see figure 6. lOn and o).
Rubbing
There was also wide variation in the expression of rubbing behaviour within groups
(see figure 6.10p). On days 22 and 36 a significant effect of analgesic treatment and
the interaction was found. Further analysis revealed that on day 22 there was a
significant difference in the expression of rubbing between HN and HD lambs
(^3,24=3.11, P=0.005). Although this result appears inconsistent with graphical
representation of the data, the extent of variation in opposite directions in these
groups may account for this anomaly. On day 36 the difference between HN and HD
lambs was found again with HD lambs expressing significantly more of the
behaviour than HN lambs (C,24=2.19, P=0.037). Overall (see figure 6.10q) analgesic
treatment had some effect on the occurrence of rubbing but this difference was close
to but did not reach significance at p<0.05 (^24=2.04, P=0.052).
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Figure 6.10. Frequency of active behaviours observed during two, 2 hour long observation periods, (a)
Mean (±sd) frequency of restlessness for each weekly observation throughout the trial, (b) Total
mean (±sd) frequency of restlessness as a summary for the whole study period, (c) Mean (±sd) easing
quarters (d) Total mean (±sd) easing quarters (e) Total median (Q1-Q3) foot-stamping (f) Mean
(±sd) REQ (g) Total mean (+sd) REQ (h) Median (Q1-Q3) tail-wagging (i) Total median (Q1-Q3)
tail-wagging (j) Mean (±sd) teat-seeking (k) Total mean (±sd) teat-seeking (1) Median (Q1-Q3)
head-turning (m) Total median (Q1-Q3) head-turning (n) Median (Q1-Q3) play (o) Total median
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6.4.1. Physical evidence ofchronic inflammatory pain?
Weight and totalfood consumption.
Anorexia is a well accepted symptom of chronic intractable pain in both human and
animal subjects, resulting in weight loss or reduced weight gain (Chapman, 1985;
Kitchell and Johnson, 1985; Zimmermann, 1986; Short, 1998). Thus, lower daily live
weight gain might be expected in CN lambs in this study as these lambs were
subjected to a putatively chronically painful treatment without the benefit of
analgesia. However, provided an efficacious dose ofNSAID had been consumed, the
effect of c+td on weight gain should be reduced or eliminated by the consumption of
flunixin meglumine in CD lambs. In fact, c+td and analgesic treatments had no
statistically significant effect on the weight of lambs. This result confirms those of
previous studies in which c+td lambs showed the same daily live-weight gain as
control animals (Kent et al, 2000). In the present study there were also no differences
in the total weight of creep feed consumed between groups confirming that there was
no effect of c+td on food intake.
Although differences between groups were not significant, the rate at which CN
lambs gained weight appeared less in comparison with other lambs as the study
progressed. Furthermore, the fact that CD lambs consistently showed a slightly (but
not significantly) higher food intake than CN lambs, suggests that any effect of c+td
on weight gain was eliminated by the consumption of analgesic and may have been
induced by pain from c+td lesions. If the severity of the lesions had persisted rather
than healed, a more significant effect on weight gain might have been observed.
However, without statistically significant evidence, the presence of chronic pain
cannot be inferred from weight data in this study.
Severity of lesions
The severity score of scrotal lesions observed in the present study was similar to that
observed in a previous study on lambs castrated at four weeks of age (Kent et al,
1999). The peak in lesions severity occurred at a similar time after application of the
RR (3-4 weeks) (Kent et al, 1999). There were some differences between the studies
however. The mean maximum width of lesions in CN lambs was lower than
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observed previously in lambs of this age and breed (18.1±5.28mm this study
compared to 21mm observed by Kent et al (1999)) and in CD lambs in this study, the
mean maximum severity score of scrotal lesions (score= 4.0 (3.5-4.0)) was slightly
higher than previously recorded (score=3.6) (Kent et al, 1999). At their most severe,
scrotal lesions in CD lambs were found to have a slightly higher score than those in
CN lambs, a result that suggests that the NSAID may have had a negative influence
on healing. However, further analysis revealed a significant influence of the weight
of the lamb, but no effect of drug treatment, on the size of the lesion. Although no
significant difference was found in the weight of lambs between groups, the weights
of CN and CD lambs were the furthest apart (see figure 6.1). The slight difference in
weight may have been sufficient to induce a significant difference in overall lesion
severity, however, because of limitations of the lesion assessment system, this theory
could not be tested on the lesion score data. Data presented by Kent et al (2000)
showed that older, larger lambs develop more severe lesions than younger lambs.
The evidence found in this study suggests that even very small differences in the size
of the lamb may have a significant effect on the severity of the chronic inflammatory
lesion.
6.4.2. Behavioural evidence ofchronic inflammatory pain?
Zimmermann (1986) suggested several changes in normal species-specific behaviour
that may occur in chronic pain syndromes. It should be noted that the changes in
behaviour that do occur are likely to be specific to the particular type of chronic pain
observed. The suggested list of changes includes guarding behaviour, expressed as
changes in movement and posture, attention to a painful region, changes in sleep
patterns, and changes in social behaviour. Such changes in behaviour have been
identified in lambs in response to chronic inflammatory lesions from RR c+td using
an ethogram developed to assess chronic pain from castration of calves (Molony et
al, 1995) and adapted from methods used for the assessment of acute pain from c+td
(Molony and Kent, 1993; Kent et al, 1995). Lambs c+td at 2 and 28 days of age have
been found to show significantly more foot-stamping, tail-wagging and total activity
and more abnormal postures, idling and suckling and less eating and playing than
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their handled control siblings over the period that chronic lesion took to form and
heal (Kent et al, 1999; Kent et al, 2000).
Some changes in the behaviour of lambs were observed in the present study. Handled
control lambs spent more observations sleeping than CN lambs and, importantly, no
significant difference in time spent sleeping was found between handled control
lambs and c+td lambs with access to analgesic (CD lambs). This result is in
accordance with the behavioural changes considered to be indicative of a chronic
pain state in animals (Zimmermann, 1985) and indicates that the consumption of
analgesic reduced the disturbance of sleep patterns in CD lambs. C+td lambs were
also more restless than handled control lambs and a higher incidence of easing
quarters was observed in CN lambs. These results are similar to those observed in
previous studies (Kent et al 1999, 2000) in which active behaviour also increased in
c+td lambs.
None of behavioural changes described above were consistently different between
groups throughout the study and few showed any temporal pattern. However a
temporal change was seen in the number of observations which CN lambs spent
eating. This declined as the scrotal lesions became more severe and then increased
again as the lesions healed. Although the occurrence of this behaviour was not
significantly different from that seen in other lambs, no such pattern of behaviour
was observed in CD lambs. This suggests that the pattern of eating observed in CN
lambs was caused by pain from c+td lesions, but that this pain was reduced by
consumption of NSAID in CD lambs. Despite there being no differences in the total
weight of feed consumed, this result supports the suggestion that the small (and non¬
significant) differences in the weight of lambs may have been induced by the
presence of the chronic inflammatory lesion.
Another behaviour that showed a temporal change was a steady decline in teat
seeking observed in all lambs as ewes reduced access for suckling. A transient rise in
tail wagging was also observed, but, as it occurred in both groups of c+td lambs and
in handled controls, this change in behaviour cannot have been related to the
formation of lesions and is likely to be indicative of an increase in the motivation to




In this study the hypothesis that lambs with lesions feel pain and that they will
therefore learn to self-administer analgesic was assessed in two ways. Firstly the
proportion of feed taken from the analgesic hopper was determined. Secondly the
plasma concentration of FM was determined. Variation was expected in the
proportion of drugged feed taken because of individual preferences. It was also
expected that more variation would be generated when the NSAID was absorbed
through the gut. Further, as the analgesic feed was placed on top of ordinary creep
feed in the hopper it was possible for lambs to avoid the analgesic feed. Thus, it was
necessary to determine whether differences in the proportion of feed taken from the
analgesic hopper resulted in real differences in plasma FM.
Analysis of the proportion of feed taken from the 'analgesic' hopper provided no
evidence that c+td lambs selected to consume a greater proportion of their feed from
the 'analgesic' hopper than handled control lambs. Lambs with access to analgesic
creep feed initially consumed the same proportion of their feed from the 'analgesic'
hopper as CN and HN lambs, with similar variability between groups. Whilst there
was a significant difference in the latency to approach the hoppers between drugged
and un-drugged lambs on day 15 after treatment, there was no difference in the
duration and frequency of visits to the hoppers and no relationship was found
between the width of the lesion and the proportion of food taken from the analgesic
hopper. In combination there is very little evidence that lambs in this study learned
about the benefits of consuming analgesic creep feed and did not self-administer
analgesic. However, when the plasma concentration of FM was analysed by GLM
with the proportion of feed taken from the analgesic hopper as a covariate in the
analysis, the results indicated that the proportion of feed taken from the analgesic
hopper had no influence on the plasma concentration of FM. It may therefore be
concluded that the proportion of feed taken from the analgesic hopper was a poor
estimate of analgesic intake.
The plasma concentration of FM was considered to be a more appropriate measure of
self-administration than the proportion of feed taken form the analgesic hopper,
because it constituted a direct measure of drug intake. There was evidence in this
data that CD lambs had in fact selected more analgesic than handled controls. The
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concentration of FM was higher in CD lambs both during training and during the
first three weeks of preference testing. This difference reached significance at P<0.05
during the first week of preference testing despite that fact that FM was measured 3-
4 hours after first access to the feed and that the variation in concentration was high.
It was on the first week of preference testing that a significantly shorter latency to
approach the hoppers was detected in drugged lambs. This evidence is supported by
the fact that there was a positive association between the size of castration lesions
and the plasma concentration of FM for most of the study. This relationship reached
significance at P<0.05 during the first and second week of choice testing (days 13
and 20 after c+td) when the severity of lesions was increasing.
By 20 days after castration (week 2 of preference testing), there was a decline in the
plasma concentration of FM in plasma in both CD and HD lambs. On day 20 there
was a highly statistically significant relationship between the width of the castration
lesion and the plasma concentration of FM, indicating that those lambs with more
severe lesions had taken in significantly more NSAID. Thus at this time, the plasma
FM concentration in CD lambs was still related to the severity of the lesion. This
suggests there was a decline in the requirement for analgesic despite the persisting
physical severity of lesions. Subsequently however, the relationship between the
severity of the lesion and FM concentration in CD disappeared. The decline in
concentration occurred in both c+td lambs and handled controls and no significant
differences in the plasma concentration of FM were found between the groups during
this time. This evidence suggests that the width and subjective assessment of the
severity of the lesions may not provide an accurate measure of the degree of pain
suffered by the lambs in association with c+td lesions. Instead it suggests that the
more severe pain is experienced prior to the development of the most severe
manifestation of the lesion.
Another possible explanation for the decline in FM concentration, despite enduring
lesion severity, is the possible development of an aversion to the analgesic feed. This
aversion could be the result of a gradual onset of adverse effects of the NSAID in the
GI tract and could simply have accelerated the rate at which the administration of
analgesic reached extinction that would be expected when the lesions healed.
Rutherford (1999) noted that lambs with access to analgesic appeared to rub
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themselves on inanimate objects more frequently and concluded that this behaviour
may be indicative a mild adverse effect of the NSAID. However, in the present
study, this is considered unlikely as only HD lambs showed more of this behaviour
than HN lambs, whist no differences were found between CD and CN lambs and the
handled controls. Another behaviour that might be affected by gastric discomfort is
rumination. Lambs with access to analgesic ruminated more than un-drugged lambs
when the behaviour was summed for the whole trial period. This difference was not a
reflection of a higher feed intake in these lambs (as far as can be assessed without
quantification of hay and straw intake). Despite some behavioural suggestions of
adverse effects of the analgesic, no evidence of changes in total plasma concentration
of protein were found. In horses, the presence of hypoproteinaemia has been used as
an indicator of detect gastric irritation, in the form of a protein-losing
gastroenteropathy, after the oral administration of NSAIDs over a period of time
(Lees et al, 1983; Higgins and Lees, 1984; Goodrich et al, 1998). The total
concentration of protein in plasma was measured in this study as a means of
detecting potential GI irritation. After an initial decline observed in all lambs, total
plasma protein remained stable at approximately 50g/L for the remainder of the
study and no differences were found between groups that had access to analgesic and
control lambs indicating that no gastric toxicity was present. The measurement of
total protein was the only measure made to assess toxicity from the NSAID and it is
noted that NSAIDs may also cause hepatotoxicity and have some toxic effects on the
kidneys. Some evidence of such toxic effects could be provided by the measurement
of parameters including aspartate aminotransferase and the serum urea: creatine ratio
for liver and renal toxicity respectively (Higgins and Lees, 1984) although this was
not attempted in this study.
The consistent pattern of feed consumption shown by all the lambs suggests another
potential cause for the development of aversion to the novel analgesic feed. The high
intake of feed on day 1 of choice was followed by a slump in consumption on day 2.
Lambs subsequently increased their daily consumption gradually over the three
remaining days of choice testing each week. This pattern of feeding is typical of that
seen when a mild aversion is learned after consumption of a certain feed to satiety
(Early and Provenza, 1998). Such a response may have been caused by the reduction
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on creep availability on the two 'off days each week. Thus, novelty of test feeds,
and potentially hunger, induced lambs to consume an excess of feed on the first day
of choice testing each week. This excessive consumption resulting in satiety and
possibly in mild indigestion and pain or malaise. CD and HD lambs had access to
two feeds with distinct characteristics at specific locations. If these lambs consumed
more of one or other of these feeds excessively on the first day of preference testing,
they may have mistakenly learned to associate pain/malaise of indigestion and the
taste of the feed and/or the position of that hopper. Thus the respective selections
made by lambs in these groups would tend to converge despite any prior learning
about the potential benefits of consuming each feed.
A final explanation for the decline in plasma concentration of FM in CD lambs,
despite the severity of lesions remaining high is that the lambs' ability to retain the
association they learned during training declines over time. It is well known that food
preferences and even aversions are dynamic. The ability to continually test
previously learned aversions in order to obtain sufficient nutrients is considered to be
adaptive, provided animals do not consume too much of the previously aversive
food. In the same way, if lambs did not eat sufficient drugged feed to obtain an
analgesic effect on a sufficient number of occasions, it is possible that they unlearned
the association between consuming the feed and its beneficial post-ingestion effects.
Thus the use of one long training session at the start of the study at a time when
putative pain from the lesions may not have been severe, might be considered
insufficient. This conclusion would be inconsistent with evidence suggesting that
sheep can remember positive associations between feeds and the consequences of
consuming them for at least a year (Squibb et al, 1990).
6.4.4. Conclusion
Some behavioural and physical evidence of pain was present during this study. Also
CD lambs appeared to have self-administered analgesic for a short period of time.
However the difference in plasma concentration of FM between CD and HD lambs
only just reached significance at P<0.05 and did not persist throughout the most
severe stages of lesion development. Thus the evidence of a self-administration
phenomenon in c+td lambs is inconclusive. The results also suggest that the method
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of lesion assessment is not a reliable indicator of the degree of pain experienced.
Several sources of extraneous variation were identified in the methodology.
Elimination of these sources of variation would increase the power of future trials.
Sources of variation include; the use of only one training period at the start of the
study and the inclusion of ordinary creep feed in the analgesic hopper. These changes
to the methodology and further redevelopments should be considered for future
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Chapter 7. Self-administration of analgesic to determine chronic inflammatory pain
from castration and tail-docking of lambs using a revised methodology.
7.1. Introduction
In the previous trial (described in Chapter 6) some evidence of self-administration of
analgesic in c+td lambs was found. A higher plasma concentration of FM was found
in CD lambs in comparison with handled controls indicating that CD lambs had
selected to consume more analgesic creep feed than handled lambs (HD). However,
the difference in plasma concentration of FM did not persist through the time when
the lesions from c+td were at their most severe and reached statistical significance
for only one observation during the trial. Furthermore variation was high between
individuals. Thus, the evidence of a true self-administration phenomenon was
considered to be inconclusive. Sources of extraneous variation were identified and
modifications were made to reduce or eliminate this variation in the methodology
used in the next study. It was undesirable to increase the numbers of lambs used both
for ethical reasons and because the protocol would have been unmanageable with
more animals.
In the previous study c+td and handled control lambs with no access to analgesic
were included to control for side preferences not related to the presence of the
analgesic. However, the proportion of feed consumed from the 'analgesic' hopper
was found not to be a true measure of drug intake and therefore the weight of each
feed consumed could not be used to provide evidence of self-administration. Instead,
the concentration of FM in plasma was used for this analysis. As a result no
comparison of side preferences could be made between lambs with and without
access to analgesic, and this variable was not controlled for as planned.
Evidence from the previous study suggested that self-administration may have
occurred initially, but a decline in plasma concentration of FM observed in CD lambs
in the previous study occurred more rapidly than lesion healing and started before
lesions reached a peak. This result suggests that there is no direct relationship
between the measures of size and subjectively-assessed severity of the c+td lesions
and the degree of pain experienced. This could not be fully statistically evaluated
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because of limitations of the assessment method. It is also possible that something
other than lesion healing initiated extinction of the self-administration phenomenon.
The schedule used for training and the scheduled variations in the total quantity of
feed given at different stages of the protocol were considered to be potential
confounding factors that may have contributed to the premature extinction of self-
administration.
Changes in behaviour thought to be indicative of pain were found in the previous
study, however these changes were also inconsistent over time. The association
between the occurrence of behaviours and the severity of lesions has been found to
be more consistent in lambs that were castrated at 6 weeks of age than at 2 or four
weeks of age (Kent et al, 1999). This was considered to be because the lesions found
in older lambs were generally more severe than those found in younger lambs. In the
study described in chapter 6, there was wide variation in the severity of lesions,
which probably increased the overall variation in the motivation to select analgesic
creep feed.
All the potentially confounding factors described above were taken into account
when this present study was designed. Thus lambs were castrated at six weeks of age
in an effort to obtain lesions that were consistently more severe and more likely to be
associated with pain behaviours. By increasing the severity of lesions in this way, the
consumption of the novel analgesic creep feed should result in the relief of pain that
is more significant to the lambs. In order to ensure that lambs had the best
opportunity to learn the association between consumption of the analgesic feed and
the relief of pain and to retain what they had learned, training was continued
throughout the study. Also, to avoid the development of an aversion to any one feed
as a result of excessive consumption of feed during training or choice testing, a
different commercially available creep feed was used as a test feed and was given at
a separate time from the feed given for nutritive purposes. Thus, the feeding regime
was more consistent and there was reduced conflict between the quantity of feed




No evidence of toxicity was found as a result of consuming the NSAID FM over a
six week period in the previous study and the schedule in which two days without
analgesic in every seven was used again in the present study.
A change of breed of sheep had to be made because of precautions taken within the
Moredun Institute to minimise and prevent disease within their experimental flocks.
As a result Scottish Blackface lambs were used. This change was not expected to
adversely affect the experiment, as SBF lambs had shown similar lesions and
behavioural evidence of chronic pain in a previous study of the effects of RR
castration. It was in this study by Kent et al (1999) that a possible relationship
between the expression of abnormal 'pain' behaviours and the presence of castration
lesions was first described. It is proposed that reduction of variation by these
methods would permit confirmation of the self-administration phenomenon, inferred




7.2.1. Animals and management
28 six-week-old, single, male lambs (Scottish Blackface) were housed, with their
dams, in adjacent, straw-bedded pens (1.6 x 3.2m) with a separate creep area, in
accordance with management procedures outlined in Section 5.1. In keeping with
general management procedures (see Section 2.2), the animals had ad libitum access
to hay and fresh water, ewes were fed 500g of concentrated feed daily and lambs had
access to their dam to suck milk. Between the hours of 17.00 and 08.00, the lambs
had ad libitum access to creep feed (Nustart Lamb Creep Pellets, Pye-Frankland
Balanced Feeds, protein 18%, fibre 8%) in a single hopper placed in the creep area.
The layout of the pen was as described in section 6.4. Between 17.00 and 08.00
hours the two hoppers, represented in the diagram, were replaced with one feed
hopper. This hopper was removed entirely from the pen at 08.00hrs.
7.2.3. Experimental feeds
Two experimental feeds were used in the self-administration protocol:
The un-drugged feed was a second brand of commercially available creep feed (Elite
Lamb Pellets, Billington Agriculture, protein 10%, fibre 9%).
The analgesic feed was made by combining this creep feed with Finadyne® granules
and repelleting the mixture as described in Section 5.2. The repelleted creep feed was
slightly paler in colour and more brittle than the original creep feed and likely to
have had a distinctive taste and smell.
7.2.4. Treatments
The 28 lambs were weighed and assigned to four groups of 7 lambs, so that live-
weight was balanced across the groups. The location of the lambs within the barn
was balanced to ensure that any variables resulting from the experimental
environment had an equal effect across groups.
The daily consumption of creep feed was recorded for each lamb during the week
prior to the beginning of the experiment so that the volume of creep feed available
could be adjusted to account for appetite.




The protocol for self-administration of analgesic was carried out over a six-day
cycle. On the first four days of each cycle a training programme was used. Here the
lambs were given the opportunity to learn the association between the comparative
benefits of consuming analgesic or un-drugged experimental feeds and the location
and taste of these feeds.
On the fifth and sixth days of the cycle, lambs were offered a choice of the
experimental feeds. The comparative volumes of analgesic and un-drugged feed
consumed were measured on choice days, providing an estimate of preference.
The self-administration protocol (training and preference testing) was started five
days after castration and tail-docking. Experimental feeds were offered to lambs for
one hour only, between 12.00 and 13.00 daily. At this time lambs had had no access
to concentrated feed for 4 hours and, although unlikely to be hungry, the lambs
showed interest in the feed hoppers.
The lambs were weighed once during every six-day cycle to ensure that the correct
dose of analgesic was offered to each lamb. The self-administration regime was
continued for 6 weeks (7 cycles) while the chronic inflammatory lesions developed
and then healed.
7.2.5.1. Training regime
The precise protocol for training was as follows: On the first day of training, lambs
in the 'drugged' groups (CD and HD) were given two hoppers at the left and right
sides of the back gate of the creep area, as illustrated in Figure 5.4. A quantity of
analgesic feed (sufficient to provide a dose of l.lmg/kg body weight) was placed in
one hopper but the second hopper was left empty. On the second training day the
hopper that had contained analgesic feed was left empty and a quantity of un-
drugged feed (equivalent to the weight required to provide a dose of drugged feed)
was placed in the second hopper. The hopper in which analgesic feed was placed did
not change nor did the position of the hoppers within the pen.
The lambs in the 'non-drugged' groups (CN and HN) were also given two hoppers at
the back of the creep area. A quantity of un-drugged feed (equivalent to the weight
required to provide a dose of drugged feed) was placed in one hopper but again the
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second hopper remained empty. On the second day of training the first hopper was
left empty and a quantity of un-drugged feed (equivalent to the weight required to
provide a dose of drugged feed) was placed in the second hopper. Again the position
of the hoppers within the pen was not changed. At 13.00hours the experimental feeds
hoppers were removed from the pen and the remaining feed was weighed.
The hopper containing feed was thus alternated daily for four training days.
In order to show preference the lambs must learn the associations between the
benefits of either consuming analgesic or un-drugged experimental feeds and
characteristics (taste, smell, texture and location) of these feeds. To facilitate
learning, it was essential that the lambs consumed the entire dose of analgesic feed
during training. Throughout training the quantity of feed given at 17.00hours for
nutritive purposes was restricted to half the estimated appetite of each lamb. This
mild restriction ensured that lambs consumed the entire dose of drugged feed during
the hour that experimental feeds were available during training.
7.2.5.2. Preference testing
On the fifth and sixth day of each cycle lambs were offered a choice of both feeds in
the designated hoppers. Again the single hopper containing nutritive feed was
removed at 08.00. The experimental feed hoppers were introduced to the pen at
12.00. Each hopper contained a dose quantity of feed (analgesic or un-drugged). The
hoppers were removed at 13.00 (for the first three cycles) and the feeds weighed.
On the nights before preference testing, it was intended that no restriction should be
made on the volume of feed consumed overnight and the quantity of feed made
available was tailored to the appetite each lamb. However, as the lambs grew older
the weight of feed they would consume increased. From the fourth cycle of self
administration until the end of the study a maximum of 600g was provided overnight
because in the previous study lambs that ate more than this showed signs of
discomfort. In order to accommodate this change in nutritive feeding, the time for
which experimental feeds were made available during preference testing was reduced
to 30 minutes during the fourth self-administration cycle until the end of the




The side (left or right) of the pen at which analgesic feed could be found for each
lamb was selected at random using random number generation (Excel, Microsoft).
For the purposes of analysis an 'analgesic' hopper was nominated at random for
lambs in the un-drugged groups (CN and HN). The proportion of the total feed
consumed that was consumed that was taken from the nominated analgesic hopper
was calculated for analysis. The latency to approach the hoppers, frequency and
duration of visits to the hoppers were also recorded.
7.2.6. Lesion assessment
The chronic inflammatory lesions resulting from castration and tail-docking were
examined and assessed twice in each six-day cycle. Each lamb was caught and
inverted. The presence or absence of the tail and scrotum was noted. The width of the
lesion was measured, using callipers, to the nearest millimetre. Subjective assessment
of the severity of the lesion was made using the scale described by Kent et al (2000)
as described in Section 2.7. Using this system, the lesion was scored for severity on a
scale of 0-5 in increments of 0.5.
7.2.7. Behavioural analysis
Observations of behaviour were made, once in each cycle, on the second day of
preference testing, for 3 hours between 14.00 and 17.00. The methods used are
explained fully in Section 2.8. Three experienced observers were spaced around the
penned area on raised platforms to ensure that every animal could be observed from
at least two angles at all times. The experimental animals were divided into 3
manageable batches for observation (two groups of 10 lambs and one group of 8).
Each batch included an equal number of animals from each treatment group as far as
possible. Observations were recorded directly onto computers (Dell Latitude
Laptops) using The Observer behavioural analysis software (Noldus Information
Technology). All observations were made according to the ethogram shown in Table
2.2. The behaviours 'chew' and 'horn' were added to the original ethogram (Molony
et al, 1995) as these behaviours occurred frequently in the penned SBF lambs.
The frequency of each active behaviour was recorded continuously throughout the
observation time. Postures of lambs were recorded during scan samples every 6
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minutes throughout the observation time. At each scan the lamb's posture and
behaviour was recorded. Two of the observers were the normal handlers of the
animals. During the week prior to the experiment beginning these handlers spent as
much time as possible in the barn with the animals in an effort to minimise the effect
of the observers on the sheep. Observers were seated on the platforms for at least 5
minutes before observations started to allow the animals time to settle.
7.2.8. Blood samples
4ml blood samples were taken (according to the methods described in Section 2.5)
within 30 minutes after the hoppers were removed on the second day of preference
testing in each cycle. The samples were immediately cooled to <4°C on ice and were
centrifuged at 3000rpm for ten minutes within ten minutes. Plasma was transferred to
labelled plastic tubes and stored at -20°C until required for analysis.
7.2.9. Colorimetric determination oftotalprotein and albumin in plasma
The concentration of total plasma protein and albumin were determined using
quantitative colorimetric assays as described in Section 5.5.
7.2.10. High performance liquid chromatographyfor extraction and quantification of
funixin meglumine in plasma.
The plasma concentration of flunixin meglumine in all animals receiving drugged
feed, was measured using isocratic, reverse-phase high performance liquid
chromatography (IIPLC) as described in section 2.6.
7.2.11. Statistical analysis
General linear models (GLM) were used to determine differences between groups in
the weight of lambs, the proportion of test feeds eaten during training (after log-tan
transformation), the total weight of creep feed eaten during choice, the proportion of
feed eaten from the analgesic hopper (first transformed using log-tan transformation),
the frequency of visits and proportion of total duration spent at the analgesic hopper
(transformed using log-tan transformation) during choice and the concentrations of
flunixin meglumine (after square root transformation) and total protein and albumin
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in plasma. GLMs were carried out for each sample point for each measure during the
study. If effects of treatment were found. Fisher's approach was used post-hoc to
determine where the differences lay. GLMs of total plasma protein and albumin were
carried out using the plasma concentration of FM as a covariate to determine any
relationship between the protein concentrations and the quantity of FM in the blood.
Student's t-tests were used to compare the width of castration lesions and Mann-
Whitney U tests to compare the severity scores for castration and tail-docking
lesions. Regression analysis was used to identify any relationship between the size of
the lesion and the proportion of feed consumed from the analgesic hopper (no
transformation). Lesion width was also used as a covariate in a GLM analysis of the
weight of lambs to determine whether the size of the lesion was affected by the
weight of the lamb. Regression analysis was also used to determine any relationship
between the proportion of feed taken from that analgesic hopper and the width of
castration lesions.
Genstat (version 5) was used to carry out generalised linear models on behavioural
data. Differences identified using generalised linear models were examined more
closely post-hoc using Fisher's approach to determine where differences lay. Data on
active behaviours were analysed using poisson distribution and the logarithmic link
function, whilst data on posture were analysed using the binomial proportions model




7.3.1. Weight of lambs
As the lambs were initially divided into groups in which the weight of lambs was
approximately equal, there was no initial statistically significant difference in the
weight of lambs between treatments at P<0.05. Over the study period the average
weight of lambs more than doubled from approximately 12kg to 28kg over the six
weeks of the trial. There were no statistically significant differences in weight of
lambs between treatment groups at any time during the study at P<0.05. The mean
weight (±sd) of lambs in each group are shown in figure 7.1.
Figure 7.1. Change in live-weight (kg) of lambs over the duration of the trial, expressed as mean
(±sd), n=7.
7.3.2. Training
The proportion (median (Q1-Q3)) of test feed consumed on training days are shown
in Figures 7.2 a and b for 'analgesic' and undrugged training days respectively.
Lambs in groups CD and HD initially ate less feed during training, irrespective of the
type of test feed provided (i.e. analgesic or undrugged feed). This difference was
found to be statistically significant during the second cycle of testing on days 12, 13
and 14 (F3;24=l 1.97, P=0.002; F3,24=8.62, P=0.007; F3,24=9.68, P=0.005). However
by day 23 only HD lambs were eating less than the other lambs (F3>24=9.45,
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P=0.005) and consumption by CD lambs was as high as that found in lambs without
access the analgesic creep. The difference between HD lambs and the other groups
occurred on two more occasions before the end of the trial (days 30^3,24=4.75,
P=0.039; day 32-F3,24=4.58, P=0.042).These results were confirmed post-hoc using
Fisher's approach. Subsequently, almost all the lambs ate all the training feeds and
no differences were found between groups.
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Total weight of feed consumed
The change in the weight of test feed consumed during the trial is shown in figure
7.3. During choice testing lambs in groups CD and HD consistently ate more of the
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test feeds than their undrugged counterparts. This difference was significant on days
10, 15, 21, 22, 28, 34, 39 and 45 after castration and tail-docking treatment. These
results were confirmed post-hoc using Fisher's approach.
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Self administration analysis
As can be seen in figure 7.4, there appeared to be no difference in the proportion of
feed that was taken from the 'analgesic' hopper between groups at any point during
the trial. This result was confirmed statistically using GLMs.
Regression analysis showed that there was no relationship between the size of the
lesion and the proportion of feed taken from the 'analgesic' hopper.
Figure 7.4. Mean (±sd) proportion of test feed consumed from the analgesic hopper during choice
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7.3.4. Behaviour at the hoppers
On days 28 and 34 an effect of analgesic treatment on the duration of visits to the
analgesic hopper was found (F3i24=6.05, P=0.021, and F3;24=4.40, P=0.039
respectively). Post-hoc testing using Fisher's approach revealed that on both days
CD and HD lambs spent longer at the hopper than CN and HN lambs, but that there
were no differences between CD and FID lambs or between CN and FIN lambs on
either day. There was no difference either in the frequency of visits to the hopper
between groups at any time during the study, or in the latency to approach the
hoppers. The data on frequency and durations of hopper visits are presented in figure
7.5.
Figure 7.5. Behaviour of lambs at the test hoppers during the first three hours after the hoppers were
placed in the pen, n=7. (a) Mean (±sd) frequency of visits to the 'analgesic' hopper, (b) Mean (±sd)
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7.3.5. Plasma concentration offlunixin meglumine
The mean (±SEM) plasma concentrations of flunixin meglumine in lambs in groups
CD and HD are presented in figure 7.6. There was a general increase in the plasma
concentration of flunixin meglumine in both groups over the time of the trial.
However, in CD lambs the concentration rose more quickly and reached a peak 34
days after c+td (0.297 ±0.075pg/ml). Subsequently the plasma concentration of FM
in CD lambs declined to the same level as that in HD lambs. The plasma
concentration of FM in HD lambs reached a maximum 40 days after c+td (0.219
±0.070pg/ml). The difference between the plasma concentration of FM measured in
CD and HD lambs neared significance at P<0.05 on day 34 when the concentration
reached a peak in CD lambs (Fi,[2=3.46, />=().088). However there were no
statistically significant differences in plasma concentration of FM at P<0.05 between
CD and HD lambs at any time during the trial. Regression analysis indicated that
there was no significant predictive relationship between the width of castration
lesions and the plasma concentration of FM in CD lambs.
Figure 7.6. Mean (SEM) concentration (pg/nil) of FM in plasma 3-4hours after test feeds were given,
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7.3.6. Plasma protein analysis
The mean (+SEM) concentrations of protein and albumin in plasma are shown in
figures 7.7a and b. Both figures show that the concentration of protein and albumin
in the plasma varied very little during the trial. There was an increase in the total
concentration of protein towards the end of the trial, which appeared to be most
important in group CN. In an initial analysis of this data, the effect of treatment was
assessed using a GLM in which no covariates were included. This analysis revealed
no differences in the total concentration of protein in plasma between treatments at
any time during the trial. Interestingly lambs that were to receive 'analgesic'
treatment showed significantly higher concentrations of albumin in plasma before the
treatments had been given, but no further differences in the concentration of albumin
were found. Further analysis was carried out in groups CD and HD to determine
whether variations in the concentration of FM in plasma might have some effect on
the total concentration of protein and the concentration of albumin in plasma. The
concentration of FM found in plasma was added as a covariate to the analysis of the
effect of castration between these groups. A slightly significant negative relationship
between the concentration of FM and the concentration of albumin in plasma at
P<0.05 was found 16 days after c+td (the second cycle of choice testing) (F3iio=
5.01, P= 0.049). Analysis of total protein data revealed no effect of the concentration
of FM but that CD lambs had a higher total concentration of protein in plasma 40
days after c+td than HD lambs. No further significant differences were found.
Figure 7.7(a) Mean (SEM) total concentration (g/L) of protein in plasma in CD and I ID lambs over
the duration of the trial, n=7. (b) Mean (SEM) plasma concentration (g/L) of albumin in CD and HD
lambs over the duration of the trial, n=7.
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7.3.7. Severity of lesions
The width and score of scrotal lesions and the score of tail lesions for lambs in
groups CD and CN are presented in figure 7.8a, b and c. As can be seen from figure
7.8a that the mean (±sd) width of the lesions observed in CD lambs rose to a peak of
22.9±2.9mm on day 31. The maximum lesion width observed in CN lambs was
observed slightly later on day 34, but reached a lower peak of 20.4±4.2mm. The
severity scores of scrotal lesions in CD and CN lambs (see figure 7.8b) rose to a
median plateau of 3.5. This plateau was reached slightly sooner in CN lambs (day
19) than in CD lambs (day 22). The lesions in CD lambs did not exceed a median
(Q1-Q3) of 3.5 (3.5-3.5) during the trial, but lesions in CN reached a peak in severity
of 4.0 (3.125-4.0) on day 40. The severity of lesion in CN lambs subsequently
dropped off faster than in CD lambs. The severity of tail lesions reached a median
(Q1-Q3) maximum of 1.0 (0.5-1.25) in CD lambs, whilst reaching only 0.75 (0.25-1)
in CN lambs (see figure 7.8c). Only four lambs in group CD and three lambs in
group CN lost their scrotums before the end of the trial. The median time taken for
the scrotums to drop off was 46 (38.5-49) and 46 (43-46) days for CD and CN lambs
respectively. The tails of all the tail-docked lambs had dropped off by day 49 (3 days
after the end of the trial). The mean time taken for tails to drop off was 28.00 (±5.74)
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and 30.14 (±5.67) days for CD and CN lambs respectively. This difference was not
significant at P<0.05 (Student's T test Tn=0.70, ,P=0.500).
There were no statistically significant differences in the width and severity of lesions
observed in lambs with and without access to analgesic. In order to distinguish
between the effect of the drug on the lesion and possible extraneous variation as a
result of the variations in the size of lambs within groups, the weight of lambs was
used as a covariate in a GLM to test for differences in lesion width between CD and
CN lambs. This analysis revealed that for the majority of the study, the weight of the
lamb had no effect on the width of the lesion observed. However, on day 34 after
c+td there was a significant negative relationship between the weight of lambs and
the width of the lesion (F3jo—6.41, P=0.030). As in the initial analysis 'analgesic'
treatment was found to have no significant effect on lesion width at any time.
Pictures of the changing severity of a chronic inflammatory lesion over the 6-weeks
after ring application in a representative lamb are shown in Appendix D.
Figure 7.8. Severity of lesions resulting from c+td of CD and CN lambs (n=7). (a) Mean (±sd) width
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HN, CD and HD lambs were recorded in S1 posture in a slightly decreasing number
of observations over the course of the trial. This pattern was most evident in HN
lambs and is shown in figure 7.9a. Lambs in group CN spent fewer observations in
SI standing posture during the first four observation periods (days 10-28). On days
10 and 22 a significant effect of c+td was found (t3,24=-2.67, P=0.008 and t3>24=-2.09,
P=0.047 respectively). Post-hoc analysis using Fisher's approach showed that this
result reflected a statistically significant difference between HN and CN lambs. On
both days CN lambs showed significantly less SI standing than HN lambs (t3,24=-
2.67, C=0.0131 and t3;24=-2.09, P=0.046 on days 10 and 22 respectively). After day
28 there was no difference in the number of observation spent SI standing, nor was
there any difference in the number of observations spent SI standing overall (see
figure 7.9b).
A statistically significant effect of c+td and of the interaction between c+td and
analgesic treatment was found on day 16 of the study (t3,24=2.80, P=0.050, t3,24=-
2.98, C=0.003). Post-hoc testing revealed that HN lambs spent fewer observations in
VI lying posture than both CN and HD lambs (t3,24=2.80, P=0.0096 and t3,24=2.40,
P=0.0237 respectively). However, the number of observations in which lambs were
observed to be in VI lying posture was low overall and no other differences in the
expression of the behaviour were found. The mean total number of observations
spent in VI posture was also not significantly different between groups although
there appeared to be a slight tendency for castrated animals to spend more time in
this posture. Data on VI posture are presented in figures 7.9c and d.
There was no pattern of variation in the number of observations spent in V2 lying
posture during the trial (see figure 7.9e and f). No statistically significant differences
were found in the occurrence of V2 lying posture between groups.
When SI, VI and V2 postures were summed to provide a measure of the expression
of normal postures (see figure 7.9g and h), there was a tendency for CN lambs to
express less normal posture over the first 4 observations (days 10-28), however this
trend did not reach significance. When the mean total number of observations of
normal behaviour was examined for the trial a statistically significant effect of c+td
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and the interaction was found. Post-hoc testing showed that CN lambs spent
significantly less time in normal postures than HN lambs (t3.24~2.68, P=0.0130). CD
lambs spent as much time in normal postures as handled lambs throughout the trial
and access to analgesic made no difference to the expression of normal postures.
CN lambs showed a tendency to express more V3 lying posture during days 10-28
of the trial (see figure 7.9i). In this group, the expression ofV3 posture rose to a peak
at day 28, coinciding with the peak in the severity of castration and tail-docking
lesions. Subsequently the expression of V3 posture declined. Differences in the
expression of V3 posture between groups did not reach significance at P<0.05 during
days 10-28. When the mean total number of observations spent in V3 lying posture
were examined for the whole trial however, a significant effect of c+td and the
interaction was found (t3,24=2.51, P=0.019 and t3,24—2.34, ,P=0.028 respectively) (see
figure 7.9j). CN lambs were found to spend significantly more time in V3 posture
than HN lambs (63,24=2.51, P=0.0189). On day 40 a significant effect of the
interaction between c+td and analgesic treatment was found and post-hoc analysis
showed that CD lambs were observed in V3 posture significantly less often than CN
lambs although this difference did not reach significance at P<0.05 (t3.24-l.7O,
P=0.0996).
SS posture contributed very little to the overall expression of abnormal behaviour
and no significant differences in the expression of this behaviour between groups
were found. However, when abnormal posture (the sum of V3 and SS postures) was
examined, an effect of the interaction was found on days 10 and 40 and when the
behaviour was summed for the duration of the study. Post-hoc analysis showed that
CN lambs expressed more abnormal behaviour than CD lambs on day 10 (t3,24—2.94,
P=0.0069) and 40 (although this differences was not significant on day 40 (t3,24—
1.70, P=0.0996)) and that CN lambs showed more abnormal postures than HN lambs
overall (t3.24=2.60, P=0.015).
Behavioural states
During observations on days 10-28 of the trial CN lambs tended to eat less than the
other groups of lambs and HN lambs tended to eat more (see figure 7.9k). These
differences were not significant, except on day 22 after c+td when CN lambs spent
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significantly less time eating than HN lambs (t3,24=-2.65, P=0.014 post-hoc Fisher's
approach). There was no overall difference in the mean total amount of time spent
eating between groups (see figure 7.91).
There was an overall decrease in the number of observations spent idling in all
groups as the trial progressed (see figure 7.9m). A significant effect of analgesic
treatment and the interaction factor was found overall 0^24=2.3, P=0.031 and t3,24=-
2.53, P=0.019 respectively) and post-hoc analysis showed that HD lambs spent
significantly more time idling than HN lambs over the whole time of the trial
(t3,24=2.29, P=0.030) (see figure 7.9n). Significant effects of treatment were found on
days 10, 16 and 22 after c+td and post-hoc analysis revealed that HD lambs showed
more idling than HN lambs on day 10 (t3,24=2.38, P=0.025)
Over the time of the trial there was a consistent increase in the number of
observations spent ruminating until 34 days after c+td. On day 34 a significant effect
of c+td and the interaction was found. After post-hoc tests HN lambs were found to
spend more time ruminating than CN lambs (t3,24=-1.97, P=0.060), although not
significantly so. However no consistent differences in the expression of this
behaviour were observed (see figure 7.9o and p) and no difference in the mean total
expression of the behaviour during the trial were found.
CD spent more time sleeping on day 10 after c+td but this difference was not
significant at P<0.05. There was an increase in the amount of time spent sleeping by
CN lambs during days 10-28. There was a significant effect of treatment on the
amount of time spent sleeping on days 16, 22 and 28 after c+td (t3,24=-2.22, P=0.026,
t3>24=-2.07, P=0.039 and t3,24=2.89, P=0.004 respectively). Post-hoc testing showed
that HN lambs spent less time sleeping than CN and CD lambs (t3,24=2.88, P=0.008
and t3,24=2.24, P=0.034 respectively) HN lambs spent less time sleeping during the
trial than the other lambs but this difference did not reach significance at P<0.05.




Figure 7.9. Proportions of observations of postures and behavioural states during two 2 hours
observation periods; obtained in scan samples every 6 minutes, (a) Mean (±sd) proportion of
observations in SI posture for each weekly observation throughout the trial, (b) Total mean (±sd)
proportion of observations observed in SI as a summary for the whole study period, (c) Median (Ql-
Q3) VI (d) Total median (Q1-Q3) VI (e) Mean (+sd) V2 (f) Total mean (+sd) V2 (g) Median (Ql-
Q3) normal (h) Total median (Q1-Q3) normal (i) Median (Q1-Q3) abnormal (j) Total median (Ql-
Q3) abnormal (k) Mean (±sd) eating (1) Total mean (±sd) eating (m) Mean (±sd) idling (n) Total
mean (±sd) idling (p) Mean (±sd) ruminating (q) Total mean (±sd) ruminating (r) Median (Q1-Q3)
sleeping (s) Total median (Q1-Q3) sleeping. CD=black bars, FID=open bars, CN=hashed bars,
HN=spotted bars.
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Frequency ofactive behaviour
For some behaviours the variance within the data was not balanced across groups
because they occurred infrequently overall but were expressed frequently by few
individuals. Where variance problems within the data were experienced statistical
analyses using generalised linear models could not be carried out, as this analysis
assumes approximately equal variance. The data are presented in graphical form in
figure 7.10.
Examination of the frequency of active behaviours revealed few differences between
treated animals and controls. As can be seen in figure 7.10a, there was no overall
change in the frequency of restlessness during the trial in any group. On day 22 c+td
was found to have a significant effect on the occurrence of restlessness P<0.05
(t3,24= 1-98, P=0.048). After post-hoc analysis using Fisher's approach the differences
between groups was not found. The total mean frequency of restlessness for the
whole time period did not differ between groups (see figure 7.10b).
The pattern of expression of easing quarters in CD and CN lambs varied over time
(see figure 7.10c). CD lambs initially expressed easing quarters with the same
frequency as HD and HN lambs, but their expression of this behaviour increased in
frequency during the trial to reach a peak in frequency 34 days after c+td. This rise
and peak coincides with the plateau of maximum severity of scrotal and tail lesions
measured during the trial. Flowever, because of the variation in the expression of the
behaviour between individuals in the group, the difference between CD lambs and
the other groups did not quite reach significance at P<0.05 on day 34 after c+td
(t3,24=2.07, P=0.050). Two peaks in the expression of the behaviour are observed in
CN lambs, the first occurred 16 days after c+td and the second 40 days after c+td.
However, the frequency of easing quarters in CN did not differ significantly from
that in the other groups at any time during the trial.
Much of the data on foot-stamping could not be analysed statistically for reasons
described above. However, the mean total expression of the behaviour was analysed
as was data for day 22 but no significant differences were found. Overall, CD lambs
expressed the behaviour more frequently (see figure 7.10e), however the variation in




The REQ score (sum of rst, eq and fsk) verified patterns of easing quarters observed
in CD and CN lambs but no differences in the frequency of expression of these
behaviours occurred either during the trial or in the total mean expression for the
whole period (see figure 7.10g and h).
There was a decline in the frequency of teat-seeking over the six weeks of the trial
(see figure 7.1 Oi and j). This decline was observed in all groups and there were no
significant differences between groups in the frequency of the behaviour. The
frequency of tail-wagging in CN lambs peaked twice during the trial, at days 16 and
40 after c+td (see figure 7.10k). These peaks in expression occurred at the same time
as peaks in the expression of easing quarters behaviour in the same lambs. The
expression of tail-wagging in lambs in the other groups did not fluctuate, but showed
an overall decline during the trial. Despite peaks in expression of tail-wagging in CN
lambs on days 16 and 40, there were no significant differences in the frequency of
tail-wagging between groups at any time point or in total for the whole study (see
figure 7.101).
Head-turning behaviour occurred very infrequently and again much of this data could
not be analysed statistically. However, there were no significant differences in the
frequency with which this behaviour was expressed between treatment groups when
considered for each target (i.e. head turn to flank, scrotum, back or outside hind leg)
separately on the occasions when variances were equal between groups and data
could be analysed. When head-turning to each target was summed to provide data on
head-turning in general (see figure 7.10m) no differences in the frequency of
expression of the behaviour between groups were found. The summary data for head
turning is presented in figure 7.1 On. Play behaviour also occurred very infrequently
during the trial and on days 10, 28, 34 and 46 the data could not be analysed. On day
16, play was observed more frequently in handled than in castrated lambs (t3,24=-
2.08, P=0.037) although again the differences were not found to be significant with
post-hoc testing. When the mean total frequency of behaviour was examined, no
statistically significant differences were found although play appeared to occur more
frequently in handled animals (see figure 7.10q). There were no differences in the
frequency of expression of rubbing (see figure 7.10o and p), chewing (see figure
7.1 Of) or horning (see figure 7.1 Or) at any time during the trial.
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Figure 7.10. Frequency of active behaviours observed during two, 2 hour long observation periods, (a)
Mean (±sd) frequency of restlessness for each weekly observation throughout the trial, (b) Total
median (Q1-Q3) frequency of restlessness as a summary for the whole study period, (c) Mean (±sd)
easing quarters (d) Total mean (±sd) easing quarters (e) Total median (Q1-Q3) foot-stamping (f)
Total median (Q1-Q3) chewing (g) Mean (+sd) REQ (h) Total median (Q1-Q3) REQ (i) Median
(Q1-Q3) tail-wagging (j) Total median (Q1-Q3) tail-wagging (k) Median (Q1-Q3) teat-seeking (1)
Total mean (±sd) teat-seeking (m) Median (Q1-Q3) head-turning (n) Total median (Q1-Q3) head-
turning (o) Total median (Q1-Q3) play (p) Median (Q1-Q3) rubbing (q) Total mean (±sd) rubbing
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7.4.1. Physical evidence ofchronic inflammatorypain?
Weight
In the present study no statistically significant differences in daily live-weight gain
were found between treatment groups. This is in accordance with the study described
in Chapter 6 and with previous studies in which c+td was found to have no effect on
weight gain (Kent et al, 2000). However, in the study described in Chapter 6 a non¬
significant trend of reduced weight gain in CN lambs was found, whilst CD lambs
showed the most rapid weight gain. CN lambs were also found to spend less time
eating than the other lambs during the period when the lesions from c+td were most
severe. Although these differences were not statistically significant, the fact that the
slight differences occurred together and that the trend was not observed in CD lambs
suggests that the changes may have been associated with pain of some degree. In the
present study no such changes in weight were found although CN lambs were found
to spend less time eating than the other lambs as was observed in the previous study.
This difference will be discussed in more detail below.
Severity oflesions
In previous studies of the chronic effects of RR castration in six-week-old, Scottish
Blackface lambs, lesions measuring 27mm across and with a severity score of 4.2
were observed (Kent et al, 2000). In the present study castration lesions with a width
of 22.9± 2.9mm and a maximum severity of 3.5 (3.5-3.5) were found in CD lambs
and a width of 20.4± 4.2mm and a maximum severity of 4.0 (3.125-4.0) were found
in CN lambs. These lesions were both smaller and less severe than those found by
Kent et al (2000). Lesions of limited severity were also found on the tails of these
lambs. Although the peak in lesion severity occurred at a similar time to that
previously reported (3-4weeks after RR application), the scrotums and tails also took
longer to drop off than in previous studies, a fact likely to be the result of the reduced
severity of lesions. The lesions found in this study were no more severe than those
found in the previous study, described in Chapter 6.
One of the most important changes in the experimental protocol for this study was
the increase in the age of lambs at the time of c+td. This change was included in an
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attempt to increase the severity and consistency of the lesions observed, thus
theoretically increasing the pain experience of the lambs. It was hypothesised that
such an increase in pain severity would increase the probability that lambs would
learn the association between analgesic effects and the consumption of a novel feed.
The severity of lesions that developed during this trial was less than expected, thus
reducing the potential effect of increasing the age of lambs at c+td. No definite
explanation can be given for these lesions being unusually mild. However it is
proposed that fresh bedding may have been provided more frequently in this study
than in previous studies, thus reducing the opportunity for bacterial contamination of
developing lesions. This aspect of the study was not controlled with respect to
previous studies. However, in this study the positioning of the lambs in different
groups was balanced across the study environment and therefore there should have
been no differences in the quantity of bedding provided to lambs in different
treatment groups. In order to ensure that consistently severe lesions were obtained in
studies of the chronic effects of RR c+td, it might be considered necessary to control
the quantity of bedding provided and to regulate the level of bacterial infection of the
lesions, by deliberate, controlled contamination of the ring or lesion.
7.4.2. Behavioural evidence ofchronic inflammatory pain?
As was observed in the previous study, CN lambs in the present study spent less time
eating than the other lambs. The amount of time CN lambs spent eating declined over
the first 3 weeks after c+td and the difference between CN lambs and the other
groups reached significance 22 days after c+td and neared significance at f<0.05
when the data was summed for the whole study period. The difference is consistent
with appetite suppression associated with chronic inflammatory pain, reaching
significance as the c+td lesions neared their maximum severity. This proposal is
supported by the fact that CD lambs showed no such time-dependent changes in the
amount of time they spent eating suggesting that the NSAID FM reduced the
experience of pain and thus prevented the appetite inhibition observed in CN lambs.
Suppression of appetite is widely accepted to be a symptom of chronic pain and is
usually associated with weight loss or reduced weight gain (Kitchell and Johnson,
1985; Zimmerman, 1986). However as was discussed above, the reduction in
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appetite in CN lambs was insufficient to induce any statistically significant change in
live-weight gain in CN lambs.
Differences in the amount of time spent in other behavioural states were also
observed. In contrast however, these differences were not consistent with changes in
behaviour that would be expected as a result of chronic inflammatory pain. It is
commonly accepted that chronic pain can result in interrupted sleep patterns
(Kitchell and Johnson, 1985; Zimmermann, 1986), but in this study CN lambs spent
significantly more time sleeping than other lambs. This result differs from that in the
previous study in which c+td lambs were found to sleep less than other lambs and
there are few reasonable explanations for these differences. One possible explanation
is that as the lambs got older they became less inclined to move around their
relatively restricted environment and therefore when they were not eating showed a
greater tendency to lie down and sleep than the younger lambs used in the previous
trial. The restriction on movement and behaviour may therefore have increased the
effect of dependence in scan sampling data, which is an unavoidable error in the
analysis.
The inconsistencies in behavioural states were less evident in the analysis of posture.
CN lambs showed more abnormal posture than the other lambs and the amount of
time spent in abnormal postures rose to a peak 28 days after c+td, coinciding with the
peak in lesion severity. In this study, V3 posture was the most common abnormal
posture observed, with very few occurrences of SS contributing to the data slightly.
Changes in posture have been considered indicative of the experience of avoidable
pain (Molony et al, 1993). Lambs are thought to adopt these postures to minimise
aggravation of sensitised tissue. The adoption of such posture during a period of
chronic inflammatory pain is likely to be particularly effective, as chronic
inflammation has been reported to result in general tenderness and the experience of
severe pain when the region is manipulated (Levine and Taiwo, 1994). The changing
expression of abnormal postures was not observed in CD lambs and the time spent in
abnormal postures was consistently lower in these lambs. Thus, it may be concluded
that the consumption of the NSAID FM reduced inflammation sufficiently to reduce
generalised inflammatory pain and therefore the appearance of abnormal postures
used to minimise harm to the affected region. This indicates that analysis of posture
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has the potential to provide a useful means of assessment of chronic inflammatory
pain.
Evidence of an effect of c+td was also found in analysis of the frequency of active
behaviours. In studies of acute pain from RR c+td, incidences of abnormal active
behaviour were considered to be indicative of inescapable pain (Molony et al, 1993).
In this study, there were few consistent differences in the occurrence of active
behaviour over time. However, c+td lambs showed more restlessness, easing quarters
and foot-stamping than handled lambs. In CD lambs, a peak in the expression of
easing quarters coincided with the time at which c+td lesions reached the maximum
of severity. In CN lambs, two coinciding but transient peaks were observed in the
frequency of both easing quarters and tail-wagging. Play behaviour was observed
more frequently in handled lambs, although not significantly so. Overall the
differences observed were not highly significant and in isolation, could not be
considered strong evidence of an effect of c+td. However, in combination their
occurrence can be considered to provide more substantial evidence of pain.
It is important to note that access to analgesic did not appear to reduce the frequency
of active behaviour in c+td lambs, with higher frequencies of behaviour found in
both CN and CD lambs. There are two possible conclusions that can be drawn from
this anomaly. Firstly, as has been discussed in relation to acute pain form RR c+td
(Molony et al, 1993), it might be proposed that two types of pain were present in
these lambs. Lambs may have experienced a general background level of chronic
inflammatory pain and were able to minimise their experience of this pain by
adopting subtle changes in posture. The consumption of FM reduced inflammation
and thus the degree of sensitisation of damaged tissue and therefore chronic
inflammatory pain and resulted in a reduced need to assume these abnormal postures.
However, movement or irritation from bedding or insects for example, may have
induced more isolated episodes of acute unavoidable pain, inducing higher than
normal frequencies of active behaviours. The presence of inflammation is also
known to increase the occurrence of spontaneous activity in nociceptors (Levine and
Taiwo, 1994), which could again result in the expression of active 'pain' behaviours.
The occurrence of this active behaviour and associated bouts of unavoidable pain,
was unaffected by analgesic in CD lambs. A second possible conclusion is that, as
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before, the changes in posture seen here are indicative of chronic inflammatory pain
that can be relieved by the consumption of the NSAID FM. The increases of active
behaviours, however may have occurred in response to transient irritation of the
wound and were not associated with pain and thus the frequency of their occurrence
was unaffected by the consumption of analgesic and was high in both groups of
castrated lambs.
7.4.3. Evidence ofself-administration ofanalgesic?
During training both CD and HD lambs initially ate less feed in total than undrugged
lambs. However, by day 23 only HD lambs consumed less feed overall, a trend that
continued until day 30 of the study. These differences occurred irrespective of which
feed was available on each training day. As the initial intake of the test feed was
different in only those groups with access to analgesic test feed (although not only
associated with days when analgesic feed was offered) it appears reasonable to
conclude that it was some aspect of the analgesic feed that caused neophobia or
aversion. The fact that CD lambs appeared to overcome neophobia more quickly than
HD lambs suggests that CD perceived the beneficial effects of consuming the
previously aversive feed, although the evidence is far from conclusive.
In contrast, during choice testing no difference in the total consumption of test feeds
between CD and HD lambs was found and both groups of lambs ate consistently
more than undrugged lambs. This result suggests that FM stimulated appetite in both
CD and HD lambs, although no reports of appetite stimulation by the NSAID could
be found in the literature.
Although CD and HD lambs spent longer at the 'analgesic' hopper than control
lambs, there was no difference in the proportion of test feed that was taken from the
this hopper. Consequently, despite there being no significant differences in the
proportion of feed taken, the analgesic did change the pattern with which the lambs
ate from the hopper.
Despite the lack of evidence that CD lambs consumed more analgesic feed than other
lambs, HPLC analysis to measure the plasma concentration of FM revealed that the
slight differences in the weight of feed taken were sufficient to result in differences
in the concentration of FM in plasma. There was a general increase in the amount of
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FM that reached the plasma of CD and FID lambs. This trend is likely to be a
reflection of the fact that the dose of FM was increased as the weight of the lambs
increased. Normally it would be expected that the plasma concentration of FM
should remain relatively stable using this dose regime. However, in this study the
lambs were fed a relatively large quantity of concentrated feed and had a restricted
space in which to move around, thus a greater than normal proportion of their body
weight was likely to have been fat (although this was not measured). As the
distribution of FM into the fat partition is minimal, a higher concentration of FM in
plasma is to be expected. Furthermore, castration is known to increase the proportion
of body mass that is made up of fat, this argument could be used to explain the more
rapid rate at which the plasma concentration of FM increased in CD lambs. However,
this argument is refuted if the rapid decline in plasma concentration of FM 34 days
after c+td is taken into account. This change coincided with lesion healing and there
was no corresponding reduction in the weight of lambs. Thus, there is some evidence
that CD lambs did select from the choice of hoppers, consuming more analgesic than
HD lambs. The difference between CD and HD lambs was close to significance
despite very high levels of individual variation within groups.
7.4.4. Evidence of toxicity
In this study no evidence of an effect of FM on the plasma concentration of albumin
or total plasma protein was found. The results of this study therefore suggest that the
NSAID FM administered orally at l.lmg/kg, had no adverse effects on the integrity
of the GI tract despite long-term administration of the drug, although it is noted that
the NSAID could have hepatic and renal effects which were not investigated. In
previous studies there was a suggestion that the incidence of rubbing might be
indicative of adverse effects of FM as the behaviour was shown more frequently in
animals with access to the drug (Chapter 6 and Rutherford 1999). No such
behavioural differences were found in this present study.
7.4.5. Alternative protocolfor self-administration
The adaptation of the original protocol is considered to have improved the study,
both by reducing variation and strengthening the opportunity lambs had to learn the
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association between consuming the drugged feed and a reduction in pain. However,
it was also considered that the protocol has limitations. In the self-administration
protocol used in both studies in this project, the dose of analgesic was dependent
upon the quantity of feed consumed. Although studies of the pharmacokinetics of
FM after oral administration in lambs (Chapter 3) indicated that the quantity of FM
reaching the plasma compartment should be sufficient to result in significant
inhibition of prostaglandins, the route of administration still resulted in variation in
the dose administered. Further it was difficult to ensure that enough analgesic feed
was consumed, quickly enough to obtain a full dose of analgesic, but that sufficient
feed was available so that lambs could not eat the selected food too quickly and
move onto the alternative feed before the choice could be assessed. This protocol
was based on that described by Colpaert et cil (1980; 1982). It is considered that
administration of FM by a route that was independent of feed intake would eliminate
analgesic dose as a source of variation. As a result the risk of overdosing would be
eliminated and the quantity of feed available to the lambs need not be limited.
Other authors using the self-administration paradigm took this approach. In a study to
examine the development of conditioned flavour aversions in lambs, Kyriazakis et al
(1998) paired flavoured feeds of similar hedonic value with oxalic acid, a naturally
occurring plant toxin. The toxin was administered orally, at different doses (or
placebo) in a gelatine capsule. Thus the dose of toxin was independent of the weight
of feed consumed and was easily controlled. In another study to examine the effects
of changes in rate of fermentation on diet selection, Kyriazakis and Oldham (1993)
administered infusions of water, urea or fructose into the rumen, through a rumen
cannula. Again the effect was independent of the quantity of food consumed.
Alternatively, the dose of analgesic administered during analgesic self-administration
studies could be given through an i.v. cannula at the same time as or shortly after
first introducing a flavoured feed to the pen. In this way variation in the dose of FM
received by lambs in the analgesic treatment group could eliminated. It should be
noted that the mean plasma concentration of FM measured in both self-
administration studies was considered sufficient to provide some degree of analgesia,




A second source of variation in these studies was the highly variable feed intake and
diet selection in individual lambs in all treatment groups. It is known that in lambs,
diet selection is influenced by social environment (Thornhallsdottir et al, 1987) and it
has been suggested that individual variation in diet selection can be greatly reduced
by housing animals in pairs (Forbes and Kyriazakis, 1995). It is proposed that twin
male lambs should be used in future studies in order to reduce variation in feed
intake. Both twins should undergo the same treatment and be considered as a single
sample in analysis. It should be noted that this would potentially double the number
of individuals used in the study and the justification for the work would have to be
carefully considered. However, housing the lambs with siblings is likely to also
likely to be beneficial as pen size would be increased and the lambs would have more
opportunity for social interaction.
7.4.6. Conclusions
The lesions resulting from RR castration and tail-docking of six-week-old lambs in
this study were smaller and less severe than expected in lambs of this age and thus
the physical indications of the presence of chronic inflammatory pain was limited.
Changes in posture and in feeding motivation as a result of c+td were identified and
their appearance was reduced by the consumption of analgesic indicating that the
plasma concentrations of FM achieved were efficacious and that such changes in
behaviour may be indicative of the experience of chronic inflammatory pain. The
increase in frequency of active behaviour in CN lambs was not reduced by the
consumption of FM in CD lambs indicating either that these behaviours are not
indicative of chronic inflammatory pain or that FM is not efficacious in the treatment
of the type of pain that induced these behaviours. Although no differences were
found in the proportion of feed that was taken from the analgesic hopper, the plasma
concentration of FM was higher in CD than in HD lambs during the 3rd, 4th and 5th
cycles of the protocol. This difference neared significance during the 5th cycle when
c+td lesions were at their maximum severity. Subsequently the plasma concentration
of FM declined. The combination of this difference in FM concentration and the
differences in posture and feeding motivation are considered the most compelling
evidence of the experience of chronic inflammatory pain in c+td lambs.
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Apart from the limited severity of the lesions observed in this study, it is considered
that the protocol used was such that variation was minimised and that the opportunity
to learn the association between consumption of the distinctive test feed and the
relief of pain was provided. Constraints of time and personnel limited the possibility
of increasing the power of the experimental protocol by increasing the numbers in
each group and the time for which behaviour was recorded. Increasing the severity of
lesions by controlled, bacterial contamination is a possibility. In a commercial
environment however, the appearance of particularly severe lesions is unusual
because most lambs are c+td at less than a week of age. Because the aim of this
research is to investigate whether the routine husbandry procedure of RR castration
and tail-docking is associated with chronic inflammatory pain, inducing lesions that
are more severe than would normally occur in order to validate a model is considered
ethically unacceptable.
Finally, it is considered that the use of a protocol in which the administration of
analgesic was independent upon the quantity of feed consumed, as described in a
study of plant toxins by Kyriazakis et al (1998), would provide a more robust basis
for analgesic self-administration studies in lambs. This would allow a consistent dose
of analgesic to be administered and reduce the need for limitation of feed intake,
increasing the chance of consistency of selections made. It is also proposed that
housing of lambs in pairs (twins) would reduce variation in feed consumption, whilst
reducing the cost of the study on the individual, Although it is noted that careful




modulation to produce stressor-specific
responses
Chapter 8.
Chapter 8. The Hypothalamo-Pituitary-Adrenal Axis: Modulation to produce
Stressor-Specific Responses.
8.1. The central nervous and endocrine systems interact to control the stress
response.
The normal functioning of an animal's body requires that it is maintained in a state of
dynamic equilibrium or homeostasis. If some external or internal challenge, or
stressor, upsets this equilibrium, it is essential that the body can mount an appropriate
behavioural, autonomic and endocrine response to restore the system to within the
bounds of equilibrium. The hypothalamo-pituitary-adrenal (HPA) axis is the point at
which the central nervous system (CNS) and the neuroendocrine system interact
(Griffin and Ojeda, 2000). Stimulation from the CNS activates the HPA axis
resulting in endocrine responses to stress. These endocrine responses include
stimulation of specific regions of the CNS resulting in the co-ordination of
behavioural and autonomic responses with endocrine responses to stress. Stressor-
specific HPA responses are stimulated by an immense array of internal and external
stressors.
8.2. The basic HPA response in acute stress.
Following stimulation by an acute stressor, the basic mechanisms by which
endocrine responses are mounted are well established. The stress system receives
information about the body and environment through sensory receptors, via neural
pathways and in the blood. The information is processed and relayed to the
hypothalamus principally via the limbic system and brain stem (Aguilera, 1998). If
this information indicates that homeostasis, against a background of diurnal
variation, has been disrupted, the HPA axis is activated. Axons from parvocellular
neurones in the paraventricular nucleus (PVN) of the hypothalamus project to the
external zone of the median eminence and terminate at the portal capillary plexus.
Upon activation, corticotrophin-releasing hormone (CRH), synthesised in these
neurosecretory cells, is released into the hypophysial portal blood (HPB)
(Berkenbosch et al, 1989). CRH is transported to the anterior pituitary where it acts
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in synergy with other hormones (principally arginine vasopressin (AVP)), via
specific receptors, to induce the release of adrenocorticotrophic hormone (ACTH)
from anterior pituitary corticotrophs into the blood (Swanson et cil, 1983). CRH also
stimulates the synthesis of proopiomelanocortin (POMC), the precursor of ACTH
(Levin et al, 1989), in anterior pituitary corticotrophs. Once released, ACTH is
carried in circulation to the cortex of the adrenal gland where it acts on its receptor to
activate protein kinases, resulting in the metabolism of cholesterol. The end products
of this breakdown cascade are the glucocorticoids (for example deoxycorticosterone,
Cortisol, corticosterone and aldosterone), which are released into circulation (Plotsky,
1991).
Glucocorticoids act via specific receptors at many target sites to inhibit, for example,
reproduction, growth and immune responses. This provides energy for the necessary
responses to the stressor. ACTH and glucocorticoids regulate their own release by
negative feedback at all levels of the HPA axis, thus minimising potential negative
effects of their continued release.
The basic stress response mechanism does not explain the occurrence of distinct
reactions to specific types of stressor. Nor does it explain changes in regulation of the
stress response that occur when exposure to a stressor is prolonged. The regulation of
the HPA axis at all levels, the mechanisms that allow specific responses to a variety
of stressors and the specific HPA responses to chronic inflammatory pain are
discussed in this chapter.
8.3. Development ofexperimental stress paradigms
In order to investigate the regulation of hypothalamic pathways in response to
different stressors various experimental stress paradigms, both acute and chronic,
have been developed and used to model aspects of stress-specific responses. These
may be broadly categorised into four overlapping groups: Psychological stressors
include isolation, immobilisation, restraint, white noise, swim stress and forced
inhalation of ether. Physiological stressors include hypernatraemia, dehydration,
insulin induced hypoglycaemia, heat stress, haemorrhage, and cold stress. Physical
stressors, often incorporating inescapable pain, include electric foot shock, intra¬
peritoneal hypertonic saline, castration and tail-docking. Finally, immunological
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stress paradigms including experimentally induced arthritis caused by injection of an
adjuvant containing heat-killed Mycobacterium butyricum. Adrenalectomy (ADX) is
also used to examine the effects of chronic hyper-activation of the HPA axis, by the
removal of negative feedback from circulating glucocorticoids.
8.4. CRH and A VP: hypothalamic mediators of the stress response
In early studies, molecular sieve chromatography was used to separate hypothalamic
extracts. This revealed high and low molecular weight proteins with corticotrophin-
releasing activity (Antoni, 1987). The low molecular weight, nonapetide, arginine
vasopressin (AVP) was first structurally elucidated by Turner et al in 1951. In this
molecule disulfide bonds link two cystine residues giving the protein a characteristic
ring structure that is essential to its biological activity (Samson, 2000). AVP is a
potent stimulus for ACTH release in vitro (Gillies and Lowry, 1979). Corticotrophin-
releasing hormone (CRH) was characterised by Vale et al (1981) and is a high
molecular weight, 41-amino acid peptide derived from a 196-amino acid precursor
molecule (Smith et al, 1987). Following the isolation of CRH from ovine
hypothalamic extracts, the hormone was found to stimulate the secretion of ACTH
and (3-endorphin from the anterior pituitary of the rat with much higher potency than
AVP. However, the potency of CRH was increased four-fold when CRH was
administered with AVP (Gillies et al, 1982). The structures of CRH and AVP are
shown in figure 8.1.
Figure 8.1 The structure ofCRH
a. The structure of corticotrophin-releasing hormone (CRH)
H-Ser-Gln-Glu-Pro-Pro-Ile-Ser-Leu-Asp-Leu-Thr-Phe-His-Leu-Leu-Arg-Glu-Val-
Leu-Glu-Met-Thr-Lys-Ala-Asp-Gln-Leu-Ala-Gln-Gln-Ala-His-Ser-Asn-Arg-Lys-
Leu-Asp-Ile-Ala-NH2 (Vale et al, 1981)
b. The structure of arginine vasopressin (AVP)
H-Cys-Tyr-Phe-Gln-Asn-Cys-Pro-Arg-Gly-NH2 (Turner et al, 1951)
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It has since been accepted that CRH acts synergistically with arginine vasopressin
(AVP) to control the release of ACTH from the anterior pituitary following
activation of the HPA axis (Antoni, 1993). This synergistic control of the HPA axis
is consistent across species, in rats, mice and sheep.
However there are species-specific differences in the degree to which each hormone
stimulates the release of ACTH. In the mouse, AVP has a more potent ACTH-
releasing effect than in the rat, although not exceeding the response to CRH (Castro
et al, 1989). Also, in in vitro studies in the sheep, AVP was found to strongly
stimulate the release of ACTH from ovine anterior pituitary corticotrophs (Familiari
et al, 1989) in a dose dependent manner and was found to be a more potent stimulus
for ACTH release than CRH (Liu et al, 1990; Canny et al, 1999).
8.5. Functional distribution ofCRH and AVP
The rat (Ivell and Richter, 1984) and bovine (Land et al, 1982) AVP neurophysin II
precursor and the human (Shibahara et al, 1983), rat (Jingami et al, 1985) and sheep
(Furutani et al, 1983) CRH precursors were cloned in the eighties. This facilitated
study of the mechanisms regulating CRH and AVP synthesis at both cellular and
molecular levels.
Immunocytochemical and in situ hybridisation studies in both rats (Paull et al, 1982;
Swanson et al, 1983; Bloch et al, 1990) and sheep (Matthews et al, 1991; 1993) have
shown that immunoreactivity and mRNA for CRH and AVP are widespread in the
CNS. The wide distribution of CRH and AVP containing neurones and behavioural
and autonomic effects induced by central administration of AVP (Parkes et al, 1988)
and CRH (Scoggins et al, 1984), provide some evidence that these neuropeptides
have neurotransmitter as well as hormonal functions. The simultaneous activation of
central CRH and AVP pathways is considered to be responsible for the co-ordination
of the behavioural and autonomic as well as the endocrine responses to homeostatic
challenge (Swanson et al, 1983; Riphagen and Pittman, 1986).
8.6. Pathways for hypothalamic control ofhypothalamo-pituitary-adrenal axis
The pituitary response to stress is controlled by hormones released from four neural
pathways in the hypothalamus into HPB from the median eminence. These are i) the
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magnocellular CRH and oxytocin expressing neurones, ii) magnocellullar AVP
expressing neurones, iii) parvocellular CRH expressing neurones and iv)
parvocellular CRH and AVP expressing neurones. Evidence that these pathways are
selectively activated during different stress paradigms is outlined below.
8.6.1. The role ofmagnocellular CRH in response to stress
CRH is co-localised with oxytocin (OT) in about a third of magnocellular neurones
in the SON and PVN (Sawchenko et al, 1984) and it has been proposed that CRH
produced in these cells modulates OT secretion during stress. Expression of CRH
mRNA in magnocellular neurones increases following stimulation by osmotic
stressors. However, parallel expression of CRH mRNA in parvocellular neurones is
reduced (Lightman and Young, 1987). Because the level of expression of CRH
mRNA in magnocellular neurones is at least one order of magnitude lower than the
expression of CRH mRNA in the parvocellular division (Holmes, 1986), there is a
net reduction in the expression of CRH mRNA overall (Dohanics et al, 1990). This is
reflected in the corresponding reduction in the release of ACTH from the anterior
pituitary (Chowdrey et al, 1991). No change in the expression of CRH in
magnocellular hypothalamic pathways is observed in response to non-osmotic
stressors (Aguilera et al, 1994)
It is thought that less than 10% of the CRH in HPB (Palkovits et al, 1991; Antoni,
1993) originates in both the magnocellular CRH neurones and from dispersed
parvocellular neurones in the perifornical region just outside the PVN (Palkovits et
al, 1991). The remaining 90+% is thought to originate in parvocellular CRH
neurones (Holmes et al, 1986).
8.6.2. The role ofmagnocellular AVP in response to stress
The principle and best-known function of AVP is as the anti-diuretic hormone
(ADH). This anti-diuretic AVP is synthesised in the magnocellular division of the
paraventricular nucleus (mPVN) and in the SON of the hypothalamus. Magnocellular
neurones in these nuclei, project to the posterior pituitary gland terminating next to
blood vessels within the gland and release hormones into circulation. AVP is carried
in the blood to the kidney where it acts on collecting ducts and distal convoluted
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tubules, increasing their permeability to water, thus reducing the excretion of water
in urine.
Magnocellular neurones in the SON and PVN express the highest levels of AVP
mRNA in the sheep and rat (Nojiri et al, 1985; Matthews et al, 1993). AVP
expressing magnocellular neurones in the ventral region of the SON also express
type II glucocorticoids receptors (Kiss et al, 1988). They are therefore a target for
glucocorticoid regulation and are likely to have a role in the control of the stress
response. Magnocellular AVP neurones in the PVN however, do not express these
receptors.
Axons from magnocellular neurones in the SON pass through the lateral
retrochiasmatic area and into the internal zone of the median eminence, before
arriving at the posterior pituitary (Antoni, 1993). Morphological studies indicate that
magnocellular neurones do not terminate next to the portal capillary plexus but that
this AVP is released from swellings (Herring bodies) that occur along the length of
the axon (Holmes et al, 1986). Portal capillaries penetrate the internal zone of the
median eminence and there are no major barriers that would prevent AVP released
from these magnocellular neurones reaching the hypthalamo-pituitary blood (HPB)
(Antoni, 1993). Antoni et al (1990) reported that lesioning of the PVN in Wistar rats
resulted in only a 10% reduction in AVP in HPB supporting the hypothesis that
magnocellular neurones in the SON are an important source of AVP in HPB.
However, collection of portal blood from the rat involves a severe operating
procedure that is likely to induce the release of AVP as an artifact, thus results from
such portal blood studies in rats have been called into question (Antoni, 1993).
The magnocellular vasopressinergic system is strongly activated in response to
osmotic stress. In a study of chronically hyponatraemic rats, a reduced ACTH
response was exhibited compared with controls (Dohanics et al, 1991). As
magnocellular but not parvocellular AVP neurones were inhibited in these studies, it
was concluded that magnocellular AVP expressing neurones are of importance in the
control of ACTH release in osmotic stress paradigms (Dohanics et al, 1991).
However, chronic water deprivation (Aguilera et al, 1994) and hypernatraemia
(Dohanics et al, 1990) result in a sustained decline in ACTH release despite
continued elevation of AVP synthesis in magnocellular neurones. This decline in
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ACTH in response to chronic osmotic stress also occurs in response to psychological
stress and is thought to be caused by receptor-mediated changes in pituitary
responsiveness (Aguilera, 1994) as will be discussed later. No change in the
expression of AVP in magnocellular pathways has been found in response to non-
osmotic stressors including psychological, immunological and physical stress
paradigms (Harbuz et al, 1994).
8.6.3. Parvocellular CRH and AVP neurones: the main source of hypothalamic
mediators in HPB
The highest density of expression of irCRH and CRH mRNA has been found in the
parvocellular PVN (pPVN) of the rat (Lightman and Young, 1987) and sheep
(Matthews et al, 1991). In the rat, there are two subpopulations of parvocellular
neurones that express CRH. Approximately 50% of these neurones express only
CRH mRNA, whilst the other half synthesise both CRH and AVP (Whitnall, 1988;
1990). Labelling for AVP mRNA is strong in CRH/AVP parvocellular neurones, but
not as strong as that found in the magnocellular division of the PVN (Matthews et al,
1993). The two subtypes of CRH expressing cells are differentially distributed within
pPVN. CRH/AVP expressing neurones are found in the dorso-lateral region while
cells expressing CRH alone are found more medially and ventrally. A small
proportion of parvocellular CRH neurones are also found scattered within the
magnocellular division of the PVN (Swanson et al, 1983). In mice only parvocellular
neurones expressing both CRH and AVP have been found (Whitnall et al, 1992) and
it is likely that variations in the ratio of parvocellular CRH and CRH/AVP expressing
neurones exist in other species.
90% of CRH and CRH/AVP expressing parvocellular neurones in the PVN project to
the external zone of the median eminence, terminate at the portal capillary plexus
and release CRH and AVP into HPB (Whitnall, 1993). More than 90% of the CRH
found in portal blood originates from parvocellular neurones in the PVN (Holmes et
al, 1986) and it is accepted that the PVN is the main source of CRH controlling the
stress response (Swanson et al, 1983). CRH and AVP are co-packaged into
neurosecretory vesicles in the terminals of these neurones for release into the HPB
(Whitnall et al, 1985). Type II glucocorticoid receptors are found on parvocellular
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CRH and CRH/AVP neurones in the PVN, showing that they are also a target for
glucocorticoid feedback.
8.7. Central control ofCRH and AVP release in response to stress
The HPA axis is controlled centrally by neurones in regions of the brain stem, the
locus coeruleus (medulla), limbic structures including the amygdala, hippocampus,
and bed nucleus of the stria terminalis (BNST) and in hypothalamic nuclei. This
control constitutes both excitation, in response to stress, and inhibition, preventing a
response to non-noxious stimuli and reducing the damaging effects of
glucocorticoids. There is evidence that excitation and inhibition are controlled by
distinct nuclei and that responses to different types of stress are also controlled by
different brain regions. These topics are reviewed and discussed in detail by Herman
and Cullinan (1997). Evidence of the roles of these nuclei in the modulation of the
HPA response to diverse stressors is summarised below.
8.7.1. The brain stem
The pPVN receives dense innervation from the brain stem, by neurones containing
adrenaline and noradrenaline (from regions A1 and A2 and CI and C2 respectively)
(Sawchenko and Swanson, 1982; Cunningham et al, 1990). Studies of immediate
early gene expression (cfos and NGF1-B) have shown that these areas are activated
by acute haemorrhage, respiratory distress and immune challenge (Plotsky et al,
1989; Ericsson et al, 1994). Deafferentation of brain stem pathways inhibits the HPA
response to acute stress (Li et al, 1996). Studies have shown that the effects of
adrenaline and noradrenaline on the HPA axis vary depending on the nature of the
stressor (Harbuz et al, 1991). However, both are thought to have excitatory and
inhibitory roles (Mezey et al, 1984; Spinedi et al, 1988; Suda et al, 1987).
8.7.2. The locus coeruleus
The locus coeruleus contains approximately half of all the noradrenergic neurones in
the brain (Nestler et al, 1999) and is extremely responsive to many stressors (Smith
et al, 1991; Cullinan et al, 1995). It shows a massive increase in activity in response
to chronic stress (Nestler et al, 1999). Innervation of the HPA directly from the locus
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coeruleus is limited (Smith et al, 1991; Cullinan et al, 1995), however, projections
from the locus coeruleus are received by limbic structures. The locus coeruleus also
receives innervation from the brainstem and PVN (Valentino et al, 1998). Therefore,
it has been proposed that the effects of this nucleus are indirect, through effects on
other stress responsive nuclei (Herman and Cullinan, 1997).
CRH mRNA and irCRH are found in the locus coeruleus (Swanson et al, 1983;
Matthews et al, 1991) indicating that CRH has a critical role in activating the nucleus
during stress. Indeed intracerebroventricular (i.e.v.) administration of CRH at
biologically relevant levels induces an increase in the rate of firing of locus coeruleus
neurones (Valentino et al, 1983). This is associated with an increase in vigilant
behaviour, which is appropriate in response to stress (Nestler et al, 1999).
All neurones in the locus coeruleus fire simultaneously and this pulsatility is
extremely important to the function of the nucleus (Nestler et al, 1997). The response
of the HPA axis to catecholaminergic stimuli from any nucleus is dependant on the
exact rate and magnitude of catecholaminergic pulse (Haisenleder et al, 2000).
Slower pulses of low magnitude favour increased expression of CRH mRNA in the
PVN, whilst higher frequency and greater magnitude pulsatility favours the
expression of AVP mRNA (Haisenleder et al, 2000). This provides another route by
which the expression of AVP and CRH can be differentially modulated to induce
stress specific responses.
8.7.3. The limbic system
The amygdala is thought to have a generally excitatory role in the control of the HPA
axis. It is also considered to have a role in behavioural and cardiovascular responses
to stress (Davis et al, 1992). Lesions of the amygdala reduce the HPA response to
stress and to ADX (Herman and Cullinan, 1997). Also the expression of cfos is
strongly up-regulated in this nucleus in response to swim and restraint stress
(Cullinan et al, 1995).
The hippocampus is considered to have a strong inhibitory effect on the pPVN. The
pPVN shows a very high density of glucocorticoid receptors (Jacobson and
Sapolsky, 1991; Herman, 1993). Hippocampal lesions result in an increase in
glucocorticoid release and an increase in CRH and AVP mRNA expression in the
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pPVN (Herman et al, 1989; Jacobson and Sapolsky, 1991; Sapolsky et al, 1991;
Herman et al, 1995).
The BNST provides a neuronal bridge connecting limbic structures to the HPA and
HPA to brain stem (Moga et al, 1989; Herman et al, 1992; Cullinan et al, 1993;
Herman et al, 1994). BNST has excitatory and inhibitory effects on pPVN neurones.
Neurones controlling the excitatory and inhibitory effects of the nucleus are spatially
separated within the nucleus. Lesioning of specific regions mimics the effects of
lesions of the amygdala or hippocampus (Herman et al, 1994; Herman et al, 1996;
Herman and Cullinan, 1997). This suggests that the BNST is simply responsible for
relaying the actions of the neural structures that it connects.
8.7.4. Hypothalamic nuclei
Local inhibition of the PVN by other hypothalamic nuclei, including the SCN,
ventromedial nucleus, and arcuate nucleus, has also been found. Studies have shown
that the response to stress increases in magnitude and duration after lesioning of each
of these nuclei (Buijs et al, 1993; Larsen et al, 1994; Suemaru et al, 1995).
8.7.5. Stressor-specific activation ofdifferent central control pathways
Herman and Cullinan (1997) discuss the hypothesis that 'processive' and 'systemic'
stressors activate different central controls. According to this hypothesis, those
stressors that constitute a direct threat to the integrity of physiological homeostasis,
i.e. systemic stressors, for example respiratory distress, activate brain stem regions
(Sawchenko et al, 1996). This allows direct activation of the HPA axis and
appropriate responses, with only one synaptic connection between the brainstem and
the PVN (Swanson and Sawchenko, 1983).
Those stressors requiring some mental processing (processive stressors), for example
novelty or restraint, activate the nuclei of the limbic system. These stressors require a
perception of the present situation, as well as the use of previous experience and do
not necessarily represent an immediate threat to the integrity of the system. They
therefore activate systems whose connections to the PVN are indirect, involving
more than one synaptic connection (Herman and Cullinan, 1997).
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While this hypothesis provides a general rule by which the expected central response
to a specific stressor could be estimated, many exceptions to this rule must exist. For
example foot-shock, would appear to constitute both an immediate threat (pain) as
well as psychological stress (inescapability), however deafferentation of the brain
stem has no effect on the HPA activity in response to foot-shock (Li et al, 1996).
8.8. Effects ofacute stress on A VP and CRH in the pPVN
The expression ofCRH and AVP mRNA also varies in response to different types of
stressor. When stimulated by an acute stressor, CRH and AVP are rapidly released
from parvocellular neurones in the PVN and an increase in CRH synthesis is induced
within 30 minutes of the onset of exposure to stress (Bartanuz et al, 1993). However
the ratio of secretion of CRH and AVP is dependant on the nature of the stressor.
pPVN responses to the 'same' stressor may also vary between researchers, reflecting
both the sensitivity of the system and the difficulty of reproducing stress paradigms.
8.8.1. Effects ofacute psychological stressors
8.8.1.1. Restraint
Psychological stress can be induced in rats by restraint in a Perspex restraining
device (Harbuz et al, 1994) or restraint cage (Imaki et al, 1993) in which movement
is restricted. CRH mRNA in the pPVN was strongly up-regulated in response to 60
minutes of restraint stress (Harbuz et al, 1994). Depending on the strain of rat used,
acute restraint induced either a small up-regulation of AVP mRNA or no change in
its expression. In all strains, the AVP response was of a lower magnitude than the
CRH response (Harbuz et al, 1994). Restraint has also been used to study the effects
of stress on sheep (Mears and Brown, 1997). 14 week-old animals were inverted and
held at the head or neck for 1 minute, as is done while shearing. No attempt was
made to examine the effects of this stress on the synthesis of CRH and AVP, but
plasma Cortisol was found to be elevated for the first 30 minutes after treatment. This
stressor must, in theory, induce some elevation in the release of CRH from the
pPVN. However, the plasma Cortisol concentration was low in this study, suggesting
that the stressor may have been insufficient to stimulate CRH synthesis and that the
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release of CRH stored in nerve terminals alone was sufficient to produce the
observed rise in plasma Cortisol.
8.8.1.2. Immobilisation
Immobilisation is a similar psychological stressor to restraint, but produces different
hypothalamic responses. Experimental immobilisation of the rat is achieved by
taping the feet to a platform, with or without head restraint, for varying lengths of
time. In a study by Bartanuz et al (1993), rats were exposed to 30 and 150 minutes of
immobilisation. They found that the expression of both CRH and AVP mRNA were
up-regulated and that this up-regulation was independent of the duration of
immobilisation.
In a similar study, Makino et al (1995) found that immobilisation for 60 minutes,
with the head restrained between two stainless steel loops, induced an increase in
CRH mRNA expression but, surprisingly, no concurrent rise in the expression of
AVP mRNA. Apart from head restraint, the only difference between the studies
appeared to be the strain of rat, Makino et al (1995) used Sprague-Dawley rats whilst
Bartanuz et al (1993) used Wistar rats. In a study by Harbuz et al (1994) the
responses of Wistar, Sprague Dawley and CFY rats to the similar stress of restraint
were compared. The difference between basal and stressed levels of plasma
corticosterone was higher in the Wistar strain than in Sprague-Dawley rats. Also the
change in expression of CRH mRNA in response to restraint was greater in Wistar
rats. The change in plasma corticosterone and expression of CRH mRNA was
greatest in CFY rats. Wistar rats appear to show a higher HPA response to stress than
Sprague-Dawley rats, which may explain the differences found in response to
immobilisation in different studies. The HPA response to acute immobilisation is
attentuated after the application of CRH antagonists (Jezova et al, 1998), showing
that CRH is critical to the regulation of this acute stress response.
8.8.1.3. Isolation
A third psychological stressor and one considered to be of special relevance in the
sheep, which is particularly social species, is isolation. In a study by Mears and
Brown (1997), isolation from flockmates, for one hour, induced a transient rise in
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plasma Cortisol that peaked at around 30 minutes after initial isolation. Matthews et
al (1993) examined the effects of 1-hour of isolation on the expression of CRH and
AVP in the pPVN. In this study isolation induced a small, but non-significant rise in
CRH mRNA in the pPVN, which appears to be in agreement with the Cortisol data
from the Mears and Brown (1997) study of restraint. No changes in AVP mRNA
expression were found. It should be noted however that Matthews et al (1993) used
only 3 sheep in this study.
8.8.2. The effects ofphysical and physiological stressors
8.8.2.1. Heat Stress
Heat stress (24 hours at 35°C) has been found to induce a three-fold increase in
plasma Cortisol in sheep (Minton and Blecha, 1990). Plasma Cortisol returned to
basal levels within 12 hours of the onset of this stress, but no attempt was made to
assess its effects on the synthesis and release of hormones in the pPVN.
8.8.2.2. Cold stress
Cold stress has been reported to induce an increase in AVP mRNA (Wu and Childs,
1990), but this group did not distinguish between AVP mRNA in parvocellular or
magnocellular neurones in the PVN. A slight, but statistically insignificant, increase
in the expression of CRH mRNA and a corresponding rise in POMC mRNA in the
anterior pituitary was found in response to cold stress by Harbuz and Lightman
(1989).
8.8.2.3. Intra-peritoneal hypertonic saline
Intra-peritoneal injection of hypertonic saline (5ml of 1.5M NaCl (Aguilera, 1994))
has been described as a physical stressor (e.g. Harbuz et al, 1994), but it incorporates
pain, as well as osmotic challenge and the psychological element of restraint
(Matthews et al, 1993). This stressor induced an increase in the expression of CRH
mRNA and stimulated AVP mRNA expression in pPVN (Harbuz et al, 1994). The
AVP response to i.p. hypertonic saline was less than that of CRH although of the
same order ofmagnitude (Lightman and Young, 1988).
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8.8.2.4. Insulin induced hypoglycaemia
CRH and AVP release during insulin-induced hypoglycaemia (IIH), was examined
by Plotsky et al (1985) who reported significant increases in portal AVP during IIH
in the rat. However, collection of portal blood from the rat involves a severe
operating procedure that is likely to induce the release of AVP as an artefact. CRH
release was not stimulated in this study. In freely-moving, conscious rams (Caraty et
al, 1990), the concentration of CRH and AVP in portal blood was increased in
response to IIH when the dose of insulin used was 0.2IU/kg (sufficient to induce a
significant drop in plasma glucose). Prior to insulin injection, the portal blood
concentration of AVP was approximately half that of CRH, corresponding with the
synthesis of AVP in approximately half of pPVN neurones (Whitnall, 1988). This
ratio of CRH to AVP was maintained following increases in the concentrations of the
hormones after IIH. However, following administration of insulin at the much higher
dose of 2.0IU/kg the concentration of CRH rose much more dramatically, to
approximately six times basal levels. The concentration of AVP exceeded that of
CRH, reaching 140pg/ml/min, approximately ten times the basal concentration of
AVP. Because this study examines only the concentration of CRH and AVP in HPB,
the source of these hormones cannot be determined.
Berkenbosch et al (1989) studied the rate of depletion of CRH and AVP in the
external zone of the median eminence of the rat after IIH. Colchicine was used to
block rapid axonal transport of newly synthesised hormones, thus preventing
replenishment of stores of CRH and AVP, and the rate of depletion was estimated
using quantitative immunocytochemistry. The rate of depletion of CRH and AVP
was similar for the first hour. At later time points the rate ofAVP depletion increased
more rapidly than that of CRH. In both these studies a dramatic rise in plasma ACTH
was concomitant with increases in release of hypothalamic releasing factors.
8.8.2.5. Experimental haemorrhage
Experimental haemorrhage of 15ml/kg over three hours in the rat induced a rise in
CRH mRNA for at least 4 hours and a transient rise in ACTH, which returned to
normal within 4 hours. The expression of AVP mRNA was not elevated, indicating
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that while a haemorrhage of this order results in stress, the CRH response is
sufficient to generate an appropriate HPA response (Darlington et al, 1992).
8.8.2.6. Inescapablefoot-shock
Imaki et al (1993) and Harbuz et al (1991) demonstrated an increase in the
expression of CRH mRNA in the pPVN in response to acute inescapable electric
foot-shock. However, the synthesis of AVP mRNA was not measured in these
studies.
8.8.3. Summary ofHPA responses to acute stress
The HPA response to acute stress varies depending on the exact nature and duration
of the stressor. Overall the parvocellular PVN response to acute stress is
characterised by an increase in CRH mRNA and release of CRH and AVP. In
response to some acute stressors AVP synthesis may also be stimulated but in
general the expression of AVP mRNA and AVP release is lower than that of CRH in
parvocellular neurones.
8.9. Effects ofadrenalectomy on A VP and CRH in the pPVN
Adrenalectomy (ADX) is widely used to model of the effects of chronic activation of
the HPA axis. The removal of glucocorticoid feedback results in a generalised
activation of the HPA axis, including up-regulation of the synthesis of CRH in the
pPVN. The synthesis of AVP in the pPVN also increases dramatically and one of the
major characteristics ofADX is that the number of parvocellular neurones expressing
AVP mRNA increases until very few neurones expressing only CRH remain (Kiss et
al, 1984; Sawchenko et al, 1984; Marti, 1999). De Goeij et al (1993) found that
ADX did not influence the level of irCRH stored in parvocellular nerve terminals in
the median eminence of Wistar rats. However, irAVP accumulated dramatically in
parvocellular CRH/AVP expressing neurones. Makino et al (1995) found that
standardised glucocorticoid replacement in ADX rats resulted in slightly lower
plasma Cortisol levels than those found in sham-operated rats. These rats showed up-
regulation of AVP mRNA in response to immobilisation, while sham-operated rats
did not. There was no change in the expression of CRH mRNA in glucocorticoid-
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replacement ADX rats when compared with sham-operated controls. This suggests
that AVP is more sensitive to glucocorticoid negative feedback than CRH and that
the small reduction in corticosterone in glucocorticoid-replaced ADX rats is
sufficient to allow escape from inhibition by AVP. The dramatic increase in AVP
mRNA expression in the pPVN and the massive accumulation of AVP in nerve
terminals after ADX supports this hypothesis (De Goeij et al, 1993).
Quantitative immunohistochemistry measuring AVP and CRH mRNA in the PVN,
measurement of the peptide content of the median eminence and of the concentration
of hormones in portal blood (Plotsky and Sawchenko, 1987) revealed much higher
secretion of AVP and CRH by 72 hours after adrenalectomy. By using colchicine to
block rapid axonal transport in ADX rats and therefore removing the effect of the
differential synthesis of the two hormones, De Goeij et al (1993) found that AVP
stores were depleted at a much faster rate than those ofCRH (8.1% vs 6.9% per hour
after 1 week and 7.8% vs 3.4% per hour after 4 weeks respectively). The rate at
which CRH is synthesised in the pPVN is approximately equal to the rate at which
the hormone is secreted from the nerve terminals. In contrast, the progressive
accumulation of ir AVP in nerve terminals indicates that the rate of synthesis ofAVP
in pPVN is higher than the rate at which the hormone is secreted. Also, as stores of
AVP in the external zone of the median eminence are depleted at a much faster rate
than those of CRH, it is concluded that AVP is preferentially released from nerve
terminals.
CRH and AVP are co-packaged in vesicles in nerve terminals and, according to
Whitnall et al (1985), the labelling of AVP and CRH in nerve terminals is uniform.
However, Bertini and Kiss (1991) conducted a study to determine if the ratio of co-
packaged neurohormones could be modulated by ADX. They found that the ratio of
AVP to CRH is dynamic and that the neurosecretory vesicles increased in size to
accommodate the increase in the rate of synthesis ofAVP and CRH and achieve their
release into the pericapillary space.
8.9.1 Summary ofHPA response to ADX
ADX results in up-regulation of CRH mRNA in the PVN and release of CRH into
HPB. An increase in the expression of AVP mRNA and the release of AVP also
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results, but is of greater magnitude than the CRH response. These changes are
characterised by the recruitment of almost all CRH expressing parvocellular
neurones to synthesise AVP. POMC mRNA expression and ACTH release also
increase in response to ADX. The effects of ADX can be reversed by the
administration of exogenous glucocorticoids. AVP appears to be much more
sensitive to glucocorticoid regulation than CRH. The proportion of AVP and CRH
released from the same neurones can be modulated with respect to their relative rates
of synthesis.
8.10. Effects ofchronic stress on A VP and CRH in the pPVN
Chronic and repeated stress paradigms result in similar changes in the HPA axis to
those observed after ADX, but are lower in magnitude. As in acute stress paradigms
the response varies depending on the nature of the stressor. In chronic stress, as with
ADX, there is a tendency for the increased synthesis and release of AVP to exceed
that of CRH. This higher magnitude AVP response is conserved across chronic stress
paradigms. In contrast, the level of synthesis and release of CRH varies depending on
the type of stressor (Ma and Aguilera, 1999).
8.10.1 Chronic psychological stress
Generally, in response to the chronic or repeated application of psychological
stressors, there is an initial activation of the HPA axis, as might be observed with
acute application of the stressor. However, as exposure to the stressor continues,
there is a progressive decline or desensitisation of the stress response (Aguilera,
1994). However, when a novel stressor is introduced, after desensitisation, HPA
hyper-responsiveness is observed.
8.10.1.1. Restraint
A study by Ma and Lightman (1998) demonstrates this desensitisation. In this study
the effects of repeated restraint stress of varying frequency and duration were
examined. It was found that CRH mRNA expression was significantly higher than
basal expression in response to a single acute restraint stress and was also increased
in response to intermittent repeated immobilisation stress for 3 hours every 7 days.
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However as the frequency and duration of the stressor was increased so the CRH
mRNA response declined, indicating that, in response to a homotypic stressor, the
HPA axis can habituate. In contrast, the expression of AVP mRNA increased
significantly as the duration and frequency of stress increased. This demonstrates that
the synthesis of AVP can be specifically facilitated in chronic stress, however, the
mechanism by which this is achieved is uncertain (Ma and Lightman, 1998).
8.10.1.2. Immobilisation
A similar increase in the expression ofCRH mRNA and AVP mRNA in the pPVN is
observed in response to repeated immobilisation stress (2 hours/ day for 14 days)
(Makino et al, 1995). The magnitude of the increase in AVP mRNA is much greater
than that of CRH mRNA, as is seen ADX rats. Generalised activation of the HPA is
demonstrated by a sustained increase in POMC mRNA in the pituitary (Makino et al,
2002). Despite this, the concentration of ACTH in the peripheral circulation was the
same as in control rats indicating that the release of ACTH was inhibited and
desensitisation had occurred.
An initial increase in the release of ACTH was observed, in Sprague-Dawley rats, in
response to intermittent immobilisation. This response declined over 16 days until
the plasma concentration of ACTH in stressed rats did not differ from that in control
rats. However, subsequent exposure to ether stress induced a massive increase in the
concentration of ACTH, reaching more than 10 times basal levels and 3 times the
concentration observed in response to the initial immobilisation (Hauger et al, 1990).
8.10.2. Chronic physical stress
In chronic physical stress paradigms, repeated stimulation does not result in
desensitisation of the HPA axis (Aguilera, 1994).
8.10.2.1. Intra-peritoneal Hypertonic Saline
I.p. hypertonic saline injections were repeated every day, for 14 days, by Ma and
Aguilera (1999), resulting in increased CRH and AVP expression in the pPVN.
Despite up-regulation of both hormones, the magnitude of the AVP mRNA response
was twice that of CRH (400% higher than controls and 250% higher than controls
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respectively). Over the 14 days no decline in CRH and AVP expression or plasma
ACTH levels were found.
8.10.2.2. Chronic inflammatory stress
Experimental arthritis can be induced in Sprague-Dawley (SD) and Piebald-Viral-
Glaxo (PVG) rats by the intra-dermal injection of an adjuvant containing heat-killed
Mycobacterium butyricum. Adjuvant induced arthritis (AA) is a model of rheumatoid
arthritis, inducing chronic inflammatory pain in joints. Joint inflammation develops
within 12 days of adjuvant injection and peaks after approximately 21 days (Sarlis et
al, 1992). In this chronic stress paradigm, CRH mRNA is not up-regulated in the
pPVN and in one study CRH synthesis and release has been shown to decline
(Haibuz et al, 1992). AVP iiiRNA expression however, is increased arrd is associated
with a rise in the concentration of AVP in HPB. The number of parvocellular
neurones in the paraventricular nucleus that express AVP mRNA increases, as does
the density of expression of AVP within these neurones (Chowdrey et al, 1995).
Expression of POMC mRNA in the anterior pituitary is increased (Stephanou et al,
1992), as are the concentrations of ACTH and corticosterone in the peripheral
circulation, despite the apparent decline in the synthesis and release of CRH
(Chowdrey et al, 1995). In this model the daily rhythmic changes in ACTH and
corticosterone release are abolished (Sarlis et al, 1992).
8.10.3. Summary ofHPA responses to chronic stress
In chronic stress, heightened expression of AVP is conserved across types of stress
paradigm. This suggests that AVP has a specific and important role in chronic stress.
This is particularly well illustrated in adjuvant-induced arthritis in rats, where no
change in CRH expression is found, but the release of ACTH still increases. Hyper-
responsiveness of the HPA axis to a novel stressor is conserved across chronic stress
paradigms and high levels of AVP mRNA and irAVP may ensure that the




8.11. Regulation ofCRH and A VP receptors contributes to stress specificity ofHPA
response
The actions of CRH and AVP throughout the body are mediated through specific
membrane receptors. Binding of the hormone to the receptors in cell membranes of
tissues induces the activation of intracellular mechanisms resulting in responses to
stress. Differential regulation of these receptors represents another route by which
specific responses to different types of stress may be produced.
8.11.1. CRH receptors
There are two subtypes of receptor that modulate the effects of CRH around the
body. Type 1 (CRH-1R) and type 2 (CRH-2R) receptors have pharmacologically
different properties and their distribution is distinct (Aguilera et al, 2001). The
differential distribution, structure and pharmacological action of the CRH receptor
subtypes indicates that they mediate distinct roles of CRH in disparate tissues (Perrin
et al, 1995). After cloning CRH-1R from human pituitary tumour cells (AtT20 cells),
Chen et al (1993) found that the cDNA of CRH-1R encodes a 415-amino-acid
protein with seven trans-membrane domains. This structure is characteristic of G-
protein coupled membrane receptors. Binding of CRH to the receptor activates a G-
protein pathway. The subsequent cascade of responses is as follows: Binding of CRH
activates G-protein, which in turn activates adenylate cyclase. Adenylate cyclase
catalyses the formation of cyclic AMP (cAMP) and cAMP stimulates
phosphorylation of intracellular proteins by protein kinase A. These mechanisms
result in the opening of ion channels, influx of Ca2+ and initiation of the exocytosis
of secretory vesicles (Imaki et al, 1996).
There are two splice variants ofCRH-2R (Perrin et al, 1995). CRH-R2a is expressed
in neural structures including the hypothalamus, lateral septum and olfactory bulb.
CRH-R2P is expressed mainly in the periphery, in lung, heart and skeletal muscle
and the smooth muscle of the cardiovascular system (Lovenberg et al, 1995).
CRH-1R has higher binding affinity for CRH than CRH-R2a (Lovenberg et al,
1995). It is found in the pituitary, cortex, limbic system, cerebellum and in some
sensory nuclei. It is by interaction with CRH-1R that the effects of CRH on anterior
pituitary corticotrophs are mediated (Abou-Samra et al, 1987).
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8.11.2. A VP receptors
The effects of AVP are mediated through three pharmacologically different receptor
subtypes (Rabadan-Diehl et al, 2000). All are G-protein coupled receptors, like those
for CRH. The V2 receptor mediates the effects of AVP in the kidney and, in
mammals, is found exclusively in the renal medulla (Antoni, 1987). Like CRH
receptors, the V2 receptor is coupled to adenylate cyclase (Jard, 1983). The Via
receptor or VI receptor is found in vascular smooth muscle, liver, testis, the adrenal
gland and the brain (Antoni, 1987). This receptor is coupled to phospholipase C
(PLC) and is known to have pressor functions. The VIb or V3 receptor is also
coupled to PLC (Sugimoto et al, 1994) but is considered to be pharmacologically
different from the Via receptor as it is not inhibited by Via receptor antagonists
(Antoni, 1987). It is found in the majority of pituitary corticotrophs and is thought to
play an important part in corticotroph responsiveness (Rabadan-Diehl et al, 1997).
The binding of AVP to the receptor activates G-protein, which in turn activates PLC.
PLC catalyses the hydrolysis of phosphotidyl-inositol 4,5-biphosphate producing the
second messengers inositol triphosphate and 1,2-diacylglycerol. Inositol triphosphate
2+releases Ca from intracellular stores and activates ion channels allowing an influx
2_j_of Ca into cytoplasm (Antoni, 1993). There is evidence that this change in
membrane potential is partially responsible for the stimulation of exocytosis from
secretory vesicles (Antoni, 1993). The other second messenger, 1,2-diacylglycerol
also mediates cellular changes that lead to exocytosis and is thought to maintain
secretion over a longer period of time (Griffin and Ojeda, 2000). Vlb receptors are
also found in many brain regions including the cerebral cortex, cerebellum,
hippocampus and hypothalamus, and in peripheral structures including the heart,
lung, thymus, uterus, kidney and breast (Lolait et al, 1995).
8.11.3. Sensitivity of tissues to CRH and A VP
The regulation of their membrane receptors represents another means by which the
effects of hormones can be modulated in response to different stressors. CRH, AVP
and glucocorticoids interact to regulate receptor mRNAs. The number of receptors
expressed and their affinity for their agonist (Aguilera et al, 2001) contribute to the
overall sensitivity of the tissue to stimulation during HPA activation.
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8.11.4. Regulation ofpituitary CRH receptors in Response to stress
The CRH-1R is the principle receptor mediating the effects of CRH in the anterior
pituitary. The regulation of these receptors varies in response to different stressors.
In acute stress the concentration of CRH and AVP in HPB increases. This activates
the rest of the HPA axis resulting in an increase in the synthesis of POMC and the
release of ACTH and subsequently of glucocorticoids. However, acute activation of
the HPA axis is initially (first 2 hours) associated with a decline in the expression of
CRH-1R mRNA followed by recovery to basal levels (4hours) (Rabadan-Diehl et al,
1996).
ADX is a preparation associated with chronic release of CRH and AVP and a lack of
glucocorticoids. Following ADX, CRH-IRs are down-regulated (Wynn et al, 1998)
as is the level of CRH-stimulated adenylate cyclase activity (Aguilera et al, 1987).
The synthesis of CRH is also transiently reduced (Rabadan-Diehl et al, 1997).
Paradoxically down-regulation is accompanied by an increase in the expression on
POMC mRNA and the release ofACTH (Marti et al, 1999).
In chronic stress paradigms there is no correlation between the number of CRH-IRs
and the magnitude of the pituitary response (Aguilera et al, 2001). Despite this,
reduced ACTH and glucocorticoid release is observed in CRH knock-out mice,
suggesting that some CRH must be present to allow normal HPA activation (Muglia
et al, 2001). The occupation of 50% ofCRH-IRs in anterior pituitary corticotrophs is
sufficient to produce a maximal ACTH response (Aguilera et al, 1987). This explains
why high levels of secretion of ACTH can still be induced after ADX when the
number of CRH-IRs available is reduced. Together this evidence suggests that CRH
is necessary for the HPA response to take place, but the concentration of CRH
released and number of receptors that are occupied is not important (Aguilera et al,
2001). Thus, CRH has a permissive role in HPA activation during chronic stress.
The effect ofAVP on the expression ofCRH-IRs appears to be the opposite ofCRH,
i.e. upregulating the receptor mRNA after acute and chronic administration
(Rabadan-Diehl et al, 1996). However AVP also potentiates the down-regulating
effect ofCRH on the number of CRH-IRs (Aguilera et al, 1987)
Glucocorticoids inhibit binding of CRH to CRH-1R. They have also been found to
reduce CRH-1R mRNA, but mRNA levels recover after a short time (Rabadan-Diehl
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et al, 1997). Small, but physiologically significant changes in glucocorticoid
concentration have been found to be sufficient to inhibit CRH-1R mRNA expression
and reduce plasma ACTH (Hauger et al, 1987). Thus, the immediate decline in
CRH-1R binding and mRNA after onset of stress may be caused by the rapid release
of glucocorticoids (Ochedalski et al, 1998). It is likely that the action of
glucocorticoids on CRH-1 R is one route by which glucocorticoid negative feedback
occurs (Aguilera et al, 1987).
8.11.5. Regulation ofpituitary A VP receptors in response to stress
In contrast to CRH-1Rs, there is a positive correlation between the number of
pituitary AVP (Vlb) receptors and ACTH responsiveness to stress (Aguilera, 1994).
The number of Vlb receptors increases in response to stressors associated with an
increase in ACTH release (Rabadan-Diehl et al, 1995).
Aguilera et al (1994) studied Vlb receptor activity in response to a range of
stressors. They found that the affinity of binding sites for AVP remained the same for
all stressors studied, but maximum binding varied depending on the stressor. In
response to water deprivation and hypernatremia, where ACTH release declines after
chronic stimulation, binding was markedly reduced. Whereas in response to i.p.
hypertonic saline, a paradigm associated with prolonged elevation of ACTH release,
binding was markedly increased. The correlation between the number of available
receptors and ACTH responsiveness suggests that Vlb receptor regulation is critical
to the maintenance of pituitary responsiveness despite chronic HPA activation and
HPA down-regulation in chronic stress (Aguilera et al, 2001). In ADX, there is a
huge rise in AVP mRNA expression and release, inducing a down-regulation of Vlb
receptor binding and a transient, 50% reduction in Vlb receptor mRNA (Rabadan-
Diehl et al, 1997). Glucocorticoid treatment of control rats induced a 50% increase in
the expression of Vlb receptor mRNA.
In some chronic stress paradigms (typically physical stressors), where glucocorticoid
concentration is high, it is thought that the ability of AVP to maintain corticotroph
responsiveness in the face of a novel stressor is facilitated by the release of
glucocorticoids (Aguilera et al, 2001). Glucocorticoids can increase the coupling
efficiency of the Vlb receptor to phospholipase C. Thus, there is an increase AVP-
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stimulated inositol phosphate formation despite receptor down-regulation (Aguilera
and Rabadan-Diehl, 2000). This could be the mechanism by which AVP maintains
corticotroph responsiveness despite elevated glucocorticoids during chronic stress.
8.12. Actions ofCRH and A VP on the anteriorpituitary
CRH has three known effects on anterior pituitary corticotrophs. It stimulates
proopiomelanocortin (POMC) transcription, the release of ACTH, and cell mitosis.
As was discussed is section 8.4, these effects of CRH are potentiated by AVP and the
release of CRH and AVP is modulated in response to different types of stressor. This
results in subtle variations in the synthesis of POMC, release of ACTH and the
subsequent release of glucocorticoids.
8.12.1. Synthesis ofPOMC
POMC is the precursor hormone for several derived proteins including melanocyte
stimulating hormone (MSH) ACTH and (3-endorphin. It is expressed throughout the
brain and in the anterior and intermediate lobes of the pituitary. The products of
POMC breakdown are dependent on the cellular location of the hormone. In the
corticotrophs of the anterior pituitary the products of POMC breakdown are ACTH
and P-endorphin (Ojeda and McCann, 2000). In anterior pituitary corticotrophs CRH
stimulates the transcription of POMC both in vivo and in vitro (Bruhn et al, 1984;
Wand et al, 1987; Levin and Roberts, 1991). In vivo studies of administration of
exogenous CRH in the rat revealed an increase in the rate of POMC gene
transcription and an increase in levels of primary nuclear transcript in the cytoplasm
(Autelitano et al, 1989). It is thought that CRH acts directly to increase the rate of
transcription of the POMC gene (Levin et al, 1989). POMC synthesis is up-regulated
by the activation of adenylate cyclase pathways (Reisine et al, 1985; Dave et al,
1987; Levin et al, 1989) and increases in intracellular Ca2+ (Dave et al, 1987; von
Dreden et al, 1988; Kuryshev et al, 1996).
CRH is not the only factor to influence POMC gene expression. These effects of
CRH are again potentiated by AVP (Wand et al, 1987). The mechanisms by which
AVP acts are complex. AVP binding increases intracellular calcium, inducing
POMC gene transcription (von Dreden et al, 1988) and potentiating CRH-stimulated
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cAMP production (Abou-Samra et al, 1987). AVP is also thought to influence
POMC gene expression at a stage after transcription, by increasing the rate of
turnover of the primary nuclear transcript (Wand et al, 1987).
In studies of the effects of ADX, the removal of glucocorticoid feedback induces a
transient rise in POMC mRNA in cytoplasm (Rabadan-Diehl et al, 1997) suggesting
that POMC gene expression is inhibited by glucocorticoids. This rise in POMC
transcription is still observed in CRH knockout mice, although of a lower magnitude
than in intact animals (Muglia et al, 1996) and in rats with lesions of the PVN
(Rabadan-Diehl et al, 1997). This indicates that POMC transcription is not dependent
on the presence of hypothalamic factors. Indeed basal levels of POMC transcription
are not influenced by PVN lesions, median deafferentation or CRH antagonists
(Rabadan-Diehl et al, 1997), suggesting that the stimulatory effects of CRH and
AVP are only relevant when their concentration in the median eminence is markedly
increased during stress (Aguilera et al, 2001).
8.12.2. ACTH release
The binding of CRH and AVP to their membrane receptors activates adenylate
cyclase and phopholipase C signal transduction pathways respectively, resulting in
changes in membrane potential and the exocytosis of secretory vesicles containing
ACTH. The effects of CRH are potentiated by the enhancement of cAMP production
by AVP. This is achieved either by the direct activation of adenylate cyclase or by
inhibiting the factors that inhibit cAMP production (Abou-Samra et al, 1987)
8.12.3. Cell mitosis
ADX produces an increase in the number of corticotrophs in the anterior pituitary
(Childs et al, 1995). Administration of CRH in vivo also induces an increase in the
number of corticotrophs and in vitro the mitogenic activity of cultured corticotrophs
is increased. However the mitogenic activity ofCRH occurs over a very narrow dose
range (0-0.5nM). At concentrations above this range CRH may in fact retard cell
growth (Childs et al, 1995).
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8.12.4. Glucocorticoids: feedback inhibition on the HPA axis
Circulating glucocorticoids are critical to the modulation of PVN responsiveness to
stress (Ma and Aguilera, 1999a). They act at all levels of the HPA axis inhibiting
HPA responsiveness to stress (Ma and Aguilera, 1999b). Their function is protective,
providing a mechanism that prevents HPA activation in response to minor deviations
from homeostasis, effectively broadening the range of acceptable stimulation of the
stress axis.
Removal of glucocorticoids by ADX is characterised by hyper-responsiveness of the
HPA axis (Plotsky and Sawchenko, 1987). However, there is evidence to suggest that
AVP is more sensitive to glucocorticoid regulation than CRH. For instance, in ADX
rats, the administration of exogenous glucocorticoids inhibits the synthesis of AVP
much more than it does CRH (Ma and Aguilera, 1999) and CRH mRNA was not
found to be inhibited at all by glucocorticoid administration to ADX rats (Ma et al,
1997). However, the administration of exogenous glucocorticoids strongly inhibited
AVP mRNA (Ma et al, 1997). The ability of parvocellular AVP neurones to
overcome glucocorticoid inhibition depends on the nature and severity of exposure to
stress and may involve the interaction of glucorticoids with other neuropeptides
released in response to stress (Herman et al, 1997).
Two types of glucocorticoid receptor are recognised. Type I receptors have a lower
distribution and preferentially bind naturally occurring corticoids (often referred to as
mineralcorticoid receptors). These receptors have a very high affinity for their
agonists and under normal circumstances most (89.5%) of these receptors are
occupied (Reul and de Kloet, 1985). It is thought that type I receptors control basal
levels of glucocorticoids (de Kloet et al, 1987). Type II receptors preferentially bind
dexamethasone, a synthetic glucocoticoid (often referred to as glucocorticoid
receptors). These receptors are more widely distributed in the limbic system,
hypothalamus and pituitary. They have a lower affinity for naturally occurring
glucocorticoids than type I receptors and basal levels of occupancy are low in
comparison with type I receptors (Reul and de Kloet, 1985). However, under
stressful circumstances, when the concentration of glucocorticoids in the blood is
high, binding to type II receptors increases. For this reason type II receptors are
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thought to mediate glucocorticoid action during stressful episodes (de Kloet et al,
1987).
8.13. Conclusion
The basic mechanisms by which the endocrine responses to stress are mounted are
well-known. However the mechanisms by which specific responses to diverse
stressors are mounted are less well understood. Currently the balance of evidence
indicates that different types of stressor activate different sets of stress-regulatory
neurones in areas of the brain including the limbic system, medulla and brainstem.
Stressors representing an immediate threat to the integrity of the animal activate
brainstem neurones, which rapidly, after only one synaptic connection, activate the
PVN. Other stressors, requiring mental processing and constituting a less immediate
threat to the animal, activate the PVN through multi-synaptic pathways, including
limbic nuclei (Swanson and Sawchenko, 1983; Sawchenko et al, 1996; Herman and
Cullinan, 1997).
In the resting state, approximately 50% of parvocellular neurones in the PVN express
both CRH and AVP (Whitnall, 1988; 1990) although this varies in different species
(Whitnall et al, 1992). In response to acute stress, the synthesis and release of CRH
in parvocellular neurones is increased. The synthesis and release ofAVP may also be
stimulated but the magnitude of the AVP response rarely exceeds that ofCRH.
After exposure to all types of chronic stressor, the proportion of parvocellular
neurones that express both CRH and AVP increases. The expression of AVP mRNA
increases dramatically after exposure to all types of chronic stress. Its expression
remains high until exposure to the stressor ceases. AVP mRNA expression far
exceeds that of CRH, and AVP is preferentially released from nerve terminals in the
median eminence during chronic stress (Bertini and Kiss, 1991).
The level of synthesis and release of CRH varies between chronic stress paradigms
and may be desensitised during a period of prolonged psychological stress (Ma and
Lightman, 1998). After prolonged exposure to a homotypic stressor, ACTH hyper-
responsiveness to a novel stressor is observed (Aguilera, 1994). Receptor studies and
studies of CRH knock-out mice indicate that the presence of some CRH is necessary
for the HPA response to chronic stress but that CRH must bind to only 50% of
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receptors to allow a full ACTH response (Aguilera et al, 1987). This evidence
suggests that the presence of CRH is permissive for the HPA response to chronic
stress and that elevated levels of AVP may help maintain anterior pituitary
responsiveness and mediate hyper-responsiveness to novel stressors (Aguilera et al,
2001).
Subtle differences in the HPA response to stress have been found between different
strains of rats (Harbuz et al, 1994). More fundamental differences exist between
animals of different species (Familiari et al, 1989; Liu et al, 1990; Whitnall et al,
1992; Canny et al, 1999). Since much of the accepted theory of the HPA axis
response to stress results from studies in the rat, care must be taken to ensure that
these theories apply to other species.
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Chapter 9. In-situ hybridisation histochemistry to validate the behavioural
assessment of chronic inflammatory pain after rubber ring castration and tail-
docking.
9.1. Introduction
9.1.1. Chronic inflammatory lesions from castration and tail-docking
Lesions begin to form 3-7 days after c+td by application of a RR to the neck of the
scrotum and to the tail. These lesions reach a peak in size and severity after
approximately 21 days (Kent et al, 1999) and can measure 4cm across. The tissue
becomes inflamed and often infected, sometimes severely as the skin breaks down at
the site of the RR.
9.1.2. Expression of 'pain ' behaviours
Intermittent expression of the behaviours used to assess acute pain from c+td have
been observed in lambs with c+td lesions (Kent et al, 1999). The changes in
behaviour observed are often very subtle, but their occurrence suggests that the
lesions are painful (Kent et al, 1999). Before these behaviours can be confidently
used to assess pain from these chronic inflammatory lesions, it must be determined
whether determine whether expression of these behaviours is associated with pain
and if so, how consistent the relationship is.
In association with behaviour and self-administration studies, it is proposed that
changes in the synthesis and release of the neuropeptides arginine vasopressin (AVP)
and corticotrophin-releasing hormone (CRH) from the hypothalamic paraventricular
nucleus (PVN) will provide further evidence of the significance of these c+td lesions
to the lambs.
9.1.3. The HPA response to chronic inflammatory pain
CRH and AVP act in synergy to mediate the hypothalamo-pituitary-adrenal (HPA)
axis response to stress (Gillies et al, 1982; Antoni, 1993). Acute stressful challenge
results in an increase in the synthesis and release of CRH from the parvocellular
division of the paraventricular nucleus (pPVN) (Bartanuz et al, 1993). An increase in
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the release of AVP is also stimulated, but up-regulation of the synthesis of AVP
depends on the nature of the stressor (Bartanuz et al, 1993; Harbuz et al, 1994). The
expression of AVP mRNA does not generally exceed that of CRH rnRNA (Lightman
and Young, 1988).
During and after chronic exposure to stress in rats, the rate of synthesis and release of
AVP and CRH from parvocellular paraventricular neurones changes. The number of
neurones expressing AVP mRNA in the pPVN and the density of expression of AVP
mRNA within these neurones increases dramatically. The concentration of AVP in
the hypothalamo-pituitary blood (HPB) also increases (Chowdrey et al, 1995; Ma
and Aguilera, 1999). However, in chronic stress, the synthesis and release of CRH
from parvocellular neurones varies depending on the nature of the stressor and is
generally exceeded by that ofAVP (Ma and Aguilera, 1999).
In adjuvant-induced arthritis in rats, an experimental model of chronic inflammatory
pain, these changes are particularly pronounced. The synthesis and release of AVP is
strongly up-regulated (Chowdrey et al, 1995), whist the synthesis of CRH does not
change at all or is slightly reduced (Harbuz et al, 1992)
These changes in the way the HPA axis is regulated in response chronic
inflammatory pain show that the roles of AVP and CRH differ when exposure to the
stressor is prolonged. AVP is considered to be essential for the maintenance of
pituitary responsiveness during chronic stress (Aguilera, 1994). However, the
presence of some CRH in HPB is also necessary for the induction of a maximal
ACTH response (Muglia et al, 2001).
9.1.4. HPA responses to removal ofsex steroids
It is also well established that sex related variations exist in the expression,
regulation and release of hormones at all levels of the HPA axis. This includes
differences between males and females in the expression of CRH and AVP in the
parvocellular PVN (Paulmyer-Lacroix et al, 1996; Viau and Meaney, 1996). These
differences are considered to reflect the differential expression of gonadal steroids in
males and females. While these sex differences are accepted, few direct comparisons
of the male and female HPA axis have been made (Canny et al, 1999).
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The effects of sex steroids are principally mediated centrally through the PVN and
through their action on glucocorticoid receptors. Although receptors for gonadal
steroids are found in the PVN, they are not found in cells that regulate the HPA axis
(Simerly etal, 1990).
In studies in the rat, variable effects of gonadal hormones on the synthesis and
release of CRH have been reported. In vitro studies have shown that oestrodiol can
increase CRH gene expression, by its action on a putative oestrogen promoter region
in the CRH gene. However, in in vivo studies oestrogen has an inhibitory effect on
CRH mRNA levels in the pPVN. Through studies of ADX, it has been shown that
the inhibitory action of oestrogen is mediated through the stimulatory effect of
oestrogen on glucocorticoid release, which in turn inhibits CRH synthesis (Paulmyer-
Lacroix et al, 1996). In sheep, pregnancy, lactation and oestradiol and progesterone
treatment were found to have no effect on the level of expression of CRH mRNA in
the PVN (Broad et al, 1995). In studies of GDX with testosterone replacement, no
differences were found in the concentration of irCRH in the median eminence
between GDX rats with and without testosterone replacement (Viau and Meany,
1996). In sheep, the concentration of irCRH in the median eminence doubled after
GDX in both rams and ewes (Canny et al, 1999).
The concentration of ir AVP was lower in GDX male rats with testosterone
replacement than in vehicle treated GDX animals (Viau and Meany, 1996).
However, the number of irAVP neurones in the PVN did not change after GDX in
male rats (Bingaman et al, 1994). Testosterone has been found to have a stimulatory
effect on the number of neurones expressing AVP mRNA in the PVN in the pig (van
Eerdenberg et al, 1991) and the rat (de Vries et al, 1994). In sheep, the concentration
of irAVP in the median eminence of 3-year old rams has been found to be
significantly higher than that in 3-year old ewes, although no differences were found
in the concentration of irCRH (Canny et al, 1999). The concentration of irAVP in the
median eminence doubled in rams after GDX, but no change was found in ewes.
Together this evidence suggests that testosterone is particularly important in the
regulation of AVP synthesis and release, but does not appear to be as important in
the regulation of CRH synthesis and release. However, some evidence suggests that
oestrogen may have an important influence on the expression of the CRH gene.
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Sex steroids, particularly testosterone, have an inhibitory influence on the HPA
response to inflammatory stress (Hadid et al, 1995). Changes in expression of
immunoreactivity for AVP and CRH in the median eminence do not reflect changes
in the synthesis of AVP and CRH in the parvocellular paraventricular nucleus
(pPVN) (Bingaman et al, 1994). However, the possibility that, in sheep, castration
induces changes in the expression of AVP and CRH mRNA as a result of the
removal of gonadal steroids cannot be ruled out. Therefore any changes in the
expression of AVP and CRH mRNA in the median eminence may be the result of
chronic inflammatory pain from the lesion or of removing testosterone and oestrogen
by castration, or both.
9.1.5. Use of in situ hybridisation histochemistry to detect changes in AVP and CRII
mRNA expression in the pPVN.
The aim of this study was to use in situ hybridisation histochemistry to test the
hypothesis that rubber-ring c+td of lambs, resulting in the formation of chronic
inflammatory lesions and associated 'pain' behaviours, causes chronic inflammatory
pain and that such pain induces changes in the expression of AVP and CRH mRNAs
in the pPVN indicative of chronic stress. A second in situ hybridisation study, in
which lambs were tail-docked but not castrated, was designed to determine whether
any changes in the expression of AVP and CRH mRNAs were associated with the





9.2.1. Animals and management
Twin male lambs were housed together in a large (5x20m) straw-bedded pen with
their dams. All animals were subject to normal management procedures as outlined
in Chapter 2 part 2.2. Briefly, animals had continuous access to fresh water and hay.
The ewes were fed 500g of ESCA ewe nuts daily. The lambs were given constant
access to lamb creep feed (Pye-Frankland Balanced Feeds, Famb Creep Pellets) and
had constant access to their dam to suck milk. The animals were brought into the
experimental environment one week prior to treatment. The lambs were weighed and
one of each pair of twins was allocated to one of the two treatments, with weight
balanced across treatment groups.
9.2.2.1. Experiment 1: Animals and treatments
Sixteen four-week-old twin male lambs (Grey Face x Suffolk) were divided between
two treatments as follows:
1. C+td by the application of tight RRs to the neck of the scrotum and tail. n=8
lambs.
2. Handled as required to c+td but without the application of the RRs. n=8
lambs.
9.2.2.2. Experiment 1: Lesion assessment
The chronic inflammatory lesions resulting from c+td were examined and assessed
twice weekly according to the lesion assessment protocol (see Section 2.7). The
lambs were humanely killed (Euthatal, sodium pentabarbitone) 28 days after




9.2.3.1. Experiment 2: Animals and treatments
Fourteen, six-week-old, twin, male lambs (Scottish Blackface) were divided between
two treatments as follows:
1. Tail-docked by the application of tight RR to the tail. n=7 lambs.
2. Handled as required to tail-dock but without the application of the RR. n=7
lambs.
9.2.3.2. Experiment 2: Lesion assessment
The chronic inflammatory lesions resulting from tail-docking were examined and
assessed, according to the lesion assessment protocol (see Chapter 2 part 2.7), 21
days after treatment, when the lambs were humanely killed (Euthatal, sodium
pentabarbitone).
9.2.4. Behavioural observation
In both experiments, behavioural observations were recorded directly onto The
Observer behavioural analysis software whilst watching the lambs. All the lambs
were observed, simultaneously in the group pen with their dams, by 3 experienced
observers.
In the first experiment observations were made for 2 hours between 13.00 and 16.00
hours on days 18 and 25 after castration, according to the ethogram described in
Section 2.8. The behaviours 'chew' and 'horn' were not recorded on this occasion as
Greyface x Suffolk lambs have very small horns and no bars were available in the
pen. Lambs could not therefore perform these behaviours. The presence of three
straw bales in the pen increased the likelihood of play behaviours in this group of
lambs.
In the second experiment observations were made for 3 hours between 13.00 and
16.00 hours on days 12 and 18 after treatment, according to the ethogram described
in Chapter 2 part 2.8. The behaviour 'chew' was not recorded on this occasion as no
bars were available in the pen and lambs could not therefore perform this behaviour.
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9.2.5. Tissue collection and sectioning
When the severity of lesions peaked, the lambs were humanely killed by overdose of
anaesthetic ('Euthatal', Sodium Pentabarbitone). From this point onwards the
methods used in both experiments were the same. Following decapitation the brains
were rapidly (<5min) removed and cut into six coronal slices. Counting from the
rostral pole, the third slice contained the paraventricular nucleus (PVN). This slice
was taken between the optic chiasma (rostrally) to a point just caudal to the median
eminence (as carried out by Matthews et al 1993). Each slice was rapidly frozen by
placing on a flat Teflon-coated metal tray pre-cooled to -85°C using dry ice. The
slices were covered with powdered dry ice. Full freezing occurred within 5 minutes.
Once frozen the slices were transferred to individually labelled polythene bags and
stored at -85°C until required for further processing.
The brain slices containing the hypothalamus were removed from the freezer and
brought to -16°C in a cryostat. A cube of tissue, measuring approximately 2x2x2cm,
was cut from the centre of the slice so that the hypothalamus and the third ventricle
were contained entirely within it. From this cube 15pm coronal sections were cut.
Sectioning began at the level of the subfornical organ and was continued serially to
the median eminence. The sections were thaw-mounted on to positively charged,
nuclease free microscope slides and stored at -85°C in sealed plastic boxes until
required for in situ hybridisation histochemistry to seek AVP and CRH mRNA in the
parvocellular division of the PVN.
9.2.6. Labelling ofoligonucleotide probes
For the detection of AVP mRNA an antisense 45-mer oligonucleotide probe was
used, as designed by Matthews et al (1993). This probe is complementary to bases
397-441 of the bovine AVP neurophysin II gene, a G-C rich (86%) area of the gene
(see figure 9.1a).
For the detection of CRH mRNA an antisense 45-mer oligonucleotide probe was
used, as described by Matthews et al (1991). This probe is complementary to bases
1424-1468 of the ovine CRH gene and is also G-C rich (51.1%) (see figure 9.1b)
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Fig 9.1. (a) Sequence of the antisense, 45-mer, oligonucleotide probe to detect AVP mRNA
in PVN. This probe is complementary to bases 397-441 of the bovine AVP neurophysin II
gene, as described by Matthews et al (1993). (b) Sequence of the antisense, 45-mer,
oligonucleotide probe to detect CRF1 mRNA in PVN. This probe is complementary to bases
1424-1468 of the ovine CRH gene, as described by Matthews et al (1991).
(a) 5 441 gta gac gcc ggg ctg ggc ggg ctc cgc ggg ctc cgg cgc
cgc cgc 397 3
(b) ^ 1468 cct att gct atg agc ttg ctg cgc taa ctg atc ggc ctt
ggt cat,4243'
The oligonucleotide probes were 3'-end-labelled with 35S deoxyadenosine
triphosphate ([35S]dATP, specific activity 1250Ci or 46.2TBq/mmole). lpl of probe
and 125pCi (4.62MBq) [35S]dATP were incubated for lhour at 37°C with 25U
terminal deoxynucleotidyl transferase (TdT) (2pl) in tailing buffer (5pi) and sterile
water (17pl), making a total volume of 25pl. 75pl of ice-cold 12mM EDTA was
added to stop the reaction and the reaction mixture was placed into crushed ice for
15minutes. The labelled probe was then purified through Microspin G25 columns, by
centrifugation, following the manufacturer's instructions. A lpl sample of the probe
mixture was taken for scintillation counting before and after purification in order to
calculate the percentage incorporation of [35S]dATP into the AVP and CRH
oligonucleotide probes. The mean (±SEM) percentage incorporations of [35S]dATP
into the AVP and CRH oligonucleotide probes were 32.8%(±1.40) and 30.7%(±2.16)
respectively. The purified probe was diluted with hybridisation buffer for storage
overnight at 20 OOOcpm/pl in a -20°C freezer.
9.2.7. Pre-hybridisation buffer
Pre-hybridisation buffer was made up under sterile conditions. The following
volumes of chemicals were mixed; 10.67ml diethyl pyrocarbonate water (DEP
water), 4.80ml 5M NaCl, 400pl 1M trisodium-HCl, pH7.5, 132pl 6% FICOLL,
132pl 6% polyvinylpyrrolidone (PVP), 668pl 6% bovine serum albumin (BSA),
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160j_il 250mM ethylene diamine tetra-acetic acid (EDTA), 2ml lOmg/ml sonicated
salmon sperm DNA, 1ml 2mg/ml glycogen and 40pl 50mg/ml yeast tRNA.
9.2.8. Hybridisation buffer
Hybridisation buffer was also prepared under sterile conditions. The following
volumes of chemicals were mixed; 4.0g dextran sulphate, dissolved in 13.17ml of
DEP water, 4.80ml 5M NaCl, 400pl 1M Tris-HCl, pH7.5, 132pl 6% FICOLL, 132pl
6% PVP, 668pl 6% BSA, 160pl 250mM EDTA, 400pl lOmg/ml sonicated salmon
sperm DNA, lOOpl 2mg/ml glycogen and 40pl 50mg/ml yeast tRNA.
Pre-hybridisation and hybridisation buffers were stored at twice the working
concentration and were diluted with an equal volume of 50% deionised formamide
before use.
9.2.9. Box buffer
Box buffer was made to provide a suitable background environment in which to
facilitate pre-hybridisation and hybridisation. Box buffer is 4x SSC, diluted from 20x
SSC using DEP water, mixed with an equal volume of deionised formamide.
9.2.10. Fixation, prehybridisation and hybridisation
Before hybridisation the sections were fixed for 10 minutes in 4% paraformaldehyde
in 0.1M phosphate buffer, pH 7.5. The sections were then immersed in two
consecutive washes of 2x SSC for 5 minutes each. The slides were then drained and
laid on foam, soaked in box buffer, in hybridisation boxes. 75pl of pre-hybridisation
buffer was dispensed on to each section and the sections were incubated for 1-3
hours at 37°C. Prehybridisation buffer was then drained from the slides and 75pi of
hybridisation buffer was applied to each section. The hybridisation buffer contained
10 OOOcpm of 35S-labelled antisense oligonucleotide and lOpl of dithiothreitol (DTT)
was added to each millilitre of buffer in order to keep the 35S if reduced form.
Hybridisation incubation of the sections at 37°C for 18-24 hours was carried out in
the sealed hybridisation boxes.
Following hybridisation the slides were washed in three successive washes of
increasing stringency (2x, lx and 0.5x SSC), for one hour each, at 37°C. The slides
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were then dehydrated, for two minutes each, in three graded ethanol solutions (50%,
70% and 90%) containing 0.3M ammonium acetate. The slides were air-dried
overnight.
9.2.11. Autoradiography and staining
Ilford G5 emulsion was melted in a water bath at 42°C and diluted with distilled
water in a 1:1 dilution by volume. The dry, hybridised slides were dip-coated in the
diluted emulsion and left to dry overnight in the darkroom. The following day the
slides were packed and sealed into light-tight plastic boxes and stored at 4°C for 3
weeks to expose. The exposed slides were developed at 19°C for 4 minutes in Ilford
Phenisol developer diluted 1:4 with distilled water. The slides were then washed
briefly in distilled water before being immersed for 4 minutes each in three
successive troughs of Ilford Hypam fixative diluted 1:4 with distilled water, before a
final 10 minute wash in a large basin of distilled water.
The slides were then stained for 30 seconds in a 1% aqueous solution of Pyronine,
followed by four successive washes in distilled water and a final soak in distilled
water for 10 minutes. The slides were then dehydrated and cleared by immersion in
acetone for two minutes, 1:1 acteone:Histoclear II for two minutes and finally two
troughs of Histoclear II for two minutes each. The slides were then mounted in
Histomount.
9.2.12. Microscopy and image analysis
The tissue sections were examined microscopically using bright-field illumination
with lOx and 20x objectives (Nikon, UK Ltd.). The total number of labelled,
parvocelluar neurones in the paraventricular nucleus was counted using a 21mm
graticule and a hand-held tally counter. The density of silver grains within labelled
parvocellular neurones was measured using NIH Image (image analysis software
made available by Roslin Institute). In order to reduce error arising from clumping of
grains, the area of silver deposit was measured rather than the numbers of individual
silver grains in each cell. Silver grain density within thirty representative cells for
each animal was used. This sample size has previously proven to be optimal,
combining ease of counting without reduced accuracy. Cells were considered
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labelled if the density of grains within the cell was at least twice that of background.
Cells were only used for quantified measurement if they contained a nucleus.
9.2.13. Comparison ofA VP and CRHmRNA content and distribution
To compare the content and distribution of AVP and CRH mRNA expressing cells,
both AVP and CRH oligonucelotide probes were used on sections from each animal.
In order to match the sections anatomically, every fifth slide was removed from the
series cut for each animal. The sections were fixed in ethanol and stained in a 1%
aqueous solution of Toluidine blue followed by four successive washes in distilled
water and a final soak for 10 minutes in distilled water. Examination of these slides
allowed adjacent and anatomically matched slides in the series to be probed with
each probe. Sections from each pair of twin animals were also matched anatomically
as far as possible to aid between treatment comparisons.
9.2.14. Controls
To ensure that positive signals of probe in this study represented RNA, the in situ
hybridisation process was carried out on sections using the AVP and CRH
oligonucleotide probes. However the sections were incubated for 1 hour at 37°C in a
solution containing RNaseA, after fixing and before pre-hybridisation. The
preparation of the RNase solution was as follows; RNase was reconstituted in
distilled water at a concentration of lOmg/ml. This solution was boiled for 10
minutes to destroy DNase. The cooled solution was diluted to 30pg/ml in lOmM
Tris-HCl, pH 7.5, containing 0.5M NaCl. Pre-incubation in RNase solution removes
all signals due to RNA.
In order to ensure that any positive signals obtained represented specifically AVP
and CRH mRNAs, the method was also carried out using 35S-labelled
oligonucelotide probes for CRH and AVP with scrambled sequence (see fig 9.2).
Such scrambled probes should produce no specific signal. Following labelling, the
mean (±SEM) percentage incorporations of [35S]dATP into the AVP and CRH
scrambled probes were 23.6%±(0.95) and 43.5%(±1.5) respectively.
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Figure 9.2. (a) Sequence of scrambled antisense, 45-rner, AVP mRNA
oligonucleotide probe, (b) Sequence of scrambled antisense, 45-mer, CRH mRNA
oligonucleotide probe.
(a) 5' GCC GGG GGG CTC GTA GAC CTG GGC CGC GGG CGC CGC CTC
CGG CGC 3'
(b)5' CTA GTC CAG GCT ATA CTA TCT ACT TTA GTA GTT CCG GTC
CGG TGG 3'
9.2.15. Statistical analyses
All data were tested using the Anderson-Darling Test for normality to confirm the
distribution of the data. Paired Student's /-tests were used to compare differences in
the distribution and density of expression of AVP and CRH mRNA in the PVN of
treated (c+td or tail-docked alone) lambs and their untreated siblings.
The behavioural data were not always normally distributed. Square root and Logio
transformation were attempted but were not sufficient to normalise data with skewed
distribution in any case. Statistical comparisons of behaviour were therefore carried





9.3.1. Experiment 1: Castration and tail-docking
9.3.1.1. Lamb weight
No effect of treatment on the daily weight gain of lambs was found during the trial.
The weights of lambs were balanced at the start of the trial to reduce any effect of
weight on treatment. Therefore, prior to treatment there was no difference between
the weights of lambs in the two treatment groups (Tij=0.49, P=0.64). After
castration and tail-docking, the weights of c+td lambs and their handled control
siblings diverged slightly, with control lambs being consistently heavier. However,
the differences between groups did not reach significance at any time between 7 and
28 days after treatment when the lambs were killed. These results are shown in figure
9.3.
Figure 9.3. Change in weight 4-week-old lambs (n=8/group) over the 28 days following either















Inflamed lesions developed at the neck of the scrotum and on the tail where the RRs
were applied in all c+td lambs. The severity of lesions was scored using the systems
-»-c+td
-a- handled controls
~~1 1 1 1 1 1
3 8 13 18 23 28
Time after castration and tail-docking (days)
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described in Section 2.7. The width of the lesion (mm) was measured. The lesion was
also subjectively assessed using the eleven-point scale described in table 2.1.
Lesion Scores: All c+td lambs developed lesions with pus (score 3.5) during the trial.
The maximum mean (+sd) lesion score from castration was 3.25 (±0.25) (figure 9.3),
reaching this peak, on average, 17 days after castration and remaining high until 28
days after treatment when the lambs were killed.
Lesion Width: The mean width of castration lesions reached a slight peak of 15.75
(±0.70)mm, 17 days after castration. At 21 days the mean width dropped to a low of
10.94 (±3.2)mm, but did not reduce further in size before the lambs were killed 28
days after treatment. None of the lambs lost their scrotums before being killed.
The tail lesions became progressively more severe throughout the trial but the mean
score did not exceed 0.56 (±0.11) recorded 28 days after treatment on the day of kill.
No pus was present in tail lesions in any of the lambs. No tails were lost before 21
days, but half of the c+td lambs had lost their tails 28 days after treatment. These
results are presented in figure 9.4.
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Figure 9.4. Change in the (a) width and (b) score of lesions produced by c+td of 4-week-old lambs
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Behaviour was observed on days 18 and 25 after castration, for two hours. There was
considerable variation in the expression of all behaviours within both groups during
both observation periods. Normal and abnormal behaviours and postures were
expressed by both groups of lambs.
Frequency of active behaviour
18 days after treatment, c+td lambs and handled control lambs expressed restless
behaviour, easing quarters, foot-stamping, head turning, and rubbing quarters.
However, no differences were found in the frequency of expression of these
behaviours between groups. C+td lambs expressed more tail-wagging than handled
lambs, although this difference did not reach significance at P<0.05. C+td lambs also
showed more teat-seeking than handled controls (Ti,7=-2.60, P=0.035). Regression
analysis was performed on these results to determine whether the number of times
lambs were observed teat-seeking could be used to predict the frequency of tail-
wagging. There was found to be a significant relationship between tail-wagging and
teat-seeking in handled lambs (T|j7=-0.71, P=0.047) but the relationship did not
reach significance in c+td lambs (Ti>7=0.55, P=0.062).
25 days after treatment c+td lambs eased-quarters more frequently than handled
lambs (T|i7=-3.90, P=0.006). C+td lambs also showed more restlessness than handled
controls but this difference was not statistically significant (Ti>7=-1.62, P=0.150).
The more frequent expression of active behaviours by c+td lambs is reflected in a
significant difference in the overall frequency of active behaviour (REQ) between
control and treated lambs (Tij=-3.45, P=0.011). No other differences between
groups in the expression of active behaviours were found 25 days after castration.
These results are presented in tables 9.1 and 9.2.
Postures and behavioural states
On the 18th day after treatment, c+td and handled lambs stood and lay in normal and
abnormal postures for a similar number observations. C+td lambs appeared to spend
more time eating (straw, hay or creep feed) than handled lambs although this
difference did not reach significance at p<0.05 (Ti)7=-2.04, P=0.080). No other
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differences in the occupation of lambs were found. Data on the number of
observations spent ruminating and sleeping on day 18 were lost because of a
computer error.
25 days after castration, no differences were found in the postures expressed by c+td
lambs and handled controls. These results are presented in tables 9.3a and b and 9.4a
and b.
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Examination of the control tissue sections (labelled with AVP or CRH
oligonucleotide probes after RNase pre-treatment, or labelled with scrambled AVP or
CRH probes), using bright-field illumination at low magnification, revealed that no
cells contained labelling and there was very little or no randomly distributed
background labelling.
After 3 weeks of incubation at 4°C, the AVP oligonucleotide probe produced clear
and consistent labelling concentrated within the PVN. Expression of CREI mRNA
was much lower than that of AVP. This may reflect problems with the in-situ
methodology using the CRH oligonucleotide probe. Very little or no randomly
distributed background labelling was present and never exceeded a density of 1.5
(±0.5) square pixels.
On visual inspection, using bright-field illumination at low magnification (xlO),
AVP-labelling was more dense in the magnocellular than parvocellular division of
the PVN. In contrast, little CRH-labelling was observed in the magnocellular region.
CRH labelled cells were found mainly in the parvocellular division of the PVN.
Counting labelled cells revealed that, on average (±SEM), 206.5 (± 19.2)
parvocellular neurones in the PVN were labelled with AVP mRNA in c+td lambs.
Handled lambs showed labelling in an average of 183.8 (±9.6) parvocellular
neurones. This difference was not statistically significant at R<0.05 (Tij7=0.91,
P=0.395).
The mean (±SEM) density of silver grains within AVP labelled parvocellular
neurones was 321.4 (±90.2) and 287.2 (±32.1) square pixels in c+td and handled
lambs respectively, but again this difference was not significant (Tij7=0.66,
P=0.532).
No differences were found in the number of parvocellular neurones expressing CRH
mRNA in the PVN (67.1 (±30.5)) and 69.5 (±21.3) in treated and control animal
respectively, (T|j=0.21, P=0.840). Likewise no difference was found in the density
of silver grains within CRH labelled cells 22.8(±10.6) and 21.3 (±8.6) in treated and
control animal respectively, (Ti>7=0.47, P=0.654).
There was also no difference between groups in either the ratio of AVP to CRH
expressing neurones 3.2(±1.2) in c+td, 3.4 (±1.7) in handled controls (Tij=0.29,
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p=0.781), nor in the ratio of the density of expression within these cells (17.7(±9.7))
in c+td and 15.3(±.3.9) in handled control lambs (Tij=0.77, /?=0.465). These results
and statistical analyses are presented in table 9.5. Bright-field photomicrographs
showing examples of the distribution and density of AVP labelling within the PVN
are presented in figure 9.5.
Table 9.5. The mean (±SEM) number of cells expressing AVP or CRH mRNA, the mean (±SEM)
density of expression of AVP or CRH within these cells and the mean ratio of AVP:CRH (±SEM)
expression are shown. The statistical test used to analyse the significance of these results and the level
of significance is also presented.
mRNA Mean no. of cells Mean density of grains Statistical difference
(±SEM) (sq pixels ±SEM) (Paired Student's T-
test n=8)
C+td Control C+td Control Cells Density
AVP 206.5(±19.2) 183.8(±9.6) 321.4(±90.2) 287.2(±32.1) T=0.91 T=0.66
P=0.395 P=0.532
CRH 67.1 (±30.5) 69.5(±21.3) 22.8(±10.6) 21,3(±8.6) T=0.21 T=0.47
P=0.840 P=0.654




Figure 9.5. Bright-field photomicrographs (using Ilford G5 emulsion) of; (a) an example of AVP
mRNA expression in the pPVN of c+td lambs, (b) an example of AVP mRNA expression in the
pPVN of handled control lambs. The greatest concentration of AVP mRNA was located in the
magnocellular division of the PVN (M), but strong labelling was also found in the parvocellular
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9.3.2. Experiment 2: Tail-docking
9.3.2.1. Lamb weight
Pairs of lambs were selected for each treatment group on the basis of weight to
ensure that weight was balanced across groups. There was therefore no difference in
the mean weight of lambs in each group at the start of the trial (T|,6=0.17, p=0.87).





The median (Q1-Q3) severity of tail lesions when lambs were euthanised for tissue
collection was 1.0(0.0-1.5).
9.3.2.3. Behavioural observations
Behaviour was observed on two occasions, for three hours each, on days 12 and 18
after treatment. There was a great deal of variation within each group in the
expression of both normal and abnormal behaviours. Both treated and control
animals performed normal and abnormal behaviours.
Frequency ofactive behaviour
12 days after treatment, all active behaviours were expressed by lambs in both
groups. Handled lambs appeared to show some more head-turning behaviour than
tail-docked lambs but this difference did not reach significance at P<0.05 (Ti,6=2.38,
E=0.063). When then different elements (head turn to back, flank or outside of hind
leg) of the combined head-turning score were examined, no differences in the
individual types of head turning were observed (W=6.0, P=0.181, T|>6=1.20, P=0.29
and Ti,6=T.OO, P=0.36 respectively). No further differences were found between
groups in expression of active behaviours.
18 days after treatment tail-docked lambs eased quarters more frequently than control
lambs. This difference did not reach significance at /?<0.05 (W=0.00, P=0.059) and
was not reflected in the overall frequency score of active behaviour (REQ, T]6=-
1.22, P=0.2S). No further differences were found between the groups. These results
are presented in tables 9.6 and 9.7.
Postures and behavioural states
Very few abnormal postures were observed in any of the lambs. Ventral lying with
extended legs (V3) was observed on a few occasions in lambs in both groups and
there was no difference between the groups (W=2.0, P=1.00 and W=0.0, P=0.371 for
12 and 18 days after treatment respectively). No differences were found in the
postures expressed by the lambs at 12 days or at 18 days after treatment. These
results are presented in tables 9.8a and b and 9.9a and b.
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Table 9.8. (a) The number of observations spent in each posture by lambs 18 days after either c+td by
RR or handling as controls (n=8). (b) The number of observations spent in each behavioural state by
lambs 18 days after either c+td by RR or handling as controls (n=8). The mean (±sd) or median (Ql-
Q3) number of observations spent in each posture or behaviour for each group and each posture is
presented. The statistical test used and the level of statistical probability is also shown.
Normal S1 V1 V2 V3
12 days C+td handled C+td handled C+td handled C+td handled C+td handled
1 30 30 21 20 0 5 8 5 1 0
2 30 30 15 20 2 0 13 10 0 0
3 30 29 21 20 3 1 6 9 0 0
4 28 30 20 17 1 0 9 13 0 0
6 30 30 26 21 0 0 8 7 0 2
7 29 28 19 24 4 0 6 6 0 0
Mean/Median 30.00 30.00 20.33 20.33 1.50 0.00 8.33 8.33 0.00 0.00











12 days Eat Idle Teat-seek Ruminate Play Sleep
C+td handled C+td handled C+td handled C+td handled C+td handled C+td handled
1 11 5 11 14 0 1 8 5 0 0 0 5
2 8 8 15 17 0 0 5 5 0 0 2 0
3 12 8 10 13 0 0 1 8 2 0 5 1
4 7 10 16 13 1 0 4 3 1 0 0 0
6 10 6 19 20 0 0 0 4 0 0 0 0
7 6 15 15 9 2 2 0 3 0 0 6 1
Mean/Median 9.00 8.67 14.33 14.33 0.00 0.00 3.00 4.67 0.50 0.00 2.17 1.17
sd/Q1-Q3 2.37 3.56 3.33 3.78 0-0.75 0-0.75 3.22 1.86 0-0.75 0-0 2.71 1.94
Test T-test T-test Wilcoxon T-test Wilcoxon T-test
T=-0.15 P =0.89 T=0.00 P =1.00 T=1.5 P=1.00 T=1.11 P=0.32 T=0.0 P =0.371 T—0.68 P =0.52
239
Chapter 9.
Table 9.9. (a) The number of observations spent in each posture by lambs 25 days after either c+td by
RR or handling as controls (n=8). (b) The number of observations spent in each behavioural state by
lambs 25 days after either c+td by RR or handling as controls (n=8). Mean (±sd) or median (Q1-Q3)
number of observations spent in each posture for each group and each posture is presented. The
statistical test used and the level of statistical probability is also shown.
18 days Normal S1 V1 V2 V3
C+td handled C+td handled C+td handled C+td handled C+td handled
1 28 30 13 17 10 3 5 10 2 0
2 30 30 9 17 8 1 13 12 0 0
3 30 30 17 22 2 2 11 6 0 0
4 29 29 19 17 1 2 9 10 1 1
6 29 30 15 21 2 1 12 8 1 0
7 30 30 22 22 5 1 3 7 0 0
Mean/Median 29.50 30.00 15.83 19.33 3.50 1.50 8.83 8.83 0.50 0.00
sd/Q1-Q3 29.0-30.0 30.0-30.0 4.58 2.58 2.0-7.25 1.0-2.0 4.02 2.23 0-1.00 0-0
Test Wilcoxon T-test T-test T-test Wilcoxon
T=3.0 P=0.371 T=2.27 P =0.073 T=-0.53P ==0.62 T=0.00 P =1.00 T=0.0 P =0.371
18 days Eat Idle Teat-seek Ruminate Play Sleep
C+td handled C+td handled C+td handled C+td handled C+td handled C+td handled
1 6 5 13 14 1 1 0 5 0 0 10 5
2 6 10 15 18 0 0 1 1 0 0 8 1
3 8 14 13 17 1 0 4 5 0 0 4 2
4 6 10 17 9 0 0 6 4 0 0 1 1
6 7 10 18 15 0 0 3 4 0 0 2 1
7 14 17 10 11 1 0 0 0 0 0 5 2
Mean/Median 7.83 11.00 14.33 14.00 0.50 0.00 2.33 3.17 0.00 0.00 5.00 2.00
sd/Q1-Q3 3.13 4.10 2.94 3.46 0.0-1.0 0-0 2.42 2.14 0.00 0.00 3.46 1.55
Test T-test T-test Wilcoxon T-test T-test




Control tissue sections (labelled with AVP or CRH oligonucleotide probes after
RNase pre-treatment, or labelled with scrambled AVP or CRH probes), showed no
cells containing labelling and very little or no randomly distributed silver grains
representing background labelling.
Again, after 3 weeks of incubation at 4°C, the AVP oligonucleotide probe produced
clear and consistent labelling concentrated within the PVN. Expression of CRH
mRNA was again much lower than that of AVP. Very little or no randomly
distributed background labelling was present and never exceeded a density of
2.0(±0.4) square pixels.
Visual inspection, using bright-field illumination at low magnification (xlO),
revealed that AVP-labelling was again more dense in the magnocellular than
parvocellular division of the PVN and that little CRH-labelling was observed in the
magnocellular region.
After quantified analysis, no differences were found between groups either in the
number of cells expressing AVP or CRH mRNA, the density of silver grains with
cells expressing CRH mRNA or in the ratio ofAVP to CRH expressing cells.
There was a difference in the density of silver grains within cells labelled with AVP.
The mean density of silver grains within these parvocellular neurones was 211.9
(±25.2) and 260.7 (34.1) square pixels in tail-docked and control lambs respectively,
however this difference did not reach significance at p<0.05 (T|,6=-2.47, P=0.069).
These results and statistical analyses are presented in table 9.10. Bright-field
photomicrographs showing examples of the distribution and density of AVP and
CRH labelling within the PVN are presented in figure 9.6.
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Table 9.10. The mean (±SEM) number of cells expressing AVP or CRH mRNA , the mean (±SEM)
density of expression of AVP or CRH within these cells and the mean ratio of AVP:CRH (±SEM)
expression are shown. The statistical test used to analyse the significance of these results and the level
of significance is also presented.
mRNA Mean no. of cells Mean density of grains Statistical difference
(+SEM) (sq pixels +SEM) Paired Student's T-
test (n=6)
td Control td Control Cells Density
AVP 287.2 (±41.8) 268.6 (±35.4) 211.9 (±25.2) 260.7 (34.1) T=0.33 T=-2.47
P=0.758 P=0.069
CRH 48.5 (±6.68) 42.4 (±3.02) 22.6 (±4.85) 22.6 (±3.27) T=0.91 T-0.01
P=0.412 P=0.994
AVP:CRH 6.0 (±0.56) 6.6 (±1.25) 10.9 (±2.01) 12.0 (±1.39) T=-0.44 T=-0.34
P=0.684 P=0.753
Figure 9.6. Bright-field photomicrographs (using Ilford G5 emulsion) of; (a) an example of AVP
mRNA expression in the pPVN of tail-docked lambs, (b) an example of AVP mRNA expression in
the pPVN of handled control lambs. The greatest concentration of AVP mRNA was located in the
magnocellular division of the PVN (M), but strong labelling was also found in the parvocellular
division (P), the area of interest in this study.
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The differences in weight between c+td lambs and handled control lambs were not
significantly different at P<0.05. However, there was a non-significant trend towards
lower weight gain between 7-14 days after treatment and for lower weight overall in
c+td lambs. This trend is consistent with effects on weight that might be expected as
an effect of the experience of chronic pain (Chapman, 1985; Kitchell and Johnson,
1985; Zimmermann, 1986; Short, 1998).
9.4.1. Severity of lesions
The average width and score of castration lesions in the experiment 1 was slightly
lower than those observed previously in four-week-old lambs (Kent et al, 1999). This
difference may be associated with breed differences in size. In the previous study,
Dorset x Finnish Landrace lambs were used (Kent et al, 1999), these lambs are larger
than Greyface x Suffolk lambs at four weeks of age (by comparison of two sets of
lambs used in this project (P=0.0069)). An increase in size has previously been
associated with more severe lesions (Kent et al, 1999). Variation in the severity of
lesions between studies may also be attributed to differences in the level of bacterial
contamination in the pen. Despite the slight reduction in the severity of castration
lesions in comparison with previous studies, all lesions in experiment 1 were
inflamed and showed evidence of infection.
9.4.2. Behaviourfollowing c+td
The variation in behaviour in all lambs in experiment 1 was extremely high, making
true differences between animals in each group more difficult to detect. Watching the
lambs for longer during each observation may have helped to expose differences
more clearly. Despite this, differences were found between c+td individuals and their
handled siblings.
Teat-seeking and tail-wagging
15 days after castration, before lesions from c+td had reached a peak, c+td lambs
showed a tendency to teak-seek more frequently than their handled sibling. This may
243
Chapter 9.
indicate that the treated lamb sought comfort or distraction from pain from the lesion.
It is considered particularly surprising and important, as twin lambs normally suckle
simultaneously in response to a signal from the ewe (Ewbank, 1967).
C+td lambs also showed a tendency to tail-wag more frequently than their handled
siblings, although this difference was not statistically significant. Two explanations
for this result may be acceptable. Tail-wagging may indicate pain or discomfort in
the tail region of c+td animals. Alternatively, as lambs wag their tails during attempts
to suckle and during suckling, the increase in tail-wagging in c+td lambs may also be
a reflection of the increased the frequency of teat-seeking observed in these animals.
Although care was taken not to record instances of tail wagging that were clearly
associated with teat seeking, closer consideration of results showed that, in handled
lambs, there was a significant predictive relationship between the number of suckling
attempts and the number of times the lambs wagged their tails. However, in c+td
lambs this relationship was slightly deviated suggesting that on some occasions,
something other than the motivation to suckle, induced c+td lambs to tail-wag. This
could have been pain. Studies in children and rats have shown that suckling and
drinking of certain components of milk, prinicipally sucrose, have some pain-
relieving properties (Blass and Watt, 1999; Mukherjee et al, 2001; Anseloni et al,
2002; Gray et al, 2002). Similar increases in teat-seeking were observed in RR c+td
lambs after naloxone pre-treatment in comparison with lambs receiving RR c+td
alone (Wood, 1991), although Landa (2000) found that suckling of sucrose or from
the dam did not influence behavioural responses to tail-docking.
Easing quarters
25 days after castration, when lesions had reached a peak, c+td lambs showed active
behaviours more frequently than handled lambs. This was reflected in a significant
difference in REQ scores (combined score of restlessness, foot stamping and easing
quarters). This score is used to determine whether there is an overall difference in
active behaviour, when individual behaviours show no difference between groups. In
this case, the difference in the REQ score was primarily the result of the highly
significant increase in the frequency of easing quarters shown by c+td lambs.
Restlessness also occurred more frequently in c+td animals, but this difference was
244
Chapter 9.
small and was not significant at P>0.05. These behaviours are also suggestive of the
experience of pain in c+td lambs.
Posture and behavioural states
Although there was no change in the posture of the lambs at either 15 or 25 days
after treatment, there was a non-significantly increased tendency to spend more time
eating in c+td lambs. Feeding behaviour, seen as teat-seeking at 15 days and eating at
25 days, may simply act as a distraction from pain, but as suggested above it may
also be a means of reducing pain or distress.
Significance of changes in behaviour
The detection of these subtle changes in behaviour is important and possible despite
the problem of wide variations between individuals in the same treatment group.
Studies of acute pain from c+td have shown that these behaviours are sensitive
indicators of the severity of acute pain suffered by an individual (Molony et al,
2002). This study confirms that changes in behaviour also occur in association with
long-lasting lesions produced by castration and docking and suggests that these
lambs experience some chronic inflammatory pain.
9.4.3. Behaviourfollowing tail-docking
In experiment 2, lambs were watched for one hour longer than in the experiment 1,
however as the variation in behaviour between individuals in the same group was
high, differences remained difficult to detect. 12 days after treatment, there was some
evidence that tail-docked lambs showed more head-turning in total, than their
untreated siblings, although the target to which the head was turned was not
important. After 18 days, tail-docked lambs eased quarters more frequently than their
untreated siblings, although again this difference was not statistically significant.
There was no difference in the overall frequency of active behaviours between tail-
docked and control lambs at either time point, nor was there any difference in the
postures of lambs. Lesions from tail-docking are not as severe as those from
castration (peak score usually 1-2 compared to 3.5-5 from castration), and are
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therefore likely to be less painful than that from castration. Also, the lesion from tail-
docking is less likely to be aggravated during locomotion.
No significant behavioural indications of pain were observed in these lambs. It is
possible that the lesions produced by tail-docking in this study were insufficiently
severe to produce significant chronic inflammatory pain.
9.4.4. Neurohistochemistry
9.4.4.1. General observations
Initial examination of the tissue sections in both studies showed that AVP mRNA
was expressed more strongly in the magnocellular division than in the parvocellular
division. This distribution of labelling is consistent with that in previous studies in
both sheep and rats (Nojiri et al, 1985; Matthews et al, 1993). Expression of CRH
mRNA in both studies was much lower than that of AVP and lower than that
observed in other in-situ hybridisation studies using ovine oligonucleotide CRH
probes (Matthews et al, 1991). This may reflect problems with the in-situ
methodology using the CRH oligonucleotide probe. For example, the stringency of
washes following hybridisation may have been too high, or the length of exposure
too short. Many other components of the procedure may also have been at fault and
more extensive experience with the method may have improved the labelling. As
changes in AVP mRNA expression are the principle characteristic of chronic stress,
improvement of the method for CRH labelling was not attempted. Analysis was
carried out on CRH results for both experiments, but no major conclusions have been
drawn from CRH data.
Despite measures to minimise error in the counting and density of labelling of cells
during in situ hybridisation histochemistry, some level of error remains. Some
magnocellular neurones are present in the parvocellular division and discrimination
between cells types is difficult. Also, in AVP mRNA studies, labelling was strong
and therefore determination of the numbers of cells that overlapped in a cluster was
difficult. This is an intrinsic difficulty with the in situ hybridisation method and does
not apply to this project alone.
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9.4.4.1. No neurohistochemical evidence ofchronic inflammatorypain
In the first study, despite inflammation and infection in lesions and the presence of
'pain' behaviours, no evidence of chronic pain was found in tissue sections
containing the PVN of c+td lambs. There was no change in the expression ofAVP or
CRH mRNA in the pPVN of treated lambs, when compared to handled controls. The
number of cells expressing mRNA, the density of silver grains within each cell and
the ratio of AVP:CRH expression did not change.
In the second study there was again no evidence of changes in the expression ofAVP
and CRH mRNA in the pPVN that are characteristic of chronic inflammatory pain.
There was however, evidence that AVP mRNA was expressed more densely in the
pPVN of untreated lambs than in tail-docked individuals. This result is the opposite
of that expected if tail-docked lambs were experiencing chronic pain and may reflect
differences in the control of the stress response in sheep (Familiari et al, 1989, Liu et
al, 1990, Canny et al, 1999)) as discussed in section 8.4.
9.4.4.3. No effect of the removal of gonadal steroids on CRH and AVP mRNA
expression.
The results of neurohistochemical analyses showed no change in the expression of
AVP and CRH mRNA, which also indicates that the removal of sex steroids by
castration had no effect on the expression of these neuropeptides in the pPVN. The
plasma concentration of testosterone in the blood of ram lambs between 4 and 17
weeks of age fluctuates, but remains approximately four times lower than that in
adult rams (Lee et al, 1976). The plasma concentrations of lutenising hormone (LH)
and follicle stimulating hormone (FSH) also vary in lambs in this age range. Peaks in
the concentration of FSH between 5 and 7 weeks and LH at 5 weeks of age exceed
the plasma concentration found in adult rams. In their study of the effects of
castration on the expression of hormones in the pPVN, Canny et al (1999) used 3-
year old adult rams. The sudden removal of a high concentration of testosterone is
likely to have had a greater influence on the expression of hormones in the pPVN,
than the removal of the lower concentration of testosterone in 4-6 week old lambs.
Also, Canny et al (1999) castrated the rams 10 months before brain tissue was
collected and examined for expression of hormones in the median eminence. The
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comparatively short-term effects of the removal of testosterone, such as those in the
present study of c+td are likely to be different from the long-term effects of
castration found by Canny et al (1999).
9.4.4.4. Do chronic inflammatory lesions from castration and tail-docking cause
chronic pain?
The lack of neurohistochemical evidence of chronic inflammatory pain may be
explained in more than one way. Firstly, the lack of changes in the expression of
AVP and CRH mRNA may indicate that, despite some behavioural evidence of pain
or discomfort, the lesions present in this study did not cause sufficient pain to induce
changes in the PVN that were indicative of chronic stress.
9.4.4.5. Species differences in HPA control: positive controls
Significant species differences exist in the potency of action ofAVP and CRH and in
the number of parvocellular neurones that express AVP mRNA in non-stressed
animals (Familiari et al, 1989, Liu et al, 1990, Whitnall et al, 1992). Therefore, an
alternative explanation for the lack of neurohistochemical evidence of chronic pain is
that the PVN response to chronic stress may be different in sheep, or responds at a
different threshold from that in the rat. In order to demonstrate that changes in the
expression of AVP and CRH mRNA are characteristic of chronic inflammatory pain
in the sheep, positive controls for this response should have been included in the
study.
Experimental models of inflammatory pain in animals include carrageenan
injections, and adjuvant induced arthritis in rodents. Other frequently used animal
models include those for neuropathic pain and central pain. These models are less
appropriate as controls for this study as they either do not last long enough or involve
limited inflammation (Walker et al, 1999).
Carrageenan
Injection of carrageenan has been used to model inflammatory pain in sheep (e.g.
Dolan et al, 1999; Dolan and Nolan, 2002) and rats (Xu et al, 1995; Willoughby et
al, 2000). Carrageenan injections produce local inflammation of the joint and soft
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tissue, with substantial swelling, for up to seven days (Walker et al, 1999). Injection
of carrageenan intra-dermally into the intra-digital skin of sheep has been found to
produce significant hyperalgesia (Dolan et al, 1999). Repeated injections of
carrageenan, such that inflammation and hyperalgesia were maintained over weeks
rather than days, could provide a suitable chronic model of chronic inflammatory
pain in the sheep, but would be difficult to justify ethically.
Arthritis
Arthritis, induced by injection of heat-killed Mycobacterium butyricum has been
used to model chronic inflammatory pain in rats and is known to induce changes in
the expression of CRH and AVP mRNAs in the PVN that are characteristic of
chronic inflammatory pain. Lambs of all ages are susceptible to arthritis of different
types, collectively known as 'joint ill'. Arthritis in lambs is caused by both
streptococcal and/or staphylococcal bacteria, and in older lambs by Erysipelothrix
rhusiopathiae. Bacteria gain access to, mainly synovial, joints either by local damage
or in the blood (Watkins 2000). Susceptibility to the different types of arthritis is
determined principally by the immune status and thus the age of the lamb. If arthritis
could be experimentally induced in immuno-compromised lambs, an arthritis model
similar to that produced in rats might be developed.
Foot-rot
Naturally occurring foot-rot has been used as models of chronic inflammatory pain in
sheep (Welsh and Nolan, 1995; Dolan et al, 2000). Foot-rot is caused by bacterial
infection of the inter-digital skin and laminae of the hoof. The feet become more
susceptible to infection when the integrity of the skin in compromised, either by
continuous exposure to wet and dirty underfoot conditions, or by injury. Two
bacteria are involved, prior infection with Fusobacterium necroforum facilitates
invasion of the epidermis by Dichilobacter nodosus. Lesions of the interdigital skin
develop and in severe cases lesions also develop within the hoof, which may result in
separation of the sole from the wall and toe of the hoof. The condition is highly
contagious and, in warm and damp conditions, has an incubation period of 10-14
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days. After this, the condition may persist and become chronic, or resolve and heal
naturally (Egerton, 2000).
The use of naturally occurring disease to model chronic inflammation has significant
disadvantages over experimentally induced models. The severity of clinical
conditions varies dramatically between individuals and therefore some means of
assessing severity must be established in order to minimise this variation. The
severity of foot-rot may be assessed using lameness scores like that defined by
(Welsh et al, 1993). The size and severity of the lesion may also be estimated, but
this may prove difficult if the lesion is contained within the hoof. Also, in order to
select a group of animals in which the onset, severity and duration of disease is
similar, access to a large flock is essential. Another problem with the use of foot-rot
as a model of chronic inflammation for this study, is that foot-rot is less common in
lambs than in the heavier ewes or rams (Egerton, 2000).
Foot-rot has been induced experimentally in Merino sheep by housing the animals in
dirty conditions after damaging the inter-digital skin (Raadsma et al, 1993). Foot-rot
induced in standardised conditions, producing standardised lesions, in susceptible
individuals might have provided a suitable positive control model of chronic
inflammatory pain in lambs and provide a positive control for this study, but would
also be difficult to justify ethically.
9.4.6. Indications ofchronic inflammatory pain at other levels of the HPA axis
As species specific differences in the mechanisms of control of the HPA axis exist, it
is possible that these mechanisms are different in sheep at the level of the pPVN.
Evidence of chronic activation should therefore be sought at other levels of the HPA
axis. In rats the HPA axis responds to the chronic inflammatory pain of adjuvant
induced arthritis at all levels. The increase in AVP mRNA expression in the pPVN is
associated with a rise in the concentration of AVP in HPB (Chowdrey et al, 1995).
The decline in CRH synthesis is associated with a decline in CRH release (Harbuz et
al, 1992). Expression of POMC mRNA in the anterior pituitary (Stephanou et al,
1992), and the concentrations of ACTH and corticosterone in the peripheral
circulation (Chowdrey et al, 1995) are increased in response to stress. The weight of
the adrenal gland has also been found to increase during chronic activation of the
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HPA axis (Harbuz et al, 1992). Thus this study would have benefited from the
measurement of AVP and CRH in HPB, ACTH and Cortisol in the systemic blood
and from measurement of changes in the weight of the adrenal gland.
9.4.7. Local endogenous analgesia.
A second explanation for the lack of neurohistochemical evidence of chronic pain, as
well as the limited behavioural evidence of pain, is that lambs are able to reduce the
intensity of pain produced by the lesions. Endogenous opioids inhibit the
hypothalamic stress response (Suda et al, 1992). Enkephalins are co-localised with
CRH in a proportion of parvocellular neurones in the PVN (Sankanaka et al, 1989;
Merchenthaler, 1992). These neurones project to the median eminence
(Merchenthaler, 1992) and secretory granules containing enkephalins along with
CRH and AVP are found in terminals in the median eminence (Hisano et al, 1987).
CRH induces the secretion of P-endorphin as a product of the breakdown of POMC.
The expression of enkephalin mRNA in the PVN (Harbuz and Lightman, 1989) and
the concentration of P-endorphin in peripheral circulation (Engler et al, 1989) has
been found to increase after exposure to stress. The level of expression and release of
these opioids is determined by the nature of the stressor.
I.c.v. administration of p-endorphin results in a reduction in the expression of CRH
mRNA in the pPVN, irCRH in the median eminence and expression of POMC
mRNA in the anterior pituitary (Suda et al, 1992). This was accompanied by a
reduction in basal and stress-induced levels of ACTH release (Suda et al, 1992).
These mechanisms depend on the activation of central mechanisms and are thus
likely to occur in association with activation of central stress responses. However,
peripheral mechanisms are also present that may minimise pain from c+td lesions,
without any activation of the PVN and other central mechanisms.
For example, CRH has autocrine and paracrine effects in the periphery. It was found
to be present in inflamed tissue at the site of immune challenge (Hargreaves et al,
1989; Karalis et al, 1991), but not simultaneously in surrounding tissue or in general
circulation (Karalis et al, 1991). In in vitro studies, CRH has been found to stimulate
immune cells, enhancing their function and their release of immune mediators
(Karalis et al, 1991). CRH also simulates the release ofACTH and P-endorphin from
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leucocytes (Karalis et al, 1991; Cabot et al, 1997). ACTH and (3-endorphin have
anti-inflammatory and anti-nociceptive function. Thus, CRH has potent anti¬
nociceptive effects, but its actions locally are dependent on the presence of an
inflammatory response in the tissue (Lariviere and Melzack, 2000).
It is proposed that if c+td lesions are below an as yet undefined 'threshold' of
severity, peripheral antinociceptive mechanisms, which may include locally released
CRH, could be sufficient to control any resulting pain. Thus, no changes in the
expression of AVP and CRH mRNA in the PVN indicating chronic inflammatory
pain would occur. This hypothesis could be tested by the local administration of
CRH antagonists (Jezova et al, 1999) or naloxone to inhibit endogenous opioids.
9.4.8. Conclusion
In conclusion, chronic inflammatory lesions from c+td resulted in some changes in
behaviour that may be indicative of chronic pain. However, no neurohistochemical
evidence of chronic inflammatory pain was found. It is proposed that this may be
because the lesions in this study were insufficient to cause significant pain and that
behaviours expressed were indicative of discomfort or irritation rather than pain.
Alternatively, the hypothalamic response to chronic inflammatory pain in the sheep
may differ from that observed in the rat.
Investigation of other models of chronic inflammatory pain in the sheep, for example
subcutaneous injection of carrageenan, adjuvant induced arthritis or experimentally
induced foot-rot, could provide positive controls and would help to establish the
detailed characteristics of the HPA response to chronic inflammatory pain in this
species. However, it is considered ethically unacceptable to induce such severe
chronic pain in order to provide positive controls for the study of the pain from c+td
lesions. Another possibility is that local endogenous anti-inflammatory and analgesic
responses induced by progressive inflammation and infection of the lesion, were
sufficient to control any pain locally and that central hypothalamic responses were






Chapter 10. General Discussion.
10.1. Introduction
The studies reported in this thesis were carried out to test the following hypotheses;
1. Lambs undergoing castration and tail-docking by tight rubber ring
experience chronic inflammatory pain for up to six weeks, in association
with chronically inflamed lesions.
2. The chronic inflammatory pain experienced by lambs is sufficient to induce
changes in their behaviour.
3. Quantification of these behavioural changes constitutes a valid measure of
the chronic inflammatory pain experienced by rubber ring castrated and tail-
docked lambs.
The analgesic self-administration paradigm has been used as a means of investigating
the experience of chronic inflammatory pain in rats suffering from AA. Evidence of
analgesic selection was used to investigate that validity of AA as a model of chronic
inflammatory pain. Similarly, in the studies reported in this thesis, the ability of RR
c+td lambs to self-administer the NSAID FM, was used to determine the presence of
chronic inflammatory pain.
Up-regulation of the synthesis of AVP and reduction in the synthesis of CRH in the
parvocellular portion of the hypothalamic paraventricular nucleus was detected in
rats with AA. Using in situ hybridisation histochemistry, such changes in the control
of the HPA axis were sought in the present studies, to confirm the presence of
chronic inflammatory pain in RR c+td lambs.
Throughout the self-administration and neurohistochemical studies, the severity of
chronic inflammatory lesions and the expression of potential 'pain' behaviours were
recorded to determine the significance of these measures with respect to chronic
inflammatory pain. Evidence of a relationship between lesion severity and the
magnitude of the change in behaviour was also sought.
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10.2. Evidence ofchronic inflammatory pain?
Some evidence of chronic inflammatory pain from RR c+td was found in the studies
reported in this thesis. This evidence is summarised and discussed below.
10.2.1. Weight.
Anorexia and reduced weight gain have been associated with the experience of
chronic pain in both humans and animals (Chapman, 1985; Kitchell and Johnson,
1985; Zimmermann, 1986; Short, 1998). The weight of c+td lambs appeared to be
consistently less than that recorded in handled control groups and than c+td lambs
with access to analgesic in the first self administration study and in lambs used in the
first neurohistochemical study (chapters 6 and 9). Further, in both studies of self-
administration of analgesic, CD lambs consistently appeared to eat more than CN
lambs, indicating that analgesia reduced the effects of pain on appetite. However, on
analysis, no statistically significant differences in weight or food intake between c+td
and handled control lambs were found. It is considered that if differences occurred,
they were small in comparison with the degree of variation within groups. This result
is in accordance with that of Kent et al (2000).
10.2.2. Severity of lesions
The severity of c+td lesions reached a peak at between 3 and 4 weeks after
application of the RR in all the studies reported in this thesis. This is in accordance
with previous studies of the chronic effects of RR c+td (Kent et al, 1997; 1999;
2000). The severity of lesions recorded in the first of the self-administration studies
was similar to that previously recorded in four-week-old lambs (Kent et al, 1999).
However, in the neurohistochemical studies and in the second of the self-
administration studies, the lesions that developed as a result of RR c+td were not as
severe as those previously recorded in lambs of the same age (Kent et al, 1999;
2000). Despite these inconsistencies in lesion severity, the presence of inflammation
and infection was recorded in all castration lesions and inflammation was recorded in
all tail lesions.
In the first self-administration study, the severity of lesions in CD lambs was found
to be greater than that in CN lambs. Further analysis revealed that administration of
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the NSAID did not have a negative impact on healing, but that the slight, non¬
significant differences in weight between CD and CN lambs was sufficient to
produce a difference in lesion severity. This effect of size is important for the use of
RR c+td in the field, where particularly large lambs could be singled out for more
careful monitoring, and for treatment if required. It is proposed that good hygiene,
aided by the frequent provision of fresh bedding, may have limited the degree of
infection and therefore the severity of lesions in the second self-administration study
and in the two groups of lambs used in neurohistochemical studies. It is also
considered likely that the imposed change of breed, from Greyface x Suffolk to
Scottish Blackface lambs, influenced the severity of lesions.
Lesion severity is a factor that must be controlled for, if c+td lesions are to be used as
a model of chronic inflammatory pain. Controlled contamination of the rubber rings,
applied to lambs housed in clean-bedded pens, is considered likely to help
standardise the lesions, reduce variation and to allow the severity of the treatment to
be properly assessed for regulatory purposes.
10.2.3. Behavioural evidence ofchronic inflammatory pain.
In both self-administration studies, CN lambs showed a transient decline in the time
spent eating when the lesions reached peak in severity. The time CN lambs spent
eating then returned to normal as the lesions healed. Whilst this change was not
reflected in a change in DLWG, it is in accordance with the assertion that anorexia is
indicative of chronic pain (Kitchell and Johnson, 1985; Zimmerman, 1986). This
feeding pattern was not evident in CD lambs, showing that this change in eating
behaviour could be reduced or eliminated by the administration of analgesic. This
provides some evidence that the transient decrease in time spent eating by CN lambs
was caused by the presence of chronic inflammatory pain.
In contrast, the lambs c+td for neurohistochemical studies spent more time eating and
showed teat-seeking more frequently than controls. An increase in suckling may be
explained if related to studies in human infants and in rats which suggest that
suckling and the consumption of milk can reduce the perception of pain (Blass and
Watt, 1999; Mukherjee et al, 2001; Anseloni et al, 2002; Gray et al, 2002). This is
consistent with the findings ofWood (1991) who showed that routinely c+td lambs
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showed less teat-seeking than lambs receiving the opioid antagonist naloxone prior to
c+td.
The inconsistencies between the eating behaviour of lambs in the self-administration
studies and the neurohistochemical studies reported in this thesis are difficult to
explain. The only recorded difference in the treatment of lambs in the different
studies was the housing condition used. Lambs in neurohistochemical studies were
housed together, with their ewes, in a group whilst, in self-administration studies, the
lambs were housed singly with their ewes. It is possible that the influence of other
lambs in the group may have increased feeding motivation in c+td lambs. This
hypothesis is supported by the studies of Thornhallsdottir et al (1987), who found
that lambs housed in groups consistently ate more than those housed separately with
their ewes.
In all studies, c+td lambs showed more active behaviours than handled controls,
although the exact behaviours expressed varied between studies and few behaviours
showed consistent changes over time after the application of the rings. Differences in
the expression of active behaviour were most apparent in the second study of self-
administration. However, in neither self-administration study, was the expression of
active behaviour consistently affected by the consumption of analgesic creep feed.
Two explanations for this result are proposed. Firstly, active behaviour may be
indicative of the intermittent experience of uncontrollable pain, associated with
aggravation of the sensitised tissue at the site of the rings and which was not relieved
by the administration of FM. Secondly, the expression of active behaviour may not
be indicative of the experience of pain in association with chronic inflammatory
lesions, but is associated with transient irritation or discomfort that is unaffected by
NSAID treatment.
The expression of abnormal postures was most apparent in the second self-
administration study and this behaviour was affected by the administration of FM.
The postures adopted by CD lambs were indistinguishable from those shown by
handled control lambs. In contrast, CN lambs spent consistently more time in
abnormal postures, a difference that was significant on three occasions and was
directly related to the severity of the chronic inflammatory lesions. It has been
suggested that subtle changes in posture can reduce the experience of pain by
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minimising aggravation of sensitised tissues (Molony et al, 1993). These postural
changes may therefore be indicative of the experience of pain over which the lambs
have some control. However, their experience of pain may still be severe (Molony et
al, 1993). This evidence supports the conclusion that the expression of abnormal
postures is directly related to the experience of chronic inflammatory pain in RR c+td
lambs.
10.2.4. Evidence ofself-administration?
Investigation of the pharmacokinetics of FM after oral administration in 6 week-old
lambs (reported in Chapter 3) indicated that, at a dose of lmg/kg, the reached a
concentration in the blood, sufficient to inhibit prostaglandins, within 30 minutes of
administration and probably sooner. Previous studies of feed selection have shown
that lambs are able to learn associations between positive and negative experiences
and the consumption of novel feeds, even with a delay between feed consumption
and perception of consequences of up to eight hours (Burritt and Provenza, 1991;
Arsenos et al, 2000). It is therefore supposed that the delay between consumption of
analgesic feed and the positive pain relieving consequences of its consumption
should not represent a barrier to learning the association. In the first study of self-
administration of analgesic, a higher plasma concentration of FM was found in CD
lambs during the first 3 weeks of preference testing. This difference was significant
only on the first week of choice, but coincided with the occurrence of a significant
association between the width of the lesions and the plasma concentration of FM in
these lambs. The plasma concentration of FM consistently declined from the first
week of testing onwards and did not follow the changing severity of chronic
inflammatory lesions. This result suggests that the severity of the experience of
chronic inflammatory pain peaks before the lesions reach their maximum severity
score. As changes in the expression of abnormal behaviour appeared to be positively
associated with the changing severity of lesions, it must either be concluded that
behavioural assessment of chronic inflammatory pain is invalid or that something
other than the decline in the experience of pain was responsible for the decline in the
plasma concentration of FM in CD lambs. Several confounding factors were
identified that could have resulted in a decline in self-administration of FM despite
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continuing experience of chronic inflammatory pain. These included; i) the feeding
schedule which encouraged over-consumption of feed on the first day of choice and
may have resulted in aversion to the test feeds, ii) the possibility of aversion as a
result of adverse gastro-intestinal effects of long term administration of the NSAID
and iii) the possibility that lambs were unable to remember what they learned during
training if, for example, they ate too little analgesic to reinforce their preference each
time they consumed some analgesic feed. Analysis of (total) protein in plasma
suggested that adverse gastrointestinal effects of NSAID administration were not a
factor.
In the second experiment, the confounding influence of the feeding regime and the
single training session were eliminated by separating test feeding from nutritive
feeding and by introducing a cycle which incorporated training days and testing days
throughout the study. In this study of self-administration, CD lambs overcame food
neophobia more quickly than HD lambs, consuming more of the analgesic feed more
quickly than HD lambs. Again there was no significant difference in the quantity of
feed consumed from the 'analgesic' hopper between groups. However, the plasma
concentration of FM increased more quickly in CD lambs, reaching a peak that
coincided with maximum lesion severity (34 days after c+td) and showing a decline
which coincided with declining lesion severity. The difference in plasma
concentration of FM in CD and HD lambs approached significance on day 34
(.P=0.088). Thus, although the differences were consistent with the suggestion that
the lambs learned to self-administer FM to relieve chronic inflammatory pain from
castration and tail-docking lesions, these differences were not statistically significant
at P<0.05.
10.2.5. Neurohistochemical evidence ofchronic inflammatory pain?
In-situ hybridisation histochemistry to seek changes in the expression of AVP and
CRH mRNAs in the pPVN, consistent with the presence of chronic inflammatory
pain, showed no evidence of an effect of c+td. There were no differences in the
number of cells expressing AVP and CRH mRNA, the density of their expression, or
in the ratio of AVP: CRH expressing cells between c+td and handled control lambs.
Paradoxically, in the study of the neurohistochemical effects of tail-docking, the
258
Chapter 10.
density of expression of AVP mRNA was significantly higher in lambs that had not
been tail-docked than in their tail-docked siblings.
The results suggest that either; i) lambs do not experience chronic inflammatory pain
as a result of RR c+td, ii) that their experience of pain as a result of RR c+td is
insufficient to result in changes in the rate of synthesis of AVP or CRH or iii) that the
HPA axis of the lamb responds differently in response to chronic inflammatory pain
to that of the rat (Harbuz et al, 1992; Chowdrey et al, 1995). Evidence of significant
species differences in the control of the HPA axis in response to acute stress already
exists in rats, mice and sheep (Familiari et al, 1989, Liu et al, 1990, Whitnall et al,
1992).
10.3. Do lambs experience chronic inflammatory pain from rubber ring castration
and tail-docking?
Evidence of chronic inflammatory pain as a result of RR c+td from self-
administration and neurohistochemical studies is limited. It is therefore considered
insufficient to validate the use of measures of changes in behaviour and of lesion
severity for the recognition and assessment of chronic inflammatory pain. On the
basis of this evidence, it might be concluded that the degree of inflammation and
tissue damage is not directly associated with the experience of pain. Similarly, the
changing expression of abnormal behaviours associated with the formation and
healing of these lesions could be associated with the experience of mild discomfort
or irritation or transient experiences of recurrent acute pain. However, this
conclusion would be in conflict with studies of acute pain resulting from RR c+td, in
which a reliable relationship between the degree of tissue damage caused by the RR
and the magnitude of the quantified behavioural response was found (Molony et al,
2002). It is noted that exact parallels between the experience of acute pain and
putative chronic inflammatory pain from RR c+td cannot be drawn, because of
differences in the peripheral and central mechanisms involved in these two pain
states.
It is proposed that the presence of a relationship between the magnitude of the
behavioural change and the severity of lesions is indicative of chronic inflammatory
pain, the significance of which remains to be determined. This suggestion is
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supported by the fact that the administration of the NSAID (FM) eliminated the
expression of abnormal postures and the reduced motivation to eat. If this is the case,
the self-administration paradigm and neurohistochemical investigation, used to
confirm the interpretation of these indices were either ineffective or inappropriate.
In the case of neurohistochemical studies it is possible that the response of the HPA
axis to chronic inflammatory pain is different in the sheep from that reported in the
rat. In the case of self-administration studies it is concluded that, either the studies
were not sufficiently well controlled or the lambs were unable to learn the
association between consuming the analgesic feed and the subsequent relief of pain.
This may either be because lambs do not have the cognitive capacity to learn the
association or because of unidentified problems with the design of the experiments.
The effects of chronic inflammatory pain on the synthesis of AVP and CRH in the
pPVN of sheep might be determined using alternative models of chronic
inflammatory pain, including chronic administration of carrageenan, experimentally
induced arthritis and experimentally induced foot rot. Further evidence of HPA
activation at the level of the median eminence, HPB, anterior pituitary and the
adrenal gland should also be sought to support the results. Several changes to the
self-administration protocol that are considered likely to reduce variation were
proposed. These include; separation of the actual administration of the analgesic
from the consumption of feed, thus reducing variation in the dose of analgesic
administered, the use of twin lambs to minimise variation in feed intake and the
controlled contamination of rubber rings in order to standardise lesion severity.
A final conclusion that could be drawn from the results of these studies combines
ideas from previous conclusions. It is possible that RR c+td lambs experience some
degree of chronic inflammatory pain in association with chronic inflammatory
lesions, but below a certain threshold of nociceptive activity, lambs are able to
control the pain by adopting changes in posture and through activation of local
endogenous analgesic mechanisms, thus avoiding the need for activation of the
pPVN or other central mechanisms. In inflamed tissue, CRH is thought to stimulate
immune cells, enhancing their release of immune mediators (Karalis et al, 1991) and
to stimulate the release of ACTH and p-endorphin from leucocytes (Karalis et al,
1991; Cabot et al, 1997). ACTH and P-endorphin have anti-inflammatory and anti-
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nociceptive function. These mediators are not necessarily found simultaneously in
surrounding tissue or in general circulation (Hargreaves et al, 1989; Karalis et al,
1991). Thus, no changes in the central control of the chronically stimulated HPA axis
would necessarily be apparent and the experience of pain may be insufficient to
enable lambs to discriminate any beneficial effect of consuming analgesic food. This
hypothesis could be tested by determining whether the local or systemic
administration of CRH antagonists (Jezova et al, 1998), naloxone or other
antagonists to inhibit endogenous anti-nociceptive systems, are accompanied by
increases in the expression of abnormal behaviours.
10.4 Conclusions and implicationsfor animal welfare
The studies reported in this thesis further support the relationship between
assessments of lesion severity and quantified changes in behaviour that have been
associated with acute pain. The validity of the use of subtle changes in posture
(including extension of the hind legs during ventral lying and statue standing) and
changes in feeding motivation to quantify chronic inflammatory pain was supported
as the consumption of analgesic creep feed resulted in elimination of the abnormal
expression of these behaviours. Some evidence that c+td lambs select more analgesic
feed was also present in these studies, although the responses were not reliable
within and between individuals.
No evidence was found of changes in the control of the HPA axis that are
characteristic of chronic inflammatory pain in rats, but it is considered possible that
this is a reflection of species differences in the control of the chronically activated
HPA axis. Definitive evidence of the experience of chronic inflammatory pain was
not provided by either the self-administration paradigm or the neurohistochemical
studies. The use of changes in behaviour to assess chronic inflammatory pain must
still be validated, but it is proposed that the incidence of abnormal lying and changes
in feeding motivation are reliably associated with the severity of chronic
inflammatory pain. The results of these studies also indicate that flunixin meglumine,
administered orally to lambs at a dose of lmg/kg, effectively reduces inflammation
and the associated experience of chronic inflammatory pain without evidence
gastrointestinal toxicity following long-term administration.
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From the perspective of the welfare of commercially reared lambs, these results
should be considered important. The evidence supports the assertion that chronic
inflammatory lesions from RR c+td are painful, a conclusion that can be used to
oppose of the use of RRs commercially in older lambs, as suggested by FAWC
(1994), particularly as the need for c+td is subject to debate.
The potential use of RR c+td lesions as a model of chronic inflammatory pain was
demonstrated in self-administration studies, where administration of FM reduced the
expression of abnormal behaviour. The c+td of lambs by RR reliably produces
chronic inflammatory lesions that form and heal over a period of 6-7 weeks, with a
peak in severity at 3-4 weeks after ring application. If a reliable association between
the severity of chronic inflammatory pain, the severity of chronic inflammatory
lesions and changes in the expression of 'pain' behaviours could be established, RR
c+td lesions in male lambs might provide a useful, ethically more acceptable and
inexpensive model in which to test the therapeutic effects of anti-inflammatory
agents and analgesics for use in sheep, for studies of antinociceptive mechanisms and
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15-keto-l3,14-dihydro Prostaglandin F2XEIA Protocol
Preparation ofsolutions
All water used in preparations of all EIA reagents and buffers must be 'Ultrapure'
i.e. free from all trace organic contaminants. Activated carbon fdter cartridges or
other organic scavengers should be used.
Solution preparations are described in appendix B.
Methodfor EIA for 13,14-dihydro, 15-keto prostaglandin F2a
Precautions
As many of the chemicals used in this procedure are volatile, highly flammable and
irritant on inhalation it is recommended that the whole procedure be carried out in a
fume cupboard. Latex rubber gloves and a lab coat should also be used at all times.
Following evaporation of methyl and ethyl acetate in the vacuum desiccator the
vacuum should only be released within the fume cupboard so that any vapour is not
inhaled.
Procedure
1. Remove required plasma samples from the freezer and leave to thaw at room
temperature.
2. Take one lOpl aliquot of prostaglandin out of the freezer and pulse
microfuge to gather all the solution into the bottom of the Eppendorf.
3. Remove lid and place in tube rack in vacuum desiccator. Desiccate for
approx. 1 hour until all methyl acetate has evaporated.
4. Meanwhile begin purification of the plasma samples. Samples should be
divided between two columns to ensure that columns are purifying the sample
with sufficient repeatability.
5. Acidify the sample for purification by adding 50pl of concentrated
hydrochloric acid per ml of plasma. Leave to sit at 4°C for 15 mins.
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6. Microfuge for 2 mins at 3000rpm to remove any precipitate. Pour off the
supernatant into a fresh Eppendorf, use a dropping pipette if necessary to
ensure all of the sample is taken.
7. Prepare the CI8 reverse phase column by washing with 2ml ethanol followed
by 2ml UHP water. Apply 500pl at a time and then use the adapter and 5ml
syringe to gently push the liquid through the column (should take approx. 30
sees to push through each aliquot) Allow the liquid coming through the
column to drip into a trough marked waste.
8. Apply 500pl of acidified sample to the column. Allow the sample to drip
through the column without pressure. Allow the liquid coming through the
column to drip into the waste beaker.
9. Wash the column with 2ml UHP water, 2ml ethanol, 2ml hexane in aliquots
as before using the adapter and syringe to apply gentle pressure as before.
Again allow the washes to drip through into the 'waste' beaker.
10. Elute the sample using 1.5ml of ethyl acetate in two 500pl lots. Apply the
first 500pl and allow to drip through the column into a fresh Eppendorf, this
should take about 5 mins. The second 500pl of ethyl acetate can then be
applied. This should be pushed gently through the column as before using
pressure from the syringe taking approx. 30 sees.
11. Dispose of columns and any waste from plasma samples in a clinical waste
bag (including columns). The contents of the 'waste' beaker can be
evaporated off in the fume cupboard over night.
12. Samples should be analysed at 2 dilutions initially to ensure that the
concentrations fall within the standard curve and can be calculated. Once the
range of concentrations of PG in plasma have been determined, only the
appropriate dilution should be necessary.
13. Take the vacuum desiccator, still under vacuum, to the fume cupboard and
release the vacuum, thus allowing fumes to disperse safely.
14. Dilutions of the PG can now be carried out to produce a standard curve for
assay. Care must be taken during these dilutions that the measurement of each
quantity is absolutely accurate or the concentrations calculated during the
assay will not be reliable.
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15. Reconstitute the PG using 1ml of EIA buffer to make a stock solution of
lOOpg/ml. Pulse microfuge and then whirlimix to ensure proper dissolution.
16. Dilute a 1 pi sample of the stock solution to lpg/ml by whirlimixing with
99pl EIA buffer.
17. From the lpg/ml solution prepare a lng/ml solution by whirlimixing a lpl
sample with 999pl EIA buffer.
18. The standard curve should have eight point made by serial 1:1 dilutions from
the lng/ml PG solution with EIA buffer.
19. Pipette 500pl of the lng/ml solution into a clean Eppendorf and mix with
500pl of EIA buffer. Whirlimix to ensure proper mixing. This will provide
the next point on the curve at a concentration of 500pg/ml.
20. Pipette 500pl of this solution into a clean Eppendorf and mix with 500pl of
EIA buffer. Whirlimix to ensure proper mixing. This will provide the next
point on the curve at a concentration of 250pg/ml.
21. Repeat step 20 until all eight concentrations for the standard curve have been
prepared.
22. PG solutions in EIA buffer should be stored on ice and used within 12hrs or
frozen immediately, as PGs and used within a few months are not stable
within aqueous buffers.
23. Meanwhile evaporate off the ethyl acetate from the samples in the vacuum
dissector
24. Once fully evaporated, reconstitute in lOpl of ethanol and 490pl EIA buffer.
25. Assay samples at two dilutions to ensure that the concentration of PG lies
within the concentration of the standard curve. (Assay at full concentration as
above and at half this concentration ie take 250pl and dilute to 500pl using
EIA buffer.)
26. The pre-coated plates may now be prepared for incubation. Take the required
number of plates from the freezer and allow them to come up to room
temperature.
27. Wash the plate using 250pl of pre-prepared wash buffer (see preparation




1 2 3 4
A Blank S1 S5 ★
B Blank S1 S5 *
C NSB S2 S6 k
D NSB S2 S6 k
E Bo S3 S7 k
F Bo S3 S7 k
G TA S4 S8 k
H TA S4 S8 k
NSB- Non-specific binding, Bo- Maximum binding, TA-Total activity, S1-S8-
standards 1-8, *-sample
28. Add lOOpl EIA buffer to NSB wells and 50pl EIA buffer to maximum
binding wells.
29. Add 50pl of standard, in duplicate and in increasing order of concentration to
each of the standard wells.
30. Add 50pl of each sample at two dilutions and in duplicate to each of the
sample wells. After the first plate has been read it will become obvious that
diluted or undiluted sample falls best within the curve and from this point on
only one dilution may be required.
31. Add 50pl of tracer to each well except the TA and Blank wells.
32. Add 50pl of antiserum to each well except the TA, NSB and Blank wells.
33. Cover the plate and incubate at 4°C for between 18 and 24 hours
34. When ready to develop the plate reconstitute sufficient vials of Ellman's
reagent (see separate protocol). Once reconstituted Ellman's reagent should
protected from light and should be used within 24 hours.
35. Empty the plate by inverting and shaking or tapping out the contents of the
wells.
36. Wash the wells 5 times using 250pl of wash buffer per well.
37. Ensure all wash buffer is removed from wells.
38. Add 200pl ofEllman's reagent to each well.
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39. Add 5p,l of tracer to the TA wells
40. Cover the plate and incubate at 4°C for 90 mins
41. When the incubation time is up ensure that the bottom of the plate is clean by
wiping with a tissue.
42. The plate should then be read at 405-420nm using an endpoint programme,





Preparations for EIA for 15-keto-13,14-dihydro PGF2a in sheep plasma.
Products required, Storage and Stability.
Product Supplier/Cat No: State Temp Stability
Ellman's Reagent Alexis Corp/Cayman Cat
No: 400050
lyophilised -20°C 1 year





unopened -20°C 1 year





concentrate 4°C 1 year
diluted 4°C 1 month
Wash Buffer Alexis Corp/Cayman Cat
No: 400062
concentrate 4°C 2 years
Diluted 4°C 1 month









lyophilised -20°C 1 year












methyl acetate -20°C 2 years
Diluted water -20°C 12 hours





Water used to prepare all EIA reagents and buffers must be de-ionised and free from
all trace contaminants, (UHP grade).
B. Ellman's Reagent- preparation from lyophilised reagent
(Alexis Corporation/ Cayman Chemical catalogue No: 400050)
Arrives lyophilised and needs to be reconstituted.
Reconstituted reagent should be protected from light.
Vials supplied containing 100 or 250 determinations (dtn).
100 dtn vial should be reconstituted using 20ml ofUHP water.






1. Take the lyophilised Ellman's reagent vials from freezer and allow to come up to
room temperature.
2. Measure required volume ofUHP water (for lOOdtn vial add 20ml UHP H2O, for
250dtn vial add 50ml UHP H20) in measuring cylinder and add to vial.
3. Leave vial for 2-3 ins before whirlimixing for a few seconds to reconstitute.
4. Store at 4°C and use within 24 hours.
C. EIA Buffer - Preparation from concentrated EIA Buffer
(Alexis Corporation/ Cayman Chemical catalogue No: 400060)
Requirements







1. Pour contents ofEIA buffer vial into 100ml volumetric flask using the funnel.
2. Rinse the vial with a small volume ofUHP H2O and pour washings into the
volumetric flask.
3. Make volume up to 100ml mark including washing from the funnel.
4. Invert flask several times to mix.
5. Store at 4°C until use.
E. Tween20 - preparation from concentrated Tween20 solution.







1 litre volumetric flasks x2
1 litre conical flask x2
1 litre beaker x2





1. Prepare a 1.0M phosphate buffer solution by combining 133g K2HPO4 and
32.15g KH2PO4 in the beaker
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2. Add approx. 800ml UHP H2O and set on the magnetic hotplate stirrer (if the
phosphates are slow to dissolve heat the solution up to 40°C) until the phosphates
have completely dissolved.
3. Decant into the volumetric flask using the funnel and make up to the 1 litre mark
including washings from the beaker and funnel.
4. Put the lid on the flask and invert several times to mix the solution.
5. Decant this solution into a conical flask and cover.
6. In a beaker combine 0.5ml (measured using 1ml syringe) of Tween20 with 10ml
of the pre-prepared phosphate buffer.
7. Dilute this solution with 500ml ofUHP H20 and set to mix on the magnetic
stirrer for 10 mins
8. Decant into a volumetric flask.
9. Make the solution up to the 1 litre mark with UHP H20 to include the washings
from the beaker and funnel.
10. Stopper the flask and invert several times to thoroughly mix the solution.
11. Decant into a 1 litre conical flask and cover.
D. Wash Buffer - preparation from concentrated wash buffer
(Alexis Corporation/ Cayman Chemical catalogue No: 400062)
Requirements












1. Using the 1OOOpl Gilson take a 2.5ml sample of wash buffer concentrate and
decant into the beaker.
2. Using the syringe measure 0.5ml the diluted solution of Tween20 and deposit
that into the beaker.
3. Decant into a volumetric flask
4. Make this mixture up to 1L with UHP H20 including washings from the beaker.
5. Invert the volumetric flask several time to mix the solution using parafilm to
cover the top.
Decant into the conical flask, cover and store at 4°C before use.
15-keto-13,14-dihydro PGF2a Acetylcholinesterase EIA Tracer - Reconstitution
(Alexis Corporation/ Cayman Chemical catalogue No: 416670)
Requirements
lOOdtn or 500dtn vial of lyophilised 15-keto-13,14-dihydro PGF2a AChE EIA
Tracer
EIA buffer (see protocol for dilution of concentrate above)
Whirlimixer
10ml syringe and needle
Procedure
1. Add 6ml to lOOdtn vial (or 30ml for 500dtns) EIA buffer to the vial using the
syringe and needle and leave to stand for 2-3 mins
2. Whirlimix the solution to ensure proper reconstitution
3. Store at 4°C until use
4. Whirlimix before use
15-keto-13,14-dihydro PGF2a EIA Antiserum - Reconstitution
(Alexis Corporation/ Cayman Chemical catalogue No: 416672)
Requirements








1. Add 6ml to 1 OOdtn vial (or 30ml for 500dtns) EIA buffer to the vial using the
needle and syringe and leave to stand for 2-3 mins
2. Whirlimix the solution to ensure proper reconstitution
3. Store at 4°C until use
4. Whirlimix before use
Standard Curve using 15-keto-13,14-dihydro PGF2a
(Alexis Corporation/ Cayman Chemical catalogue No: 16670)
Requirements
EIA buffer
15-keto-13,14-dihydro PGF2a lmg/100pl in methyl acetate
Access to a fume cupboard
1.5ml snap top Eppendorfs





1. Aliquot contents of vial of 15-keto-13,14-dihydro PGF2a in lOpl lots into 1.5ml
snap top Eppendorfs
2. Return excess Eppendorfs to the freezer for future use
3. Place one aliquot into vacuum desiccator and desiccate for 1 hour
4. Take the vacuum desiccator, still under vacuum, to the fume cupboard and
release the vacuum.
5. Dilutions of the PG can now be carried out to produce a standard curve for assay.
Care must be taken during these dilutions that all measuring of samples is
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absolutely accurate 01 the concentrations calculated during the assay will not be
reliable.
6. Reconstitute the PG using 1ml of EIA buffer to make a stock solution of
lOOpg/ml. Pulse microfuge and then whirlimix to ensure proper dissolution.
7. Dilute a 1 pi sample of the stock solution to lpg/ml by whirlimixing with 99pl
EIA buffer.
8. From the lpg/ml solution prepare a lng/ml solution by whirlimixing a lpl
sample with 999pl EIA buffer.
9. The standard curve should have eight point made by serial 1:1 dilutions from the
lng/ml PG solution with EIA buffer.
10. Pipette 500pl of the lng/ml solution into a clean Eppendorf and mix with 500pl
of EIA buffer. Whirlimix to ensure proper mixing. This will provide the next
point on the curve at a concentration of 500pg/ml.
11. Pipette 500pl of this solution into a clean Eppendorf and mix with 500pl of EIA
buffer. Whirlimix to ensure proper mixing. This will provide the next point on
the curve at a concentration of 250pg/ml.
12. Repeat step 11 until all eight concentrations for the standard curve have been
prepared.
13. All PG solutions in EIA buffer should be stored on ice and used within 12hrs as





Functions of components of in situ protocol.
Component Function
Prehybridisation incubation Facilitates penetration of hybridisation buffer into the tissues, optimising
blocking of non-specific binding sites before the probe is added to the buffer.
Hybridisation incubation Facilitates hybridisation of the denatured probe to the target mRNA.
J5S-adenosine triphosphate
(36SdATP)
Radioactive nucleotide that will bind to oligonucleotide probe.
terminal deoxynucleotidyl
transferase (TdT)
A DNA polymerase that catalyses the tailing of the radioactive nucleoide to
the 3'-OH terminal of an oligonucleotide probe
EDTA Deactivates Mg^+ ions that activate nucleases, thereby stopping the tailing
reaction when required. Also acts as a buffer to provide a suitable
environment for hybridisation
NaCI A buffer ingredient for hybridisation, stabilises pH without affecting
stringency
Tris HCI A buffer ingredient for hybridisation, stabilises pH without affecting
stringency
Ficoll A non-ionic polymer of sucrose, increases the volume and the effective
concentration of the probe without effecting ionic balance of hybridisation
buffer. May also bind impurities.
PVP Increases the volume and the effective concentration of the probe. May also
bind impurities.
BSA Protein used to out-compete non-specific binding of the probe to protein.
Salmon sperm DNA Used to out-compete binding of the probe to proteins and other non-specific
DNA binding sites.
Glycogen Large polymer to deter non-specific binding.
Yeast tRNA Used to out-compete binding of the probe to non-specific RNA binding sites.
Dextran sulphate Increases the volume of hybridisation mixture without diluting the probe,
increasing the effective probe concentration allowing effective coverage
without excessive use of probe.
Formamide Denatures the oligonucleotide allowing hybridisation at lower temperatures.
Can be used to increase stringency of washes to remove non-specific
binding but this is unnecessary for oligonucleotide probes.
Paraformaldehyde Mild protein cross-linking agent providing preservation suitable for light
microscopy, but also allowing penetration of probe.
SSC Used as a buffer controlling the ionic concentration of washes, thus
controlling stringency. Decreasing concentration of SSC increases the
stringency of the wash therefore reducing non-specific binding of the probe.
37°C Temperature of washes also important, any change in temperature has a
large effect on stringency. Any significant increase in temperature during





Photographic images of the chronic inflammatory lesion caused by rubber ring
castration in a representative lamb.
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